rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTGGGACGGATGTGAGTGGGGCTACACCTTCGGTTCG	CASSWDGCEWGYTF	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-02	01	3	0	7	8	0	12	19	-1	37	32	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDGCEWGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCTCACAGGTTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	85	9.200309130386781E-5		40	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	4	17	3	17	19	32	40	35	57														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCAAGGGGGGGGCAGCCCCAACATTTTGGTGAT		Out	VDJ	1	104	1.1256848818355591E-4		40	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	9	0	16	5	10	19	31	43	36	53														X+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD02-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGTCAGAAGCTTACGGATCGGGAGGTACATGGCTACACCTTCGGTTCG		Out	VDJ	1	106	1.1473326680247044E-4		44	TCRBV07	TCRBV07-05	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	1	6	5	3	18	33	45	38	48														X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*02	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGGCAGGTATTTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	177	1.915829077739365E-4		40	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	4	3	0	9	19	-1	31	27	40														X+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGACGGCAGGGGCTACACCTTCGGTTCG	CASSEDGRGYTF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	36	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	8	4	0	23	39	-1	43	47														CASSEDGRGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAAGGCCCCCTCTTTGAAGCTTTCTTTGGACAA	CASSEEGPLFEAFF	In	VDJ	1	92	9.95798164700687E-5	1.1723389180840923E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	5	4	7	1	9	23	39	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEGPLFEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTGGTAGCGGGGGAGCAGAGACCCAGTACTTCGGGCCA	CASSEVGSGGAETQYF	In	VDJ	1	112	1.2122760265921406E-4	1.4271952046241123E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	5	2	4	4	3	23	39	52	43	55														CASSEVGSGGAETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCGAAGGGGGGGGAGAGGCTTTCTTTGGACAA	CASSEAEGGGEAFF	In	VDJ	1	204	2.2080741912928274E-4	2.599534122708205E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	11	4	5	23	40	51	44	56														CASSEAEGGGEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTCCGGGGTAGCTATGGCTACACCTTCGGTTCG	CASSEVRGSYGYTF	In	VDJ	1	240	2.597734342697444E-4	3.058275438480241E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	3	4	2	3	23	39	46	41	49														CASSEVRGSYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGTGNTGELFF	In	VDJ	1	241	2.608558235792017E-4	3.071018252807242E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	4	1	0	0	23	-1	-1	39	46														CASSEGTGNTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSEAGMNTEAFF	In	VDJ	1	246	2.66267770126488E-4	3.134732324442247E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	0	5	4	0	0	2	23	-1	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAGMNTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTAGCGGGGGGGTTTACAATGAGCAGTTCTTCGGGCCA	CASSEASGGVYNEQFF	In	VDJ	1	266	2.879155563156334E-4	3.3895886109822673E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	4	0	2	23	-1	51	40	53														CASSEASGGVYNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGAGGAACCTTAACTATGGCTACACCTTCGGTTCG	CASSEARNLNYGYTF	In	VDJ	1	311	3.366230752412105E-4	3.9630152556973124E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	1	1	0	5	23	-1	44	40	49														CASSEARNLNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGTGGGGATAGACACTGAAGCTTTCTTTGGACAA	CASSEGVGIDTEAFF	In	VDJ	1	312	3.3770546455066773E-4	3.9757580700243135E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	0	8	3	5	3	23	39	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGVGIDTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGACAGGGTCAAATCAGCCCCAGCATTTTGGTGAT	CASSEETGSNQPQHF	In	VDJ	1	322	3.485293576452404E-4	4.1031862132943236E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	3	4	1	3	23	39	47	40	50														CASSEETGSNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGACTAGGGTCAGCAATGAGCAGTTCTTCGGGCCA	CASSEGTRVSNEQFF	In	VDJ	1	353	3.8208342623841573E-4	4.4982134574313544E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	8	6	0	6	23	-1	46	39	52						01,02								CASSEGTRVSNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGAGACGCTAGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGETLVSGANVLTF	In	VDJ	2	396	4.286261665450783E-4	5.046154473492397E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	9	2	0	0	8	23	-1	44	39	52														CASSEGETLVSGANVLTF+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCACCAGGGGCAAATCAGCCCCAGCATTTTGGTGAT	CASSEAPGANQPQHF	In	VDJ	3	806	8.724057834225583E-4	0.001027070834756281	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	4	2	2	23	40	48	42	50														CASSEAPGANQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCCGGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASSEAPGQNQPQHF	In	VDJ	4	966	0.0010455880729357211	0.001230955863988297	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-05	01	0	8	0	4	4	2	23	40	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAPGQNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCCTCCCACTTCTTAATGAGCAGTTCTTCGGGCCA	CASSEALPLLNEQFF	In	VDJ	5	1279	0.0013843759267958462	0.0016298059524234283	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	10	7	6	4	23	40	49	46	53						01,02								CASSEALPLLNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGCCCCAGGGATCTATGGCTACACCTTCGGTTCG	CASSLAPGIYGYTF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	42	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	4	2	2	22	39	46	41	48														CASSLAPGIYGYTF+TCRBV07-04+TCRBJ01-02	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCATTAAGGTTAGGGTGCTACGGGTACGAGCAGTACTTCGGGCCG	CASSSLRLGCYGYEQYF	In	VDJ	1	109	1.1798043473084225E-4	1.3889667616431094E-4	51	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-07	01	4	5	3	4	10	9	22	35	49	45	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLRLGCYGYEQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGAGCGGGGGCCATAGATACGCAGTATTTTGGCCCA	CAWSRAGAIDTQYF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	2	5	2	4	26	38	48	40	52			unresolved										Vb 20	CAWSRAGAIDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGTTAAAGGGGAATGAAAAACTGTTTTTTGGCAGT	CAWSVLKGNEKLFF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	5	5	0	26	40	-1	45	50			unresolved										Vb 20	CAWSVLKGNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGCAAGCCACGTTTGGTGCTTCTCAGTGACTCTGGCTTTATCTCTGTGCCTGGACGGCGGCAGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	81	8.767353406603873E-5		35	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	21	4	2	6	22	0	46	39	-1	61	67													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGGTGGTAGGCAAAAACATTCAGTACTTCGGCGCC	CAWSVRVVGKNIQYF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-04	01	0	5	3	3	1	7	26	40	45	41	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVRVVGKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*02		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGATTCAAATGAGCAGTTCTTCGGGCCA	CAWSVDSNEQFF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	0	2	8	7	1	4	26	40	43	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCCGAGGCGGGATCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWGRGGITNTGELFF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	3	0	7	3	26	35	48	42	51													Vb 20	CAWGRGGITNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGGACAGGGGTGGGTCACTGAAGCTTTCTTTGGACAA	CAWTGQGWVTEAFF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	4	2	5	26	36	47	38	52													Vb 20	CAWTGQGWVTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGCCGAGGCCGGGGAGCTGTTTTTTGGAGAA	CAWGAEAGELFF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	7	0	6	0	5	26	-1	40	35	45													Vb 20	CAWGAEAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ACGTTTGGTGCTTCTCAGTGACTCTGGCTTCTTCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	103	1.1148609887409864E-4		44	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	19	10	2	0	11	12	37	32	47	43	59													Vb 20	X+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGACGGCCTTTGGGGGGAGACCCAGTACTTCGGGCCA	CAWNDGLWGETQYF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	4	6	1	5	12	0	26	36	-1	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNDGLWGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGACCCTGGCAGAGACAGATACGCAGTATTTTGGCCCA	CAWKTLAETDTQYF	In	VDJ	1	111	1.2014521334975679E-4	1.4144523902971114E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	4	2	7	3	1	10	26	36	40	37	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKTLAETDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACGCTCGGGGGGCTCACTGAAGCTTTCTTTGGACAA	CAWRTLGGLTEAFF	In	VDJ	1	114	1.233923812781286E-4	1.4526808332781144E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	4	6	2	26	37	50	43	52			unresolved										Vb 20	CAWRTLGGLTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGCAAGCCACGTTTGGTGCTTCTCAGTGACTCTGGCTCTATCTCTGTGCCTGGACGGCGGCAGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	116	1.2555715989704313E-4		35	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	22	4	2	6	23	0	46	38	-1	61	67													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGGGGGCTTAGGCACTGAAGCTTTCTTTGGACAA	CAWAGGLGTEAFF	In	VDJ	1	132	1.4287538884835943E-4	1.6820514911641325E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	1	4	0	6	26	-1	43	35	49			unresolved										Vb 20	CAWAGGLGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGTTCCAAGAGACCCAGTACTTCGGGCCA	CAWRFQETQYF	In	VJ	1	132	1.4287538884835943E-4	1.6820514911641325E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	3	0	0	1	0	3	26	-1	37	-1	40													Vb 20	CAWRFQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ACGTTTGGTGCTTCTCAGTGACTCTGGCTTTATCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	136	1.4720494608618849E-4		44	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	21	10	2	0	13	12	37	30	47	43	59			01,02										Vb 20	X+TCRBV30-01+TCRBJ02-04	TCRBV30-01	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGTCACGTGGACAGAGGATCTACAATGAGCAGTTCTTCGGGCCA	CAWSLSRGQRIYNEQFF	In	VDJ	1	138	1.4936972470510303E-4	1.7585083771261387E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	5	3	9	5	26	38	53	47	58													Vb 20	CAWSLSRGQRIYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACACAGGCCTACGAGCAGTACTTCGGGCCG	CAWTQAYEQYF	In	VDJ	1	155	1.677703429658766E-4	1.9751362206851556E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	4	2	1	0	26	36	-1	37	42			unresolved										Vb 20	CAWTQAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCGGGGTCTCCGGGGATACGCAGTATTTTGGCCCA	CAWSVRGVSGDTQYF	In	VDJ	1	156	1.6885273227533386E-4	1.9878790350121568E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	6	2	8	26	40	48	42	56			unresolved										Vb 20	CAWSVRGVSGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGTCAGGGTGGACAGATACGCAGTATTTTGGCCCA	CAWRSGWTDTQYF	In	VDJ	1	160	1.7318228951316292E-4	2.0388502923201606E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	3	2	3	26	37	44	39	47													Vb 20	CAWRSGWTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ACGTTTGGTGCTTCTCAGTGACTCTGGCTCTATCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSVSDLAKNIQYF	In	VDJ	1	178	1.9266529708339376E-4	2.2682209502061787E-4	45	TCRBV30	TCRBV30-01					TCRBJ02	TCRBJ02-04	01	0	2	8	0	4	3	36	50	56	54	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSDLAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGATGACTACAATGAGCAGTTCTTCGGGCCA	CAWSDDYNEQFF	In	VDJ	1	180	1.948300757023083E-4	2.2937065788601808E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	3	2	8	3	1	3	26	37	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSDDYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTACCGGGAGACCCTCAGTGGCTACACCTTCGGTTCG	CAYRETLSGYTF	In	VDJ	1	184	1.991596329401374E-4	2.3446778361681846E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	8	2	7	2	8	26	33	41	35	49			unresolved										Vb 20	CAYRETLSGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACAGGGAACAGCTATGGCTACACCTTCGGTTCG	CAWGTGNSYGYTF	In	VDJ	1	196	2.121483046536246E-4	2.497591608092197E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	0	5	26	-1	44	35	49			unresolved										Vb 20	CAWGTGNSYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGGGACCTTAATGAAAAACTGTTTTTTGGCAGT	CAGDLNEKLFF	In	VDJ	1	221	2.392080373900563E-4	2.8161619662672217E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	8	0	7	4	1	2	26	32	38	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAGDLNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGACTCGAATGAGCAGTTCTTCGGGCCA	CAWSPDSNEQFF	In	VDJ	1	224	2.4245520531842812E-4	2.8543904092482247E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	10	7	2	2	26	38	45	40	47						01,02							Vb 20	CAWSPDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGTTAGGGACAGCAAGCACAGATACGCAGTATTTTGGCCCA	CAWGLGTASTDTQYF	In	VDJ	1	234	2.532790984130008E-4	2.981818552518235E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	0	6	2	26	35	48	41	50													Vb 20	CAWGLGTASTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGCTAGCGGGGGTTTGGAGACCCAGTACTTCGGGCCA	CAWKASGGLETQYF	In	VDJ	1	250	2.705973273643171E-4	3.1857035817502513E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	5	3	4	26	36	49	39	53			unresolved										Vb 20	CAWKASGGLETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGGGACATTAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSPGDISNQPQHF	In	VDJ	1	260	2.8142122045888977E-4	3.313131725020261E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	6	0	4	1	26	38	48	42	49			unresolved										Vb 20	CAWSPGDISNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTTCACAAACACTGAAGCTTTCTTTGGACAA	CAWTFTNTEAFF	In	VDJ	1	284	3.0739856388586423E-4	3.618959268868285E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	6	2	5	0	26	36	-1	41	44			unresolved										Vb 20	CAWTFTNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTCCGGGACAGGGTCGTAACATTCAGTACTTCGGCGCC	CAWSAPGQGRNIQYF	In	VDJ	1	296	3.2038723559935144E-4	3.771873040792297E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	3	7	4	4	26	39	52	43	56													Vb 20	CAWSAPGQGRNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGGTACAGGGGGAAGGCACGCAGTATTTTGGCCCA	CAWEVQGEGTQYF	In	VDJ	1	319	3.452821897168686E-4	4.06495777031332E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	1	9	5	5	26	35	48	40	53													Vb 20	CAWEVQGEGTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGAGTGGGGAAGTACTGAAGCTTTCTTTGGACAA	CAWSVEWGSTEAFF	In	VDJ	1	358	3.8749537278570206E-4	4.56192752906636E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	5	6	3	26	40	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVEWGSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTGGACTAGCGGGGGGCCGGTTCGCCGAGGAGACCCAGTACTTCGGGCCA	CAWSPGLAGGRFAEETQYF	In	VDJ	1	361	3.9074254071407385E-4	4.6001559720473627E-4	57	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	1	1	5	3	13	24	36	53	39	66			01,02										Vb 20	CAWSPGLAGGRFAEETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAAAGGGGGGATCAGCCCCAGCATTTTGGTGAT	CAWRERGDQPQHF	In	VDJ	1	370	4.0048404449918927E-4	4.7148413009903716E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	3	5	1	5	4	1	26	37	47	41	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRERGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGGCCAGGATGAAAAACTGTTTTTTGGCAGT	CAWGGQDEKLFF	In	VDJ	2	399	4.3187333447345007E-4	5.0843829164734E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	6	0	6	0	4	26	-1	41	35	45			unresolved										Vb 20	CAWGGQDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCACAACACAGGCCATCAGCCCCAGCATTTTGGTGAT	CAWSHNTGHQPQHF	In	VDJ	2	414	4.481091741153091E-4	5.275525131378416E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	4	5	6	2	26	38	49	44	51			unresolved										Vb 20	CAWSHNTGHQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCAGGGGTTCCAGCCCCAGCATTTTGGTGAT	CAWSPQGFQPQHF	In	VDJ	2	427	4.6218023513825356E-4	5.441181717629429E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	7	3	3	26	38	47	41	50			unresolved										Vb 20	CAWSPQGFQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCGTGGATCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWIVDPNTGELFF	In	VDJ	2	468	5.065581968260016E-4	5.96363710503647E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	4	1	8	0	4	2	26	36	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIVDPNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGCAAAGGAGTAGGAGAGACCCAGTACTTCGGGCCA	CVCKGVGETQYF	In	VDJ	2	478	5.173820899205743E-4	6.09106524830648E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	2	4	4	4	26	34	42	38	46			unresolved										Vb 20	CVCKGVGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGGCGTCCAACTCTGGAAACACCATATATTTTGGAGAG	CALASNSGNTIYF	In	VDJ	2	495	5.357827081813478E-4	6.307693091865497E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	7	9	0	0	1	6	26	33	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CALASNSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGTCGCGGACAGGGAGAATTCACCCCTCCACTTTGGGAAC	CAWKVADRENSPLHF	In	VDJ	2	504	5.455242119664633E-4	6.422378420808506E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	3	7	7	2	26	36	51	43	53			unresolved										Vb 20	CAWKVADRENSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGCCGGACAGGGTCTGGAAACACCATATATTTTGGAGAG	CAWSSRTGSGNTIYF	In	VDJ	2	508	5.498537692042923E-4	6.47334967811651E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	3	1	4	0	26	38	-1	42	50			unresolved										Vb 20	CAWSSRTGSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGAGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CAWGRTVNTEAFF	In	VDJ	2	579	6.267034101757584E-4	7.378089495333581E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	5	1	5	0	4	0	26	35	-1	39	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGRTVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAACGTGATCGGGACAGGGAACCACGAGCAGTACTTCGGGCCG		Out	VDJ	3	664	7.187065014796262E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	5	9	4	26	34	52	43	56			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGACAGGGGGCTGTAGATACGCAGTATTTTGGCCCA	CAWSRQGAVDTQYF	In	VDJ	3	719	7.782379134997759E-4	9.162083501113722E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	0	5	1	3	26	38	49	39	52			unresolved										Vb 20	CAWSRQGAVDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGCCTACAGGGATACACTGAAGCTTTCTTTGGACAA	CAWRLQGYTEAFF	In	VDJ	3	724	7.836498600470623E-4	9.225797572748727E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	3	5	2	26	35	46	40	48			unresolved										Vb 20	CAWRLQGYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAAGAGGACAGACATCCCTACGAGCAGTACTTCGGGCCG	CAWEEDRHPYEQYF	In	VDJ	3	731	7.912265852132632E-4	9.314997273037734E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	2	5	5	26	35	46	40	51			unresolved										Vb 20	CAWEEDRHPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAAAAGGGGGAGCCTTTTTCGCTTTCTTTGGACAA	CAWSGKGGAFFAFF	In	VDJ	3	740	8.009680889983785E-4	9.429682601980743E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	1	11	4	10	26	39	49	43	59			unresolved										Vb 20	CAWSGKGGAFFAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAGAGGTTCCGGGCTTTCTTTGGACAA	CAWRERFRAFF	In	VDJ	3	750	8.117919820929513E-4	9.557110745250753E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	11	0	9	26	-1	41	37	50													Vb 20	CAWRERFRAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGGGAATCACAATGAGCAGTTCTTCGGGCCA	CAWAGNHNEQFF	In	VDJ	3	796	8.615818903279856E-4	0.00101432802042928	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	5	0	4	26	-1	41	35	45			unresolved										Vb 20	CAWAGNHNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGGCATTGGTAGGGACAGGTAGGCCCCAGCATTTTGGTGAT	CAWSMALVGTGRPQHF	In	VDJ	3	840	9.092070199441054E-4	0.0010703964034680844	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	4	9	12	3	26	38	58	50	61			unresolved										Vb 20	CAWSMALVGTGRPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCGGACAGCAATGAGCAGTTCTTCGGGCCA	CAWSPDSNEQFF	In	VDJ	5	1302	0.0014092708809133633	0.0016591144253755308	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	6	3	0	26	37	-1	40	46			unresolved										Vb 20	CAWSPDSNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGATGTCAATGAGCAGTTCTTCGGGCCA	CAWSGDVNEQFF	In	VDJ	7	1760	0.0019050051846447923	0.002242735321552177	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	1	0	8	6	0	3	26	-1	43	39	46			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGDVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCTGACAGGGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	10	2589	0.0028023059221848677		41	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	0	3	1	26	35	46	38	47			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCTCGGCAGGGGATGGCTACACCTTCGGTTCG	CAWTSAGDGYTF	In	VDJ	14	3614	0.003911754964378568	0.004605253097778163	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	6	6	0	26	36	-1	42	48			unresolved										Vb 20	CAWTSAGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCATGGGGCAAGGTGAAGCTTTCTTTGGACAA	CAWSMGQGEAFF	In	VDJ	15	3935	0.004259201932714351	0.0050142974376748955	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	7	3	4	26	37	45	40	49			unresolved										Vb 20	CAWSMGQGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGCGGCAGGGGATGGCTACACCTTCGGTTCG	CAWTAAGDGYTF	In	VDJ	86	22250	0.024083162135424222	0.028352761877577234	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	6	6	0	26	36	-1	42	48			unresolved										Vb 20	CAWTAAGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCTGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSVSDLAKNIQYF	In	VDJ	158	40936	0.04430868877194274	0.05216398472901131	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-04	01	0	2	8	0	4	3	26	40	46	44	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSDLAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATCCGGGGGAACTTAATGAAAAACTGTTTTTTGGCAGT	CASSVDPGELNEKLFF	In	VDJ	1	70	7.576725166200879E-5	8.919970028900702E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	2	4	3	4	23	39	48	42	52			01,02										Vb 1	CASSVDPGELNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAAGCAAAGGCTAGCGGGACTAGAGACCCAGTACTTCGGGCCA	CAKQRLAGLETQYF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	4	3	4	8	2	23	30	47	38	49			01,02										Vb 1	CAKQRLAGLETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTGGGGGCCCCAGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	74	8.009680889983786E-5		44	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	5	1	6	23	39	46	40	52			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGAAGTCCATCTCTCTGGAAACACCATATATTTTGGAGAG	CASSVEVHLSGNTIYF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	48	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	2	1	8	0	0	9	23	-1	40	37	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEVHLSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGAGTACTTTCCTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	81	8.767353406603873E-5		49	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	1	10	0	23	32	-1	42	51			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCCCAGCTTGGGGGAGAGGAGCTTTCTTTGGACAA	CASTPAWGRGAFF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	6	6	1	10	9	5	23	33	47	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASTPAWGRGAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTCGAACAGTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVRTVNTGELFF	In	VDJ	1	96	1.0390937370789777E-4	1.2233101753920963E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	5	2	4	2	23	37	45	41	47			01,02										Vb 1	CASSVRTVNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAGTTTCTACTAGCGGGGGGCCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	97	1.0499176301735503E-4		53	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	0	7	3	23	33	52	40	55			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCTGGACAGCCAGCACAGATACGCAGTATTTTGGCCCA	CASSSWTASTDTQYF	In	VDJ	1	111	1.2014521334975679E-4	1.4144523902971114E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	0	4	2	23	35	45	39	47			01,02										Vb 1	CASSSWTASTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAACGGCAGCTATGAACACTGAAGCTTTCTTTGGACAA	CASSETAAMNTEAFF	In	VDJ	1	117	1.266395492065004E-4	1.4909092762591174E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	5	4	5	0	8	3	23	34	45	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSETAAMNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACATACCCCGGGACAGTTAGTGAAGCTTTCTTTGGACAA	CASTYPGTVSEAFF	In	VDJ	1	122	1.3205149575378674E-4	1.5546233478941224E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	7	8	4	23	33	48	41	52			01,02										Vb 1	CASTYPGTVSEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAGGGGGGACATACGAACACTGAAGCTTTCTTTGGACAA	CASSQGGHTNTEAFF	In	VDJ	1	139	1.504521140145603E-4	1.7712511914531396E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	1	0	7	23	-1	42	35	49			01,02										Vb 1	CASSQGGHTNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAGAAAAGCCCCTGGGGGACCCCTCCTACGAGCAGTACTTCGGGCCG	CASREKPLGDPSYEQYF	In	VDJ	1	147	1.5911122849021845E-4	1.8731937060691476E-4	51	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	5	0	7	0	14	2	23	34	53	48	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASREKPLGDPSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTAGTAGGGAGCGATGGCTACACCTTCGGTTCG	CASSVVVGSDGYTF	In	VDJ	1	148	1.6019361779967572E-4	1.8859365203961485E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	2	6	5	2	23	39	49	44	51			01,02										Vb 1	CASSVVVGSDGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGGGGTACAGAACACTGAAGCTTTCTTTGGACAA	CASGVQNTEAFF	In	VDJ	1	157	1.6993512158479114E-4	2.0006218493391577E-4	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	7	6	2	1	0	4	23	-1	36	32	40			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASGVQNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCTCCCTAGCGGGGGGGAATGATGAGACCCAGTACTTCGGGCCA	CASSVSLAGGNDETQYF	In	VDJ	1	177	1.915829077739365E-4	2.2554781358791778E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	0	5	4	6	23	37	53	41	59			01,02										Vb 1	CASSVSLAGGNDETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCGAAAAACTTATTACATTACACAGATACGCAGTATTTTGGCCCA	CASSKNLLHYTDTQYF	In	VDJ	1	187	2.0240680086850918E-4	2.382906279149188E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	7	3	6	2	14	3	23	32	49	46	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSKNLLHYTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCTAGGGGGAATGAGCAGTTCTTCGGGCCA	CASSSRGNEQFF	In	VDJ	1	205	2.2188980843874E-4	2.6122769370352057E-4	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	1	7	3	0	23	35	-1	38	44			01,02										Vb 1	CASSSRGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCAAAGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSAKSSGNTIYF	In	VDJ	1	209	2.2621936567656907E-4	2.66324819434321E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	2	0	4	0	23	36	-1	40	43			01,02										Vb 1	CASSAKSSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGGACGGAATTACTATGGCTACACCTTCGGTTCG	CASSVEGRNYYGYTF	In	VDJ	1	217	2.3487848015222722E-4	2.765190708959218E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	0	7	3	1	6	23	39	45	40	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGRNYYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGGCCGCGGGACTAGCAGATTCACAGATACGCAGTATTTTGGCCCA	CASSVGRGTSRFTDTQYF	In	VDJ	1	225	2.435375946278854E-4	2.867133223575226E-4	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	7	2	7	5	23	37	53	44	58			01,02			01,02							Vb 1	CASSVGRGTSRFTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVRTGELFF	In	VDJ	1	238	2.5760865565082984E-4	3.032789809826239E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	1	5	4	5	0	0	23	-1	-1	38	41			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVRTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTGGCTCTACAATGAGCAGTTCTTCGGGCCA	CASSVDWLYNEQFF	In	VDJ	1	238	2.5760865565082984E-4	3.032789809826239E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	3	3	1	23	39	45	42	46			01,02										Vb 1	CASSVDWLYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGACATCGATAGGGAGACCCAGTACTTCGGGCCA	CASSADIDRETQYF	In	VDJ	1	241	2.608558235792017E-4	3.071018252807242E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	6	5	1	8	23	36	42	37	50			01,02										Vb 1	CASSADIDRETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGCTTACCAATCAGCCCCAGCATTTTGGTGAT	CASSVGLTNQPQHF	In	VDJ	1	255	2.7600927391160343E-4	3.249417653385256E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	9	0	3	0	4	23	-1	42	39	46			01,02										Vb 1	CASSVGLTNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGGTTCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSEGSAKNIQYF	In	VDJ	1	272	2.9440989217237697E-4	3.466045496944273E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	11	0	0	1	3	23	34	40	35	43			01,02										Vb 1	CASSEGSAKNIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTGCCCGACAATGAGCAGTTCTTCGGGCCA	CASSVVPDNEQFF	In	VDJ	1	299	3.236344035277232E-4	3.8101014837733005E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	10	0	5	1	3	23	39	42	40	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVVPDNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCTTAGCGGGGATGAGCAGTTCTTCGGGCCA	CASSALSGDEQFF	In	VDJ	1	302	3.2688157145609507E-4	3.8483299267543034E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	3	8	4	0	23	36	-1	40	48			01,02										Vb 1	CASSALSGDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACCGGGGGGCGAGCAGTTCTTCGGGCCA	CASSAPGGEQFF	In	VDJ	1	312	3.3770546455066773E-4	3.9757580700243135E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	10	3	1	23	36	46	39	47			01,02										Vb 1	CASSAPGGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTCGATGGGCTCGAGCAGTACTTCGGGCCG	CASSVVDGLEQYF	In	VDJ	1	329	3.5610608281144127E-4	4.19238591358333E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	6	5	1	23	39	48	44	49			01,02										Vb 1	CASSVVDGLEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAATCGGATCAATGCCTTCCGCAGATACGCAGTATTTTGGCCCA	CASSVIGSMPSADTQYF	In	VDJ	1	337	3.6476519728709944E-4	4.2943284281993384E-4	51	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	1	1	8	4	3	13	23	38	44	41	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVIGSMPSADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGTGGGTGGGACGGGCGAGCAGTACTTCGGGCCG	CASSVDVGGTGEQYF	In	VDJ	2	422	4.5676828859096723E-4	5.377467645994423E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	0	0	7	6	8	3	23	39	52	47	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDVGGTGEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAACGACAGGGGAGTCGATCTATGGCTACACCTTCGGTTCG	CASSLTTGESIYGYTF	In	VDJ	2	423	4.5785067790042453E-4	5.390210460321425E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	4	5	7	23	35	48	40	55			01,02										Vb 1	CASSLTTGESIYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTTTTTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSVGFSTNEKLFF	In	VJ	2	452	4.892399678746853E-4	5.759752075804454E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-04	01	0	0	0	0	0	6	23	-1	39	-1	45			01,02										Vb 1	CASSVGFSTNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGAACCAGTCGAGCACAGATACGCAGTATTTTGGCCCA	CASSANQSSTDTQYF	In	VDJ	2	453	4.903223571841426E-4	5.772494890131455E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	5	0	5	3	23	36	44	41	47			01,02										Vb 1	CASSANQSSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAACTCAGGGGCGGGGGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASNSGAGVNTGELFF	In	VDJ	2	567	6.137147384622712E-4	7.22517572340957E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	7	2	2	8	2	23	33	48	41	50			01,02										Vb 1	CASNSGAGVNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVEGPSYNEQFF	In	VDJ	3	660	7.143769442417971E-4	8.410257455820663E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	5	3	0	1	2	23	39	44	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGPSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACAGGGTGGTGGCTACACCTTCGGTTCG	CASSVGQGGGYTF	In	VDJ	3	764	8.269454324253531E-4	9.735510145828767E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	7	0	3	23	-1	46	39	49			01,02										Vb 1	CASSVGQGGGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATATATGAACACTGAAGCTTTCTTTGGACAA	CASSVYMNTEAFF	In	VDJ	16	4210	0.0045568589928151	0.005364724831667423	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	9	0	0	2	23	-1	40	38	42			01,02			01,02							Vb 1	CASSVYMNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGGGTCCCTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSQGGSLAKNIQYF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-04	01	1	6	1	1	0	6	29	-1	50	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGGSLAKNIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCGGGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRASGANVLTF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	4	8	0	0	3	0	29	42	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPRASGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGAGTTTATTTCTGTGCCAGCAGCCAAGAAAAAGCAAGGGATAGCGGGCTTCCTTTCAATGAGCAGTTCTTCGGGCCA	CASSQEKARDSGLPFNEQFF	In	VDJ	1	100	1.0823893094572684E-4	1.2742814327001005E-4	60	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	4	6	12	8	12	29	48	41	56						01,02							Vb 16	CASSQEKARDSGLPFNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGACAGGAGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	115	1.2447477058758586E-4		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	4	3	0	3	29	-1	53	45	56													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCGGATAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	150	1.6235839641859026E-4		32	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-06	01	8	1	8	7	0	2	29	-1	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTTTTCCGCAGGGAAACACCATATATTTTGGAGAG	CASSPFPQGNTIYF	In	VDJ	1	153	1.6560556434696205E-4	1.9496505920311535E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	5	4	8	0	29	42	-1	50	53													Vb 16	CASSPFPQGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGAAAAACAGGAGCCTATAATTCACCCCTCCACTTTGGGAAC	CASRKTGAYNSPLHF	In	VDJ	2	493	5.336179295624333E-4	6.282207463211495E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	4	2	4	2	29	40	49	44	51													Vb 16	CASRKTGAYNSPLHF+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTTATCCAAGCCCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	515	5.574304943704933E-4		46	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	6	7	2	8	2	29	44	55	52	57						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTGAGACCCGGGGTTTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	552	5.974788988204121E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	3	0	8	5	28	40	53	48	58													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTTGGGCAGGGGGATATTGAAGCTTTCTTTGGACAA	CASSQDLGQGDIEAFF	In	VDJ	2	636	6.883996008148227E-4	8.104429911972639E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	7	7	4	29	46	60	53	64													Vb 16	CASSQDLGQGDIEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGTATGGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSQEGMGPNEQFF	In	VDJ	4	1122	0.0012144408052110552	0.0014297437674895127	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	6	6	1	29	46	57	52	58													Vb 16	CASSQEGMGPNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACTTCGAGGGAGAGGATACGCAGTATTTTGGCCCA	CASSHFEGEDTQYF	In	VDJ	5	1178	0.0012750546065406622	0.0015011035277207182	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	6	6	2	29	43	54	49	56													Vb 16	CASSHFEGEDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCTCCGCCCTAGGGGGGACCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSALGGTANTGELFF	In	VDJ	5	1188	0.0012858784996352347	0.0015138463420477193	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	8	5	1	0	8	5	29	38	52	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSALGGTANTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGACTCGAAGAGACCCAGTACTTCGGGCCA	CASSPGLEETQYF	In	VDJ	12	3181	0.0034430803933835708	0.00405348923741902	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	3	1	2	29	42	49	43	51						01,02							Vb 16	CASSPGLEETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGACTGCAAGAGACCCAGTACTTCGGGCCA	CASSQGLQETQYF	In	VDJ	15	4013	0.004343628298852018	0.005113691389425503	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	10	2	0	1	29	-1	49	43	50						01,02							Vb 16	CASSQGLQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGAGAGGGGAGGTCCTACGAGCAGTACTTCGGGCCG	CASSREGRSYEQYF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	1	1	6	0	24	36	-1	42	48														CASSREGRSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAGGACCCCAGGACGCAGATACGCAGTATTTTGGCCCA	CASSEGPQDADTQYF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	6	1	7	4	4	9	24	35	43	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPQDADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACTCCCCAGGGTGGGAATGAAAAACTGTTTTTTGGCAGT	CASSTPQGGNEKLFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	3	5	5	4	24	37	47	42	51														CASSTPQGGNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCTCTCGGGCTTACTATGGCTACACCTTCGGTTCG	CASSSSRAYYGYTF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	8	0	3	7	2	24	36	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSRAYYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTATCGCGGGGGTGGTGGCAGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	75	8.117919820929513E-5		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	7	2	4	4	8	24	36	47	40	55														X+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGGGGACAGGTTGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSPGTGWGDTEAFF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	3	3	8	24	36	47	39	55														CASSPGTGWGDTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGATTCCGGGACAGGGCTACACCTTCGGTTCG		Out	VDJ	1	78	8.442636613766693E-5		38	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	8	8	0	24	35	-1	43	50														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGCCGGGACTCTCAGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSAGTLSAGELFF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	6	4	7	24	35	45	39	52						01,02								CASSAGTLSAGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGAAGATGGGTCAGTCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	89	9.633264854169688E-5		50	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	0	9	1	10	6	24	36	49	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAATCCCGACACCTTGGGAAAAACTGTTTTTTGGCAGT	CASSKIPTPWEKLFF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	6	8	5	6	24	39	48	44	54														CASSKIPTPWEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGCACCGGGACAGGCCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRTGTGRSGANVLTF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	4	0	6	3	24	36	50	42	53														CASSRTGTGRSGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAATCTCCAAGGCCTGAGTGAAAGACCTATGGCTACACCTCCGGTTCG		Out	VDJ	1	98	1.060741523268123E-4		53	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	19	23	15	24	35	61	58	76				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGAAGCTTTTATAGCGGAACTGAGCAGTACTTCGGGCCG	CASGSFYSGTEQYF	In	VDJ	1	108	1.1689804542138499E-4	1.3762239473161085E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	5	5	7	13	4	24	31	50	44	54						01,02								CASGSFYSGTEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATCGGGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIGTTNEKLFF	In	VDJ	1	112	1.2122760265921406E-4	1.4271952046241123E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	8	3	0	1	0	24	37	-1	38	43														CASSIGTTNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCCCAGTTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSVGPVLAKNIQYF	In	VDJ	1	135	1.4612255677673124E-4	1.7202799341451354E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-04	01	5	4	5	0	7	4	24	36	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGPVLAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCGAAAGCGGGGGCTATGAAGGGGATGAGCAGTTCTTCGGGCCA	CASSVGESGGYEGDEQFF	In	VDJ	1	196	2.121483046536246E-4	2.497591608092197E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	2	8	9	11	24	36	53	45	64														CASSVGESGGYEGDEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGGACCTCCGGGGTACCCCTCCACTTTGGGAAC	CASSLGTSGVPLHF	In	VDJ	1	213	2.3054892291439816E-4	2.714219451651214E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	0	7	12	3	9	24	36	44	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTSGVPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTAGTCCCTGGGATGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	242	2.6193821288865893E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	0	8	4	8	16	24	35	47	43	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGGGACAGGGGGTGTTTGAGACCCAGTACTTCGGGCCA	CASSLGQGVFETQYF	In	VDJ	1	265	2.868331670061761E-4	3.376845796655266E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	5	2	5	24	36	49	38	54														CASSLGQGVFETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTACCTAGCGGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSYLAGPYNEQFF	In	VDJ	1	321	3.4744696833578315E-4	4.0904433989673224E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	4	3	3	24	36	48	39	51														CASSYLAGPYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGTGGACTAGCGGGGTTCGACGAGCAGTACTTCGGGCCG	CASSGGLAGFDEQYF	In	VDJ	1	332	3.593532507398131E-4	4.230614356564333E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	5	3	4	24	36	51	39	55														CASSGGLAGFDEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACCGGGACAGGGGAGAATCAGCCCCAGCATTTTGGTGAT	CASSTGTGENQPQHF	In	VDJ	1	366	3.9615448726136024E-4	4.6638700436823675E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	2	4	2	2	24	37	49	39	51														CASSTGTGENQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGAAGACGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSLEDGGTDTQYF	In	VDJ	1	372	4.026488231181038E-4	4.7403269296443734E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	3	8	0	24	36	-1	44	51														CASSLEDGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCCGACCCTCTGACAGAACTATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSARPSDRTMNTGELFF	In	VDJ	2	391	4.2321421999779195E-4	4.982440401857393E-4	57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	5	1	12	6	24	36	53	48	59														CASSARPSDRTMNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGTTAGACAGGCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	976	0.0010564119660302939		43	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	4	2	4	3	24	35	45	39	48														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCAAGGGGGACAGCCCTGAACACTGAAGCTTTCTTTGGACAA	CASSLSRGTALNTEAFF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	0	6	3	19	34	47	40	50													Vb 5.1	CASSLSRGTALNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGGGACAGACAAAAGAGACCCAGTACTTCGGGCCA	CASSGGQTKETQYF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	3	2	4	19	31	40	33	44													Vb 5.1	CASSGGQTKETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCAGGGGTTTCGGCGGCTACACCTTCGGTTCG	CASSLARGFGGYTF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	8	1	7	19	35	42	36	49													Vb 5.1	CASSLARGFGGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGTACAGGGGGCCCTGGATGAACACTGAAGCTTTCTTTGGACAA	CASRYRGPWMNTEAFF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	0	2	6	19	30	41	32	47													Vb 5.1	CASRYRGPWMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGGGGGTTAATACTGAAGCTTTCTTTGGACAA	CASSPGGVNTEAFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	5	2	5	19	31	41	33	46													Vb 5.1	CASSPGGVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGACAGGTGGGCGGAACACTGAAGCTTTCTTTGGACAA	CASSPTGGRNTEAFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	2	6	19	31	39	33	45													Vb 5.1	CASSPTGGRNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGATCTTATCTCACGGGGACGGAGTATGGCTACACCTTCGGTTCG	CARSYLTGTEYGYTF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	8	0	7	5	13	4	19	27	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CARSYLTGTEYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTGGCGGGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGTTGELFF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	7	3	4	3	2	19	34	43	37	45													Vb 5.1	CASSLLAGTTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTGGCCCAGGGATACGGGGAGCTGTTTTTTGGAGAA	CASSLAQGYGELFF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	7	2	3	19	35	42	37	45													Vb 5.1	CASSLAQGYGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCACTACTTCGGGGCTACGAGCAGTACGTCGGGCCG	CASSPLLRGYEQYV	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	7	0	17	10	13	19	31	46	41	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPLLRGYEQYV+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGGACCGGGACAGGGGTCTCCCCCCTCCACTTTGGGAAC	CASSRTGTGVSPLHF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	2	13	6	5	19	31	47	37	52													Vb 5.1	CASSRTGTGVSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCGACTTGAGGTCGGGTGGATGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASRLEVGWMGAQETQYF	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	6	0	1	20	0	19	28	-1	48	54													Vb 5.1	CASRLEVGWMGAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGGACAGGAAACTATGGCTACACCTTCGGTTCG	CASSLGGTGNYGYTF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	4	2	2	1	19	35	45	37	46													Vb 5.1	CASSLGGTGNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTCTACCTCTGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLPLGTDTQYF	In	VDJ	1	85	9.200309130386781E-5	1.0831392177950854E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	9	1	1	7	19	33	37	34	44						01,02							Vb 5.1	CASSFLPLGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCRCCAGCAGCTCGATACAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CXSSSIQGTNTEAFF	In	VDJ	1	87	9.416786992278235E-5	1.1086248464490874E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	1	4	2	19	32	43	36	45													Vb 5.1	CXSSSIQGTNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCCCCCGCGGGGTTTTCCGCTCTGGAAACACCATATATTTTGGAGAG	CASTPRGVFRSGNTIYF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	7	3	0	6	7	19	29	41	35	48													Vb 5.1	CASTPRGVFRSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATAGGGACGGATCACACAGATACGCAGTATTTTGGCCCA	CASSIGTDHTDTQYF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	4	0	7	2	3	6	19	31	39	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSIGTDHTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGGGACAGGCATTTCGAAGCAGTACGTCGGGCCG	CASSLEGTGISKQYV	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	4	17	2	17	19	35	45	37	62													Vb 5.1	CASSLEGTGISKQYV+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGGACTAGCCGCCTCTAATACGCAGTATTTTGGCCCA	CASSLEGLAASNTQYF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	7	7	1	8	19	35	45	36	53						01,02							Vb 5.1	CASSLEGLAASNTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTGAAGGGGGGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSPEGGGGETQYF	In	VDJ	1	92	9.95798164700687E-5	1.1723389180840923E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	0	4	6	4	19	31	44	37	48													Vb 5.1	CASSPEGGGGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCTGGAGGAGCCGAACACTGAAGCTTTCTTTGGACAA	CASSSLEEPNTEAFF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	1	4	4	19	32	41	36	45													Vb 5.1	CASSSLEEPNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTATCGACAGGGGACTTCTCTGGAAACACCATATATTTTGGAGAG	CASSLSTGDFSGNTIYF	In	VDJ	1	99	1.0715654163626957E-4	1.2615386183730993E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	2	0	5	4	19	31	44	36	48													Vb 5.1	CASSLSTGDFSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCGCGAGGGTAGGAGATACGCAGTATTTTGGCCCA	CASSLAARVGDTQYF	In	VDJ	1	100	1.0823893094572684E-4	1.2742814327001005E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	11	0	5	4	4	19	35	44	39	48													Vb 5.1	CASSLAARVGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGAGGACAGGGAGGGTTGGATCAGCCCCAGCATTTTGGTGAT	CASSGGQGGLDQPQHF	In	VDJ	1	101	1.093213202551841E-4	1.2870242470271014E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	5	3	8	19	31	42	34	50													Vb 5.1	CASSGGQGGLDQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTCCCAGGGGGCAACACTGAAGCTTTCTTTGGACAA	CASSLFPGGNTEAFF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	0	2	4	0	19	34	-1	38	46													Vb 5.1	CASSLFPGGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTGGGGACTAGCGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTSGANTGELFF	In	VDJ	1	103	1.1148609887409864E-4	1.3125098756811034E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	1	3	0	0	0	19	-1	-1	35	47													Vb 5.1	CASSLGTSGANTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTCACAGGGTTTTATGACGAGCAGTACTTCGGGCCG	CASSVTGFYDEQYF	In	VDJ	1	103	1.1148609887409864E-4	1.3125098756811034E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	5	3	7	19	31	40	34	47													Vb 5.1	CASSVTGFYDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGATGGGACCCTTGGAGAGACCCAGTACTTCGGGCCA	CASSLGDGTLGETQYF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	0	0	7	4	5	6	19	35	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGDGTLGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGAGCGGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPESGGPYEQYF	In	VDJ	1	107	1.1581565611192772E-4	1.3634811329891076E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	1	2	6	1	19	31	46	37	47													Vb 5.1	CASSPESGGPYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGCGAAGGGACAGATACGCAGTATTTTGGCCCA	CASSPGEGTDTQYF	In	VDJ	1	109	1.1798043473084225E-4	1.3889667616431094E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	4	5	3	3	8	0	19	31	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPGEGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAACAGGTCCGGGACGTTCGAGGGCACAGATACGCAGTATTTTGGCCCA	CANRSGTFEGTDTQYF	In	VDJ	1	113	1.2230999196867132E-4	1.4399380189511135E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	5	0	7	1	4	8	19	30	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CANRSGTFEGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGAGGACTAGCGGGGATTTCAATGAGCAGTTCTTCGGGCCA	CASSSRTSGDFNEQFF	In	VDJ	1	115	1.2447477058758586E-4	1.4654236476051156E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	1	3	6	3	4	19	32	47	35	51													Vb 5.1	CASSSRTSGDFNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCCCGGACAGTTTTCGCGGGGAGCTGTTTTTTGGAGAA	CASTPDSFRGELFF	In	VDJ	1	126	1.3638105299161582E-4	1.6055946052021265E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	7	4	6	19	29	39	33	45													Vb 5.1	CASTPDSFRGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTCGAGGGGATGAGACAGATACGCAGTATTTTGGCCCA	CASSLVRGDETDTQYF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	0	5	2	3	4	5	19	35	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVRGDETDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLGGAQETQYF	In	VDJ	1	136	1.4720494608618849E-4	1.7330227484721366E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	1	2	0	19	35	-1	37	42													Vb 5.1	CASSLGGAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTACGACAGGGGGGGCCAACACTGAAGCTTTCTTTGGACAA	CASTTGGANTEAFF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	1	2	3	4	19	27	39	30	43													Vb 5.1	CASTTGGANTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCAAGGGGCTTGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	149	1.61276007109133E-4		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	6	4	5	19	31	40	35	45													Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTACAGGGGGGGCCTGGAATGAGCAGTTCTTCGGGCCA	CASSLGTGGAWNEQFF	In	VDJ	1	150	1.6235839641859026E-4	1.9114221490501506E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	1	7	2	7	19	35	45	37	52													Vb 5.1	CASSLGTGGAWNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGTACTCCCCCGGGACAGGGGAATGAAAAACTGTTTTTTGGCAGT	CASTPPGQGNEKLFF	In	VDJ	1	157	1.6993512158479114E-4	2.0006218493391577E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	2	5	9	0	19	27	-1	36	46													Vb 5.1	CASTPPGQGNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGGACAGCTCACACTGAAGCTTTCTTTGGACAA	CASSLGGTAHTEAFF	In	VDJ	1	158	1.710175108942484E-4	2.0133646636661586E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	3	2	3	19	35	44	37	47													Vb 5.1	CASSLGGTAHTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGTTTGGGGGGGGCTGGTCCTACGAGCAGTACTTCGGGCCG	CASSLEFGGGWSYEQYF	In	VDJ	1	159	1.7209990020370568E-4	2.0261074779931597E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	1	5	5	19	35	47	40	52													Vb 5.1	CASSLEFGGGWSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACGGGACGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGTANTGELFF	In	VDJ	1	168	1.8184140398882107E-4	2.1407928069361686E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	3	0	7	0	2	2	19	32	39	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSYGTANTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACCGAGGGGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYRGDSGANVLTF	In	VDJ	1	182	1.9699485432122285E-4	2.3191922075141828E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-06	01	3	5	2	0	4	1	19	32	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSYRGDSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCTGGACAGGGAATGACAATGAGCAGTTCTTCGGGCCA	CASSPWTGNDNEQFF	In	VDJ	1	197	2.1323069396308187E-4	2.510334422419198E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	5	4	4	19	31	43	35	47													Vb 5.1	CASSPWTGNDNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGAGACTAGCGGGGGAGGTGAGCAGTTCTTCGGGCCA	CASSLGETSGGGEQFF	In	VDJ	1	254	2.7492688460214614E-4	3.236674839058255E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	2	9	4	3	19	35	51	39	54													Vb 5.1	CASSLGETSGGGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCACTCCGTGCCCCGGATGAGCAGTTCTTCGGGCCA	CASSSLRAPDEQFF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	10	8	1	11	19	32	36	33	47						01,02							Vb 5.1	CASSSLRAPDEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAACCGGGACACTTTACACTGAAGCTTTCTTTGGACAA	CASSSTGTLYTEAFF	In	VDJ	1	326	3.528589148830695E-4	4.154157470602327E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	3	5	4	19	32	43	37	47													Vb 5.1	CASSSTGTLYTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGTTAGAACCCGGGGGACTCAATGAGCAGTTCTTCGGGCCA	CASRLEPGGLNEQFF	In	VDJ	2	443	4.7949846408956986E-4	5.645066746861445E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	6	12	0	19	30	-1	42	48						01,02							Vb 5.1	CASRLEPGGLNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGTGGGCAGGACGGGGGGAAAATTGATGAAGCTTTCTTTGGACAA	CASSRGQDGGKIDEAFF	In	VDJ	5	1174	0.001270725049302833	0.001496006401989918	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	1	7	11	8	19	31	49	42	57													Vb 5.1	CASSRGQDGGKIDEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGTTCCGGGACAGGGAATCAGCCCCAGCATTTTGGTGAT	YASSSGTGNQPQHF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	42	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	3	4	12	0	22	25	-1	37	46														YASSSGTGNQPQHF+TCRBV17-01+TCRBJ01-05	TCRBV17-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTGGGACAGGGAACGAACACTGAAGCTTTCTTTGGACAA	CASSFLGQGTNTEAFF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	1	3	3	25	39	51	42	54													Vb 3	CASSFLGQGTNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGGTATGGGCCCAGATACGCAGTATTTTGGCCCA	CASRGGMGPDTQYF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	1	4	0	8	25	-1	42	36	50													Vb 3	CASRGGMGPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTTGGGGTGAGAACACTGAAGCTTTCTTTGGACAA	CASSLFWGENTEAFF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	1	6	2	1	3	3	25	41	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLFWGENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTCGGTGGGGAGCAGTACTTCGGGCCG	CASSFVGGEQYF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	7	7	0	25	39	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFVGGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAACGGTAGCGGACAGGGTCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	142	1.5369928194293212E-4		52	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	3	9	3	25	40	57	49	60													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGGGACTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRDFSTDTQYF	In	VDJ	1	150	1.6235839641859026E-4	1.9114221490501506E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	0	5	2	25	36	47	41	49						01,02							Vb 3	CASSPRDFSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCCCGGGAAGCGCGGTGGAGTATGGCTACACCTTCGGTTCG	CASSFPPGSAVEYGYTF	In	VDJ	1	160	1.7318228951316292E-4	2.0388502923201606E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	3	5	5	12	25	39	49	44	61													Vb 3	CASSFPPGSAVEYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTCGTGTACCTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	174	1.883357398455647E-4		47	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	0	9	2	0	11	25	-1	42	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCTTGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSSLGSNTEAFF	In	VDJ	1	218	2.359608694616845E-4	2.7779335232862187E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	6	2	1	6	2	25	36	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSLGSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGGGCCCCGGGCCAGGGGCTTTCTTTGGACAA	CASSLRGPGPGAFF	In	VDJ	1	310	3.355406859317532E-4	3.950272441370311E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	11	13	0	25	40	-1	53	58													Vb 3	CASSLRGPGPGAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCGGGGACAGGAGGGCAGATACGCAGTATTTTGGCCCA	CASTPGDRRADTQYF	In	VDJ	1	316	3.420350217884968E-4	4.026729327332317E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	4	4	6	4	25	35	49	41	53													Vb 3	CASTPGDRRADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGCAGTCAAGTCTCAGGGGGAAGGGGCTACACCTTCGGTTCG	CVSSQVSGGRGYTF	In	VDJ	1	324	3.5069413626415493E-4	4.1286718419483254E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	8	7	4	25	37	51	44	55													Vb 3	CVSSQVSGGRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATGGACACTGAAGCTTTCTTTGGACAA	CASSLMDTEAFF	In	VDJ	1	354	3.83165815547873E-4	4.5109562717583556E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	0	10	3	2	0	25	40	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLMDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGACAGAAGAGACCCAGTACTTCGGGCCA	CASSGTEETQYF	In	VDJ	1	359	3.8857776209515936E-4	4.5746703433933604E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	3	1	0	25	36	-1	37	44													Vb 3	CASSGTEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCCCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLPGTDTQYF	In	VDJ	1	381	4.1239032690321923E-4	4.8550122585873823E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	1	4	0	25	37	-1	41	44						01,02							Vb 3	CASSLPGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCGGGGCAGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSTGAGATNEKLFF	In	VDJ	2	398	4.307909451639928E-4	5.0716401021464E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	7	0	0	4	5	25	36	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTGAGATNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCGGGACACTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	574	6.21291463628472E-4		43	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	5	5	3	25	37	48	42	51													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGCGGGTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSPAGFQETQYF	In	VDJ	2	581	6.288681887946729E-4	7.403575123987584E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	4	1	4	3	25	36	45	40	48						01,02							Vb 3	CASSPAGFQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCCCGGACAGACGCCTATGGCTACACCTTCGGTTCG	CASSFSRTDAYGYTF	In	VDJ	3	832	9.005479054684473E-4	0.0010602021520064835	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	4	5	4	25	39	50	44	54													Vb 3	CASSFSRTDAYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAGCCACGTTTGGTGGGACTCGGCCGTGTATGTCTGGGCAAGGCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	69	7.468486235255151E-5		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCATCTCGGACTAGCGGGGGGGGTTGGTTCCCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CAISD*RGGLVPLAKNIQYF	Stop	VDJ	1	81	8.767353406603873E-5		60	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	12	1	0	0	6	12	18	23	44	29	56														CAISD*RGGLVPLAKNIQYF+TCRBV12-02+TCRBJ02-04	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAGCCACGTTTGGTGGGACTCGGCCGTGTATGGCTGTGCAAGGCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	99	1.0715654163626957E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	35	-1	59	52	62														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCAACGGTTAATATTACAGGGGAAGGTGGAAACACCATATATTTTGGAGAG	CATVNITGEGGNTIYF	In	VDJ	1	180	1.948300757023083E-4	2.2937065788601808E-4	48	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	3	2	3	11	4	18	25	43	36	47														CATVNITGEGGNTIYF+TCRBV12-02+TCRBJ01-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCCCAGCGGGGAAGCGGGGGCCGGGGCTAACGAGCAGTACGTCGGGCCG		Out	VDJ	1	253	2.738444952926889E-4		55	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	2	17	12	21	18	30	50	42	71														X+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGTCTTCAAAGGACAGGCAATACAAGGGATTCACCCCTCCACTTTGGGAAC	CASLQRTGNTRDSPLHF	In	VDJ	1	254	2.7492688460214614E-4	3.236674839058255E-4	51	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	1	4	8	6	11	18	28	41	34	52														CASLQRTGNTRDSPLHF+TCRBV12-02+TCRBJ01-06	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCGGGGGGGCGGCACCGGGAAGCTGTTTTTTGGAGAA		Out	VDJ	1	360	3.896601514046166E-4		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	12	0	11	18	-1	42	35	53														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCTGTGTATCTCTGTGCAAGTCGCTTAGCGGGGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	1633	0.0017675417423437191		46	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	4	0	3	19	-1	43	36	46														X+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGCAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGQGAYNEQFF	In	VDJ	1	81	8.767353406603873E-5	1.0321679604870813E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	2	2	0	23	39	-1	41	48														CASSQGQGAYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTACAAGGGGGTAACACAGATACGCAGTATTTTGGCCCA	CASSLQGGNTDTQYF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	1	2	4	3	23	36	46	40	49														CASSLQGGNTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACCGGGACAGGGGTTTGGCTATGGCTACACCTTCGGTTCG	CASSQPGQGFGYGYTF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	4	2	5	23	38	50	40	55														CASSQPGQGFGYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCCACCGACCCAGGGTAGTTCAGCCCCAGCATTTTGGTGAT	CASHRPRVVQPQHF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	3	6	8	4	23	32	45	40	49														CASHRPRVVQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGTCACCTCCTACGAGCAGTACTTCGGGCCG	CASSQGVTSYEQYF	In	VDJ	1	119	1.2880432782541492E-4	1.5163949049131194E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	1	0	9	0	0	4	23	-1	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVTSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGGCGGGAGGTCCTACGAGCAGTACGTCGGGCCG	CASSQGGGRSYEQYV	In	VDJ	1	146	1.5802883918076118E-4	1.8604508917421467E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	1	17	3	16	23	39	50	42	66														CASSQGGGRSYEQYV+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTGGGGACTAGCGGGCTAGGGGAGACCCAGTACTTCGGGCCA	CASSLGTSGLGETQYF	In	VDJ	1	161	1.742646788226202E-4	2.0515931066471618E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	4	5	2	6	23	36	50	38	56						01,02								CASSLGTSGLGETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGCTAGCGGGGGCCGCATACAATGAGCAGTTCTTCGGGCCA	CASSQELAGAAYNEQFF	In	VDJ	1	173	1.8725335053610743E-4	2.2045068785711737E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	4	1	5	23	40	51	41	56														CASSQELAGAAYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCACTGGGGGGCTGAACGAGGGCAATTCACCCCTCCACTTTGGGAAC	CASTGGLNEGNSPLHF	In	VDJ	1	180	1.948300757023083E-4	2.2937065788601808E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-06	01	7	6	0	7	3	11	23	33	42	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGGLNEGNSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCACCTTGGGCAGAGATAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	229	2.478671518657145E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	8	0	4	4	6	23	37	45	41	51														X+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACTCGGGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQELGTATNEKLFF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	5	0	4	0	23	40	-1	44	51														CASSQELGTATNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGCCTAACTTCTATACGAGCAGTACGTCGGGCCG	CTSSQA*LLYEQYV	Stop	VDJ	1	291	3.149752890520651E-4		42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	17	17	4	23	39	59	56	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSQA*LLYEQYV+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGAGGGACAACAGAGTACTCCTACGAGCAGTACTTCGGGCCG	CASSRGTTEYSYEQYF	In	VDJ	1	328	3.55023693501984E-4	4.1796430992563295E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	0	2	8	23	36	44	38	52														CASSRGTTEYSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACTCCCGACAGGGCCGAGTGAAAAACTGTTTTTTGGCAGT	CASSQLPTGPSEKLFF	In	VDJ	1	350	3.7883625831004394E-4	4.4599850144503515E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	3	7	5	5	23	38	50	43	55														CASSQLPTGPSEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGTGGGGACAGGGGGATTATTCACCCCTCCACTTTGGGAAC	CASSQGWGQGDYSPLHF	In	VDJ	1	378	4.0914315897484744E-4	4.8167838156063794E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	1	8	4	3	23	39	54	43	57														CASSQGWGQGDYSPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGACCCCCGGGGGTAGCGGGGGGGCAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	481	5.206292578489461E-4		56	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	9	10	5	23	40	61	50	66														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTATCGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVYRTANTGELFF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	0	4	0	25	34	-1	38	44													Vb 4	CSVYRTANTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAAGAGTCTGGGGGAGACCCAGTACTTCGGGCCA	CSVEKSLGETQYF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	2	6	2	5	8	0	25	37	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEKSLGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGCCACGTTTGGTGGCCCTGAAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGTGGGACAGGGTTACTAATGAAAAACTGTTTTTTGGCAGT	CSVWDRVTNEKLFF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	2	2	2	25	33	44	35	46													Vb 4	CSVWDRVTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACCTCTTCCTTCGGGACAGGGGTTGCTTTCTTTGGACAA	CSVTSSFGTGVAFF	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	11	12	2	25	34	56	46	58													Vb 4	CSVTSSFGTGVAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAACTCTGGCGGTCGGGACCGGGGAGCTGTTTTTTGGAGAA	CSVTLAVGTGELFF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	5	5	7	5	25	33	44	40	49						01,02							Vb 4	CSVTLAVGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGTACAGGAGACACTGAAGCTTTCTTTGGACAA	CSVRTGDTEAFF	In	VDJ	1	113	1.2230999196867132E-4	1.4399380189511135E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	3	4	2	25	33	42	37	44													Vb 4	CSVRTGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATATTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	115	1.2447477058758586E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	17	3	3	6	14	5	43	40	60	54	65													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGGAGGAGACCCAGTACTTCGGGCCA	CSVETGEETQYF	In	VDJ	1	118	1.2772193851595768E-4	1.5036520905861185E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	2	5	0	2	25	-1	44	37	46													Vb 4	CSVETGEETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACRCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	130	1.4071061022944488E-4	1.6565658625101304E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGMAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	144	1.5586406056184663E-4	1.8349652630881446E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGACAGGGGGCGAATGAGCAGTTCTTCGGGCCA	CSVRQGANEQFF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	7	1	1	25	34	45	35	46													Vb 4	CSVRQGANEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATCTCCAGGTCAATGAGCAGTTCTTCGGGCCA	CSVDLQVNEQFF	In	VDJ	1	168	1.8184140398882107E-4	2.1407928069361686E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	4	6	4	1	25	36	44	40	45													Vb 4	CSVDLQVNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTGTATGAGGGCACTGAAGCTTTCTTTGGACAA	CSVELYEGTEAFF	In	VDJ	1	172	1.8617096122665016E-4	2.1917640642441728E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	4	6	0	25	37	-1	43	48													Vb 4	CSVELYEGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTCGGGTGGGACAGGGGGCCTATGGCTACACCTTCGGTTCG	CSVEVRVGQGAYGYTF	In	VDJ	1	188	2.0348919017796645E-4	2.3956490934761888E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	0	4	7	0	25	38	-1	45	57													Vb 4	CSVEVRVGQGAYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCCCCCGGGGGCTACATTCAGTACTTCGGCGCC	CSVSPGGYIQYF	In	VDJ	1	189	2.0457157948742372E-4	2.4083919078031897E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-04	01	6	6	0	8	7	1	25	33	46	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVSPGGYIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGMGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	1	215	2.327137015333127E-4	2.739705080305216E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCCCCGAGGGAGGGAACACTGAAGCTTTCTTTGGACAA	CSVLPEGGNTEAFF	In	VDJ	1	222	2.4029042669951358E-4	2.828904780594223E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	1	8	0	25	34	-1	42	48													Vb 4	CSVLPEGGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATATTCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	227	2.4570237324679994E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	19	3	3	6	16	5	43	38	60	54	65													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATGGTGGAGAGCGGCTATGGCTACACCTTCGGTTCG	CSVMVESGYGYTF	In	VDJ	1	239	2.5869104496028714E-4	3.04553262415324E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	5	4	9	0	25	34	-1	43	48						01,02							Vb 4	CSVMVESGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGTCTCTGGGGCTTCGAACACTGAAGCTTTCTTTGGACAA	CSAVSGASNTEAFF	In	VDJ	1	276	2.9873944941020606E-4	3.5170167542522774E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	7	0	1	8	3	25	32	45	40	48													Vb 4	CSAVSGASNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGGGCGACACAGATACGCAGTATTTTGGCCCA	CSVGGGDTDTQYF	In	VDJ	1	285	3.084809531953215E-4	3.631702083195286E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	2	1	2	25	35	43	36	45													Vb 4	CSVGGGDTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTCTACACGGCAGCTCCTATGGCTACACCTTCGGTTCG	CSALHGSSYGYTF	In	VDJ	1	288	3.1172812112369326E-4	3.669930526176289E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	3	6	4	4	9	25	32	39	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSALHGSSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGCAGGTCAAGAGACCCAGTACTTCGGGCCA	CSVRAGQETQYF	In	VDJ	1	296	3.2038723559935144E-4	3.771873040792297E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	2	0	5	25	-1	38	33	43													Vb 4	CSVRAGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAGACACATTCAGATACGCAGTATTTTGGCCCA	CSVKTHSDTQYF	In	VDJ	1	297	3.214696249088087E-4	3.784615855119298E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	4	3	4	25	33	40	36	44													Vb 4	CSVKTHSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCGGGACACCCAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSGRDTQTNTGELFF	In	VDJ	1	355	3.842482048573303E-4	4.523699086085356E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	6	0	3	6	25	32	41	35	47													Vb 4	CSGRDTQTNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	385	4.167198841410483E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	21	3	3	6	18	5	43	36	60	54	65													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACGGGACTAACTATGGCTACACCTTCGGTTCG	CSVEDGTNYGYTF	In	VDJ	1	387	4.1888466275996286E-4	4.931469144549388E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	3	0	3	0	25	36	-1	39	44													Vb 4	CSVEDGTNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCAGCGGGGGACAATGAGCAGTTCTTCGGGCCA	CSVSAGDNEQFF	In	VDJ	1	388	4.199670520694201E-4	4.94421195887639E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	2	5	2	0	25	34	-1	36	44													Vb 4	CSVSAGDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	2	396	4.286261665450783E-4	5.046154473492397E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGCTCAGGGGGACAGGGAGAATACGCAGTATTTTGGCCCA	CSVAQGDRENTQYF	In	VDJ	2	404	4.372852810207364E-4	5.148096988108405E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	7	8	3	25	33	50	41	53													Vb 4	CSVAQGDRENTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGAGAGGGCGAAGAGACCCAGTACTTCGGGCCA	CSVGEGEETQYF	In	VDJ	2	474	5.130525326827452E-4	6.040093990998476E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	2	3	0	6	25	-1	38	33	44													Vb 4	CSVGEGEETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGAGGACGTGGGCTACTATGGCTACACCTTCGGTTCG	CSAEDVGYYGYTF	In	VDJ	2	477	5.16299700611117E-4	6.07832243397948E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	1	7	3	4	7	25	32	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAEDVGYYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCGGACAGGCATGAGGTAAAGGCTGGAAACACCATATATTTTGGAGAG	CSVPDRHEVKAGNTIYF	In	VDJ	2	477	5.16299700611117E-4	6.07832243397948E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	4	2	3	13	25	33	43	36	56													Vb 4	CSVPDRHEVKAGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGACAGGGGGCGACCACAATGAGCAGTTCTTCGGGCCA	CSVATGGDHNEQFF	In	VDJ	2	488	5.282059830151469E-4	6.21849339157649E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	0	5	1	4	25	35	46	36	50													Vb 4	CSVATGGDHNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGTACAGGGGTCAGCCTCTGGAAACACCATATATTTTGGAGAG	CSAVQGSASGNTIYF	In	VDJ	2	563	6.093851812244421E-4	7.174204466101565E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	2	0	4	5	25	32	43	36	48													Vb 4	CSAVQGSASGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAAACAGGGAAAGATACGCAGTATTTTGGCCCA	CSVKTGKDTQYF	In	VDJ	3	651	7.046354404566817E-4	8.295572126877654E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	5	4	2	25	33	43	37	45													Vb 4	CSVKTGKDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCWATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	3	774	8.377693255199257E-4	9.862938289098777E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	42	-1	60	54	65													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGAGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSVDETGDTEAFF	In	VDJ	3	794	8.59417111709071E-4	0.0010117794575638798	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	3	3	0	25	36	-1	39	47													Vb 4	CSVDETGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGCAGTTATGGGGAGACAAACGGCTACACCTTCGGTTCG	CSGGSYGETNGYTF	In	VDJ	3	849	9.189485237292209E-4	0.0010818649363623853	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	7	0	8	0	18	25	-1	37	32	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGGSYGETNGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCCGGGGACACCGACCTAACAGATACGCAGTATTTTGGCCCA	CSASGDTDLTDTQYF	In	VDJ	3	861	9.31937195442708E-4	0.0010971563135547865	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	6	3	6	8	25	32	44	38	52													Vb 4	CSASGDTDLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCATCCGCGAGGTGGACTCGGGAGGAAACACCATATATTTTGGAGAG	CSIREVDSGGNTIYF	In	VDJ	4	998	0.0010802245308383538	0.0012717328698347002	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	8	1	10	4	11	5	25	31	47	42	52						01,02							Vb 4	CSIREVDSGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGATATTCCACGGGACAGCACATGAACACTGAAGCTTTCTTTGGACAA	CSARYSTGQHMNTEAFF	In	VDJ	17	4336	0.004693240045806716	0.005525284292187635	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	0	13	4	25	32	52	45	56													Vb 4	CSARYSTGQHMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGAAGGCTCAGCCCCAGCATTTTGGTGAT	CSVETGKAQPQHF	In	VDJ	397	102858	0.11133239959215571	0.13107003960466693	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	0	5	25	-1	43	37	48													Vb 4	CSVETGKAQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCTGGACTAGCGGTATTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSPGLAVFAGELFF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	1	5	6	4	6	23	34	48	38	54						01,02							Vb 22	CASSPGLAVFAGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACGGGCGCTGGGGGGCCGATGGCTACACCTTCGGTTCG	CASSDGRWGADGYTF	In	VDJ	1	109	1.1798043473084225E-4	1.3889667616431094E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	3	6	0	6	9	2	23	37	52	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDGRWGADGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGCTTTACAGGGGCGACAATCAGCCCCAGCATTTTGGTGAT	CASSEALYRGDNQPQHF	In	VDJ	1	130	1.4071061022944488E-4	1.6565658625101304E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	2	3	5	3	23	40	52	45	55													Vb 22	CASSEALYRGDNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTGACCCGGGGGGACTATGGCTACACCTTCGGTTCG	CASSVTRGDYGYTF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	3	7	0	23	34	-1	41	48													Vb 22	CASSVTRGDYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGAGGGCTCCGGTAATGAAAAACTGTTTTTTGGCAGT	CASREGSGNEKLFF	In	VDJ	1	147	1.5911122849021845E-4	1.8731937060691476E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	10	0	4	0	6	23	-1	40	34	46													Vb 22	CASREGSGNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTAGAGGCAGTTCCGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	156	1.6885273227533386E-4		55	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	1	5	1	18	23	35	40	36	58													Vb 22	X+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTGGGGGATTCACCCCTCCACTTTGGGAAC	CASSVGDSPLHF	In	VDJ	1	210	2.2730175498602634E-4	2.675991008670211E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-06	01	4	6	1	8	1	0	23	36	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVGDSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCGGACAGGGGGTAGAGACCCAGTACTTCGGGCCA	CAGQGVETQYF	In	VDJ	1	203	2.1972502981982547E-4	2.586791308381204E-4	33	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	1	1	4	0	1	28	-1	44	34	45			01,02											CAGQGVETQYF+TCRBV06-04+TCRBJ02-05	TCRBV06-04	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGGAGGAAAGAGACCCAGTACTTCGGGCCA	CASRRKETQYF	In	VDJ	2	601	6.505159749838182E-4	7.658431410527604E-4	33	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	1	3	0	1	28	-1	43	39	44			01,02											CASRRKETQYF+TCRBV06-04+TCRBJ02-05	TCRBV06-04	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCCAAGACAGGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASTQDRGSNQPQHF	In	VDJ	1	151	1.6344078572804753E-4	1.9241649633771517E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	2	1	5	1	26	36	49	41	50														CASTQDRGSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGCGGGCCGCGACTAGCTGGGTACGAGCAGTACGTCGGGCCG	CASSGGPRLAGYEQYV	In	VDJ	1	331	3.582708614303558E-4	4.2178715422373325E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	7	17	10	17	26	38	55	48	72						01,02								CASSGGPRLAGYEQYV+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCCATTGAGAGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	569	6.158795170811857E-4		50	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-04	01	2	5	2	2	9	0	26	41	-1	50	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCGAACAACTCAGGGTTGGGAGACCCAGTACTTCGGGCCA	CASSRTTQGWETQYF	In	VDJ	1	284	3.0739856388586423E-4	3.618959268868285E-4	45	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	5	8	4	29	42	55	50	59			01,02											CASSRTTQGWETQYF+TCRBV16-01+TCRBJ02-05	TCRBV16-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTCCCCGGCAGGAAACACCATATATTTTGGAGAG	CASSSPAGNTIYF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-03	01	4	9	0	4	4	1	18	31	38	35	39		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPAGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGCTCAGGAGGGGGGTTGGGGGAGACCCAGTACTTCGGGCCA	CASSYSGSGGGLGETQYF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	54	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	0	5	1	5	9	7	23	40	55	49	62		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGSGGGLGETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCAGTAGTGTTAAGGCTGGAAAGACCTATGGCTCGGTTCG		Out	VDJ	1	77	8.334397682820966E-5		44	TCRBV11	unresolved					TCRBJ01	TCRBJ01-02	01	5	1	8	18	15	12	18	30	48	45	60		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCACAGGGGGATTCTATGGCTACACCTTCGGTTCG	CASSTGGFYGYTF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	39	TCRBV07	unresolved		unresolved			TCRBJ01	TCRBJ01-02	01	1	0	8	4	1	2	22	38	43	39	45		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02										CASSTGGFYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGGCGGGGGTGTAGAGACCCAGTACTTCGGGCCA	CASSEGGGVETQYF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	2	4	1	3	23	38	46	39	49		TCRBV10-01,TCRBV10-02												CASSEGGGVETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCGCCCCGGGACACAATAAGCAGTTCTTCGGGCCA	CASSAPGHNKQFF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	11	5	5	22	34	45	39	50		TCRBV07-01,TCRBV07-02												CASSAPGHNKQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTGGCCTAGCCCCCCTAGGCGGACGCAGTATTTTGGCCCA	CASSEWPSPPRRTQYF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	7	9	3	12	23	39	47	42	59		TCRBV10-01,TCRBV10-02				01,02								CASSEWPSPPRRTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTTCCCGACCCGATCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSEFPTRSAGELFF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	48	TCRBV10	unresolved					TCRBJ02	TCRBJ02-02	01	1	2	7	6	4	8	23	39	46	43	54		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEFPTRSAGELFF+TCRBV10-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACACCCTAGAACGTGGAGGCCCCATCAGCCCCAGCATTTTGGTGAT	CASRHPRTWRPHQPQHF	In	VDJ	1	101	1.093213202551841E-4	1.2870242470271014E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	1	5	14	4	26	37	56	51	60		TCRBV06-07,TCRBV06-08												CASRHPRTWRPHQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACAAGGGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	104	1.1256848818355591E-4		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	5	2	0	1	0	23	38	-1	39	44		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCGGGGAGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAGEGSGANVLTF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	11	9	0	1	1	1	22	28	36	29	37		TCRBV07-01,TCRBV07-04												CAGEGSGANVLTF+TCRBV07-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGCGTCGGGTGAGGGTAATGAGCAGTTCTTCGGGCCA	CASSYASGEGNEQFF	In	VDJ	1	112	1.2122760265921406E-4	1.4271952046241123E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	7	9	1	23	38	52	47	53		TCRBV06-07,TCRBV06-08												CASSYASGEGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGACAGGGACAGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	115	1.2447477058758586E-4		41	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	4	4	4	1	23	34	46	38	47		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCCCCTCCCTTGGGGGCTACACCTTCGGTTCG	CASSPSLGGYTF	In	VDJ	1	122	1.3205149575378674E-4	1.5546233478941224E-4	36	TCRBV10	unresolved					TCRBJ01	TCRBJ01-02	01	6	0	9	8	10	0	23	34	-1	44	47		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSLGGYTF+TCRBV10-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGGGACAGGGGGCAGAGGTTGGAAACACCATATATTTTGGAGAG	CASRGQGAEVGNTIYF	In	VDJ	1	122	1.3205149575378674E-4	1.5546233478941224E-4	48	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	0	3	0	6	23	-1	46	34	52		TCRBV10-01,TCRBV10-02												CASRGQGAEVGNTIYF+TCRBV10-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCAGCGACGGTGGTCAGCCCCAGCATTTTGGTGAT	CASSSDGGQPQHF	In	VDJ	1	125	1.3529866368215855E-4	1.5928517908751256E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	6	6	6	0	7	18	-1	34	30	41		TCRBV07-02,TCRBV07-04				01,02								CASSSDGGQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGCCGGCGGGGGTGACGATGAGCAGTTCTTCGGGCCA	CASSEAGGGDDEQFF	In	VDJ	1	132	1.4287538884835943E-4	1.6820514911641325E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	2	8	5	5	23	37	49	42	54		TCRBV10-01,TCRBV10-02												CASSEAGGGDDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCTCAACCAGATACGCAGTATTTTGGCCCA	CASSESQPDTQYF	In	VDJ	1	144	1.5586406056184663E-4	1.8349652630881446E-4	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	0	3	7	4	3	0	26	43	-1	46	48		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESQPDTQYF+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGAGGGGTTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	150	1.6235839641859026E-4		40	TCRBV10	unresolved					TCRBJ01	TCRBJ01-02	01	2	5	2	4	1	3	23	38	44	39	47		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCACGGCACCTCCCAACACTGAAGCTTTCTTTGGACAA	CASTAPPNTEAFF	In	VDJ	1	156	1.6885273227533386E-4	1.9878790350121568E-4	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	7	9	0	2	1	7	18	28	32	29	39		TCRBV07-02,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTAPPNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGGGTCGGGCGATGAGCAGTTCTTCGGGCCA	CASSESGSGDEQFF	In	VDJ	1	163	1.7642945744153474E-4	2.0770787353011636E-4	42	TCRBV10	unresolved					TCRBJ02	TCRBJ02-01	01	0	6	2	8	0	7	23	-1	44	40	51		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESGSGDEQFF+TCRBV10-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAAGGGGTGGGGGGGAGCGTTCACCCCTCCACTTTGGGAAC	CASSERGGGERSPLHF	In	VDJ	1	167	1.8075901467936383E-4	2.1280499926091677E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	9	0	9	6	4	23	38	51	44	55		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSERGGGERSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACACAGGGCACGGGGAGCTGTTTTTTGGAGAA	CASSYTGHGELFF	In	VDJ	1	191	2.0673635810633826E-4	2.4338775364571917E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	3	7	0	2	23	-1	44	38	46		TCRBV06-07,TCRBV06-08												CASSYTGHGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGGACGGCGAAGTGCTTTGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	196	2.121483046536246E-4		49	TCRBV06	unresolved					TCRBJ01	TCRBJ01-03	01	6	0	7	3	0	14	23	-1	39	34	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGTCGAAACGAATTCCCGAGCTTTCTTTGGACAA	CASSESVETNSRAFF	In	VDJ	1	199	2.153954725819964E-4	2.5358200510732E-4	45	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	0	0	10	10	0	16	26	-1	45	43	61		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESVETNSRAFF+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCACAGGGGTTCGACCAGCCCCAGCATTTTGGTGAT	CASSSQGFDQPQHF	In	VDJ	1	216	2.3379609084276997E-4	2.752447894632217E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	7	1	6	23	36	44	37	50		TCRBV06-07,TCRBV06-08												CASSSQGFDQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGAGTTTTGGAGGCGAGCAGTTCTTCGGGCCA	CASSYSSFGGEQFF	In	VDJ	1	241	2.608558235792017E-4	3.071018252807242E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	1	10	7	1	26	43	55	50	56		TCRBV06-07,TCRBV06-08												CASSYSSFGGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCATACAACCGGGACACTCCTACAATGAGCAGTTCTTCGGGCCA	CASIQPGHSYNEQFF	In	VDJ	1	250	2.705973273643171E-4	3.1857035817502513E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	6	0	7	0	26	36	-1	43	49		TCRBV06-07,TCRBV06-08												CASIQPGHSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCTGGAAGCAGGGACGAGCAGTACTTCGGGCCG	CASSESGSRDEQYF	In	VDJ	1	257	2.78174052530518E-4	3.274903282039258E-4	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	5	6	0	26	43	-1	49	54		TCRBV10-01,TCRBV10-02												CASSESGSRDEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGTACACGGCCGGGAGACCCAGTACTTCGGGCCA	CASRVHGRETQYF	In	VDJ	1	261	2.8250360976834706E-4	3.325874539347262E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	6	3	6	5	3	7	26	37	43	40	50		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVHGRETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGGGAGGGGAAGCACTGAAGCTTTCTTTGGACAA	CASSESGRGSTEAFF	In	VDJ	1	263	2.8466838838726155E-4	3.3513601680012643E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	0	4	1	4	23	40	48	41	52		TCRBV10-01,TCRBV10-02												CASSESGRGSTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAGAACATCCAGGCACAGAAATCAATGAGCAGTTCTTCGGGCCA	CASREHPGTEINEQFF	In	VDJ	1	295	3.1930484628989414E-4	3.7591302264652963E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	5	6	13	4	23	34	51	47	55		TCRBV06-07,TCRBV06-08												CASREHPGTEINEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCATACGTGCCGGGGGCAGTACTCAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	303	3.279639607655523E-4		50	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	7	6	0	7	8	8	26	36	50	44	58		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCTGGGCAGGGGGCTGACATTCAGTACTTCGGCGCC	CASSESGQGADIQYF	In	VDJ	1	320	3.4636457902632585E-4	4.077700584640321E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	0	8	4	2	23	40	52	44	54		TCRBV10-01,TCRBV10-02												CASSESGQGADIQYF+TCRBV10-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACTCCTCCCGGGACAGTCACTGAAGCTTTCTTTGGACAA	CASTPPGTVTEAFF	In	VDJ	1	336	3.6368280797764214E-4	4.281585613872337E-4	42	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	0	5	4	13	1	26	31	51	44	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTPPGTVTEAFF+TCRBV12-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGTCCCAGTCGGGAGGAACCCTCCACTTTGGGAAC	CASRSQSGGTLHF	In	VDJ	1	343	3.7125953314384307E-4	4.3707853141613444E-4	39	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	8	1	14	8	2	26	37	52	45	54		TCRBV10-01,TCRBV10-02												CASRSQSGGTLHF+TCRBV10-X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGCCCGACTAGTGGCCGGGGAGCTGTTTTTTGGAGAA	CASARLVAGELFF	In	VDJ	2	417	4.513563420436809E-4	5.313753574359419E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	2	8	6	4	3	26	35	45	39	48		TCRBV06-07,TCRBV06-08				01,02								CASARLVAGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCACCCAAGATGGTGGAGGGCTCACTGAAGCTTTCTTTGGACAA	CATQDGGGLTEAFF	In	VDJ	2	429	4.643450137571681E-4	5.466667346283431E-4	42	TCRBV12	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	12	10	0	4	13	2	26	31	50	44	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CATQDGGGLTEAFF+TCRBV12-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGAGACAAGGACCTACACAGATACGCAGTATTTTGGCCCA	CASETRTYTDTQYF	In	VDJ	2	537	5.812430591785531E-4	6.842891293599539E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	8	1	7	2	7	3	23	32	43	39	46		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASETRTYTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACCTTATTCGGGACAGGGCCTCCCCGGGGAGCTGTTTTTTGGAGAA	CASRPYSGQGLPGELFF	In	VDJ	2	569	6.158795170811857E-4	7.250661352063571E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	6	9	5	23	34	52	43	57		TCRBV06-07,TCRBV06-08												CASRPYSGQGLPGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCGCGTGTGACCTTGGATTTAGGGTAGTACCCAGTACTTCGGGCCA		Out	VDJ	2	635	6.873172115053654E-4		47	TCRBV10	unresolved					TCRBJ02	TCRBJ02-05	01	8	5	3	8	18	4	23	32	54	50	58		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCAGGTAGCGGGGATGAGCAGTTCTTCGGGCCA	CASSESGSGDEQFF	In	VDJ	3	782	8.464284399955839E-4	9.964880803714786E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	3	0	26	43	-1	46	54		TCRBV10-01,TCRBV10-02												CASSESGSGDEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCCGAAGTAACAGGACAGAGAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	61	15757	0.017055208349118178		56	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	5	1	11	4	23	34	51	45	55		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATTTCCTAGCGGGGGCCCCCCGAGATGAGCAGTTCTTCGGGCCA	YASSQDFLAGAPRDEQFF	In	VDJ	1	121	1.3096910644432946E-4	1.5418805335671215E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	8	4	9	22	39	53	43	62													Vb 7.1	YASSQDFLAGAPRDEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGGGGACTAGCGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSGGLAGNTDTQYF	In	VDJ	1	72	7.793203028092332E-5	9.174826315440723E-5	48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	2	1	2	26	39	53	40	55			01,02										Vb 12	CASSGGLAGNTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCCGGACAGGGGGACGAGCAGTACTTCGGGCCG	CASSESGQGDEQYF	In	VDJ	1	251	2.7167971667377435E-4	3.198446396077252E-4	42	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	1	5	1	0	26	43	-1	44	54			01,02										Vb 12	CASSESGQGDEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTCACCTATTCCAGCTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	79	8.55087554471242E-5		52	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	4	2	7	4	20	0	22	35	-1	55	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCAAGGACAGGGAAATGGCTGCACCTTCGGTTCG	CASSQGQGNGCTF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	13	3	9	22	34	45	37	54														CASSQGQGNGCTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCGCATGGGGGTAACACTGAAGCTTTCTTTGGACAA	CASSPHGGNTEAFF	In	VDJ	1	348	3.766714796911294E-4	4.4344993857963497E-4	42	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-01	01	5	6	1	2	6	1	22	34	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHGGNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCGAGAGTATTTAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSREYLTNTGELFF	In	VDJ	1	72	7.793203028092332E-5	9.174826315440723E-5	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	2	0	2	9	23	34	39	36	48													Vb 12	CASSREYLTNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAACGGGATGGGAGAAGGTGTTTTTTGGAGAA		Out	VDJ	1	72	7.793203028092332E-5		40	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	3	15	2	10	23	38	45	40	55													Vb 12	X+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCCGGGAGAGGGGCACATCCAAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	84	9.092070199441054E-5		55	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	8	2	5	2	14	23	38	46	40	60													Vb 12	X+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAGGAACAGGGGGGATGTACGAGCAGTACTTCGGGCCG	CASRGTGGMYEQYF	In	VDJ	1	85	9.200309130386781E-5	1.0831392177950854E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	4	4	4	23	34	46	38	50													Vb 12	CASRGTGGMYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGACAGGGAGACGAGCAGTACTTCGGGCCG	CASSESGQGDEQYF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	0	2	23	-1	49	40	51													Vb 12	CASSESGQGDEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCGGGACACCTTCGAGTTTATAATTCACCCCTCCACTTTGGGAAC	CASSEPGHLRVYNSPLHF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	54	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	6	4	2	10	23	38	46	40	56													Vb 12	CASSEPGHLRVYNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCTTGCCTTGCGAGTGAGTGAAGACCCAGTACTTCGGGCCA	CASTLPCE*VKTQYF	Stop	VDJ	1	114	1.233923812781286E-4		45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	7	6	6	9	9	23	33	45	42	54						01,02							Vb 12	CASTLPCE*VKTQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACGGGGACAGAAGAGACCCAGTACTTCGGGCCA	CASTGTEETQYF	In	VDJ	1	118	1.2772193851595768E-4	1.5036520905861185E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	5	3	2	0	23	33	-1	35	42													Vb 12	CASTGTEETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAAGTACCGGGTCTCGGAAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSKYRVSESNQPQHF	In	VDJ	1	156	1.6885273227533386E-4	1.9878790350121568E-4	51	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	8	4	1	2	8	23	39	45	41	53						01,02							Vb 12	CASSKYRVSESNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTCCTAGCGGGGGGGCCGAATACGCAGTATTTTGGCCCA	CASSEVLAGGPNTQYF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	0	7	3	4	23	38	53	41	57													Vb 12	CASSEVLAGGPNTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGTAGGAGGAGGCTACACCTTCGGTTCG	CASSESVGGGYTF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	1	8	4	1	23	40	49	44	50													Vb 12	CASSESVGGGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCTCGGGGACCTTAACTATGGCTACACCTTCGGTTCG	CASSELGDLNYGYTF	In	VDJ	1	163	1.7642945744153474E-4	2.0770787353011636E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	2	0	7	1	4	2	23	38	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSELGDLNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTCTTTATCGGGGATACGCAGTATTTTGGCCCA	CASSVFIGDTQYF	In	VDJ	1	165	1.7859423606044928E-4	2.1025643639551657E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	6	7	0	23	36	-1	43	47						01,02							Vb 12	CASSVFIGDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGTACGGGGAATTAGACTATGGCTACACCTTCGGTTCG	CASSESYGELDYGYTF	In	VDJ	1	185	2.0024202224959463E-4	2.3574206504951858E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	3	3	6	23	40	48	43	54													Vb 12	CASSESYGELDYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAACCCGGGACAGACACTGAAGCTTTCTTTGGACAA	CASSEPGTDTEAFF	In	VDJ	1	190	2.05653968796881E-4	2.4211347221301908E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	3	4	0	23	37	-1	41	48													Vb 12	CASSEPGTDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCACCAGCAGACCGACAGGCATGAACACTGAAGCTTTCTTTGGACAA	CTSRPTGMNTEAFF	In	VDJ	1	199	2.153954725819964E-4	2.5358200510732E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	0	3	2	23	34	43	37	45													Vb 12	CTSRPTGMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTATCTAGCGGGGGTGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	202	2.186426405103682E-4		49	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	2	3	3	2	23	39	52	42	54													Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCTCCGAGACAGGGGGCAAGAGGGCCTGGCTACACCTTCGGTTCG		Out	VDJ	1	231	2.5003193048462897E-4		50	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	7	7	9	23	34	51	41	60													Vb 12	X+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGACAGAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSESTESSYEQYF	In	VDJ	1	281	3.041513959574924E-4	3.580730825887282E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	5	0	0	4	23	-1	45	40	49													Vb 12	CASSESTESSYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAACCCATCGGAGACCCAGTACTTCGGGCCA	CASSENPSETQYF	In	VDJ	1	290	3.138928997426078E-4	3.695416154830291E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	2	3	7	5	1	6	23	38	41	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSENPSETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCATCGGGGGGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	307	3.322935180033814E-4		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	1	4	2	0	23	40	-1	42	49													Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCAGGGGTTATAACTATGGCTACACCTTCGGTTCG	CASSESRGYNYGYTF	In	VDJ	1	349	3.7775386900058665E-4	4.4472422001233503E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	1	0	3	23	-1	46	40	49													Vb 12	CASSESRGYNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGGCAATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSERAISNQPQHF	In	VDJ	2	397	4.297085558545355E-4	5.058897287819399E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	2	5	3	0	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSERAISNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAGGGACCGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSRDRTYNEQFF	In	VDJ	2	494	5.347003188718905E-4	6.294950277538496E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	5	0	7	2	1	4	23	35	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSRDRTYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGGGGTGGAGGTCAGCCCCAGCATTTTGGTGAT	CASSESGGGGQPQHF	In	VDJ	6	1558	0.001686362544134424	0.0019853304721467566	45	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	6	1	6	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGGGGQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAACCCGGGACAGGGGGTCTATGGCTACACCTTCGGTTCG	CASNPGQGVYGYTF	In	VDJ	23	6054	0.006552784879454303	0.0077144997935664076	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	1	4	4	1	23	33	48	37	49													Vb 12	CASNPGQGVYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCGACTAGCGGGGGATCGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	88	9.525025923223961E-5		47	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	2	2	9	1	4	23	40	53	41	57													Vb 12	X+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCATTCAGGGGCGCCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	98	1.060741523268123E-4		44	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	2	1	6	4	24	31	43	37	47													Vb 12	X+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGAAGGAGGGGGTCGAGACTACACCTTCGGTTCG	CAISEEGGGRDYTF	In	VDJ	1	155	1.677703429658766E-4	1.9751362206851556E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	2	5	1	10	5	6	23	38	49	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEEGGGRDYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGATATCGGCAGCGGGGGGGCAAGGTACGCAGTATTTTGGCCCA	CAISESISAAGGQGTQYF	In	VDJ	1	158	1.710175108942484E-4	2.0133646636661586E-4	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	8	9	5	23	40	59	49	64													Vb 12	CAISESISAAGGQGTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTATCGAGGCGACGCCAAAAACATTCAGTACTTCGGCGCC	CAISEYRGDAKNIQYF	In	VDJ	1	232	2.5111431979408627E-4	2.956332923864233E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	11	1	1	3	4	23	39	46	42	50													Vb 12	CAISEYRGDAKNIQYF+TCRBV10-03+TCRBJ02-04	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACCGGACCAAGGAGAAACACTGAAGCTTTCTTTGGACAA	CAISETGPRRNTEAFF	In	VDJ	1	364	3.939897086424457E-4	4.6383844150283657E-4	48	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	2	1	7	2	3	8	23	38	45	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISETGPRRNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTTCGGACAGCCCAACTGAAGCTTTCTTTGGACAA	CAISESSDSPTEAFF	In	VDJ	2	399	4.3187333447345007E-4	5.0843829164734E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	5	3	4	23	40	49	43	53													Vb 12	CAISESSDSPTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGAAGCAGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSTPKQSQETQYF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	4	4	5	1	8	2	27	40	51	48	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPKQSQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIYLNTGELFF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	10	1	4	0	27	41	-1	45	47			01,02			01,02							Vb 17	CASSIYLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGACCCCGGGACAGTACATGGCTACACCTTCGGTTCG	CASDPGTVHGYTF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	0	5	6	7	3	27	35	49	42	52			01,02										Vb 17	CASDPGTVHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGGGACAGGTCGGCACTGAAGCTTTCTTTGGACAA	CASSKGGQVGTEAFF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	4	4	4	27	40	52	44	56			01,02										Vb 17	CASSKGGQVGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGCGGGACTAGCTGTCGAGGAGACCCAGTACTTCGGGCCA	CASSKAGLAVEETQYF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	7	5	4	7	27	40	53	44	60			01,02			01,02							Vb 17	CASSKAGLAVEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGCGACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASTATGGSGNTIYF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	1	0	4	0	27	37	-1	41	50			01,02										Vb 17	CASTATGGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAATAAACAGGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASRINRGSNQPQHF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	1	1	1	27	42	50	43	51			01,02										Vb 17	CASRINRGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGGATGGAGACCCAGTACTTCGGGCCA	CASSIEGMETQYF	In	VDJ	1	86	9.308548061332508E-5	1.0958820321220864E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	0	8	5	1	2	27	44	49	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGMETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTTGGGGTGAAGCTCCTACGAGCAGTACTTTGGGCCG		Out	VDJ	1	87	9.416786992278235E-5		43	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	7	6	2	19	5	24	27	37	46	42	70			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCCGGTCCCCCGAGGCCGGAAACACCATATATTTTGGAGAG	CASIRSPEAGNTIYF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	11	1	4	11	2	27	37	52	48	54			01,02										Vb 17	CASIRSPEAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTTAACACTGAAGCTTTCTTTGGACAA	CASSFNTEAFF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	10	2	0	2	27	-1	40	38	42			01,02			01,02							Vb 17	CASSFNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACCTTTCGGGGCAGGGCGGACTATGGCTACACCTTCGGTTCG	CASTFRGRADYGYTF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	9	4	3	3	12	3	27	35	52	47	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTFRGRADYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGTAAGGGACGGCTACACCTTCGGTTCG	CASRVRDGYTF	In	VDJ	1	98	1.060741523268123E-4	1.2487958040460984E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	0	7	8	5	0	27	38	-1	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRVRDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCCGAGTCAGGGCATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRAESGHSNQPQHF	In	VDJ	1	100	1.0823893094572684E-4	1.2742814327001005E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	0	8	2	27	38	51	46	53			01,02										Vb 17	CASRAESGHSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTTTTCTCGGTCTCCGCGAAGGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	101	1.093213202551841E-4		52	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	0	7	17	21	10	27	41	67	62	77			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGGTAATGGCTACACCTTCGGTTCG	CASSIGGNGYTF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	2	6	0	2	27	-1	47	41	49			01,02										Vb 17	CASSIGGNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGGGCCGCTCCACAGATACGCAGTATTTTGGCCCA	CASSGRSTDTQYF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	8	0	2	2	5	27	36	42	38	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTAGGGAGGATCAGCCCCAGCATTTTGGTGAT	CASSSREDQPQHF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	1	5	3	0	27	40	-1	43	49			01,02										Vb 17	CASSSREDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCAGGGGGACAGGATCGGCAATCAGCCCCAGCATTTTGGTGAT	CASQGDRIGNQPQHF	In	VDJ	1	108	1.1689804542138499E-4	1.3762239473161085E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	4	2	5	4	27	35	48	40	52			01,02										Vb 17	CASQGDRIGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGGGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSIAGGPYNEQFF	In	VDJ	1	108	1.1689804542138499E-4	1.3762239473161085E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	1	2	0	2	27	-1	50	43	52			01,02										Vb 17	CASSIAGGPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCATCAACAGGGGGACTATCTATGGCTACACCTTCGGTTCG	CASSAINRGTIYGYTF	In	VDJ	1	109	1.1798043473084225E-4	1.3889667616431094E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	1	4	7	5	27	39	54	46	59			01,02										Vb 17	CASSAINRGTIYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGCCTGGGGCTACACCTTCGGTTCG	CASSMGAWGYTF	In	VDJ	1	118	1.2772193851595768E-4	1.5036520905861185E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	8	0	4	27	-1	47	41	51			01,02										Vb 17	CASSMGAWGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTGATTGGGGGGCCTGAAGCTTTCTTTGGACAA	CASSIDLIGGPEAFF	In	VDJ	1	121	1.3096910644432946E-4	1.5418805335671215E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	6	0	6	8	0	27	44	-1	52	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDLIGGPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGAAGAGACCCAGTACTTCGGGCCA	CASSIREETQYF	In	VDJ	1	121	1.3096910644432946E-4	1.5418805335671215E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	3	0	0	27	-1	-1	41	46			01,02										Vb 17	CASSIREETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSISVNTEAFF	In	VDJ	1	123	1.33133885063244E-4	1.5673661622211236E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	5	0	1	0	27	42	-1	43	46			01,02			01,02							Vb 17	CASSISVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCAGGCAAAAGAATCAGCCCCAGCATTTTGGTGAT	CASSIGRQKNQPQHF	In	VDJ	1	124	1.3421627437270128E-4	1.5801089765481245E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	4	4	1	6	27	43	48	44	54			01,02										Vb 17	CASSIGRQKNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTCAGGGGGCTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASTLRGLGTGELFF	In	VDJ	1	125	1.3529866368215855E-4	1.5928517908751256E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	0	4	4	4	27	37	49	41	53			01,02										Vb 17	CASTLRGLGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGGGACAGGGGGAGTCGGGGAGCTGTTTTTTGGAGAA	CASSVGTGGVGELFF	In	VDJ	1	125	1.3529866368215855E-4	1.5928517908751256E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	1	7	3	3	27	39	53	42	56			01,02										Vb 17	CASSVGTGGVGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATCCAGGGCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSIIQGHTGELFF	In	VDJ	1	130	1.4071061022944488E-4	1.6565658625101304E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	3	4	2	27	41	50	45	52			01,02										Vb 17	CASSIIQGHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTATTTGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	134	1.4504016746727397E-4		38	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	1	8	1	2	0	27	41	-1	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATCGGTTCACCCCTCCACTTTGGGAAC	CASSIIGSPLHF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	8	5	9	2	0	27	42	-1	44	47			01,02			01,02							Vb 17	CASSIIGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASGGTGELFF	In	VDJ	1	147	1.5911122849021845E-4	1.8731937060691476E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	9	8	2	4	0	0	27	-1	-1	35	41			01,02										Vb 17	CASGGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGCTGACAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSIDADSSYNSPLHF	In	VDJ	1	148	1.6019361779967572E-4	1.8859365203961485E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	5	0	4	0	27	44	-1	48	53			01,02										Vb 17	CASSIDADSSYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGGTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSIWVAGELFF	In	VDJ	1	149	1.61276007109133E-4	1.8986793347231497E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	0	9	6	2	3	27	41	46	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWVAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCAGGCGGGGGTGCCGGGGAGCTGTTTTTTGGAGAA	CASTPGGGAGELFF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	7	2	6	6	2	27	37	50	43	52			01,02										Vb 17	CASTPGGGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAATTCTCCTTTGGGAGTGGGGGTTCACCCCTCCACTTTGGGAAC	CASSQFSFGSGGSPLHF	In	VDJ	1	153	1.6560556434696205E-4	1.9496505920311535E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	5	6	1	9	18	0	27	39	-1	57	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSQFSFGSGGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGACAGGGAAGCGAGACCCAGTACTTCGGGCCA	CASSIRQGSETQYF	In	VDJ	1	155	1.677703429658766E-4	1.9751362206851556E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	5	2	4	27	41	50	43	54			01,02										Vb 17	CASSIRQGSETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCTGTGCCAGTAACCGTTGGGGGGGAGGACAGGGGTCTTACTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNRWGGGQGSYYSGANVLTF	In	VDJ	1	157	1.6993512158479114E-4	2.0006218493391577E-4	66	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	1	2	0	14	8	2	12	35	26	43			01,02										Vb 17	CASNRWGGGQGSYYSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSIEAGQPQHF	In	VDJ	1	159	1.7209990020370568E-4	2.0261074779931597E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	6	4	6	0	0	27	-1	-1	44	50			01,02			01,02							Vb 17	CASSIEAGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSKGGETQYF	In	VDJ	1	160	1.7318228951316292E-4	2.0388502923201606E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	4	1	0	27	40	-1	41	47			01,02										Vb 17	CASSKGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGAACAGGGGTCGGAGGTAATTCACCCCTCCACTTTGGGAAC	CASSRTGVGGNSPLHF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	2	6	4	7	27	38	49	42	56			01,02										Vb 17	CASSRTGVGGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCGGTGTCACCCCTGCTCTGGAAACACCATATATTTTGGAGAG	CASNRCHPCSGNTIYF	In	VDJ	1	164	1.77511846750992E-4	2.0898215496281648E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	8	5	0	2	11	27	37	42	39	53			01,02			01,02							Vb 17	CASNRCHPCSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSMGTATNEKLFF	In	VDJ	1	164	1.77511846750992E-4	2.0898215496281648E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	0	7	0	1	2	27	41	47	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGTATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTCGACCATCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	170	1.8400618260773561E-4		40	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	2	7	2	4	4	27	39	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGCTCGCACAGATACGCAGTATTTTGGCCCA	CASSLARTDTQYF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	1	2	2	27	39	44	41	46			01,02										Vb 17	CASSLARTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCTCAGGGGCACGGAACACTGAAGCTTTCTTTGGACAA	CASSISSGARNTEAFF	In	VDJ	1	172	1.8617096122665016E-4	2.1917640642441728E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	1	4	4	27	42	52	46	56			01,02										Vb 17	CASSISSGARNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACGGACGGACTATGGCTACACCTTCGGTTCG	CASSPRTDYGYTF	In	VDJ	1	175	1.8941812915502197E-4	2.2299925072251757E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	1	7	3	4	2	27	39	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRTDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGTCTTTGTCGGGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSASLSGGQETQYF	In	VDJ	1	175	1.8941812915502197E-4	2.2299925072251757E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	8	0	1	11	2	27	39	54	50	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSASLSGGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCATGACAGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSTMTGATGELFF	In	VDJ	1	181	1.9591246501176557E-4	2.3064493931871817E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	4	6	1	27	38	52	44	53			01,02										Vb 17	CASSTMTGATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCAGGGAACAGCCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	195	2.1106591534416732E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	4	3	0	3	7	27	37	45	40	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGACAGGGCGTGCTGAAGCTTTCTTTGGACAA	CASSTRTGRAEAFF	In	VDJ	1	195	2.1106591534416732E-4	2.4848487937651956E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	6	3	4	27	40	51	43	55			01,02										Vb 17	CASSTRTGRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGAGGGGGGCAGCTACGAGCAGTACTTCGGGCCG	CASSMEGGSYEQYF	In	VDJ	1	199	2.153954725819964E-4	2.5358200510732E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	5	1	3	2	4	27	41	49	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMEGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCTTTAGGGGGCCGCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFRGPRSYNEQFF	In	VDJ	1	200	2.1647786189145368E-4	2.548562865400201E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	5	0	0	6	4	27	36	49	42	53			01,02										Vb 17	CASSFRGPRSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCTTAGACAGTATAGCACAGATACGCAGTATTTTGGCCCA	CASSTLRQYSTDTQYF	In	VDJ	1	207	2.2405458705765456E-4	2.637762565689208E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	0	6	3	27	40	51	46	54			01,02										Vb 17	CASSTLRQYSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATCCGGGCGGGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSNPGGSSYNEQFF	In	VDJ	1	216	2.3379609084276997E-4	2.752447894632217E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	4	0	6	2	27	40	51	46	53			01,02			01,02							Vb 17	CASSNPGGSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCGGGACGGATTCTGGAAACACCATATATTTTGGAGAG	CASSSGTDSGNTIYF	In	VDJ	1	225	2.435375946278854E-4	2.867133223575226E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	7	3	1	0	5	27	-1	46	40	51			01,02										Vb 17	CASSSGTDSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGACAGGGTGGACTGAAGCTTTCTTTGGACAA	CASSLGTGWTEAFF	In	VDJ	1	226	2.4461998393734264E-4	2.879876037902227E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	5	3	3	27	39	51	42	54			01,02										Vb 17	CASSLGTGWTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGTTAGGGGGCGCGTCTATGGCTACACCTTCGGTTCG	CASSLVRGRVYGYTF	In	VDJ	1	234	2.532790984130008E-4	2.981818552518235E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	0	4	6	4	27	39	52	45	56			01,02										Vb 17	CASSLVRGRVYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCTTTCTCACAGAACACTGAAGCTTTCTTTGGACAA	CASAFSQNTEAFF	In	VDJ	1	243	2.6302060219811623E-4	3.096503881461244E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	6	1	8	0	27	36	-1	44	47			01,02										Vb 17	CASAFSQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACAAAATTGGCAGGTCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASKQNWQVSSGANVLTF	In	VDJ	1	258	2.792564418399752E-4	3.287646096366259E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	4	4	0	11	4	27	37	52	48	56			01,02										Vb 17	CASKQNWQVSSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGGGTTTCGGTGAAAAACTGTTTTTTGGCAGT	CASSIRGFGEKLFF	In	VDJ	1	258	2.792564418399752E-4	3.287646096366259E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	2	7	1	6	27	41	47	42	53			01,02										Vb 17	CASSIRGFGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTAAACAACTGGGGACATCCTAGGGGTATACTGAAGCTTTCTTTGGACAA	CASTKQLGTS*GYTEAFF	Stop	VDJ	1	259	2.803388311494325E-4		54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	5	11	12	27	37	54	48	66			01,02										Vb 17	CASTKQLGTS*GYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGGACAGGGCTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSRDRASSGNTIYF	In	VDJ	1	266	2.879155563156334E-4	3.3895886109822673E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	3	0	2	4	27	38	49	40	53			01,02										Vb 17	CASSRDRASSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGTTGGACAGCTTATGGCTACACCTTCGGTTCG	CASSGWTAYGYTF	In	VDJ	1	272	2.9440989217237697E-4	3.466045496944273E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	5	4	2	27	39	49	43	51			01,02										Vb 17	CASSGWTAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCGGGACAGCCTATGGCTACACCTTCGGTTCG	CASTPGTAYGYTF	In	VDJ	1	291	3.149752890520651E-4	3.708158969157292E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	4	5	1	27	37	49	42	50			01,02										Vb 17	CASTPGTAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGCAGCTACCACCTATGGCTACACCTTCGGTTCG	CASSIGAATTYGYTF	In	VDJ	1	296	3.2038723559935144E-4	3.771873040792297E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	8	0	4	0	9	27	-1	47	43	56			01,02										Vb 17	CASSIGAATTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGCCCAGGGGGGTGCACCCCTCCACTTTGGGAAC	CASTAQGGAPLHF	In	VDJ	1	316	3.420350217884968E-4	4.026729327332317E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	4	1	11	5	3	27	37	49	42	52			01,02										Vb 17	CASTAQGGAPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAAGGGTGCAGGGGCCGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	348	3.766714796911294E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	4	9	3	27	38	53	47	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGAGGGAGCGAATGGCTACACCTTCGGTTCG	CASSTEGANGYTF	In	VDJ	1	349	3.7775386900058665E-4	4.4472422001233503E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	0	6	1	5	27	40	47	41	52			01,02										Vb 17	CASSTEGANGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGTGGACAGCCCCAGCATTTTGGTGAT	CASSIEGGQPQHF	In	VDJ	1	350	3.7883625831004394E-4	4.4599850144503515E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	1	8	7	4	0	27	44	-1	48	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTAACCCTAGCGGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLTLAGGYNEQFF	In	VDJ	1	356	3.853305941667875E-4	4.5364419004123574E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	4	6	0	27	39	-1	45	57			01,02										Vb 17	CASSLTLAGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGCCCGGGCGAGCAGTACTTCGGGCCG	CASSIDRPGEQYF	In	VDJ	1	367	3.972368765708175E-4	4.6766128580093687E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	4	6	5	0	27	44	-1	49	53			01,02			01,02							Vb 17	CASSIDRPGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACCGCAGGGACCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	389	4.210494413788774E-4		47	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	0	0	7	3	5	0	27	44	-1	49	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAAGGCGCCTATGGCTACACCTTCGGTTCG	CASSIEGAYGYTF	In	VDJ	2	401	4.340381130923646E-4	5.109868545127402E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	5	4	4	3	3	27	41	47	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGCAACGAACACTGAAGCTTTCTTTGGACAA	CASRATNTEAFF	In	VDJ	2	406	4.3945005963965094E-4	5.173582616762408E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	1	0	3	27	-1	41	38	44			01,02										Vb 17	CASRATNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCGCCTACACCTTCGGTTCG	CASSIGGAYTF	In	VDJ	2	434	4.6975696030445444E-4	5.530381417918436E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	7	0	10	0	2	27	-1	48	43	50			01,02										Vb 17	CASSIGGAYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCACAGGAGGATTAATGAAAAAACTGTTTTTTGGCAGT	CASRPTGGLMKKLFF	In	VDJ	2	436	4.71921738923369E-4	5.555867046572437E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	3	4	9	4	11	27	38	47	42	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPTGGLMKKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGCGGGAGGATGGCTACACCTTCGGTTCG	CASGREDGYTF	In	VDJ	2	437	4.730041282328263E-4	5.568609860899439E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	7	1	6	2	0	27	36	-1	38	46			01,02										Vb 17	CASGREDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCTATCTCTGTGCCAGTAGTATAGGGCACTCCGTCCGGGACACCCCATCCTTTAATCAGCCCCAGCATTTTGGTGAT	CASSIGHSVRDTPSFNQPQHF	In	VDJ	2	439	4.751689068517408E-4	5.59409548955344E-4	63	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	6	4	12	11	8	24	42	36	53			01,02										Vb 17	CASSIGHSVRDTPSFNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGTTTCAATCTACCGGGGGGGAAAAACTGTTTTTTGGCAGT	CASSVFQSTGGEKLFF	In	VDJ	2	442	4.784160747801126E-4	5.632323932534443E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	1	8	14	0	27	39	-1	53	60			01,02										Vb 17	CASSVFQSTGGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAGGGTTTAACACTGAAGTTTTCTTTGGACAA	CASSMGTGFNTEVFF	In	VDJ	2	443	4.7949846408956986E-4	5.645066746861445E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	13	1	14	27	41	51	42	65			01,02										Vb 17	CASSMGTGFNTEVFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTGGGGATACAATCAGCCCCAGCATTTTGGTGAT	CASSTWGYNQPQHF	In	VDJ	2	447	4.8382802132739894E-4	5.696038004169449E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	8	3	4	2	27	40	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTWGYNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGATGGGGGACAGGCTATGGCTACACCTTCGGTTCG	CASRWGTGYGYTF	In	VDJ	2	450	4.870751892557708E-4	5.734266447150452E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	0	4	4	7	0	27	35	-1	42	50			01,02										Vb 17	CASRWGTGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCGCCGGGACACGGAATGAGGCCCAGTACTTCGGGCCA	CASSTPAGTRNEAQYF	In	VDJ	2	467	5.054758075165443E-4	5.950894290709469E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	6	9	8	10	27	40	54	48	64			01,02										Vb 17	CASSTPAGTRNEAQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGACACAGGGAATCGACCACCTTCGGTTCG		Out	VDJ	2	486	5.260412043962325E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	13	5	7	27	40	51	45	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGACAGGGAATCAATCAGCCCCAGCATTTTGGTGAT	CASSIGQGINQPQHF	In	VDJ	2	489	5.292883723246042E-4	6.231236205903491E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	3	3	1	3	27	41	50	42	53			01,02										Vb 17	CASSIGQGINQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACTGGAGGGGGGGAGCTTACGAGCAGTACTTCGGGCCG	CASSHWRGGAYEQYF	In	VDJ	2	499	5.401122654191769E-4	6.358664349173501E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	9	0	4	7	4	27	39	53	46	57			01,02										Vb 17	CASSHWRGGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGGGGAGAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	500	5.411946547286342E-4		37	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	3	4	1	4	27	38	44	39	48			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAGAGGGGAGTCAGCCCCAGCATTTTGGTGAT	CAREGSQPQHF	In	VDJ	2	501	5.422770440380914E-4	6.384149977827503E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	9	5	2	6	2	2	27	35	42	37	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAREGSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGACCGTTGAGCGGGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPLSGGNTGELFF	In	VDJ	2	505	5.466066012759205E-4	6.435121235135507E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	9	6	2	2	10	1	27	35	53	45	54			01,02										Vb 17	CASRPLSGGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGCCCGGACAGGGGCTCTTCAGCCCCAGCATTTTGGTGAT	CASSPARTGALQPQHF	In	VDJ	2	515	5.574304943704933E-4	6.562549378405517E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	2	6	7	4	27	39	55	46	59			01,02										Vb 17	CASSPARTGALQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGACGGAATATGGCTACACCTTCGGTTCG	CASSTGTEYGYTF	In	VDJ	2	518	5.60677662298865E-4	6.60077782138652E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	4	0	7	5	2	4	27	40	47	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTGTEYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAATAGTATGGGACAGGGTGATGGCTACACCTTCGGTTCG	CANSMGQGDGYTF	In	VDJ	2	522	5.650072195366941E-4	6.651749078694524E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	6	0	2	27	-1	50	41	52			01,02										Vb 17	CANSMGQGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCACGGGGTAGGCGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	534	5.779958912501813E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	3	0	2	7	27	36	43	38	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGGGTCCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIRGSGTGELFF	In	VDJ	2	572	6.191266850095575E-4	7.288889795044575E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	0	4	1	5	27	42	48	43	53			01,02										Vb 17	CASSIRGSGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTCGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASSIFGGNTEAFF	In	VDJ	2	606	6.559279215311046E-4	7.722145482162608E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	1	5	0	27	41	-1	46	50			01,02			01,02							Vb 17	CASSIFGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACAGGGCTCGGGGACACTGAAGCTTTCTTTGGACAA	CASSITGLGDTEAFF	In	VDJ	2	634	6.862348221959081E-4	8.078944283318637E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	3	0	7	27	-1	48	42	55			01,02										Vb 17	CASSITGLGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSIAGETQYF	In	VDJ	3	652	7.05717829766139E-4	8.308314941204654E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	3	5	0	0	27	-1	-1	43	48			01,02										Vb 17	CASSIAGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCGGGACCGTCAATGAGCAGTTCTTCGGGCCA	CASSTPGTVNEQFF	In	VDJ	3	655	7.089649976945107E-4	8.346543384185657E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	0	7	6	5	3	27	40	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTPGTVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACCCTGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTLYSNQPQHF	In	VDJ	3	675	7.306127838836562E-4	8.601399670725677E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	9	3	7	0	1	6	27	35	38	36	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTLYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGTCACAGACCAATAATTCACCCCTCCACTTTGGGAAC	CASSIGSQTNNSPLHF	In	VDJ	3	677	7.327775625025707E-4	8.62688529937968E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	3	5	5	4	4	27	43	51	47	55			01,02										Vb 17	CASSIGSQTNNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGTCTACCAGGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGLPGGSGANVLTF	In	VDJ	3	677	7.327775625025707E-4	8.62688529937968E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	4	1	0	7	0	27	36	-1	43	50			01,02										Vb 17	CASGLPGGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCCCGCTGGGGCAACCTACAATGAGCAGTTCTTCGGGCCA	CASSHPAGATYNEQFF	In	VDJ	3	767	8.301926003537248E-4	9.77373858880977E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	2	9	2	27	39	53	48	55			01,02										Vb 17	CASSHPAGATYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATACTGGACACTCGAACACTGAAGCTTTCTTTGGACAA	CASSIDTGHSNTEAFF	In	VDJ	3	776	8.399341041388402E-4	9.88842391775278E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	6	1	4	3	27	44	53	48	56			01,02										Vb 17	CASSIDTGHSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTTTGGGGCGGCAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSMVWGGRGNQPQHF	In	VDJ	3	779	8.43181272067212E-4	9.926652360733783E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	2	12	0	27	41	-1	53	58			01,02										Vb 17	CASSMVWGGRGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTTGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSWTGGYNEQFF	In	VDJ	3	782	8.464284399955839E-4	9.964880803714786E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	3	4	0	27	39	-1	43	53			01,02										Vb 17	CASSSWTGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGCTAGCGGGGGGGCTTCCCGAGATACGCAGTATTTTGGCCCA	CASSIDASGGASRDTQYF	In	VDJ	3	803	8.691586154941865E-4	0.0010232479904581807	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	5	2	7	27	44	58	46	65			01,02										Vb 17	CASSIDASGGASRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGATCGGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSIGSVATNEKLFF	In	VDJ	3	803	8.691586154941865E-4	0.0010232479904581807	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	5	0	3	3	27	43	49	46	52			01,02			01,02							Vb 17	CASSIGSVATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGAAGAGGCACAGATACGCAGTATTTTGGCCCA	CASRRGTDTQYF	In	VDJ	3	803	8.691586154941865E-4	0.0010232479904581807	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	11	2	1	4	0	27	36	-1	40	43			01,02										Vb 17	CASRRGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCACCAGGTGGGTAGAAGAGACCCAGTACTTCGGGCCA	CASSPTRWVEETQYF	In	VDJ	3	856	9.265252488954217E-4	0.001090784906391286	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	4	3	6	7	27	38	48	44	55			01,02										Vb 17	CASSPTRWVEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTACGGACAGGGTAGGTGCTCAGCCCCAGCATTTTGGTGAT	CASTTDRVGAQPQHF	In	VDJ	4	907	9.817271036777423E-4	0.001155773259458991	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	3	6	4	7	27	37	49	41	56			01,02										Vb 17	CASTTDRVGAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCAGGGAACACTGAAGCTTTTTTTGGACAA	CASSMAGNTEAFF	In	VDJ	4	943	0.001020693118818204	0.0012016473910361947	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	17	2	15	27	41	48	43	63			01,02										Vb 17	CASSMAGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCCGACAGGGACGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSNPTGTLNTGELFF	In	VDJ	4	967	0.0010466704622451785	0.001232230145420997	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	1	4	5	27	40	51	44	56			01,02										Vb 17	CASSNPTGTLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTATGGTCCCCACCTACGAGCAGTACTTCGGGCCG	CASSIMVPTYEQYF	In	VDJ	4	972	0.001052082408792465	0.0012386015525844977	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	0	10	2	3	6	27	41	46	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIMVPTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCCAAAACACTGAAGCTTTCTTTGGACAA	CASSISQNTEAFF	In	VDJ	4	1014	0.0010975427597896702	0.0012921213727579018	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	6	2	3	1	27	42	47	45	48			01,02										Vb 17	CASSISQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGGACATTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	1015	0.0010986251490991274		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	2	2	2	27	39	47	41	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTAGGGACAGCCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLGTASTNEKLFF	In	VDJ	4	1032	0.0011170257673599009	0.0013150584385465036	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	5	0	0	3	27	-1	49	43	52			01,02										Vb 17	CASSLGTASTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGAGGCCGGGACTCTCCACACCGGGGAGCTGTTTTTTGGAGAA	CASEAGTLHTGELFF	In	VDJ	4	1042	0.0011278496604544737	0.0013278012528735047	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	0	10	3	7	4	27	35	48	42	52			01,02			01,02							Vb 17	CASEAGTLHTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGAAGAGATTACAATGAGCAGTTCTTCGGGCCA	CASRRRDYNEQFF	In	VDJ	5	1295	0.0014016941557471625	0.00165019445534663	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	2	4	5	2	27	38	46	43	48			01,02										Vb 17	CASRRRDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTAATGCGGGACCAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPNAGPSNQPQHF	In	VDJ	5	1320	0.0014287538884835943	0.0016820514911641325	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	7	3	1	7	3	27	38	51	45	54			01,02										Vb 17	CASSPNAGPSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGAACAGGCCGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	1344	0.0014547312319105686		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	4	3	3	5	27	36	44	39	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAAATCCTAGCGGGGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASEILAGRTGELFF	In	VDJ	5	1364	0.001476379018099714	0.001738119874202937	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	5	6	3	27	36	51	42	54			01,02										Vb 17	CASEILAGRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTGAAGGGAACTGAAGCTTTCTTTGGACAA	CASLKGTEAFF	In	VDJ	6	1442	0.001560805384237381	0.0018375138259535447	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	8	0	8	5	5	0	27	36	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASLKGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCTAGCGGGGGGGTCCGATGAGCAGTTCTTCGGGCCA	CASSPLAGGSDEQFF	In	VDJ	6	1523	0.0016484789183034197	0.001940730622002253	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	8	3	4	27	39	54	42	58			01,02										Vb 17	CASSPLAGGSDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACTCTGATGGGTCTGACACTGAAGCTTTCTTTGGACAA	CASRDSDGSDTEAFF	In	VDJ	6	1612	0.0017448115668451166	0.002054141669512562	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	10	3	0	12	27	-1	43	38	55			01,02			01,02							Vb 17	CASRDSDGSDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGAGACGGCTTATGGCTACACCTTCGGTTCG	CASSVETAYGYTF	In	VDJ	8	2047	0.0022156509164590285	0.0026084540927371054	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	0	2	7	5	0	4	27	-1	47	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVETAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCATCCGGGACAGGGGTCCAATGAGCAGTTCTTCGGGCCA	CASHPGQGSNEQFF	In	VDJ	8	2181	0.0023606910839263024	0.002779207804718919	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	6	5	2	27	36	51	41	53			01,02										Vb 17	CASHPGQGSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGACCAACAGGGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	9	2291	0.002479753907966602		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	4	7	1	27	38	51	45	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACGAAGAGGACAGGGGGCAACTATGGCTACACCTTCGGTTCG	CATKRTGGNYGYTF	In	VDJ	12	3225	0.0034907055229996906	0.004109557620457824	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	0	2	6	0	27	34	-1	40	51			01,02										Vb 17	CATKRTGGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTAGGGACTTAGGGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	23	5956	0.006446710727127491		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	2	2	6	27	39	47	41	53			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACTCAGGGAACTGAAGCTTTCTTTGGACAA	CASRTQGTEAFF	In	VDJ	26	6793	0.007352670579143224	0.008656193772331781	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	5	4	1	27	38	47	42	48			01,02										Vb 17	CASRTQGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTCAGGGAGGGGGGAACGGACAGTACGTCGGGCCG		Out	VDJ	32	8197	0.008872345169621229		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	17	5	16	27	38	50	43	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAATGCGGTTAACTACAATGAGCAGTTCTTCGGGCCA	CASNAVNYNEQFF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	7	5	3	2	4	23	33	39	35	43						01,02							Vb 11	CASNAVNYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCATCCCCGGGACAAGTGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	84	9.092070199441054E-5		40	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	6	6	5	5	23	33	44	38	49													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTCTCATAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	86	9.308548061332508E-5		43	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-06	01	5	4	6	5	3	6	23	35	40	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGCCAGACAGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASARQGGQETQYF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	2	1	1	4	1	23	32	45	36	46													Vb 11	CASARQGGQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCCGAGGGGGGTTTAATTTAGAAGCTTTCTTTGGACAA	CASRGGFNLEAFF	In	VDJ	1	135	1.4612255677673124E-4	1.7202799341451354E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	8	5	1	8	2	10	23	32	40	34	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASRGGFNLEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGGACAGGCCTAACTATGGCTACACCTTCGGTTCG	CASSGDRPNYGYTF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	0	0	1	23	-1	44	36	45													Vb 11	CASSGDRPNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTCGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSELGGPDTQYF	In	VDJ	1	173	1.8725335053610743E-4	2.2045068785711737E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	1	4	2	1	23	38	47	40	48													Vb 11	CASSELGGPDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCTAGCGGGGGTCCCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGVPGTGELFF	In	VDJ	1	187	2.0240680086850918E-4	2.382906279149188E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	5	0	8	23	-1	45	35	53													Vb 11	CASSLAGVPGTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGGTAGGGGGCTTCCCCTATGGCTACACCTTCGGTTCG	CASSEWVGGFPYGYTF	In	VDJ	1	193	2.0890113672525278E-4	2.459363165111194E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	0	4	4	5	23	39	50	43	55													Vb 11	CASSEWVGGFPYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGAGGTTATCGCCGAGCAGTACGTCGGGCCG	CASSEEVIAEQYV	In	VDJ	1	235	2.5436148772245806E-4	2.994561366845236E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	1	17	0	18	23	-1	42	37	60													Vb 11	CASSEEVIAEQYV+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTACGGGACAAGGGAGACCCAGTACTTCGGGCCA	CASSYGTRETQYF	In	VDJ	1	235	2.5436148772245806E-4	2.994561366845236E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	5	3	3	23	35	44	38	47													Vb 11	CASSYGTRETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATTCCAGGACAGGGGGTTATTCACCCCTCCACTTTGGGAAC	CASSDSRTGGYSPLHF	In	VDJ	1	244	2.6410299150757347E-4	3.109246695788245E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	1	8	5	2	23	37	52	42	54													Vb 11	CASSDSRTGGYSPLHF+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCTGTTCAAGAGACCCAGTACTTCGGGCCA	CASSEPVQETQYF	In	VDJ	1	248	2.6843254874540256E-4	3.160217953096249E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	10	2	1	3	23	38	41	39	44						01,02							Vb 11	CASSEPVQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTTGCCCAAGGGGTCGGGGCTGAAGCTTTCTTTGGACAA	CASSEFAQGVGAEAFF	In	VDJ	1	261	2.8250360976834706E-4	3.325874539347262E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	1	5	2	6	7	6	23	39	51	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEFAQGVGAEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCGCACGGGAGTGCTAACACTGAAGCTTTCTTTGGACAA	CASSEPHGSANTEAFF	In	VDJ	1	269	2.911627242440052E-4	3.42781705396327E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	2	2	5	4	23	38	49	43	53													Vb 11	CASSEPHGSANTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGGGGAGGGTCAGCCCCAGCATTTTGGTGAT	CASSESGEGQPQHF	In	VDJ	1	320	3.4636457902632585E-4	4.077700584640321E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	0	6	3	0	23	39	-1	42	49													Vb 11	CASSESGEGQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGGTAGCGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	691	7.479310128349724E-4		44	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	6	2	3	1	23	37	45	40	46						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTTGAGGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEFEGATNEKLFF	In	VDJ	4	983	0.0010639886911964949	0.0012526186483441987	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	11	0	0	2	2	23	39	46	41	48													Vb 11	CASSEFEGATNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTTACCGGACAGGGGCCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	132	1.4287538884835943E-4		56	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	1	2	0	4	3	22	37	50	41	53														X+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCCGGGAGGGCAAGAGACCCAGTACTTCGGGCCA	CATSRDPGGQETQYF	In	VDJ	1	116	1.2555715989704313E-4	1.4781664619321165E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	8	0	2	2	0	18	35	-1	37	45														CATSRDPGGQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGACCGAGGGGCGATGGTAATGAAAAACTGTTTTTTGGCAGT	CATRPRGDGNEKLFF	In	VDJ	1	120	1.298867171348722E-4	1.5291377192401206E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	6	5	2	4	4	6	18	29	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRPRGDGNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAACGGTCCAGCTACGAGCAGTACTTCGGGCCG	CATSRERSSYEQYF	In	VDJ	1	172	1.8617096122665016E-4	2.1917640642441728E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	0	4	5	3	6	0	18	35	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRERSSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCGGCTAGCGCAGATACGCAGTATTTTGGCCCA	CATSRDPASADTQYF	In	VDJ	1	178	1.9266529708339376E-4	2.2682209502061787E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	6	4	5	0	18	35	-1	40	46						01,02								CATSRDPASADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATCAGCGGGTGGGCCCATTTTAACTATGGCTACACCTTCGGTTCG	CATSRDISGWAHFNYGYTF	In	VDJ	1	255	2.7600927391160343E-4	3.249417653385256E-4	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	6	4	1	4	11	18	35	45	39	56						01,02								CATSRDISGWAHFNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGCCAGGGAGGAGCCGATACGCAGTATTTTGGCCCA	CATSSGQGGADTQYF	In	VDJ	1	301	3.2579918214663777E-4	3.8355871124273023E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	1	6	6	4	18	32	44	38	48														CATSSGQGGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGTTCCTTCCGGGGGTAAACACTGAAGCTTTCTTTGGACAA	CATSRFLPGVNTEAFF	In	VDJ	1	381	4.1239032690321923E-4	4.8550122585873823E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	2	2	8	2	18	32	46	40	48														CATSRFLPGVNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAAGGGACTACCACCTCCTACTGACAATGAGCAGTTCTTCGGGCCA	CATKGLPPPTDNEQFF	In	VDJ	2	519	5.617600516083222E-4	6.613520635713521E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	5	1	13	18	28	36	29	49						01,02								CATKGLPPPTDNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACGTGACAGGGGAAAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	3	653	7.068002190755963E-4		41	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	2	17	2	21	18	26	36	28	57														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CATSRVGVNTEAFF	In	VDJ	3	702	7.598372952390024E-4	8.945455657554705E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	0	1	0	18	34	-1	35	40														CATSRVGVNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACTTACGGACCGGGCGAGGGGAAGGCACTGAAGCTTTCTTTGGACAA	CATSRDLRTGRGEGTEAFF	In	VDJ	5	1302	0.0014092708809133633	0.0016591144253755308	57	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	5	2	4	15	4	18	35	55	50	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDLRTGRGEGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CATSRGTGDTEAFF	In	VDJ	6	1549	0.0016766210403493086	0.0019738619392524557	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	2	3	0	0	18	-1	-1	34	43														CATSRGTGDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGGTCGGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CATSREGSGATNEKLFF	In	VDJ	7	1769	0.0019147466884299076	0.0022542038544464777	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	8	2	0	5	0	18	35	-1	40	46														CATSREGSGATNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGAAGGGGGAACGCAGTATTTTGGCCCA	CASSEGGTQYF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	33	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	9	3	1	26	37	46	40	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSEGGTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCTTAAGCAGGGAGACGCTGGAAACACCATATATTTTGGAGAG	CASSLKQGDAGNTIYF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	48	unresolved						TCRBJ01	TCRBJ01-03	01	4	4	3	2	5	5	26	39	49	44	54	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKQGDAGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAGGGAAAACAGGGGGCAAAATTAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	67	7.252008373363698E-5		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	0	8	8	6	26	35	52	43	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGCAATCCTCAGGGGCCTTCTATGGCTACACCTTCGGTTCG	CSAWQSSGAFYGYTF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	4	10	4	26	35	51	45	55		TCRBV20-01,TCRBV20-or09_02												CSAWQSSGAFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAGGACGCGGACAGGGATGATCCTACGAGCAGTACGTCGGGCCG	CATRGRGQG*SYEQYV	Stop	VDJ	1	67	7.252008373363698E-5		48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	17	7	20	24	35	50	42	70		TCRBV24-01,TCRBV24-or09_02												CATRGRGQG*SYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTTCCTTCCGGGGCTGGGGGAGAGACCCAGTACTTCGGGCCA	CASSLLPSGAGGETQYF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	51	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	6	1	4	18	0	24	36	-1	54	59		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLPSGAGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACAGCTTGGGGGTCATGGTTCACCCCTCCACTTTGGGAAC	CASSRQLGGHGSPLHF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	48	TCRBV03						TCRBJ01	TCRBJ01-06	01	4	2	5	9	0	14	26	-1	44	39	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQLGGHGSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCAGGGAGAGACCCAGTACTTCGGGCCA	CSAAQGETQYF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	4	3	0	26	35	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSAAQGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCTGGGCACAGCCTTTTGCTACCATATATTTTGGAGAG	CSARSWAQPFATIYF	In	VDJ	1	69	7.468486235255151E-5	8.792541885630693E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	5	10	9	9	26	37	50	46	59		TCRBV20-01,TCRBV20-or09_02												CSARSWAQPFATIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGTGACAGGAAATACCGGGGAGCTGTTTTTTGGAGAA	CATSDLVTGNTGELFF	In	VDJ	1	70	7.576725166200879E-5	8.919970028900702E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	4	5	2	4	24	42	50	44	54		TCRBV24-01,TCRBV24-or09_02												CATSDLVTGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAAGTGGAGGGAGGAGTTGGGAGACCCAGTACTTCGGGCCA	CASRSGGRSWETQYF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	1	5	7	6	26	37	50	44	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSGGRSWETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCTTGGACGGGGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	71	7.684964097146606E-5		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	1	3	7	0	26	42	-1	49	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAGAGGGGTAGACTATGGCTACACCTTCGGTTCG	CASSPRGVDYGYTF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	5	2	3	4	3	26	39	48	43	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGVDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCGGGACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDPGTGSYNEQFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	1	4	0	26	40	-1	44	53		TCRBV20-01,TCRBV20-or09_02												CSARDPGTGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGATAAAAGGAGAAAATGAGCAGTTCTTCGGGCCA	CSARDLIKGENEQFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	2	7	10	2	26	40	54	50	56		TCRBV20-01,TCRBV20-or09_02												CSARDLIKGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCGTAATGGACAGTCTGGGTTCACCCCTCCACTTTGGGAAC	CASSPVMDSLGSPLHF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	5	9	7	6	23	36	49	43	55	TCRBV01,TCRBV04													CASSPVMDSLGSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATACGGAGGGTTTGACTGAAGCTTTCTTTGGACAA	CAISDTEGLTEAFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	42				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	5	5	4	23	35	46	40	50	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDTEGLTEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCCAGGGACAGGGCTGAACGAAAAACTGTTTTTTGGCAGT	CASSPGTGLNEKLFF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	8	3	6	19	31	43	34	49	TCRBV05,TCRBV07													CASSPGTGLNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGAACAGGCTGACAATCAGCCCCAGCATTTTGGTGAT	CSAREQADNQPQHF	In	VDJ	1	72	7.793203028092332E-5	9.174826315440723E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	4	3	0	4	26	-1	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSAREQADNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGTGGGAGGCTACGAGCAGTACTTCGGGCCG	CSARRVGGYEQYF	In	VDJ	1	72	7.793203028092332E-5	9.174826315440723E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	1	3	5	0	26	38	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSARRVGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCACCGACTAGCGGGGGGCCTAGCTGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	72	7.793203028092332E-5		52	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	1	4	4	8	20	31	48	35	56	TCRBV07,TCRBV23													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGAAGCCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSWEASSGANVLTF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	48	TCRBV12						TCRBJ02	TCRBJ02-06	01	4	0	8	0	0	6	26	-1	43	39	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWEASSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGGACGTCAGGGGTTCAGGCAATGAGCAGTTCTTCGGGCCA	CASRDVRGSGNEQFF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	6	6	6	22	33	45	39	51		TCRBV12-03,TCRBV12-04												CASRDVRGSGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGACGGAGCTAGCTACGAGCAGTACTTCGGGCCG	CASSVDGASYEQYF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	8	3	10	0	24	36	-1	46	50	TCRBV09,TCRBV21					01,02								CASSVDGASYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCAAAGTCGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQSRSNQPQHF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	42	unresolved						TCRBJ01	TCRBJ01-05	01	5	4	6	0	1	6	23	34	37	35	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSRSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGACGGGAACACTGAAGCTTTCTTTGGACAA	CASSFDGNTEAFF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	2	7	1	1	2	26	40	44	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTGGAGGGTAGAGGTGAACTCACCCCTCCACTTTGGGAAC	CASSQDWRVEVNSPLHF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	51				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	10	0	10	2	11	18	35	43	37	54	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDWRVEVNSPLHF+X+TCRBJ01-06		TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCTAGGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSSRGDQETQYF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	42	unresolved						TCRBJ02	TCRBJ02-05	01	4	5	1	0	2	1	18	31	39	33	40	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGDQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACTAGCGGGGGCCACGAGCAGTACTTCGGGCCG	CASSLTSGGHEQYF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	5	0	2	26	-1	52	40	54		TCRBV12-03,TCRBV12-04												CASSLTSGGHEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCGGGACAGTGGCAACACTGAAGCTTTCTTTGGACAA	CSATRDSGNTEAFF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	2	3	4	26	36	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSATRDSGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCAATAGCGGCGGGGTGAATGAGCAGTTCTTCGGGCCA	CASSSNSGGVNEQFF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	5	7	4	7	18	31	41	35	48	TCRBV07,TCRBV11					01,02								CASSSNSGGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTGCTGGGGGCTCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSSAGGSYQETQYF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	0	5	4	26	39	50	44	54		TCRBV12-03,TCRBV12-04												CASSSAGGSYQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGGGGAGATACGCAGTATTTTGGCCCA	CASSLGGDTQYF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	2	5	1	0	26	39	-1	40	46		TCRBV03-01,TCRBV03-02												CASSLGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTAACCGGGCCTGGGAGCACTGAAGCTTTCTTTGGACAA	CSAVTGPGSTEAFF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	2	4	13	0	26	34	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSAVTGPGSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGACCAGCAGATACGCAGTATTTTGGCCCA	CSAGGPADTQYF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	0	7	4	2	3	26	35	42	37	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGGPADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGTGGACTAGCGGGGGCCTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	76	8.226158751875239E-5		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	1	2	5	1	4	23	39	53	40	57	TCRBV02,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGCCAGCGGGGGGGATAACCTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSSPAGGITFTGELFF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	6	0	4	4	8	26	39	53	43	61		TCRBV12-03,TCRBV12-04												CASSSPAGGITFTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGAGGCGGCGTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGGVSSYNEQFF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	7	5	0	3	6	26	42	49	45	55		TCRBV12-03,TCRBV12-04				01,02								CASSLGGGVSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATTTATGGGGGGGAGCTTTCTTTGGACAA	XASSQDLWGGAFF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	10	5	0	23	40	-1	45	52	TCRBV01,TCRBV04													XASSQDLWGGAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGACACAGGGGATGAGCAGTTCTTCGGGCCA	CATSEDTGDEQFF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	8	4	0	24	38	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSEDTGDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGGTATTGCGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	77	8.334397682820966E-5		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	5	2	7	0	24	37	-1	44	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCAAGAAGGGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSKKGAGANVLTF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	45	unresolved						TCRBJ02	TCRBJ02-06	01	5	5	3	2	4	2	18	30	38	34	40	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKKGAGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTTAGGCAGGGGGAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	78	8.442636613766693E-5		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	2	9	2	24	36	52	45	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGWGACWCKGCWSTGTATYTCTGYGCCAGCAGCTTAACTGGGGAGGATACGCAGTATTTTGGCCCA	CASSLTGEDTQYF	In	VDJ	1	78	8.442636613766693E-5	9.939395175060784E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	2	6	8	0	20	31	-1	39	44	TCRBV03,TCRBV23													CASSLTGEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTCCTCGTGGACAGCGTGAAGCTTTCTTTGGACAA	CASSPRGQREAFF	In	VDJ	1	78	8.442636613766693E-5	9.939395175060784E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	7	6	2	23	35	47	41	49	TCRBV02,TCRBV12													CASSPRGQREAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCTCCCCAAGGGGCGAGACTGAAGCTTTCTTTGGACAA	CSAGSPRGETEAFF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	5	9	4	26	35	49	44	53		TCRBV20-01,TCRBV20-or09_02												CSAGSPRGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGACTAGGACAGTATGGCGGGGAGCTGTTTTTTGGAGAA	CASRLGQYGGELFF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	7	4	5	18	29	39	33	44	TCRBV05,TCRBV11													CASRLGQYGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTCGACAGGATACGAGCAGTACGTCGGGCCG	CASSSTGYEQYV	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	4	17	1	14	26	39	46	40	60	TCRBV12,TCRBV21													CASSSTGYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGTTCGAATAGCGGGGCATGGGAGCAGTACGTCGGGCCG	CSASRSNSGAWEQYV	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	3	17	9	15	26	37	54	46	69		TCRBV20-01,TCRBV20-or09_02												CSASRSNSGAWEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTGTAGCGGGGGCCTTATACAATGAGCAGTTCTTCGGGCCA	CASSSVAGALYNEQFF	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	4	4	5	24	36	49	40	54		TCRBV24-01,TCRBV24-or09_02												CASSSVAGALYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGCGTCCCGGGACTAGCGGGGATATTCCAAGAGACCCAGTACTTCGGGCCA	CASSRVPGLAGIFQETQYF	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	57	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	1	8	5	24	36	57	44	62		TCRBV12-03,TCRBV12-04												CASSRVPGLAGIFQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGGTGACAGGGTGGATGAAAAACTGTTTTTTGGCAGT	CASSLGDRVDEKLFF	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	3	6	4	3	18	32	43	36	46	TCRBV05,TCRBV11													CASSLGDRVDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGTGCCGGGACTAACGCAGATACGCAGTATTTTGGCCCA	CASSAGTNADTQYF	In	VDJ	1	81	8.767353406603873E-5	1.0321679604870813E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	9	4	7	3	19	27	41	34	44	TCRBV07,TCRBV11					01,02								CASSAGTNADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGCATGCTCGGGGGGGCGGGTGAGACCCAGTACTTCGGGCCA	CASSMLGGAGETQYF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	5	6	5	36	47	61	53	66	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSMLGGAGETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCTAGTCAGGGGATTAACACTGAAGCTTTCTTTGGACAA	CASSPSQGINTEAFF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	2	7	3	26	37	50	44	53		TCRBV03-01,TCRBV03-02												CASSPSQGINTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGCATTTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSEHLSSYNSPLHF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	48	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	2	4	6	0	0	6	24	-1	41	39	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASSEHLSSYNSPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAAGTACAGGGGGAATGAACACTGAAGCTTTCTTTGGACAA	CSARDLSTGGMNTEAFF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	1	0	7	2	26	40	55	47	57		TCRBV20-01,TCRBV20-or09_02												CSARDLSTGGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAACAAGCTAGCGGGTAACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	83	8.983831268495328E-5		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	4	4	7	4	22	35	50	42	54	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACGGACGGGGGCGGAGATACGCAGTATTTTGGCCCA	CASSPTDGGGDTQYF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	6	0	5	8	2	26	39	53	47	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTDGGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAAACAGCGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	84	9.092070199441054E-5		34	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	4	6	5	0	26	36	-1	41	47		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTTAGCCTCCAAGAGACCCAGTACTTCGGGCCA	CSARLSLQETQYF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	7	1	2	2	26	38	44	40	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLSLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCAAAGGAATGCAGCCCGGAGGGGTCCCTCCACTTTGGGAAC		Out	VDJ	1	84	9.092070199441054E-5		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	10	10	0	14	17	2	23	30	53	47	55	TCRBV06,TCRBV10													X+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTAAAGAGCACAATGAGCAGTTCTTCGGGCCA	CSARVKEHNEQFF	In	VDJ	1	85	9.200309130386781E-5	1.0831392177950854E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	7	5	6	0	26	39	-1	45	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVKEHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGGACGGGGATCAGCCCCAGCATTTTGGTGAT	CSAVDGDQPQHF	In	VDJ	1	85	9.200309130386781E-5	1.0831392177950854E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	5	5	0	26	35	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSAVDGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCAGACAGCCAAATCAGCCCCAGCATTTTGGTGAT	CATSGRQPNQPQHF	In	VDJ	1	85	9.200309130386781E-5	1.0831392177950854E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	4	3	3	24	37	45	40	48		TCRBV24-01,TCRBV24-or09_02												CATSGRQPNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTGGGGACTAGCGGGGCACAATGAGCAGTTCTTCGGGCCA	CASSWGLAGHNEQFF	In	VDJ	1	85	9.200309130386781E-5	1.0831392177950854E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	5	1	1	18	31	45	32	46	TCRBV07,TCRBV11													CASSWGLAGHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCTTCAGGGGGCTAGCGGGGGAAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	85	9.200309130386781E-5		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	12	4	2	4	10	3	18	23	43	33	46	TCRBV07,TCRBV12													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAAGGGACAGCTGTTTGGGAAGCTTTCTTTGGACAA	CSASQGTAVWEAFF	In	VDJ	1	86	9.308548061332508E-5	1.0958820321220864E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	8	4	8	26	37	48	41	56		TCRBV20-01,TCRBV20-or09_02												CSASQGTAVWEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGGGACTCAGCTGTGTACTTCTGTGTCAGCAGCGGACGGGGGGACGAGGGGGAAAAACTGTTTTTTGGCAGT	CVSSGRGDEGEKLFF	In	VDJ	1	86	9.308548061332508E-5	1.0958820321220864E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	8	4	8	22	33	44	37	52		TCRBV12-03,TCRBV12-04												CVSSGRGDEGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCTAGCGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSPSGGTDTQYF	In	VDJ	1	86	9.308548061332508E-5	1.0958820321220864E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	5	1	1	2	18	30	38	31	40	TCRBV05,TCRBV11					01,02								CASSPSGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGGCCGGGACAGGGGCACCTACGAGCAGTACGTCGGGCCG	CASGRDRGTYEQYV	In	VDJ	1	86	9.308548061332508E-5	1.0958820321220864E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	17	4	17	23	32	46	36	63	TCRBV02,TCRBV09													CASGRDRGTYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCCGCCCAGCCAATTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	87	9.416786992278235E-5		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	8	0	3	0	13	26	-1	41	37	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCCGGGACAGGGACAAGAGACCCAGTACTTCGGGCCA	CSVPGQGQETQYF	In	VDJ	1	87	9.416786992278235E-5	1.1086248464490874E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	3	2	4	1	26	33	46	37	47		TCRBV20-01,TCRBV20-or09_02												CSVPGQGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCCCGCCGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSSPAVMNTEAFF	In	VDJ	1	87	9.416786992278235E-5	1.1086248464490874E-4	45	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	4	6	0	11	0	24	36	-1	47	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPAVMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACGGCCTTGGTGGTGCGGTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSDGLGGAVAGELFF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	7	5	6	13	3	24	38	55	51	58	TCRBV06,TCRBV10					01,02								CASSDGLGGAVAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSAMGATNEKLFF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	4	6	1	0	1	0	26	36	-1	37	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMGATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAGGGGGGCCTAATGAAAAACTGTTTTTTGGCAGT	CSARGGPNEKLFF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	6	0	3	0	0	26	-1	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGGPNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGACAGGGAGTATACATTCAGTACTTCGGCGCC		Out	VDJ	1	88	9.525025923223961E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	3	8	1	5	24	41	49	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATCTCTCGAGAAGCTTTCTTTGGACAA	CASSISREAFF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	33	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	2	8	8	7	0	26	38	-1	45	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSISREAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGACTAGCGGGGGAATACAATGAGCAGTTCTTCGGGCCA	CASSPGLAGEYNEQFF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	4	2	2	26	38	54	40	56		TCRBV12-03,TCRBV12-04												CASSPGLAGEYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGTACCGTGTCCTATGGCTACACCTTCGGTTCG	CASSLGTVSYGYTF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	42	TCRBV12						TCRBJ01	TCRBJ01-02	01	1	3	7	4	2	6	26	42	46	44	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTVSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAACGGGGACAGCCTTGAATGAGCAGTTCTTCGGGCCA	CSAQTGTALNEQFF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	7	6	5	26	35	48	41	53		TCRBV20-01,TCRBV20-or09_02												CSAQTGTALNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGACCCCCAAGATGAGCAGTTCTTCGGGCCA	CAISDPQDEQFF	In	VDJ	1	89	9.633264854169688E-5	1.1341104751030894E-4	36	unresolved						TCRBJ02	TCRBJ02-01	01	5	2	7	8	0	7	23	-1	38	35	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDPQDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCTCAGGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSVAQGGGETQYF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	4	9	2	26	37	53	46	55	TCRBV09,TCRBV12													CASSVAQGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTTACCAGGGTTCCTATAATTCACCCCTCCACTTTGGGAAC	CSARAYQGSYNSPLHF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	1	5	1	26	39	49	44	50		TCRBV20-01,TCRBV20-or09_02												CSARAYQGSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGACCCGATAAACACAGATACGCAGTATTTTGGCCCA	CSAPDPINTDTQYF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	1	7	2	2	8	26	35	41	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDPINTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCTCCTCAGGGGTCAGGGAGACCCAGTACTTCGGGCCA	CASSLSSGVRETQYF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	2	5	7	5	18	30	43	37	48	TCRBV07,TCRBV11													CASSLSSGVRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGTAGGGAGGCAGCGAATGAAAAACTGTTTTTTGGCAGT	CASREAANEKLFF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	9	9	1	5	2	5	20	28	36	30	41	TCRBV07,TCRBV23													CASREAANEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCCCCGGTCTCCGAACACTGAAGCTTTCTTTGGACAA	XASSPRSPNTEAFF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	1	3	5	22	34	40	37	45	TCRBV01,TCRBV07,TCRBV17					01,02								XASSPRSPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAATCCGGGAAGGGCCCTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	91	9.849742716061142E-5		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	3	4	5	8	24	36	46	41	54	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCGACAGGATCTGGAAACACCATATATTTTGGAGAG	CASSSTGSGNTIYF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	4	1	2	1	24	36	44	38	45	TCRBV09,TCRBV21													CASSSTGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGTCGGAGGGGGTGGCACTGAAGCTTTCTTTGGACAA	CATVGGGGTEAFF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	10	5	1	4	6	3	24	32	44	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATVGGGGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGCAAGCCAGAATAATGAAAAACTGTTTTTTGGCAGT	CASRASQNNEKLFF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	42	TCRBV24						TCRBJ01	TCRBJ01-04	01	7	4	5	4	7	2	24	35	45	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRASQNNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGCCGCCCGGGGAGCTGTTTTTTGGAGAA	CASSSPPGELFF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	36	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	10	0	6	2	3	24	36	40	38	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPPGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGACAGGGCCGATCGTTAGACCCGGGGAGCTGTTTTTTGGAGAA	CASSLSTGPIVRPGELFF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	6	5	13	24	36	48	41	61	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSTGPIVRPGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGACTTCGGGATTCACCCCTCCACTTTGGGAAC	CASSPGLRDSPLHF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	0	10	8	2	5	26	38	46	40	51		TCRBV12-03,TCRBV12-04				01,02								CASSPGLRDSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGACCAACAGTGATGAACACTGAAGCTTTCTTTGGACAA	CASRPTVMNTEAFF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	5	0	7	3	19	27	38	34	41	TCRBV07,TCRBV11													CASRPTVMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAACTCCTGGGATGAGGGCGGGGAAGATACGCAGTATTTTGGCCCA	CASNSWDEGGEDTQYF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	3	5	15	1	19	29	50	44	51	TCRBV05,TCRBV11													CASNSWDEGGEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGACCGGGACAGGGCCTTCGATGAGCAGTTCTTCGGGCCA	CASSDRDRAFDEQFF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	4	6	24	36	49	40	55	TCRBV12,TCRBV21													CASSDRDRAFDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGACAGTCACACCCCTCCACTTTGGGAAC	CASSLTVTPLHF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	5	11	2	3	26	38	45	40	48		TCRBV12-03,TCRBV12-04												CASSLTVTPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTTCCAGACAGGGGGCCTTTCCTACGAGCAGTACGTCGGGCCG	CASSFQTGGLSYEQYV	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	17	5	19	24	36	51	41	70	TCRBV09,TCRBV21													CASSFQTGGLSYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACCACAGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSLTTGPTDTQYF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	2	4	2	26	40	50	44	52		TCRBV12-03,TCRBV12-04												CASSLTTGPTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGGGCGAACCCACCAAGAGACCCAGTACTTCGGGCCA	CASSRGRTHQETQYF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	4	0	0	7	26	-1	44	39	51		TCRBV03-01,TCRBV03-02				01,02								CASSRGRTHQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGAAGTGCAGGACATCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	97	1.0499176301735503E-4		37	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	6	17	8	15	24	31	44	39	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCGAGTCTGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRESGATNEKLFF	In	VDJ	1	98	1.060741523268123E-4	1.2487958040460984E-4	48	TCRBV12						TCRBJ01	TCRBJ01-04	01	6	6	2	0	10	0	26	37	-1	47	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRESGATNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCCCCGGACAGGTTCTCTTGCATTTTGGTGAT	CASSPPGQVLLHF	In	VDJ	1	98	1.060741523268123E-4	1.2487958040460984E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	15	6	7	22	34	47	40	54		TCRBV12-03,TCRBV12-04												CASSPPGQVLLHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGGGGATTCAAGCGGGGGGAACTCCTATTCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	99	1.0715654163626957E-4		56				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	1	4	9	12	24	35	53	44	65	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCCTCTGAGACAGAGGACAGCCCCAGCATTTTGGTGAT	CARSL*DRGQPQHF	Stop	VDJ	1	99	1.0715654163626957E-4		42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	5	7	6	4	18	30	41	36	45	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												CARSL*DRGQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCCTAGCGGGGGAGGCAATGAGCAGTTCTTCGGGCCA	XASSPSGGGNEQFF	In	VDJ	1	99	1.0715654163626957E-4	1.2615386183730993E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	6	1	3	22	34	45	35	48	TCRBV04,TCRBV07,TCRBV17													XASSPSGGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGTCCGGGACAGGGTCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	100	1.0823893094572684E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	3	4	1	18	30	43	34	44	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAGGGGGAGTCGAACGAGCAGTACGTCGGGCCG	CSASQGESNEQYV	In	VDJ	1	101	1.093213202551841E-4	1.2870242470271014E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	17	1	18	26	37	45	38	63		TCRBV20-01,TCRBV20-or09_02												CSASQGESNEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATGGAGACAGGGGGAACTATGGCTACACCTTCGGTTCG	CASSHGDRGNYGYTF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	1	2	4	0	23	37	-1	41	50	TCRBV01,TCRBV04													CASSHGDRGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCAGTTATCGCGCTTGTAGAGACCCAGTACTTCGGGCCA	CASSQPVIALVETQYF	In	VDJ	1	103	1.1148609887409864E-4	1.3125098756811034E-4	48	TCRBV03						TCRBJ02	TCRBJ02-05	01	2	4	5	4	1	13	26	41	45	42	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPVIALVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGACGGGGCGTCCATGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSATDGASMYSNQPQHF	In	VDJ	1	104	1.1256848818355591E-4	1.3252526900081043E-4	51	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	7	0	0	1	9	26	40	46	41	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDGASMYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGACTAGCGGGGACAACAATGAGCAGTTCTTCGGGCCA	CASSLTSGDNNEQFF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	5	2	3	26	38	51	40	54		TCRBV12-03,TCRBV12-04												CASSLTSGDNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACCGGGACAACTTTTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	105	1.1365087749301317E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	6	0	4	7	26	36	46	40	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCCGAGCGGGGGGATTACTTGGCAGATACGCAGTATTTTGGCCCA	CATSPERGDYLADTQYF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	1	4	4	9	24	36	49	40	58		TCRBV24-01,TCRBV24-or09_02												CATSPERGDYLADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGTTGGTACGAGACCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	105	1.1365087749301317E-4		52	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	2	7	0	14	0	24	36	-1	50	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQEDTGELFF	In	VDJ	1	106	1.1473326680247044E-4	1.3507383186621064E-4	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	0	10	3	0	0	26	-1	-1	43	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCTCGGCTTCACAGATACGCAGTATTTTGGCCCA	CSAPLGFTDTQYF	In	VDJ	1	106	1.1473326680247044E-4	1.3507383186621064E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	9	0	2	6	2	26	35	44	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPLGFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCAGGGGTGGGACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	106	1.1473326680247044E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	17	3	20	24	36	45	39	65		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAGGGATATGAACACTGAAGCTTTCTTTGGACAA	CASSLRDMNTEAFF	In	VDJ	1	106	1.1473326680247044E-4	1.3507383186621064E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	8	0	1	2	18	33	38	34	40	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRDMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACCGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSPTGGQETQYF	In	VDJ	1	107	1.1581565611192772E-4	1.3634811329891076E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	2	2	4	1	26	39	49	43	50		TCRBV03-01,TCRBV03-02												CASSPTGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGGTAGATGGGACCCAATACTTCGGGCCA	CSASRVDGTQYF	In	VDJ	1	107	1.1581565611192772E-4	1.3634811329891076E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	0	7	14	10	4	26	37	52	47	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRVDGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACTAAGAGGACTAGCGGGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	107	1.1581565611192772E-4		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	11	1	3	2	7	2	24	31	50	38	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCGGCGGAAGGTCCGTGTTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	107	1.1581565611192772E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	7	5	7	3	12	23	35	42	38	54	TCRBV06,TCRBV10					01,02								X+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGATCTACTAGCGGGGGCCAGTTACAATGAGCAGTTCTTCGGGCCA	CASSDLLAGASYNEQFF	In	VDJ	1	107	1.1581565611192772E-4	1.3634811329891076E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	4	5	5	18	30	46	35	51	TCRBV07,TCRBV11													CASSDLLAGASYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAACTCCAGGGGGCGAAGTAGAGAGACCCAGTACTTCGGGCCA	CASNSRGRSRETQYF	In	VDJ	1	108	1.1689804542138499E-4	1.3762239473161085E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	0	4	4	7	22	32	44	36	51	TCRBV02,TCRBV12													CASNSRGRSRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCAAAGACAGGGTTCTCGTACAATGAGCAGTTCTTCGGGCCA	CASSVAKTGFSYNEQFF	In	VDJ	1	108	1.1689804542138499E-4	1.3762239473161085E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	3	4	4	6	23	39	50	43	56	TCRBV09,TCRBV21													CASSVAKTGFSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGAGGAGGAGCAGGGGGAAAAACTGTTTTTTGGCAGT	XASSQEEEQGEKLFF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	2	8	7	0	23	40	-1	47	53	TCRBV01,TCRBV04													XASSQEEEQGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCGGGGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDSGGTSYNEQFF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	0	0	2	26	-1	50	40	52		TCRBV20-01,TCRBV20-or09_02												CSARDSGGTSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGGGAGGAAGGCACAGTATGGCTACACCTTCGGTTCG	CASSQGRKAQYGYTF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	1	5	0	9	20	-1	41	35	50	TCRBV04,TCRBV23													CASSQGRKAQYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCGCGAAGGTAGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CAAKVESSYEQYF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	11	5	4	0	4	7	24	30	37	34	44	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAAKVESSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGGGATAGGGGTGAGCAGTTCTTCGGGCCA	CASSQDRDRGEQFF	In	VDJ	1	111	1.2014521334975679E-4	1.4144523902971114E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	9	0	7	26	-1	48	43	55		TCRBV03-01,TCRBV03-02												CASSQDRDRGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGACAGGGGGGGCAGATACGCAGTATTTTGGCCCA	CSARETGGADTQYF	In	VDJ	1	112	1.2122760265921406E-4	1.4271952046241123E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	1	4	0	2	26	-1	49	40	51		TCRBV20-01,TCRBV20-or09_02												CSARETGGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGTTCGAAGGGACAGGGACCCAATGAGCAGTTCTTCGGGCCA	CASSSKGQGPNEQFF	In	VDJ	1	112	1.2122760265921406E-4	1.4271952046241123E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	6	6	3	18	29	44	35	47	TCRBV07,TCRBV11													CASSSKGQGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGTTCAACTAGCGGGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSSTSGGTGELFF	In	VDJ	1	113	1.2230999196867132E-4	1.4399380189511135E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	3	2	5	0	1	22	-1	48	37	49	TCRBV07,TCRBV12													CASSSTSGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCCGGCCACACAGATACGCAGTATTTTGGCCCA	CASSQPGHTDTQYF	In	VDJ	1	114	1.233923812781286E-4	1.4526808332781144E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	2	9	0	2	3	2	26	41	47	44	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGHTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGAGCAGGTTTTGCAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQVGAGFAAGANVLTF	In	VDJ	1	114	1.233923812781286E-4	1.4526808332781144E-4	57	TCRBV03						TCRBJ02	TCRBJ02-06	01	1	4	4	2	6	8	24	40	50	46	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGAGFAAGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATAGGGGGAAGATATGGCTACACCTTCGGTTCG	CASSFIGGRYGYTF	In	VDJ	1	115	1.2447477058758586E-4	1.4654236476051156E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	1	5	3	4	26	40	49	43	53		TCRBV12-03,TCRBV12-04												CASSFIGGRYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTCGCTGGTAACACTGAAGCTTTCTTTGGACAA	CASSFAGNTEAFF	In	VDJ	1	115	1.2447477058758586E-4	1.4654236476051156E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	0	10	2	7	1	20	31	40	38	41	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGGACAGGGGTCAAAGGGACGCTGGAGCAGTACGTCGGGCCG		Out	VDJ	1	116	1.2555715989704313E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	17	2	24	26	43	55	45	79		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACCGTCGAGGAGGCGACCGGCTCACCCCTCCACTTTGGGAAC	CASTVEEATGSPLHF	In	VDJ	1	116	1.2555715989704313E-4	1.4781664619321165E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	10	1	10	7	8	22	32	44	39	52	TCRBV02,TCRBV12													CASTVEEATGSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATGGGGACAGGGGACAATGAGCAGTTCTTCGGGCCA	CATMGTGDNEQFF	In	VDJ	1	116	1.2555715989704313E-4	1.4781664619321165E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	5	2	0	24	34	-1	36	46		TCRBV24-01,TCRBV24-or09_02												CATMGTGDNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCGGACAGGGAAACTATGGCTACACCTTCGGTTCG	CASGQGNYGYTF	In	VDJ	1	116	1.2555715989704313E-4	1.4781664619321165E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	3	2	0	1	23	-1	40	32	41	TCRBV02,TCRBV21													CASGQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACAGCGGGGGGGATCGACAGATACGCAGTATTTTGGCCCA	CASSLQRGGSTDTQYF	In	VDJ	1	117	1.266395492065004E-4	1.4909092762591174E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	0	3	3	4	26	39	52	42	56		TCRBV03-01,TCRBV03-02												CASSLQRGGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGGGCAGGCCTAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLRAGLSSGNTIYF	In	VDJ	1	117	1.266395492065004E-4	1.4909092762591174E-4	51	TCRBV24						TCRBJ01	TCRBJ01-03	01	6	4	4	0	7	6	24	36	47	43	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRAGLSSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGCTCACCCGGGACTAGCGGGGGAGCATCCTACAATGAGCAGTTCTTCGGGCCA	CSASSPGTSGGASYNEQFF	In	VDJ	1	118	1.2772193851595768E-4	1.5036520905861185E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	1	10	4	24	32	56	42	60		TCRBV20-01,TCRBV20-or09_02												CSASSPGTSGGASYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCACAGGTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPQVSSYNEQFF	In	VDJ	1	118	1.2772193851595768E-4	1.5036520905861185E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	4	0	2	4	18	30	37	32	41	TCRBV07,TCRBV11													CASSPQVSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAACCAGCGGTCACAGATACGCAGTATTTTGGCCCA	CASKPAVTDTQYF	In	VDJ	1	119	1.2880432782541492E-4	1.5163949049131194E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	6	5	2	7	1	24	31	43	38	44		TCRBV24-01,TCRBV24-or09_02				01,02								CASKPAVTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGGGACAGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGDSYSNQPQHF	In	VDJ	1	119	1.2880432782541492E-4	1.5163949049131194E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	0	2	3	18	32	41	34	44	TCRBV07,TCRBV11													CASSLGDSYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGDTGELFF	In	VDJ	1	120	1.298867171348722E-4	1.5291377192401206E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	3	3	4	0	26	39	-1	43	48		TCRBV03-01,TCRBV03-02												CASSPPGDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCCGGGCCTAGCCCCAAATACGCAGTATTTTGGCCCA	CASSPPGLAPNTQYF	In	VDJ	1	121	1.3096910644432946E-4	1.5418805335671215E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	7	7	9	5	24	36	50	45	55	TCRBV09,TCRBV21					01,02								CASSPPGLAPNTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAACTATGGTCCGGGTTCACCCCTCCACTTTGGGAAC	CASSQENYGPGSPLHF	In	VDJ	1	122	1.3205149575378674E-4	1.5546233478941224E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	3	9	9	2	9	26	43	49	45	58		TCRBV03-01,TCRBV03-02				01,02								CASSQENYGPGSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCCCGGGACTCATCCTCCACGATGAGCAGTTCTTCGGGCCA	CASSPPGLILHDEQFF	In	VDJ	1	122	1.3205149575378674E-4	1.5546233478941224E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	10	8	6	11	24	35	47	41	58		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPPGLILHDEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCGACGGGGGGAGAGAGACCCAGTACTTCGGGCCA	CATSDPDGGRETQYF	In	VDJ	1	123	1.33133885063244E-4	1.5673661622211236E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	4	5	2	24	39	51	44	53		TCRBV24-01,TCRBV24-or09_02												CATSDPDGGRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCCGGGAGCCTCTATCAGCCCCAGCATTTTGGTGAT	CASSLSGSLYQPQHF	In	VDJ	1	124	1.3421627437270128E-4	1.5801089765481245E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	8	2	5	2	5	26	41	49	43	54		TCRBV12-03,TCRBV12-04												CASSLSGSLYQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGGGGGGGAAGGGCTACACCTTCGGTTCG	CSATGGKGYTF	In	VDJ	1	124	1.3421627437270128E-4	1.5801089765481245E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	0	8	2	3	26	34	44	36	47		TCRBV20-01,TCRBV20-or09_02												CSATGGKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCTGGACAGTGCGGACACTGAAGCTTTCTTTGGACAA	CSARALDSADTEAFF	In	VDJ	1	124	1.3421627437270128E-4	1.5801089765481245E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	5	3	4	5	26	39	49	43	54		TCRBV20-01,TCRBV20-or09_02												CSARALDSADTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGAAACGGCGGATCAGCCCCAGCATTTTGGTGAT	CASRETADQPQHF	In	VDJ	1	124	1.3421627437270128E-4	1.5801089765481245E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	7	5	5	7	0	24	35	-1	42	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASRETADQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTACAACTAGTACAGAGACCCAGTACTTCGGGCCA	CSARGTTSTETQYF	In	VDJ	1	125	1.3529866368215855E-4	1.5928517908751256E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	8	4	5	3	26	39	49	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGTTSTETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCAGGCCAAACTAGCACAGATACGCAGTATTTTGGCCCA	CATSSGQTSTDTQYF	In	VDJ	1	125	1.3529866368215855E-4	1.5928517908751256E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	0	1	7	24	36	41	37	48		TCRBV24-01,TCRBV24-or09_02												CATSSGQTSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTAGACAGCTTAAACATTCAGTACTTCGGCGCC	CASSQDVDSLNIQYF	In	VDJ	1	126	1.3638105299161582E-4	1.6055946052021265E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	5	6	4	3	26	43	52	47	55		TCRBV03-01,TCRBV03-02												CASSQDVDSLNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSHAGQPQHF	In	VDJ	1	127	1.3746344230107307E-4	1.6183374195291274E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	4	6	1	0	23	37	-1	38	43	TCRBV01,TCRBV04					01,02								CASSHAGQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCCTATCAGTTCGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSSYQFAGSYNEQFF	In	VDJ	1	128	1.3854583161053034E-4	1.6310802338561286E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	3	1	12	0	26	32	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSSYQFAGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAGCGGGGAGGGACCCAGTACTTCGGGCCA	CASSLERGGTQYF	In	VDJ	1	128	1.3854583161053034E-4	1.6310802338561286E-4	39				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	6	3	7	0	3	18	-1	41	34	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02												CASSLERGGTQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCGACCGGGGGGGCCTTGGAGACCCAGTACTTCGGGCCA	CASSSTGGALETQYF	In	VDJ	1	128	1.3854583161053034E-4	1.6310802338561286E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	0	5	4	5	18	31	43	35	48	TCRBV07,TCRBV11													CASSSTGGALETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGAGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGYTGELFF	In	VDJ	1	130	1.4071061022944488E-4	1.6565658625101304E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	1	3	2	2	26	39	46	41	48		TCRBV03-01,TCRBV03-02												CASSPGGYTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTAGAGGGACGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDFRGTVNTGELFF	In	VDJ	1	130	1.4071061022944488E-4	1.6565658625101304E-4	51	TCRBV24						TCRBJ02	TCRBJ02-02	01	1	0	7	1	4	3	24	41	50	45	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFRGTVNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGTGAGACCCAGTACTTCGGGCCA	CSARDSETQYF	In	VDJ	1	131	1.4179299953890215E-4	1.6693086768371316E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	5	5	0	1	26	-1	43	40	44		TCRBV20-01,TCRBV20-or09_02												CSARDSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGCAGGAACTGGAAACACCATATATTTTGGAGAG	CSARDMAGTGNTIYF	In	VDJ	1	133	1.439577781578167E-4	1.6947943054911336E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	4	2	5	2	26	40	49	45	51		TCRBV20-01,TCRBV20-or09_02												CSARDMAGTGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGCCCAAGAGACCCAGTACTTCGGGCCA	CASSFAQETQYF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	36	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	10	0	1	1	0	26	40	-1	41	43		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGATGAGGTGGCGGTACCAGATACGCAGTATTTTGGCCCA	CSAGDEVAVPDTQYF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	0	8	4	1	14	26	35	40	36	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGDEVAVPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTAGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVVGGNTGELFF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	1	1	5	0	24	36	-1	41	47	TCRBV09,TCRBV21													CASSVVGGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTAACGGACAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSNGQANTGELFF	In	VDJ	1	135	1.4612255677673124E-4	1.7202799341451354E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	4	0	4	0	26	37	-1	41	48		TCRBV03-01,TCRBV03-02												CASSNGQANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATAGGGACAGGCGGCAGTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	135	1.4612255677673124E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	4	0	2	7	24	34	44	36	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGACACCGGGACACCGAACACTGAAGCTTTCTTTGGACAA	CASSDTGTPNTEAFF	In	VDJ	1	135	1.4612255677673124E-4	1.7202799341451354E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	1	5	2	23	36	47	41	49	TCRBV09,TCRBV21													CASSDTGTPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACAGGGGGAAAGCTGCAGTATTTTGGCCCA	CSARTGGKLQYF	In	VDJ	1	136	1.4720494608618849E-4	1.7330227484721366E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	1	11	0	6	26	-1	46	38	52		TCRBV20-01,TCRBV20-or09_02												CSARTGGKLQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCATCAGCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPISYTGELFF	In	VDJ	1	137	1.4828733539564576E-4	1.7457655627991375E-4	42	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	4	5	3	6	2	26	37	46	43	48		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPISYTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAACGAACCTAATGAAAAATTGTTTTTTGGCAGT	CSASNEPNEKLFF	In	VDJ	1	137	1.4828733539564576E-4	1.7457655627991375E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	4	9	15	8	9	26	37	48	45	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSASNEPNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGTCAAGCCGGGACAGTCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	137	1.4828733539564576E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	2	8	2	18	30	45	38	47	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTCCGGGGTCCGGGGGAAGCCCCAGCATTTTGGTGAT	CASSSGVRGKPQHF	In	VDJ	1	138	1.4936972470510303E-4	1.7585083771261387E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	2	8	8	1	26	39	53	47	54		TCRBV12-03,TCRBV12-04												CASSSGVRGKPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAGAGGAGTTTTGAACACTGAAGCTTTCTTTGGACAA	CASSQDRGVLNTEAFF	In	VDJ	1	138	1.4936972470510303E-4	1.7585083771261387E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	0	4	3	23	40	48	44	51	TCRBV01,TCRBV04													CASSQDRGVLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGATTACTCTGGAAACACCATATATTTTGGAGAG	CASSPDYSGNTIYF	In	VDJ	1	139	1.504521140145603E-4	1.7712511914531396E-4	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	1	8	0	1	3	26	39	43	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDYSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCTTGGACAGGCTATGGCTACACCTTCGGTTCG	CASSQSWTGYGYTF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	4	5	0	26	40	-1	45	52		TCRBV03-01,TCRBV03-02												CASSQSWTGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGGACGGCGAAGGAGGAGATACGCAGTATTTTGGCCCA	CASSPGDGEGGDTQYF	In	VDJ	1	141	1.5261689263347484E-4	1.7967368201071417E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	2	5	0	13	26	-1	45	39	58		TCRBV03-01,TCRBV03-02												CASSPGDGEGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTACAGGGGAAGCTTTCTTTGGACAA	CATSDSTGEAFF	In	VDJ	1	142	1.5369928194293212E-4	1.8094796344341426E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	8	2	0	24	40	-1	42	48		TCRBV24-01,TCRBV24-or09_02												CATSDSTGEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGAGGGGGCGGGTGAGACCCAGTACTTCGGGCCA	CASSLEGAGETQYF	In	VDJ	1	142	1.5369928194293212E-4	1.8094796344341426E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	0	4	19	-1	42	35	46		TCRBV05-06,TCRBV05-07												CASSLEGAGETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGACAGGGGAAACATTCAGTACTTCGGCGCC	CASSPDRGNIQYF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	2	2	6	4	0	26	37	-1	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPDRGNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGACAGATCCTACGAGCAGTACTTCGGGCCG	CSAKDRSYEQYF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	1	1	1	26	36	43	37	44		TCRBV20-01,TCRBV20-or09_02												CSAKDRSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGTCTGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSVWDSSYEQYF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	0	4	0	19	31	-1	35	42	TCRBV07,TCRBV11													CASSVWDSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCGTCGACAATCCGGCATGGCTACACCTTCGGTTCG	CASSSSTIRHGYTF	In	VDJ	1	144	1.5586406056184663E-4	1.8349652630881446E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	6	6	4	7	18	31	39	35	46	TCRBV05,TCRBV11													CASSSSTIRHGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGACAGCCGACCTACGAGCAGTACTTCGGGCCG	CASSRGQPTYEQYF	In	VDJ	1	146	1.5802883918076118E-4	1.8604508917421467E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	2	1	4	26	39	47	40	51		TCRBV03-01,TCRBV03-02												CASSRGQPTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGTACTAGCGTCAATTGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	147	1.5911122849021845E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	6	8	4	9	26	39	50	43	59		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCACCGGTGGCTGAGAATTCACCCCTCCACTTTGGGAAC	CSASPPVAENSPLHF	In	VDJ	1	147	1.5911122849021845E-4	1.8731937060691476E-4	45	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	9	0	7	9	4	26	37	49	46	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPPVAENSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCACCCCCCAGGGGGTTACCTATGGCTACACCTTCGGTTCG	CASTPQGVTYGYTF	In	VDJ	1	148	1.6019361779967572E-4	1.8859365203961485E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	4	5	4	18	28	40	33	44	TCRBV05,TCRBV11													CASTPQGVTYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGCACAGGGGGACTATGGCTACACCTTCGGTTCG	CASRAQGDYGYTF	In	VDJ	1	149	1.61276007109133E-4	1.8986793347231497E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	1	3	3	0	22	33	-1	36	44	TCRBV02,TCRBV12													CASRAQGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCCAGGGAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	150	1.6235839641859026E-4		46	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	4	3	1	4	2	26	40	49	44	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGGGACAGGGGACTATGGCTACACCTTCGGTTCG	CSARAGTGDYGYTF	In	VDJ	1	150	1.6235839641859026E-4	1.9114221490501506E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	2	3	2	0	26	39	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSARAGTGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACGAGAGCAGCGCGACTGTGTACTTCTGTGCCAGCAGTCTAGGCCATATGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	151	1.6344078572804753E-4		53	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	3	6	5	9	5	28	44	56	53	61		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCTGGACCGCCTTCGGCCAAACTGTTTTTTGGCAGT	CASSPGPPSAKLFF	In	VDJ	1	151	1.6344078572804753E-4	1.9241649633771517E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	5	1	7	11	3	11	18	30	37	33	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPPSAKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGCCCAGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSAQETGELFF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	4	5	4	2	22	33	41	37	43	TCRBV09,TCRBV12													CASSAQETGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCGCGGAGCGGGGGACGAGCAGTACTTCGGGCCG	CATSGRGAGDEQYF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	2	5	7	0	24	37	-1	44	52		TCRBV24-01,TCRBV24-or09_02												CATSGRGAGDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCCCGGAGTCCTGTAGACTCGTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	152	1.6452317503750478E-4		58	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	2	10	0	17	3	23	35	56	52	59		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCCCCCGGGACAGGGGGTGTAGATACGCAGTATTTTGGCCCA	CASSPPGTGGVDTQYF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	1	5	6	3	22	34	51	40	54	TCRBV07,TCRBV11													CASSPPGTGGVDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTAGCGGGGGTCGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGVGDTGELFF	In	VDJ	1	153	1.6560556434696205E-4	1.9496505920311535E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	5	2	3	0	6	23	-1	45	36	51	TCRBV01,TCRBV04													CASSLAGVGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGGACCCCGCGGGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	XASSQDPAGGSYNEQFF	In	VDJ	1	153	1.6560556434696205E-4	1.9496505920311535E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	1	1	7	1	22	36	51	43	52	TCRBV01,TCRBV04,TCRBV07,TCRBV17													XASSQDPAGGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCCTGGACCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGPVTGELFF	In	VDJ	1	154	1.6668795365641932E-4	1.9623934063581547E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	6	1	7	4	4	4	23	34	42	38	46	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPVTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACCCGGCCGAGGGCGCGGGTGGCACTGAAGCTTTCTTTGGACAA	CSAYPAEGAGGTEAFF	In	VDJ	1	155	1.677703429658766E-4	1.9751362206851556E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	4	15	3	26	35	55	50	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYPAEGAGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGGGACAGGGCTATGAGCAGTTCTTCGGGCCA	CASSVGQGYEQFF	In	VDJ	1	155	1.677703429658766E-4	1.9751362206851556E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	8	0	2	23	-1	46	37	48	TCRBV09,TCRBV21													CASSVGQGYEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTTTGCAAGAAAAACTGTTTTTTGGCAGT	CASSSLQEKLFF	In	VDJ	1	156	1.6885273227533386E-4	1.9878790350121568E-4	36	TCRBV12						TCRBJ01	TCRBJ01-04	01	4	4	6	8	5	1	26	39	46	44	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLQEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCTCAGCAGGGGGACCGGGGGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	156	1.6885273227533386E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	4	1	9	4	8	26	29	40	33	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCGCACTTGGAGCGGGTCGGAGACCCAGTACTTCGGGCCA	CASSRTWSGSETQYF	In	VDJ	1	157	1.6993512158479114E-4	2.0006218493391577E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	4	5	9	3	18	30	45	39	48	TCRBV07,TCRBV11					01,02								CASSRTWSGSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTTCTACGTGGGTGGCTACACCTTCGGTTCG	CASSFYVGGYTF	In	VDJ	1	158	1.710175108942484E-4	2.0133646636661586E-4	36	unresolved						TCRBJ01	TCRBJ01-02	01	6	0	9	7	9	0	26	37	-1	46	49	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFYVGGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATCTAAACACTGAAGCTTTCTTTGGACAA	CAISDLNTEAFF	In	VDJ	1	158	1.710175108942484E-4	2.0133646636661586E-4	36				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	4	9	2	3	0	23	35	-1	38	41	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDLNTEAFF+X+TCRBJ01-01		TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCAATCGGAGAGACAATGAGCAGTTCTTCGGGCCA	CASSNRRDNEQFF	In	VDJ	1	158	1.710175108942484E-4	2.0133646636661586E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	5	2	2	24	38	44	40	46	TCRBV12,TCRBV21													CASSNRRDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCACCTTGGTCGGGACACTGAAGCTTTCTTTGGACAA	CASSHLGRDTEAFF	In	VDJ	1	160	1.7318228951316292E-4	2.0388502923201606E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	3	9	0	26	38	-1	47	51		TCRBV12-03,TCRBV12-04				01,02								CASSHLGRDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGAACCCACCTGGGGAGGGACGCAGTATTTTGGCCCA	CASSEPTWGGTQYF	In	VDJ	1	161	1.742646788226202E-4	2.0515931066471618E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	9	9	0	24	38	-1	47	54		TCRBV24-01,TCRBV24-or09_02												CASSEPTWGGTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACTGGACAGGGCCCATGCGGAGACCCAGTACTTCGGGCCA	CASRLDRAHAETQYF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	1	3	5	3	8	24	35	46	38	54		TCRBV24-01,TCRBV24-or09_02												CASRLDRAHAETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	1	164	1.77511846750992E-4	2.0898215496281648E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	33	48	60	54	79		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTTAGGCCTAAAGGAGACCCAGTACTTCGGGCCA	CASSLGLKETQYF	In	VDJ	1	164	1.77511846750992E-4	2.0898215496281648E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	4	5	4	5	1	7	22	35	39	36	46	TCRBV07,TCRBV12			TCRBD01,TCRBD02										CASSLGLKETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACTCCCTAGCGCGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	165	1.7859423606044928E-4		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	6	6	4	2	23	40	50	44	52	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAACAGAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSQTEGSGNTIYF	In	VDJ	1	165	1.7859423606044928E-4	2.1025643639551657E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	0	0	6	0	18	30	-1	36	41	TCRBV05,TCRBV11													CASSQTEGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACAGCCGGGGAGCTGTTTTTTGGAGAA	CASSLTAGELFF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	5	6	0	0	26	-1	-1	40	45		TCRBV12-03,TCRBV12-04												CASSLTAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGACTAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSPGLAGETQYF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	5	2	0	26	39	-1	41	53		TCRBV03-01,TCRBV03-02												CASSPGLAGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGAATTATTATCGGAGGGCTACACCTTCGGTTCG	CASSELLSEGYTF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	2	8	9	0	24	38	-1	47	51		TCRBV24-01,TCRBV24-or09_02												CASSELLSEGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAACCTCTAGTGGGAAAATACGAGCAGTACTTCGGGCCG	CASSQPLVGKYEQYF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	8	4	11	3	18	30	45	41	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPLVGKYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGCTCTTAAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	166	1.7967662536990655E-4		41	unresolved						TCRBJ02	TCRBJ02-05	01	0	5	4	4	5	0	23	40	-1	45	48	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGTGGTGGACAGGCCGGAGTGTGATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	168	1.8184140398882107E-4		58	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	4	0	4	13	18	29	40	33	53	TCRBV11,TCRBV23													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTATAGGCACTGAAGCTTTCTTTGGACAA	CASSVAIGTEAFF	In	VDJ	1	169	1.8292379329827834E-4	2.1535356212631698E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	5	7	4	2	6	26	37	43	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVAIGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCACCGGGACTAGCGGGGGAGTATCAGTACTTCGGCGCC	CASSESPGLAGEYQYF	In	VDJ	1	169	1.8292379329827834E-4	2.1535356212631698E-4	48	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	0	2	12	5	4	23	38	57	43	61		TCRBV06-01,TCRBV06-08												CASSESPGLAGEYQYF+TCRBV06-X+TCRBJ02-04	TCRBV06	TCRBD02-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAACGAACAGGGGTAGAGACCCAGTACTTCGGGCCA	CSARERTGVETQYF	In	VDJ	1	170	1.8400618260773561E-4	2.1662784355901707E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	2	4	7	1	26	37	51	44	52		TCRBV20-01,TCRBV20-or09_02												CSARERTGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCATCCGGCGGGGGCACTACGCAGTATTTTGGCCCA	CSAPSGGGTTQYF	In	VDJ	1	170	1.8400618260773561E-4	2.1662784355901707E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	8	7	3	26	35	49	42	52		TCRBV20-01,TCRBV20-or09_02												CSAPSGGGTTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGCCGGACAGGGATGGCTACACCTTCGGTTCG	CASSPPDRDGYTF	In	VDJ	1	170	1.8400618260773561E-4	2.1662784355901707E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	6	5	0	24	36	-1	41	49		TCRBV24-01,TCRBV24-or09_02												CASSPPDRDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCCCGTTCGCGGGGCTGAAGACCCAGTACTTCGGGCCA	CASSPFAGLKTQYF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	3	6	7	4	26	37	50	44	54	TCRBV11,TCRBV12													CASSPFAGLKTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAACGAGCGGGTTAGACAATGAGCAGTTCTTCGGGCCA	CSARTSGLDNEQFF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	4	5	6	4	26	35	47	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSGLDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCGTTTAGGAGAGACCCAGTACTTCGGGCCA	CASSPRLGETQYF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	39	unresolved						TCRBJ02	TCRBJ02-05	01	4	5	4	4	8	0	23	35	-1	43	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRLGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACGACTAGCGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSLRLAGTTDTQYF	In	VDJ	1	172	1.8617096122665016E-4	2.1917640642441728E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	2	4	2	24	36	51	40	53		TCRBV24-01,TCRBV24-or09_02												CASSLRLAGTTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACAAGATCGGTTAGGAAACACCATATATTTTGGAGAG	CASSEQDRLGNTIYF	In	VDJ	1	172	1.8617096122665016E-4	2.1917640642441728E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	2	8	5	4	6	3	23	38	47	44	50	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSEQDRLGNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAATGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	174	1.883357398455647E-4		34	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	0	10	6	5	0	26	40	-1	45	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAATGGGGGTTGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	174	1.883357398455647E-4		38	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	6	1	6	3	5	24	35	43	38	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGAGCTCGGGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSELGTVNTGELFF	In	VDJ	1	174	1.883357398455647E-4	2.2172496928981748E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	1	4	1	24	38	49	42	50		TCRBV24-01,TCRBV24-or09_02												CASSELGTVNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGAATCCTTCCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA	CASS*ILPFVMQDTQYF	Stop	VDJ	1	175	1.8941812915502197E-4		51	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	2	8	5	1	20	26	38	41	39	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*ILPFVMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGCCGGGATCCAGATACGCAGTATTTTGGCCCA	CATSDGRDPDTQYF	In	VDJ	1	175	1.8941812915502197E-4	2.2299925072251757E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	3	4	3	2	24	39	47	42	49		TCRBV24-01,TCRBV24-or09_02												CATSDGRDPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGGACAGCTCAAGTGGCTACACCTTCGGTTCG	CSAGDSSSGYTF	In	VDJ	1	179	1.9374768639285103E-4	2.28096376453318E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	7	2	6	26	34	43	36	49		TCRBV20-01,TCRBV20-or09_02												CSAGDSSSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCCGGAGATACGCAGTATTTTGGCCCA	CSASPGDTQYF	In	VDJ	1	179	1.9374768639285103E-4	2.28096376453318E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	5	5	0	26	35	-1	40	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCAGGGTAACTATGGCTACACCTTCGGTTCG	CATSQGNYGYTF	In	VDJ	1	181	1.9591246501176557E-4	2.3064493931871817E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	1	0	0	24	-1	-1	36	41		TCRBV24-01,TCRBV24-or09_02												CATSQGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCCCCGGAGCAATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRSNGANVLTF	In	VDJ	1	181	1.9591246501176557E-4	2.3064493931871817E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	2	3	4	3	24	36	44	40	47	TCRBV12,TCRBV21													CASSPRSNGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAGGGGGGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	182	1.9699485432122285E-4		40	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	3	0	2	19	-1	38	31	40		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGGAAGAGCCTTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQEGRAFATNEKLFF	In	VDJ	1	184	1.991596329401374E-4	2.3446778361681846E-4	54	unresolved						TCRBJ01	TCRBJ01-04	01	0	0	8	0	0	10	23	-1	44	40	54	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGRAFATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACGGGGGTCGACGGCAATCAGCCCCAGCATTTTGGTGAT	CASTGVDGNQPQHF	In	VDJ	1	184	1.991596329401374E-4	2.3446778361681846E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	2	2	0	6	23	-1	39	33	45	TCRBV02,TCRBV12													CASTGVDGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCATAGGGGACGGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	185	2.0024202224959463E-4		44	TCRBV20						TCRBJ01	TCRBJ01-05	01	5	0	7	0	6	2	26	35	46	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGACTAGCGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSLGTSGGNEQFF	In	VDJ	1	186	2.013244115590519E-4	2.3701634648221867E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	7	1	0	26	40	-1	41	56		TCRBV12-03,TCRBV12-04												CASSLGTSGGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCTCTTGCGGGACAGGTAAGAAGAGACCCAGTACTTCGGGCCA	YASSLLRDR*EETQYF	Stop	VDJ	1	186	2.013244115590519E-4		48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	3	7	4	22	34	49	41	53	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSLLRDR*EETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACCCTAGCGGCTCAATGCGTGAGACCCAGTACTTCGGGCCA	CSASHPSGSMRETQYF	In	VDJ	1	187	2.0240680086850918E-4	2.382906279149188E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	5	5	10	26	37	49	42	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSASHPSGSMRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAACTAGGGGCGGCCGGGGAGCTGTTTTTTGGAGAA	CASSELGAAGELFF	In	VDJ	1	187	2.0240680086850918E-4	2.382906279149188E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	2	5	2	6	2	3	23	38	45	40	48	TCRBV02,TCRBV12			TCRBD01,TCRBD02										CASSELGAAGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAAAAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	189	2.0457157948742372E-4		43	unresolved						TCRBJ02	TCRBJ02-02	01	6	5	3	1	6	0	20	31	-1	37	41	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCAGGGCTTGGAGATATGGCTACACCTTCGGTTCG		Out	VDJ	1	190	2.05653968796881E-4		41	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	5	2	8	26	37	44	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAACAGGCCCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CANRPLSYNEQFF	In	VDJ	1	191	2.0673635810633826E-4	2.4338775364571917E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	6	10	0	0	0	4	23	-1	36	34	40	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANRPLSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGGGGACTAGCGGCACCTACAATGAGCAGTTCTTCGGGCCA	XASSQGTSGTYNEQFF	In	VDJ	1	192	2.0781874741579554E-4	2.4466203507841926E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	2	1	2	23	37	49	38	51	TCRBV01,TCRBV04,TCRBV07,TCRBV17					01,02								XASSQGTSGTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTCCAGGGACCGGGGGGCTACACCTTCGGTTCG	CASSFQGPGGYTF	In	VDJ	1	192	2.0781874741579554E-4	2.4466203507841926E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	3	0	7	8	3	5	18	32	40	35	45	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQGPGGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAACCGGGACAGGCCTGATACAGCCCCAGCATTTTGGTGAT	CASRTGTGLIQPQHF	In	VDJ	1	193	2.0890113672525278E-4	2.459363165111194E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	7	4	7	26	37	49	41	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRTGTGLIQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATGAAGGAGACCCAGTACTTCGGGCCA	CASSLMKETQYF	In	VDJ	1	193	2.0890113672525278E-4	2.459363165111194E-4	36	TCRBV12						TCRBJ02	TCRBJ02-05	01	2	2	8	5	2	2	26	41	45	43	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMKETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTACTTGACTAGCTCGATCCTTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	193	2.0890113672525278E-4		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	2	7	5	6	11	26	31	44	37	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTAGGCAGACTCTACAATGAGCAGTTCTTCGGGCCA	CASSELGRLYNEQFF	In	VDJ	1	194	2.0998352603471005E-4	2.472105979438195E-4	45	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	10	3	7	0	23	38	-1	45	49		TCRBV06-01,TCRBV06-08				01,02								CASSELGRLYNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGCTACGGGGGAAAGGGAGCAGTTCTTCGGGCCA	CRATGEREQFF	In	VDJ	1	195	2.1106591534416732E-4	2.4848487937651956E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	10	0	5	26	-1	42	36	47		TCRBV20-01,TCRBV20-or09_02												CRATGEREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTCCGGCAGCCAACGGGGCAGTATTTTGGCCCA	CASSVRQPTGQYF	In	VDJ	1	195	2.1106591534416732E-4	2.4848487937651956E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	4	11	13	0	22	34	-1	47	51	TCRBV02,TCRBV12					01,02								CASSVRQPTGQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAATATAAAAGAGCCGGCGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	196	2.121483046536246E-4		43	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	10	7	3	4	14	0	23	30	-1	44	50	TCRBV02,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACGGGGGGAGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	1	198	2.1431308327253914E-4	2.5230772367461986E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	4	5	3	26	37	49	42	52		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGACGGGTGGAGGGGCTACACCTTCGGTTCG	CASSLADGWRGYTF	In	VDJ	1	198	2.1431308327253914E-4	2.5230772367461986E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	1	8	8	0	18	35	-1	43	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLADGWRGYTF+X+TCRBJ01-02		TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGAGAGTTGGCAGGTAAATCAGCCCCAGCATTTTGGTGAT	XASSQESWQVNQPQHF	In	VDJ	1	199	2.153954725819964E-4	2.5358200510732E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	4	7	2	22	39	50	46	52	TCRBV01,TCRBV04													XASSQESWQVNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGGGGGCAGGGGCGGATGGCTACACCTTCGGTTCG	CASRGAGADGYTF	In	VDJ	1	200	2.1647786189145368E-4	2.548562865400201E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	6	5	3	26	37	48	42	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRGAGADGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCTTACAGGGCTATGGCTACACCTTCGGTTCG	CASSSLQGYGYTF	In	VDJ	1	201	2.1756025120091093E-4	2.561305679727202E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	4	5	0	24	36	-1	41	47	TCRBV24,TCRBV27													CASSSLQGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCCCGACTAGCGGGGGCAGTGCGGGGGCCAACGTCCTGACTTTCGGGGCC	CAISPTSGGSAGANVLTF	In	VDJ	1	201	2.1756025120091093E-4	2.561305679727202E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	6	2	2	4	3	7	23	34	49	37	56	TCRBV06,TCRBV10													CAISPTSGGSAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTCGGACAGGTACGCGAGCAGTACTTCGGGCCG	CASSVGQVREQYF	In	VDJ	1	201	2.1756025120091093E-4	2.561305679727202E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	6	4	4	23	34	45	38	49	TCRBV02,TCRBV09													CASSVGQVREQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAGGAGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	202	2.186426405103682E-4		35	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	5	2	0	26	38	-1	40	46		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATGGGGGATACGCAGTATTTTGGCCCA	CASSQEMGDTQYF	In	VDJ	1	202	2.186426405103682E-4	2.5740484940542027E-4	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	6	2	6	3	0	26	43	-1	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEMGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGAACATTGGGATCACTGAAGCTTTCTTTGGACAA	CASRNIGITEAFF	In	VDJ	1	203	2.1972502981982547E-4	2.586791308381204E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	0	8	4	7	1	24	35	46	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNIGITEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAACCGGGACTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	204	2.2080741912928274E-4		53	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	4	1	6	0	26	39	-1	45	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCATAAGGGTCGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CAIRVENTGELFF	In	VDJ	1	204	2.2080741912928274E-4	2.599534122708205E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	10	5	3	1	2	4	22	29	35	31	39	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRVENTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCGCCGGGACAGGGTCTGAAGCTTTCTTTGGACAA	CASSFAGTGSEAFF	In	VDJ	1	204	2.2080741912928274E-4	2.599534122708205E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	6	4	1	18	32	45	36	46	TCRBV07,TCRBV11													CASSFAGTGSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGAGGATTCTTCGGGGGGCAGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSGGFFGGQRNTGELFF	In	VDJ	1	205	2.2188980843874E-4	2.6122769370352057E-4	57	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	1	1	10	5	24	37	54	47	59		TCRBV24-01,TCRBV24-or09_02												CATSGGFFGGQRNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGGGACAGCCAAGAGACCCAGTACTTCGGGCCA	CATSDRDSQETQYF	In	VDJ	1	208	2.2513697636711183E-4	2.6505053800162087E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	1	1	0	24	39	-1	40	47		TCRBV24-01,TCRBV24-or09_02												CATSDRDSQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACTAGCGGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGGYTGELFF	In	VDJ	1	209	2.2621936567656907E-4	2.66324819434321E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	2	0	3	0	1	26	-1	56	42	57		TCRBV12-03,TCRBV12-04												CASSLGLAGGYTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCCCGGGACAGGGAAGCTATGGCTACACCTTCGGTTCG	CASSLVPGQGSYGYTF	In	VDJ	1	211	2.2838414429548362E-4	2.6887338229972116E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	4	4	3	26	42	55	46	58		TCRBV12-03,TCRBV12-04												CASSLVPGQGSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGACGGTCCCTACGAGCAGTACTTCGGGCCG	CASSLADGPYEQYF	In	VDJ	1	212	2.294665336049409E-4	2.701476637324213E-4	42							TCRBJ02	TCRBJ02-07	01	0	1	7	2	0	4	18	-1	39	35	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLADGPYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCTTCTGATGGTCCGGCTGTTGACTCTGGAAACACCATATATTTTGGAGAG	CASSASDGPAVDSGNTIYF	In	VDJ	1	212	2.294665336049409E-4	2.701476637324213E-4	57	unresolved						TCRBJ01	TCRBJ01-03	01	3	9	0	0	13	6	23	36	52	49	58	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASDGPAVDSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGGCGGGGGGGACCCCGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASRAGGTPVSYNEQFF	In	VDJ	1	213	2.3054892291439816E-4	2.714219451651214E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	0	0	4	8	26	37	50	41	58		TCRBV20-01,TCRBV20-or09_02												CSASRAGGTPVSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCAGGCACAGGGTGGGGAAAAACTGTTTTTTGGCAGT	CASSQQAQGGEKLFF	In	VDJ	1	214	2.3163131222385543E-4	2.726962265978215E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	8	6	4	26	40	52	46	56		TCRBV03-01,TCRBV03-02												CASSQQAQGGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCAGCGGGGCCTCAGCACAGATACGCAGTATTTTGGCCCA	CASSLQRGLSTDTQYF	In	VDJ	1	216	2.3379609084276997E-4	2.752447894632217E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	0	3	4	26	39	49	42	53		TCRBV03-01,TCRBV03-02												CASSLQRGLSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTACTCGGGGGGTTTACGAGCAGTACGTCGGGCCG	CASSTRGVYEQYV	In	VDJ	1	216	2.3379609084276997E-4	2.752447894632217E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	17	3	15	22	34	44	37	59		TCRBV12-03,TCRBV12-04												CASSTRGVYEQYV+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCACAGAGAAGACCCAGTACTTCGGGCCA	CASSFTEKTQYF	In	VDJ	1	217	2.3487848015222722E-4	2.765190708959218E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	5	6	1	3	26	40	45	41	48		TCRBV12-03,TCRBV12-04												CASSFTEKTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCCACGTATAGTCGAGTGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	217	2.3487848015222722E-4		56				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	8	2	8	8	18	35	46	43	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								X+X+TCRBJ01-05		TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACACAGCGGGGGGCCCCACAACAAATACGCAGTATTTTGGCCCA	CSANTAGGPTTNTQYF	In	VDJ	1	218	2.359608694616845E-4	2.7779335232862187E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	1	7	4	11	26	36	49	40	60		TCRBV20-01,TCRBV20-or09_02												CSANTAGGPTTNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCCGGGGAGGGTGGAACATTCAGTACTTCGGCGCC	CSARDSRGGWNIQYF	In	VDJ	1	218	2.359608694616845E-4	2.7779335232862187E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	9	0	7	6	3	26	40	53	46	56		TCRBV20-01,TCRBV20-or09_02												CSARDSRGGWNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACCTACAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSTYRGQETQYF	In	VDJ	1	221	2.392080373900563E-4	2.8161619662672217E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	1	2	4	0	24	36	-1	40	48		TCRBV24-01,TCRBV24-or09_02												CASSTYRGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGATAAAAGACTAAGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSDKRLRPGELFF	In	VDJ	1	223	2.4137281600897085E-4	2.841647594921224E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	9	6	7	4	22	34	46	41	50	TCRBV09,TCRBV12					01,02								CASSDKRLRPGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCACAGACAATGAGCAGTTCTTCGGGCCA	CATSDFTDNEQFF	In	VDJ	1	223	2.4137281600897085E-4	2.841647594921224E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	5	5	1	0	24	41	-1	42	46		TCRBV24-01,TCRBV24-or09_02												CATSDFTDNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGGGGATCGCCAAGAGACCCAGTACTTCGGGCCA	CSARRGDRQETQYF	In	VDJ	1	224	2.4245520531842812E-4	2.8543904092482247E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	1	1	0	4	26	-1	45	38	49		TCRBV20-01,TCRBV20-or09_02												CSARRGDRQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGTTGAGCCAGGGGAGAAATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	224	2.4245520531842812E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	4	2	4	8	6	24	33	47	41	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGTCCGGGACAGGGCAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	224	2.4245520531842812E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	1	7	2	24	36	52	43	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGACAACTCTGGAAACACCATATATTTTGGAGAG	CASSLDNSGNTIYF	In	VDJ	1	224	2.4245520531842812E-4	2.8543904092482247E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	6	0	0	1	18	-1	37	32	38	TCRBV05,TCRBV11													CASSLDNSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGGACAGGGTGTGGCTACACCTTCGGTTCG	CATSDRTGCGYTF	In	VDJ	1	226	2.4461998393734264E-4	2.879876037902227E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	7	1	2	24	39	48	40	50		TCRBV24-01,TCRBV24-or09_02												CATSDRTGCGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCTGGCCAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	226	2.4461998393734264E-4		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	5	4	6	0	24	37	-1	43	46		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGACTAGCGGACAAGAGACCCAGTACTTCGGGCCA	CATGTSGQETQYF	In	VDJ	1	226	2.4461998393734264E-4	2.879876037902227E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	0	5	2	0	1	24	-1	44	33	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATGTSGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACAATACGGGGGCCGGCACAGATACGCAGTATTTTGGCCCA	CASSHNTGAGTDTQYF	In	VDJ	1	227	2.4570237324679994E-4	2.892618852229228E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	3	6	0	1	6	2	23	37	49	43	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHNTGAGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCCGGGACAGGGGTACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRDRGTGANVLTF	In	VDJ	1	227	2.4570237324679994E-4	2.892618852229228E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	2	2	4	2	18	30	44	34	46	TCRBV07,TCRBV11													CASSPRDRGTGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCAGCCTCCTTTGGGGCGGGGGCCCAAATTAGGGGGCAACAGTTCTTCGGGCCA		Out	VDJ	1	228	2.467847625562572E-4		55	unresolved						TCRBJ02	TCRBJ02-01	01	4	5	0	13	24	2	26	39	70	63	72	TCRBV03,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGTGGGGGAGGTTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASGGGSSNQPQHF	In	VDJ	1	228	2.467847625562572E-4	2.905361666556229E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	9	9	1	1	3	4	23	31	40	34	44	TCRBV02,TCRBV12													CASGGGSSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCCCTTCTGGGACAGGGGGTCGTGGCTACACCTTCGGTTCG	CASSLVPSGTGGRGYTF	In	VDJ	1	229	2.478671518657145E-4	2.91810448088323E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	7	8	3	26	42	61	50	64		TCRBV12-03,TCRBV12-04												CASSLVPSGTGGRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCCCCCAGGGTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	231	2.5003193048462897E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	4	7	2	26	36	48	43	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGCTACCCAGATTGCTCCGTTCTTCGGGCCA	CASSATQIAPFF	In	VDJ	1	231	2.5003193048462897E-4	2.943590109537232E-4	36	unresolved						TCRBJ02	TCRBJ02-01	01	6	4	5	15	7	8	23	34	44	41	52	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSATQIAPFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAATCGGGGCGGTAGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	232	2.5111431979408627E-4		46	unresolved						TCRBJ02	TCRBJ02-03	01	5	7	0	3	5	6	26	38	48	43	54	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGTACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSAVQGNTEAFF	In	VDJ	1	232	2.5111431979408627E-4	2.956332923864233E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	3	0	26	34	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAVQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTTAGGTAGAATGAGCAGTTCTTCGGGCCA	CASSVVR*NEQFF	Stop	VDJ	1	234	2.532790984130008E-4		39	unresolved						TCRBJ02	TCRBJ02-01	01	5	5	4	7	6	3	24	36	45	42	48	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVR*NEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGCCCGGACTAGCGGGGTAAATGAGCAGTTCTTCGGGCCA	CSAARTSGVNEQFF	In	VDJ	1	236	2.5544387703191535E-4	3.007304181172237E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	7	5	2	26	34	51	39	53		TCRBV20-01,TCRBV20-or09_02												CSAARTSGVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGACAGGGATCCATGGCTACACCTTCGGTTCG	CASSQVTGIHGYTF	In	VDJ	1	238	2.5760865565082984E-4	3.032789809826239E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	6	1	4	26	42	50	43	54		TCRBV03-01,TCRBV03-02												CASSQVTGIHGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTTCTGACAAATGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	239	2.5869104496028714E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	6	1	6	4	26	40	50	46	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGACAGGGGGCGGTTCGAAGCTTTCTTTGGACAA	CSAREDRGRFEAFF	In	VDJ	1	239	2.5869104496028714E-4	3.04553262415324E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	0	8	0	5	26	-1	51	40	56		TCRBV20-01,TCRBV20-or09_02												CSAREDRGRFEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGACTCTGGAAACACCATATATTTTGGAGAG	CASRDSGNTIYF	In	VDJ	1	239	2.5869104496028714E-4	3.04553262415324E-4	36	unresolved						TCRBJ01	TCRBJ01-03	01	6	1	8	0	0	0	23	-1	-1	34	37	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRDSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCACGGTGGCAGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	240	2.597734342697444E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	8	0	19	31	-1	39	45	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGAAGGGAGCCAGCGGGGACACCATATATTTTGGAGAG	CASRKGASGDTIYF	In	VDJ	1	241	2.608558235792017E-4	3.071018252807242E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	6	3	8	10	0	26	37	-1	47	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRKGASGDTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCTTACAGCGGGGGGGCCGCAATGAGCAGTTCTTCGGGCCA	CASSLQRGGRNEQFF	In	VDJ	1	243	2.6302060219811623E-4	3.096503881461244E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	6	1	3	18	33	44	34	47	TCRBV11,TCRBV21													CASSLQRGGRNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCGGCCCGGTCTAACTATGGCTACACCTTCGGTTCG	CASSAARSNYGYTF	In	VDJ	1	244	2.6410299150757347E-4	3.109246695788245E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	3	9	0	0	1	5	23	36	40	37	45	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSAARSNYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGAGGCTGAACTCGAGCAGTACTTCGGGCCG	CASSLEAELEQYF	In	VDJ	1	245	2.6518538081703077E-4	3.121989510115246E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	1	5	4	6	0	7	18	-1	37	34	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLEAELEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGGGGGTCATCGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDLGVIAGELFF	In	VDJ	1	246	2.66267770126488E-4	3.134732324442247E-4	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	6	1	6	3	6	26	43	51	46	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGVIAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGAGGGACGGCTACTAATCAGCCCCAGCATTTTGGTGAT	CATSDRGTATNQPQHF	In	VDJ	1	247	2.6735015943594526E-4	3.147475138769248E-4	48	TCRBV24						TCRBJ01	TCRBJ01-05	01	3	0	7	4	3	7	24	39	47	42	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDRGTATNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTTCGTTCGATCGATGAGCAGTTCTTCGGGCCA	CASSFRSIDEQFF	In	VDJ	1	247	2.6735015943594526E-4	3.147475138769248E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	3	2	8	8	6	3	18	32	40	38	43	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRSIDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGTCCACAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLGSTGEETQYF	In	VDJ	1	249	2.695149380548598E-4	3.17296076742325E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	2	3	5	0	18	34	-1	39	46	TCRBV07,TCRBV11													CASSLGSTGEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGAGACATATGGGGGGCCTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	250	2.705973273643171E-4		49	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	6	0	2	11	3	26	37	54	48	57		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATATTCGGGGGGCGGTGAAGCAGATACGCAGTATTTTGGCCCA	CASSEYSGGGEADTQYF	In	VDJ	1	253	2.738444952926889E-4	3.223932024731254E-4	51	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	1	4	4	8	23	38	49	42	57		TCRBV06-01,TCRBV06-08												CASSEYSGGGEADTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTACCACCGGGCCCGGGACAGGGACCGGGGCCAACGTCCTGACTTTCGGGGCC	CSVTTGPGTGTGANVLTF	In	VDJ	1	254	2.7492688460214614E-4	3.236674839058255E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	0	3	4	14	3	26	33	56	47	59		TCRBV20-01,TCRBV20-or09_02												CSVTTGPGTGTGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGGCGGGGGGGAAAATGGAGAGACCCAGTACTTCGGGCCA	CSVGGGENGETQYF	In	VDJ	1	255	2.7600927391160343E-4	3.249417653385256E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	7	0	4	3	7	26	33	45	36	52		TCRBV20-01,TCRBV20-or09_02												CSVGGGENGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGAGAGGACTAGCGGGGGGGTCCATGAGCAGTTCTTCGGGCCA	CASSERTSGGVHEQFF	In	VDJ	1	255	2.7600927391160343E-4	3.249417653385256E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	1	0	8	3	3	23	36	54	39	57	TCRBV09,TCRBV12													CASSERTSGGVHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCACCCGGCGACAGGGGATTCGGGGAGCTGTTTTTTGGAGAA	CASSPPGDRGFGELFF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	7	9	3	26	38	55	47	58		TCRBV12-03,TCRBV12-04												CASSPPGDRGFGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGAATCGGGGACTTCTCGGACCCAACTATGGCTACACCTTCGGTTCG	CSARGNRGLLGPNYGYTF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	0	10	2	9	10	26	37	52	46	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGNRGLLGPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAAAGGGGGCTCTCGGGGAGATTTATGGCTACACCTTCGGTTCG	CASSEKGALGEIYGYTF	In	VDJ	1	257	2.78174052530518E-4	3.274903282039258E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	0	5	4	13	22	34	45	38	58		TCRBV12-03,TCRBV12-04												CASSEKGALGEIYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCGCAAGATACTCTCAGGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	260	2.8142122045888977E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	4	4	15	0	26	32	-1	47	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCAGGGACGGGTGGCTACACCTTCGGTTCG	CASSESGTGGYTF	In	VDJ	1	260	2.8142122045888977E-4	3.313131725020261E-4	39	TCRBV06						TCRBJ01	TCRBJ01-02	01	2	0	7	7	3	3	23	38	46	41	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESGTGGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGAGGGATGGGACACGGGACAAAATTCACCCCTCCACTTTGGGAAC	CASSLEGWDTGQNSPLHF	In	VDJ	1	262	2.835859990778043E-4	3.338617353674263E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	6	7	10	8	24	36	52	46	60		TCRBV24-01,TCRBV24-or09_02												CASSLEGWDTGQNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCGACCCGAGGCAGATACGCAGTATTTTGGCCCA	CASSFRPEADTQYF	In	VDJ	1	263	2.8466838838726155E-4	3.3513601680012643E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	4	7	0	26	40	-1	47	51		TCRBV12-03,TCRBV12-04												CASSFRPEADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGAGGGAGATGGAAGCTTTCTTTGGACAA	CSARDRREMEAFF	In	VDJ	1	264	2.8575077769671885E-4	3.364102982328265E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	8	2	5	26	40	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDRREMEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTTGGTAGGGCCATTCAGTACTTCGGCGCC	CASSQDLGRAIQYF	In	VDJ	1	266	2.879155563156334E-4	3.3895886109822673E-4	42	TCRBV03						TCRBJ02	TCRBJ02-04	01	0	5	3	9	7	1	26	43	54	50	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGRAIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACGATTGGGGTAAGGAGTGAAGCTTTCTTTGGACAA	CSTIGVRSEAFF	In	VDJ	1	268	2.9008033493454794E-4	3.415074239636269E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	8	6	2	7	6	7	26	32	42	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTIGVRSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATTTGGGCAGGGAAGGACATTCAGTACTTCGGCGCC	CSARDIWAGKDIQYF	In	VDJ	1	268	2.9008033493454794E-4	3.415074239636269E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	3	8	8	4	26	40	53	48	57		TCRBV20-01,TCRBV20-or09_02												CSARDIWAGKDIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCTCGGAGGGGGCGATCTACGAGCAGTACGTCGGGCCG	CASSEGAIYEQYV	In	VDJ	1	268	2.9008033493454794E-4	3.415074239636269E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	5	0	17	4	17	23	32	43	36	60	TCRBV02,TCRBV12													CASSEGAIYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTGCAGGGGAGTACAGATACGCAGTATTTTGGCCCA	CASSVQGSTDTQYF	In	VDJ	1	269	2.911627242440052E-4	3.42781705396327E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	3	4	3	26	37	47	41	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVQGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAAGGGGGCATGGACAGATACGCAGTATTTTGGCCCA	CSAPKGAWTDTQYF	In	VDJ	1	269	2.911627242440052E-4	3.42781705396327E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	3	4	4	26	35	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSAPKGAWTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCACTACAGGGGGCTGGGAGCCCCAGCATTTTGGTGAT	CASTTGGWEPQHF	In	VDJ	1	270	2.922451135534625E-4	3.440559868290271E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	0	8	2	4	22	32	43	34	47	TCRBV09,TCRBV12													CASTTGGWEPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCCTGCTAGCGGGGGGGGTCACAGATACGCAGTATTTTGGCCCA	CSARDPLLAGGVTDTQYF	In	VDJ	1	271	2.933275028629197E-4	3.453302682617272E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	2	7	2	26	40	59	47	61		TCRBV20-01,TCRBV20-or09_02												CSARDPLLAGGVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGGACCGATTTCCAGCCCCAGCATTTTGGTGAT	CASSERTDFQPQHF	In	VDJ	1	271	2.933275028629197E-4	3.453302682617272E-4	42	TCRBV06						TCRBJ01	TCRBJ01-05	01	2	1	7	7	1	7	23	38	43	39	50		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERTDFQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCTCCGGGACTAGCGGAATATACAATGAGCAGTTCTTCGGGCCA	CASGTSGIYNEQFF	In	VDJ	1	275	2.976570601007488E-4	3.504273939925276E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	0	5	4	3	4	24	30	44	33	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASGTSGIYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCTCTCGAGTGCGGGCACAGATACGCAGTATTTTGGCCCA	XASSLSSAGTDTQYF	In	VDJ	1	275	2.976570601007488E-4	3.504273939925276E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	5	1	9	0	22	34	-1	43	47	TCRBV01,TCRBV07,TCRBV17					01,02								XASSLSSAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGCTGAGGGCGGGGGGGCCGCTGAGCAGTTCTTCGGGCCA	CASSLAEGGGAAEQFF	In	VDJ	1	277	2.9982183871966336E-4	3.529759568579278E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	9	10	4	24	36	55	46	59		TCRBV24-01,TCRBV24-or09_02												CASSLAEGGGAAEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTAGGACAATTTGAAAAACTGTTTTTTGGCAGT	CASSLGQFEKLFF	In	VDJ	1	277	2.9982183871966336E-4	3.529759568579278E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	6	7	0	3	18	-1	38	34	41	TCRBV03,TCRBV07													CASSLGQFEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACTTAGAGGGGACAGGGAGGGAGACCCAGTACTTCGGGCCA	CSADLEGTGRETQYF	In	VDJ	1	278	3.009042280291206E-4	3.542502382906279E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	5	10	3	26	34	53	44	56		TCRBV20-01,TCRBV20-or09_02												CSADLEGTGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGGGGGGGCGCTTCCGAGACCCAGTACTTCGGGCCA	CSAPGGGASETQYF	In	VDJ	1	278	3.009042280291206E-4	3.542502382906279E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	1	9	26	35	44	36	53		TCRBV20-01,TCRBV20-or09_02												CSAPGGGASETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTCTTTCCGACAACAGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	279	3.0198661733857785E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	3	4	0	13	2	24	31	49	44	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTAAGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSKGLNTEAFF	In	VDJ	1	279	3.0198661733857785E-4	3.5552451972332803E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	0	2	1	23	34	41	36	42	TCRBV09,TCRBV12													CASSKGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGACTCGAGCTCCTATAATGAGCAGTTCTTCGGGCCA	CASRDSSSYNEQFF	In	VDJ	1	280	3.0306900664803514E-4	3.567988011560281E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	10	7	0	11	26	-1	42	37	53		TCRBV03-01,TCRBV03-02				01,02								CASRDSSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAATCCAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPIQGNTEAFF	In	VDJ	1	281	3.041513959574924E-4	3.580730825887282E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	1	5	0	23	36	-1	41	46	TCRBV01,TCRBV04													CASSPIQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCGTTCCCCAGGGCCCTTCATCTCTCCTCCACTTTGGGAAC		Out	VDJ	1	284	3.0739856388586423E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	4	3	15	8	12	24	33	46	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAACGTGGCAGGCGACCTAACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	284	3.0739856388586423E-4		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	4	0	8	8	22	35	47	43	55	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAATTGGGGGGCCGGGGAGACCCAGTACTTCGGGCCA	CASSQNWGAGETQYF	In	VDJ	1	286	3.095633425047788E-4	3.6444448975222874E-4	45	TCRBV03						TCRBJ02	TCRBJ02-05	01	2	6	0	5	5	4	26	41	52	46	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNWGAGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGCCACGGCAGGACGCGTGTTGAGCTACACCTTCGGTTCG	CASSQATAGRVLSYTF	In	VDJ	1	286	3.095633425047788E-4	3.6444448975222874E-4	48	unresolved						TCRBJ01	TCRBJ01-02	01	3	1	7	9	10	9	23	37	51	47	60	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQATAGRVLSYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGGCAGGCAGGGTACACAGATACGCAGTATTTTGGCCCA	CASSRQAGYTDTQYF	In	VDJ	1	286	3.095633425047788E-4	3.6444448975222874E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	2	6	2	23	36	47	42	49	TCRBV01,TCRBV04													CASSRQAGYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCCCGAGCGTGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPSVGSYNEQFF	In	VDJ	1	286	3.095633425047788E-4	3.6444448975222874E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	6	0	7	4	22	33	44	40	48		TCRBV12-03,TCRBV12-04				01,02								CASSPPSVGSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTCCAGGGGGAAAACATTCAGTACTTCGGCGCC	CASSLVQGENIQYF	In	VDJ	1	286	3.095633425047788E-4	3.6444448975222874E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	1	5	2	0	19	35	-1	37	44	TCRBV07,TCRBV11													CASSLVQGENIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAACGGGCGGGGGGTGGACAGATACGCAGTATTTTGGCCCA	CASSLTGGGWTDTQYF	In	VDJ	1	286	3.095633425047788E-4	3.6444448975222874E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	1	3	4	3	18	33	45	37	48	TCRBV03,TCRBV11													CASSLTGGGWTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGCAGATGAACACTGAAGCTTTCTTTGGACAA	CASSLRQMNTEAFF	In	VDJ	1	290	3.138928997426078E-4	3.695416154830291E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	4	5	0	3	1	26	41	47	44	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRQMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGATCCTTCTTTTGAAGCTTTCTTTGGACAA	CASSLDPSFEAFF	In	VDJ	1	290	3.138928997426078E-4	3.695416154830291E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	1	8	7	0	9	26	-1	43	40	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPSFEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGTCCGGGACAGACACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	290	3.138928997426078E-4		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	3	5	3	24	42	54	47	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCATTAGCGGGGGGCGACCTCAATGAGCAGTTCTTCGGGCCA	CASSSLAGGDLNEQFF	In	VDJ	1	291	3.149752890520651E-4	3.708158969157292E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	6	4	6	26	38	52	42	58		TCRBV03-01,TCRBV03-02												CASSSLAGGDLNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACAGGGCTCGATAATTCACCCCTCCACTTTGGGAAC	CSARTGLDNSPLHF	In	VDJ	1	291	3.149752890520651E-4	3.708158969157292E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	5	2	4	26	34	44	36	48		TCRBV20-01,TCRBV20-or09_02												CSARTGLDNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAAGCGGGACAGGGTACGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	295	3.1930484628989414E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	7	7	4	24	36	52	43	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCATCAAGCCTGTCCCGGACAGGAGAGACCCAGTACTTCGGGCCA	CSASSSLSRTGETQYF	In	VDJ	1	298	3.22552014218266E-4	3.7973586694462993E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	4	4	17	0	26	34	-1	51	58		TCRBV20-01,TCRBV20-or09_02												CSASSSLSRTGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCCAGGGCGGCAGGGGAGAATACACCGGGGAGCTGTTTTTTGGAGAA	CASSFQGGRGEYTGELFF	In	VDJ	1	301	3.2579918214663777E-4	3.8355871124273023E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	3	9	5	19	33	48	42	53	TCRBV05,TCRBV11													CASSFQGGRGEYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGTGGGGGCGTACTATGGCTACACCTTCGGTTCG	CSAKVGAYYGYTF	In	VDJ	1	302	3.2688157145609507E-4	3.8483299267543034E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	3	4	2	26	36	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAKVGAYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGACCGGGACTAGCGGGGGGGCCAGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	307	3.322935180033814E-4		53	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	0	4	7	5	26	34	57	41	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGGGACTAGCGGGGATATACGCAGTATTTTGGCCCA	CATSDLGD*RGYTQYF	Stop	VDJ	1	309	3.3445829662229594E-4		48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	3	7	1	2	24	42	56	43	58		TCRBV24-01,TCRBV24-or09_02												CATSDLGD*RGYTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCATTAATCTCTTTAGCGGCAGGGACACTGAAGCTTTCTTTGGACAA	CASINLFSGRDTEAFF	In	VDJ	1	312	3.3770546455066773E-4	3.9757580700243135E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	5	5	3	10	5	22	32	48	42	53	TCRBV09,TCRBV12					01,02								CASINLFSGRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGAACAGGACACTGAAGCTTTCTTTGGACAA	CASSLEQDTEAFF	In	VDJ	1	312	3.3770546455066773E-4	3.9757580700243135E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	3	5	0	24	36	-1	41	46		TCRBV24-01,TCRBV24-or09_02												CASSLEQDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCTTGCGTGGGGAGAACACTGAAGCTTTCTTTGGACAA	CSAVLRGENTEAFF	In	VDJ	1	313	3.38787853860125E-4	3.988500884351314E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	8	1	10	0	26	35	-1	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVLRGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCTGGGACAGGTCCAACTATGGCTACACCTTCGGTTCG	CATWDRSNYGYTF	In	VDJ	1	313	3.38787853860125E-4	3.988500884351314E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	4	2	3	3	23	30	41	33	44	TCRBV06,TCRBV10													CATWDRSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGGAGACRCAGCMMKGTAYYTSTGTGCCAGCAGCCCTGACGGGGGGGGTCGGCCAGATACGCAGTATTTTGGCCCA	CASSPDGGGRPDTQYF	In	VDJ	1	314	3.3987024316958227E-4	4.0012436986783153E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	4	5	6	18	30	43	35	49	TCRBV15,TCRBV21													CASSPDGGGRPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTGGGGCCACAAGGGCCAATGAGCAGTTCTTCGGGCCA	CASSPGATRANEQFF	In	VDJ	1	315	3.409526324790395E-4	4.0139865130053165E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	6	4	9	26	37	46	41	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGATRANEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTCAACAGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQLNRLNTEAFF	In	VDJ	1	320	3.4636457902632585E-4	4.077700584640321E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	4	0	4	1	26	41	50	45	51		TCRBV03-01,TCRBV03-02												CASSQLNRLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGGTACCGGGGAGGGAGATACGCAGTATTTTGGCCCA	CASSLGTGEGDTQYF	In	VDJ	1	323	3.496117469546977E-4	4.115929027621324E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	0	5	6	0	26	42	-1	48	55		TCRBV12-03,TCRBV12-04												CASSLGTGEGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTAGCGGAGGGGTTAGATACGCAGTATTTTGGCCCA	CASSQLAEGLDTQYF	In	VDJ	1	323	3.496117469546977E-4	4.115929027621324E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	5	5	0	7	26	-1	48	41	55		TCRBV03-01,TCRBV03-02				01,02								CASSQLAEGLDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCTGGGTGGAGGGGGCGACGAGCAGTACTTCGGGCCG	CASSLGGGGDEQYF	In	VDJ	1	323	3.496117469546977E-4	4.115929027621324E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	0	5	9	1	23	34	50	43	51	TCRBV02,TCRBV09													CASSLGGGGDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCTCCATCGAGGAGCGGGGTAACTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	324	3.5069413626415493E-4		58	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	3	2	15	6	23	34	56	49	62		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACTAGCGGGTACACAGATACGCAGTATTTTGGCCCA	CASSETSGYTDTQYF	In	VDJ	1	324	3.5069413626415493E-4	4.1286718419483254E-4	45	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	4	2	0	2	23	-1	47	38	49		TCRBV06-01,TCRBV06-08				01,02								CASSETSGYTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGCTATATGGGCAGGGAAGTCGGAGTGAATCAGCCCCAGCATTTTGGTGAT	CASSQDRYMGREVGVNQPQHF	In	VDJ	1	325	3.5177652557361223E-4	4.1414146562753266E-4	63	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	4	12	11	6	23	40	35	51	TCRBV01,TCRBV04													CASSQDRYMGREVGVNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGTGGGGAGAGAGCACTGAAGCTTTCTTTGGACAA	CASSLWGESTEAFF	In	VDJ	1	327	3.539413041925268E-4	4.1669002849293284E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	2	4	3	4	18	32	40	35	44	TCRBV07,TCRBV11													CASSLWGESTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCCGGGACTGCACAATGAGCAGTTCTTCGGGCCA	CASSPGLHNEQFF	In	VDJ	1	328	3.55023693501984E-4	4.1796430992563295E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	5	2	2	18	30	38	32	40	TCRBV07,TCRBV23					01,02								CASSPGLHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCCGGGGACCTCCAATGAGCAGTTTTTCGGGCCA	CASSPGTSNEQFF	In	VDJ	1	328	3.55023693501984E-4	4.1796430992563295E-4	39	unresolved						TCRBJ02			5	0	7	19	4	16	23	34	43	38	59	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSPGTSNEQFF+X+TCRBJ02-X	unresolved		TCRBJ02	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGCGGGGGAAAATGAGCAGTTCTTCGGGCCA	CASSRAGENEQFF	In	VDJ	1	329	3.5610608281144127E-4	4.19238591358333E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	7	1	2	26	39	48	40	50		TCRBV03-01,TCRBV03-02												CASSRAGENEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGGGGCACCAATGAGCAGTTCTTCGGGCCA	CASSLAGGTNEQFF	In	VDJ	1	330	3.5718847212089856E-4	4.2051287279103313E-4	42							TCRBJ02	TCRBJ02-01	01	0	6	0	6	1	2	18	35	42	36	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGGTNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACTCAAAGCACTGAAGCTTTCTTTGGACAA	CASSQGTQSTEAFF	In	VDJ	1	331	3.582708614303558E-4	4.2178715422373325E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	10	4	0	5	26	-1	47	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSQGTQSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGATCTCGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	333	3.6043564004927035E-4		40	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	6	6	0	24	39	-1	45	49		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGCGGGGGACAGGGGTACTGAAGCTTTCTTTGGACAA	CASSFAGDRGTEAFF	In	VDJ	1	334	3.6151802935872765E-4	4.2560999852183355E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	5	5	1	26	40	55	45	56		TCRBV12-03,TCRBV12-04												CASSFAGDRGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAACTACAGGGTTCAATCAGCCCCAGCATTTTGGTGAT	CATSETTGFNQPQHF	In	VDJ	1	335	3.626004186681849E-4	4.2688427995453366E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	3	4	2	24	38	48	42	50		TCRBV24-01,TCRBV24-or09_02												CATSETTGFNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCTCGGGTGGGGGGGAGAATGAGCAGTTCTTCGGGCCA	CSARDPSGGGENEQFF	In	VDJ	1	338	3.658475865965567E-4	4.3070712425263396E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	7	10	2	26	40	57	50	59		TCRBV20-01,TCRBV20-or09_02												CSARDPSGGGENEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAGACAGATACGCAGTATTTTGGCCCA	CASSLETDTQYF	In	VDJ	1	340	3.6801236521547123E-4	4.3325568711803414E-4	36	TCRBV12						TCRBJ02	TCRBJ02-03	01	1	5	5	3	0	0	26	-1	-1	42	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLETDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCTTGCCCGCGGCAGGGGGCCGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	341	3.690947545249285E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	4	0	8	12	4	26	31	51	43	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGGCCGGGGGGGTATAATGAGCAGTTCTTCGGGCCA	CASSLRPGGYNEQFF	In	VDJ	1	343	3.7125953314384307E-4	4.3707853141613444E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	7	4	3	26	41	53	45	56		TCRBV12-03,TCRBV12-04												CASSLRPGGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGTGGAAGGACTTGCCTACGAGCAGTACGTCGGGCCG	CASSQDVEGLAYEQYV	In	VDJ	1	346	3.7450670107221486E-4	4.4090137571423473E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	10	17	7	17	23	40	52	47	69	TCRBV01,TCRBV04					01,02								CASSQDVEGLAYEQYV+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCACCCCAGGCGGCGCCTACGAGCAGTACGTCGGGCCG	CSATTPGGAYEQYV	In	VDJ	1	346	3.7450670107221486E-4	4.4090137571423473E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	4	4	17	6	20	26	36	46	42	66		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATTPGGAYEQYV+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCCGAACACTGAAGCTTTCTTTGGACAA	CAISDPNTEAFF	In	VDJ	1	346	3.7450670107221486E-4	4.4090137571423473E-4	36							TCRBJ01	TCRBJ01-01	01	5	2	7	1	0	2	23	-1	38	35	40	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDPNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGAGGACTAGCGCGGCAGAGACCCAGTACTTCGGGCCA	CASRRTSAAETQYF	In	VDJ	1	346	3.7450670107221486E-4	4.4090137571423473E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	6	4	2	4	23	34	45	36	49	TCRBV02,TCRBV09					01,02								CASRRTSAAETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACTGTTGAGGGGACTGCGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	347	3.755890903816721E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	0	10	2	8	3	23	33	47	41	50	TCRBV06,TCRBV10					01,02								X+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGCTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGSSSYNEQFF	In	VDJ	1	350	3.7883625831004394E-4	4.4599850144503515E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	0	2	5	24	36	42	38	47		TCRBV24-01,TCRBV24-or09_02												CASSLGSSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCGCCCAAGGGTCTGGGGACAGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAPKGLGTVNTGELFF	In	VDJ	1	352	3.8100103692895843E-4	4.4854706431043533E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	2	15	2	24	36	58	51	60	TCRBV09,TCRBV21													CASSAPKGLGTVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTATTCCCCAGGGGCGGCTACACCTTCGGTTCG	CSARVFPRGGYTF	In	VDJ	1	354	3.83165815547873E-4	4.5109562717583556E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	2	8	7	1	26	39	52	46	53		TCRBV20-01,TCRBV20-or09_02												CSARVFPRGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACGGGGGGGTCAGAGACCCAGTACTTCGGGCCA	CASSTGGSETQYF	In	VDJ	1	356	3.853305941667875E-4	4.5364419004123574E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	4	1	2	24	36	45	37	47		TCRBV24-01,TCRBV24-or09_02												CASSTGGSETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAATTACCAAGAGACCCAGTACTTCGGGCCA	CSARENYQETQYF	In	VJ	1	357	3.864129834762448E-4	4.5491847147393586E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	0	0	0	0	5	26	-1	40	-1	45		TCRBV20-01,TCRBV20-or09_02												CSARENYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTAGCGGGGGAACAAGAGACCCAGTACTTCGGGCCA	CASSVVAGEQETQYF	In	VDJ	1	357	3.864129834762448E-4	4.5491847147393586E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	2	0	2	23	-1	48	39	50	TCRBV09,TCRBV21													CASSVVAGEQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCGCTCCGGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CSARAPGDSNQPQHF	In	VDJ	1	358	3.8749537278570206E-4	4.56192752906636E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	2	0	8	1	26	34	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSARAPGDSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTTCGGGGGTCGACACTGAAGCTTTCTTTGGACAA	CSARVSGVDTEAFF	In	VDJ	1	358	3.8749537278570206E-4	4.56192752906636E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	2	3	3	3	26	39	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSARVSGVDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGGGTGGCGGCAGTTCTTCGGGCCA	CATSDSGWRQFF	In	VDJ	1	358	3.8749537278570206E-4	4.56192752906636E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	12	0	5	24	-1	45	40	50		TCRBV24-01,TCRBV24-or09_02												CATSDSGWRQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTGGGGGATCCCAAAGAGACCCAGTACTTCGGGCCA	CATSDLGDPKETQYF	In	VDJ	1	362	3.9182493002353115E-4	4.6128987863743633E-4	45	TCRBV24						TCRBJ02	TCRBJ02-05	01	4	6	1	3	3	6	24	38	46	41	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLGDPKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCCAGCATTTCGACACTGAAGCTTTCTTTGGACAA	CASSQHFDTEAFF	In	VDJ	1	363	3.929073193329884E-4	4.6256416007013645E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	5	4	5	3	0	7	22	-1	37	34	44	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQHFDTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGACTAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	365	3.9507209795190294E-4		35	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	9	3	1	0	24	35	-1	36	41	TCRBV12,TCRBV21					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCAGCTTCTACATCTGCAGTGCCCCCCAGGGTTGGACTAGCGGGGGGGCGGCGGGAGACAATGAGCAGTTCTTCGGGCCA	CSAPQGWTSGGAAGDNEQFF	In	VDJ	1	367	3.972368765708175E-4	4.6766128580093687E-4	60	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	0	5	11	9	15	23	49	34	58		TCRBV20-01,TCRBV20-or09_02												CSAPQGWTSGGAAGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGGACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDGDPNTGELFF	In	VDJ	1	367	3.972368765708175E-4	4.6766128580093687E-4	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	0	7	0	2	1	26	43	50	45	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGDPNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCTGGGACGGAACCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQAWDGTSSYNEQFF	In	VDJ	1	367	3.972368765708175E-4	4.6766128580093687E-4	54	TCRBV03						TCRBJ02	TCRBJ02-01	01	1	0	7	0	3	8	26	42	50	45	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAWDGTSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCACACAGGGGGCGGCCTCAGATACGCAGTATTTTGGCCCA	CASSTQGAASDTQYF	In	VDJ	1	368	3.983192658802748E-4	4.6893556723363693E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	0	4	3	5	23	34	46	37	51	TCRBV06,TCRBV10													CASSTQGAASDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTCGGACAGGACACAGATACGCAGTATTTTGGCCCA	CATSDLGQDTDTQYF	In	VDJ	1	369	3.99401655189732E-4	4.7020984866633705E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	4	2	4	1	24	38	49	42	50		TCRBV24-01,TCRBV24-or09_02												CATSDLGQDTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGTCATGGGGGGATTCGGATACGCAGTATTTTGGCCCA	CSAGSWGDSDTQYF	In	VDJ	1	370	4.0048404449918927E-4	4.7148413009903716E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	1	6	7	5	26	35	48	42	53		TCRBV20-01,TCRBV20-or09_02												CSAGSWGDSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAATATAACAGGGGGCGGGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	371	4.0156643380864657E-4		55				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	0	1	5	5	18	35	49	40	54	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGGGGACAGGGGCGTTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQVGTGAFGANVLTF	In	VDJ	1	374	4.0481360173701836E-4	4.765812558298376E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	0	2	4	2	5	23	39	51	41	56	TCRBV01,TCRBV04													CASSQVGTGAFGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCTGGCCAGGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSSGQGSGELFF	In	VDJ	1	375	4.0589599104647565E-4	4.7785553726253764E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	6	5	1	18	31	42	36	43	TCRBV07,TCRBV11													CASSSGQGSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGACAGGGTCACAGATACGCAGTATTTTGGCCCA	CATRDRVTDTQYF	In	VDJ	1	376	4.069783803559329E-4	4.7912981869523776E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	0	3	2	1	1	24	33	43	34	44		TCRBV24-01,TCRBV24-or09_02												CATRDRVTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGGAAGAGTGGGGGAGACCCAGTACTTCGGGCCA	CASSEGRVGETQYF	In	VDJ	1	379	4.102255482843047E-4	4.8295266299333805E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	1	6	2	5	7	0	23	39	-1	46	50	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGRVGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGCGTGACGCAGCAGCCTCCGGTGAGACCCAGTACTTCGGGCCA	CSARPRDAAASGETQYF	In	VDJ	1	381	4.1239032690321923E-4	4.8550122585873823E-4	51	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	2	7	5	6	15	26	38	47	44	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPRDAAASGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCGATTTGAGGGGCTCCAACCTATAATTCACCCCTCCACTTTGGGAAC	CAPI*GAPTYNSPLHF	Stop	VDJ	1	381	4.1239032690321923E-4		48	TCRBV24						TCRBJ01	TCRBJ01-06	01	12	5	2	2	8	6	24	30	43	38	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAPI*GAPTYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTGGAGAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	382	4.1347271621267653E-4		40	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	2	4	2	3	26	41	47	43	50		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGCAAGGAAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRQGSGTGELFF	In	VDJ	1	382	4.1347271621267653E-4	4.8677550729143835E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	6	5	4	2	0	26	42	-1	44	49		TCRBV03-01,TCRBV03-02				01,02								CASRQGSGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGTCTAGCGGGGGGCTGGGGGACCCAGTACTTCGGGCCA	CSAREGLAGGWGTQYF	In	VDJ	1	386	4.1780227345050556E-4	4.918726330222388E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	7	4	6	26	40	55	44	61		TCRBV20-01,TCRBV20-or09_02												CSAREGLAGGWGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTCCAGGGGTGGACACTGAAGCTTTCTTTGGACAA	CSARAPGVDTEAFF	In	VDJ	2	389	4.210494413788774E-4	4.956954773203391E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	2	3	3	3	26	39	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSARAPGVDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGACTAGCGGGGCAGATACGCAGTATTTTGGCCCA	CSAPRTSGADTQYF	In	VDJ	2	389	4.210494413788774E-4	4.956954773203391E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	4	4	0	26	35	-1	39	51		TCRBV20-01,TCRBV20-or09_02												CSAPRTSGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGCAGACTTAACCTACGAGCAGTACTTCGGGCCG	CASSADLTYEQYF	In	VDJ	2	389	4.210494413788774E-4	4.956954773203391E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	10	2	4	3	24	35	43	39	46	TCRBV09,TCRBV21					01,02								CASSADLTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTATACCGGGACTATGGATCTACGAGCAGTACTTCGGGCCG	CASSIPGLWIYEQYF	In	VDJ	2	390	4.2213183068833465E-4	4.969697587530391E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	3	6	5	23	34	47	40	52	TCRBV02,TCRBV09					01,02								CASSIPGLWIYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTAAGTTCGGGACAGTCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CSARAKFGTVDSNQPQHF	In	VDJ	2	392	4.242966093072492E-4	4.995183216184394E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	5	0	8	4	26	39	54	47	58		TCRBV20-01,TCRBV20-or09_02												CSARAKFGTVDSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTAGACCAGGGGTCGGCTAATGAAAAACTGTTTTTTGGCAGT	CSARDLDQGSANEKLFF	In	VDJ	2	394	4.2646138792616373E-4	5.020668844838396E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	2	3	7	4	26	40	53	47	57		TCRBV20-01,TCRBV20-or09_02												CSARDLDQGSANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCTTGGGAGGTGAGGGAATAATCACAGATACGCAGTATTTTGGCCCA	CATSLGGEGIITDTQYF	In	VDJ	2	395	4.27543777235621E-4	5.033411659165397E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	1	2	3	12	24	35	44	38	56		TCRBV24-01,TCRBV24-or09_02												CATSLGGEGIITDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTTACGACCGGAGTCCGACACAGATACGCAGTATTTTGGCCCA	CASSLRPESDTDTQYF	In	VDJ	2	396	4.286261665450783E-4	5.046154473492397E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	2	2	8	5	23	35	47	43	52	TCRBV09,TCRBV12													CASSLRPESDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCACTCAGGGCTGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	397	4.297085558545355E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	1	5	3	26	38	48	43	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCGCAGGTCGGTGGGTGACAGATACGCAGTATTTTGGCCCA	CASSAGRWVTDTQYF	In	VDJ	2	399	4.3187333447345007E-4	5.0843829164734E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	3	2	10	23	34	40	36	50	TCRBV02,TCRBV12													CASSAGRWVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTAATAGACAGGCTTCCCCCTCCTACGAGCAGTACTTCGGGCCG	CSARTNRQASPSYEQYF	In	VDJ	2	401	4.340381130923646E-4	5.109868545127402E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	4	0	7	7	26	38	51	45	58		TCRBV20-01,TCRBV20-or09_02												CSARTNRQASPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGACCTACAGGGGATTATGAGCAGTTCTTCGGGCCA	CASRPTGDYEQFF	In	VDJ	2	402	4.3512050240182185E-4	5.122611359454404E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	8	4	3	23	34	45	38	48	TCRBV02,TCRBV09													CASRPTGDYEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGAGGACTAGCGGGGGGGCCAATGAGCAGTTCTTCGGGCCA	CSAPRTSGGANEQFF	In	VDJ	2	403	4.3620289171127915E-4	5.135354173781405E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	0	6	5	1	26	34	54	39	55		TCRBV20-01,TCRBV20-or09_02												CSAPRTSGGANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGACTAGCGGGGGGGCCCGCGTACCCAGATACGCAGTATTTTGGCCCA	CSARAGLAGGPAYPDTQYF	In	VDJ	2	403	4.3620289171127915E-4	5.135354173781405E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	0	0	4	1	10	24	37	54	38	64		TCRBV20-01,TCRBV20-or09_02												CSARAGLAGGPAYPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCTCCCGACTAGCGGAGTTTACAATGAGCAGTTCTTCGGGCCA	CASSPLPTSGVYNEQFF	In	VDJ	2	406	4.3945005963965094E-4	5.173582616762408E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	4	8	4	24	36	53	44	57		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPLPTSGVYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGTGAGTGGCCGTACTATGGCTACACCTTCGGTTCG	CASGEWPYYGYTF	In	VDJ	2	406	4.3945005963965094E-4	5.173582616762408E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	9	0	3	2	3	24	38	43	40	46		TCRBV24-01,TCRBV24-or09_02												CASGEWPYYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCAAGGGTCCGGGGGGGCACTATGAGCAGTTCTTCGGGCCA	CSAPKGPGGHYEQFF	In	VDJ	2	407	4.4053244894910824E-4	5.186325431089408E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	8	11	4	26	34	53	45	57		TCRBV20-01,TCRBV20-or09_02												CSAPKGPGGHYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATGAGGGGGGGGCAATGGCGACAGATACGCAGTATTTTGGCCCA	CASSHEGGAMATDTQYF	In	VDJ	2	408	4.416148382585655E-4	5.19906824541641E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	3	3	9	23	37	47	40	56	TCRBV01,TCRBV04													CASSHEGGAMATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATATGAGGGGAGTAATTCACCCCTCCACTTTGGGAAC	CASSEYEGSNSPLHF	In	VDJ	2	414	4.481091741153091E-4	5.275525131378416E-4	45	TCRBV06						TCRBJ01	TCRBJ01-06	01	2	5	2	6	4	2	23	38	47	42	49		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEYEGSNSPLHF+TCRBV06-X+TCRBJ01-06	TCRBV06		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGCGGCATCCAATGAGCAGTTCTTCGGGCCA	CASSQDAASNEQFF	In	VDJ	2	416	4.5027395273422366E-4	5.301010760032417E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	6	1	4	26	43	48	44	52		TCRBV03-01,TCRBV03-02				01,02								CASSQDAASNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCCCCCTAACGGGGGGACCTGTAGACCCAGTACTTCGGGCCA		Out	VDJ	2	416	4.5027395273422366E-4		43	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	8	1	6	7	6	18	27	41	34	47	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGSGGTDTQYF	In	VDJ	2	419	4.5352112066259544E-4	5.33923920301342E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	3	1	3	0	26	40	-1	43	51		TCRBV12-03,TCRBV12-04												CASSLGSGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGTTCGGGGGGAGGGGACGACTATGGCTACACCTTCGGTTCG	CATSGSGGGDDYGYTF	In	VDJ	2	419	4.5352112066259544E-4	5.33923920301342E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	1	3	3	8	24	37	47	40	55		TCRBV24-01,TCRBV24-or09_02				01,02								CATSGSGGGDDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAAGGGAGCGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	425	4.600154565193391E-4		43				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	9	2	8	3	3	18	35	43	38	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ01-04		TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATCCAGCGGGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	426	4.610978458287963E-4		40	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	11	6	1	3	7	0	24	31	-1	38	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACGGGGAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLYGEGGELFF	In	VDJ	2	429	4.643450137571681E-4	5.466667346283431E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	0	7	7	0	24	36	-1	43	50		TCRBV24-01,TCRBV24-or09_02												CASSLYGEGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGGCAGACTGACAATGAGCAGTTCTTCGGGCCA	CASSLRQTDNEQFF	In	VDJ	2	431	4.6650979237608265E-4	5.492152974937433E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	10	5	5	1	26	41	50	46	51		TCRBV12-03,TCRBV12-04				01,02								CASSLRQTDNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGGCGATAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	433	4.686745709949972E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	8	0	2	0	4	24	-1	42	38	46		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFESSYEQYF	In	VDJ	2	435	4.7083934961391174E-4	5.543124232245437E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	2	8	0	1	3	26	40	43	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFESSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCCCCGGGTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSANPRVAGSYNEQFF	In	VDJ	2	440	4.7625129616119807E-4	5.606838303880442E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	5	3	1	9	0	26	36	-1	45	53		TCRBV20-01,TCRBV20-or09_02												CSANPRVAGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACCCGGTCCTGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	445	4.816632427084844E-4		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	5	5	4	7	26	39	46	43	53		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCGCAGGGAGGGGACAGATACGCAGTATTTTGGCCCA	CASRREGTDTQYF	In	VDJ	2	445	4.816632427084844E-4	5.670552375515446E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	0	3	4	1	23	32	43	36	44	TCRBV09,TCRBV21													CASRREGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCGGGACTTATCGTACGAGCAGTACTTCGGGCCG	CASRRDLSYEQYF	In	VDJ	2	447	4.8382802132739894E-4	5.696038004169449E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	10	4	2	5	24	35	43	37	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASRRDLSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAAGTCAGAGTAGTAAGACGCAGTATTTTGGCCCA	CASSVESQSSKTQYF	In	VDJ	2	448	4.8491041063685624E-4	5.708780818496449E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	0	4	5	9	5	9	23	39	47	44	56	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVESQSSKTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGGGTGTGGTAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDRGVVTNTGELFF	In	VDJ	2	450	4.870751892557708E-4	5.734266447150452E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	0	1	8	23	40	46	41	54	TCRBV01,TCRBV04													CASSQDRGVVTNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGATTCTCCTCAGACAGGGGGGACACCCCTCCACTTTGGGAAC	CASSLDSPQTGGTPLHF	In	VDJ	2	454	4.914047464935999E-4	5.785237704458456E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	1	11	9	2	18	35	53	44	55	TCRBV07,TCRBV11													CASSLDSPQTGGTPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGGGAGTCCATGGCTACACCTTCGGTTCG	CSARAGVHGYTF	In	VDJ	2	455	4.924871358030571E-4	5.797980518785457E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	7	2	6	1	3	26	37	45	38	48		TCRBV20-01,TCRBV20-or09_02												CSARAGVHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGGACAGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CSATRTGGGTEAFF	In	VDJ	2	458	4.95734303731429E-4	5.83620896176646E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	4	3	3	26	36	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSATRTGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCATACCGGGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CSASYRGGGTEAFF	In	VDJ	2	459	4.968166930408861E-4	5.848951776093461E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	4	6	3	26	35	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSASYRGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTAGCCGAGGGTGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	459	4.968166930408861E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	11	0	2	7	2	24	36	48	43	50	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGACAGGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSPRDRVYNEQFF	In	VDJ	2	461	4.989814716598007E-4	5.874437404747463E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	4	3	2	26	39	51	42	53		TCRBV03-01,TCRBV03-02												CASSPRDRVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCAGACCCCACTCCCGGGGGAAAAACTGTTTTTTGGCAGT	CASSQTPLPGEKLFF	In	VDJ	2	463	5.011462502787152E-4	5.899923033401465E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	8	3	8	14	0	24	35	-1	49	54	TCRBV24,TCRBV27													CASSQTPLPGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGAGGGGCTAAAAACATTCAGTACTTCGGCGCC	CASSQGGAKNIQYF	In	VDJ	2	465	5.033110288976298E-4	5.925408662055467E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	9	0	4	0	3	26	-1	47	40	50		TCRBV03-01,TCRBV03-02												CASSQGGAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCACCTCACAGGGAGCGCTGAAAAACTGTTTTTTGGCAGT	CASSHLTGSAEKLFF	In	VDJ	2	472	5.108877540638307E-4	6.014608362344474E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	7	6	5	24	36	48	42	53		TCRBV24-01,TCRBV24-or09_02												CASSHLTGSAEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCCAGTTCCCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSQDPVPSNEKLFF	In	VDJ	2	474	5.130525326827452E-4	6.040093990998476E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	5	3	2	6	23	40	45	42	51	TCRBV01,TCRBV04													CASSQDPVPSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CSARDTGANTEAFF	In	VDJ	2	475	5.141349219922025E-4	6.052836805325477E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	6	0	1	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDTGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGACAGGGGGACTATAGCAATCAGCCCCAGCATTTTGGTGAT	CATSDGQGDYSNQPQHF	In	VDJ	2	475	5.141349219922025E-4	6.052836805325477E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	1	0	1	4	24	38	49	39	53		TCRBV24-01,TCRBV24-or09_02												CATSDGQGDYSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGCGAACACTGAAGCTTTCTTTGGACAA	CSARDPANTEAFF	In	VDJ	2	476	5.152173113016597E-4	6.065579619652478E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	9	0	1	3	0	26	40	-1	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACCCATGGCAGGGACGGCTATGGCTACACCTTCGGTTCG	CATSDTHGRDGYGYTF	In	VDJ	2	480	5.195468685394888E-4	6.116550876960482E-4	48	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	7	4	11	2	24	38	54	49	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTHGRDGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCCCGGGCCTAGCCCCAGATACGCAGTATTTTGGCCCA	CASSPPGLAPDTQYF	In	VDJ	2	481	5.206292578489461E-4	6.129293691287483E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	7	4	9	2	23	35	49	44	51	TCRBV09,TCRBV21					01,02								CASSPPGLAPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGTTTCGACTGGGGGACAGGGGGAAAAATGAGCAGTTCTTCGGGCCA	CASSQFRLGDRGKNEQFF	In	VDJ	2	490	5.303707616340615E-4	6.243979020230492E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	7	11	3	23	37	59	48	62	TCRBV01,TCRBV04													CASSQFRLGDRGKNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGGAGGGGGATGGAATGAGCAGTTCTTCGGGCCA	CATGGGWNEQFF	In	VDJ	2	493	5.336179295624333E-4	6.282207463211495E-4	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	9	0	7	0	6	24	-1	39	32	45		TCRBV24-01,TCRBV24-or09_02												CATGGGWNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTTAGCTGATTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	496	5.368650974908051E-4		40	unresolved						TCRBJ01	TCRBJ01-02	01	0	2	8	1	1	1	26	43	46	44	47	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGGACCCACCTACGAGCAGTACTTCGGGCCG	CSASGGPTYEQYF	In	VDJ	2	496	5.368650974908051E-4	6.320435906192498E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	0	7	2	3	3	26	37	45	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGPTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCACCGGGACAGGGCTTGAAAAACTGTTTTTTGGCAGT	CASSTGTGLEKLFF	In	VDJ	2	497	5.379474868002624E-4	6.333178720519499E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	7	4	2	26	37	50	41	52	TCRBV12,TCRBV21													CASSTGTGLEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGAGCAGGGCTGGACGGGGAGCTGTTTTTTGGAGAA	CASSPRAGLDGELFF	In	VDJ	2	500	5.411946547286342E-4	6.371407163500503E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	7	6	5	26	39	50	45	55		TCRBV03-01,TCRBV03-02												CASSPRAGLDGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGCGGAGGGCCTGCCATTGAGCAGTTCTTCGGGCCA	CASSPGGGPAIEQFF	In	VDJ	2	503	5.44441822657006E-4	6.409635606481506E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	0	9	5	8	26	39	50	44	58		TCRBV03-01,TCRBV03-02												CASSPGGGPAIEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCAGGGTGACTGAAGCTTTCTTTGGACAA	CASSQARVTEAFF	In	VDJ	2	504	5.455242119664633E-4	6.422378420808506E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	5	1	2	26	42	48	43	50		TCRBV03-01,TCRBV03-02												CASSQARVTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGACAGGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSARDMDRGGNTEAFF	In	VDJ	2	507	5.487713798948351E-4	6.460606863789509E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	1	1	3	2	26	40	53	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDMDRGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTAGGACAGGGGGCTCGACAGATACGCAGTATTTTGGCCCA	CSAPRTGGSTDTQYF	In	VDJ	2	507	5.487713798948351E-4	6.460606863789509E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	3	4	3	26	35	50	39	53		TCRBV20-01,TCRBV20-or09_02												CSAPRTGGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLLTNEKLFF	In	VDJ	2	511	5.531009371326642E-4	6.511578121097513E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	3	10	1	2	0	24	36	-1	38	41		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLLTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCTCCCAAGGGGACCCTACCTCTACGTGCAGTACGTCGGGCCG		Out	VDJ	2	521	5.639248302272368E-4		44	unresolved						TCRBJ02	TCRBJ02-07	01	1	0	7	17	0	21	23	-1	44	39	65	TCRBV04,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGCGGGATACCAAGATACGCAGTATTTTGGCCCA	CASSLAGYQDTQYF	In	VDJ	2	521	5.639248302272368E-4	6.639006264367523E-4	42							TCRBJ02	TCRBJ02-03	01	0	0	8	5	0	5	18	-1	39	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGYQDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACCCTCTGTCAGAGGGGATGGGACTGAAGCTTTCTTTGGACAA	CASSEPSVRGDGTEAFF	In	VDJ	2	525	5.682543874650659E-4	6.689977521675527E-4	51	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	5	2	5	11	5	23	38	54	49	59		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEPSVRGDGTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTAGCGGGGATACAAGAGACCCAGTACTTCGGGCCA	CASSLLAGIQETQYF	In	VDJ	2	529	5.72583944702895E-4	6.740948778983532E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	2	0	3	26	-1	50	41	53		TCRBV12-03,TCRBV12-04												CASSLLAGIQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TTTCTGTGCCAGCAGCAAAGCGCTTTTGGCCGGTTGGGTAGGGGTGAATAACCTCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	531	5.747487233218095E-4		68	TCRBV21			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	3	18	12	4	21	44	39	56		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ02-07	TCRBV21	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGTTCGGGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSLRFGGGTDTQYF	In	VDJ	2	533	5.76913501940724E-4	6.791920036291535E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	2	1	5	2	26	41	52	46	54		TCRBV12-03,TCRBV12-04												CASSLRFGGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGGGAGACAAACAAGAGACCCAGTACTTCGGGCCA	CSARRGDKQETQYF	In	VDJ	2	534	5.779958912501813E-4	6.804662850618536E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	3	2	0	7	26	-1	43	37	50		TCRBV20-01,TCRBV20-or09_02												CSARRGDKQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGGGGGGCAATGGCAGAAGCTAACTATGGCTACACCTTCGGTTCG	CARGAMAEANYGYTF	In	VDJ	2	535	5.790782805596386E-4	6.817405664945538E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	6	0	0	0	11	23	-1	37	31	48	TCRBV02,TCRBV09													CARGAMAEANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TATTTYTGTGCCAGCAGTTTAGCTAGGACTAGCGGGGGGCCCATATAATAACAAGAGACCCAGTACTTCGGGCCA	CASSLARTSGGPI**QETQYF	Stop	VDJ	2	536	5.801606698690959E-4		63	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	1	1	2	2	12	6	23	39	25	51	TCRBV12,TCRBV21													CASSLARTSGGPI**QETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTCCTAGGCCCTAATTCACCCCTCCACTTTGGGAAC	CSARLLGPNSPLHF	In	VDJ	2	538	5.823254484880104E-4	6.85563410792654E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	4	8	6	3	4	26	38	45	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLLGPNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTAGGGGGGAGTACTGAAGCTTTCTTTGGACAA	CASSLGGSTEAFF	In	VDJ	2	538	5.823254484880104E-4	6.85563410792654E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	5	1	5	3	4	20	31	40	34	44	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAATTTTACTCTGGAAACACCATATATTTTGGAGAG	CASSEFYSGNTIYF	In	VDJ	2	540	5.84490227106925E-4	6.881119736580542E-4	42	unresolved						TCRBJ01	TCRBJ01-03	01	5	2	8	0	1	6	23	34	37	35	43	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEFYSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCCGGGGGGCAGCCCCAGCATTTTGGTGAT	CASSHPGGQPQHF	In	VDJ	2	541	5.855726164163822E-4	6.893862550907543E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	1	7	3	0	26	40	-1	43	50		TCRBV03-01,TCRBV03-02												CASSHPGGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATATCCTAGCGGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDILAGVNTGELFF	In	VDJ	2	552	5.974788988204121E-4	7.034033508504555E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	1	4	1	23	40	54	44	55	TCRBV01,TCRBV04													CASSQDILAGVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCATGCTCGGGGGGGCGGGGGAGACCCAGTACTTCGGGCCA	CASSMLGGAGETQYF	In	VDJ	2	557	6.028908453676985E-4	7.097747580139559E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	0	5	6	5	24	35	49	41	54		TCRBV24-01,TCRBV24-or09_02												CASSMLGGAGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATCTGCCGGACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	568	6.147971277717285E-4		47	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	1	8	3	8	0	26	43	-1	51	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCCAGGGGATATCAGAATGAGCAGTTCTTCGGGCCA	CSARDARGYQNEQFF	In	VDJ	2	569	6.158795170811857E-4	7.250661352063571E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	7	3	7	26	40	49	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDARGYQNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGATTGGACAGGATGGGTCAGCCCCAGCATTTTGGTGAT	CASRLDRMGQPQHF	In	VDJ	2	569	6.158795170811857E-4	7.250661352063571E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	6	3	5	23	34	44	37	49	TCRBV09,TCRBV12													CASRLDRMGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSARPGGGQETQYF	In	VDJ	2	572	6.191266850095575E-4	7.288889795044575E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	2	1	4	0	26	38	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARPGGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCCCTACAGGGAAGAGAGACCCAGTACTTCGGGCCA	CASSALQGRETQYF	In	VDJ	2	573	6.202090743190147E-4	7.301632609371576E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	4	4	3	24	37	47	41	50		TCRBV24-01,TCRBV24-or09_02												CASSALQGRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGTCCCGCAGAGACCCAGTACTTCGGGCCA	CSASSPAETQYF	In	VDJ	2	576	6.234562422473865E-4	7.339861052352578E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	5	4	0	6	26	-1	40	37	46		TCRBV20-01,TCRBV20-or09_02												CSASSPAETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGAGGGACCGCGTGTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	588	6.364449139608738E-4		52	TCRBV24						TCRBJ02	TCRBJ02-01	01	4	0	7	2	5	8	24	38	48	43	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGAATCTCTGGAAACACCATATATTTTGGAGAG	CASSQEGISGNTIYF	In	VDJ	2	589	6.375273032703311E-4	7.505517638603591E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	0	1	8	0	1	2	23	40	44	41	46	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGISGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCCGACAGGGGGAAACATTCAGTACTTCGGCGCC	CAISDPTGGNIQYF	In	VDJ	2	589	6.375273032703311E-4	7.505517638603591E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	6	5	0	23	35	-1	40	49	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDPTGGNIQYF+X+TCRBJ02-04		TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSQADSTDTQYF	In	VDJ	2	605	6.548455322216473E-4	7.709402667835608E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	3	1	7	0	3	0	26	40	-1	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQADSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGCTCCGGGACACTGAAGCTTTCTTTGGACAA	CSAKLRDTEAFF	In	VDJ	2	608	6.580927001500191E-4	7.74763111081661E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	3	5	0	26	36	-1	41	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKLRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGACAGCCAGGCCAACGTCCTGACTTTCGGGGCC	CASSQDSQANVLTF	In	VDJ	2	615	6.6566942531622E-4	7.836830811105617E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	5	6	0	3	26	-1	46	40	49		TCRBV03-01,TCRBV03-02												CASSQDSQANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTTGGGGAAACACCATATATTTTGGAGAG	CSAGWGNTIYF	In	VDJ	2	616	6.667518146256773E-4	7.849573625432619E-4	33	TCRBV20						TCRBJ01	TCRBJ01-03	01	5	0	10	4	0	4	26	-1	37	35	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGWGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACTCCCGGGACAGGGAACGACGAGCAGTACTTCGGGCCG	CSASTPGTGNDEQYF	In	VDJ	2	617	6.678342039351346E-4	7.862316439759619E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	5	7	4	26	37	53	44	57		TCRBV20-01,TCRBV20-or09_02												CSASTPGTGNDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGACCGGGACAAAGGACTGAAGCTTTCTTTGGACAA	CASRGPGQRTEAFF	In	VDJ	2	622	6.73246150482421E-4	7.926030511394625E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	5	6	4	26	37	49	43	53		TCRBV03-01,TCRBV03-02												CASRGPGQRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCCCGGGGTAGCGGATCAAGAGACCCAGTACTTCGGGCCA	CATSAPGVADQETQYF	In	VDJ	2	638	6.905643794337372E-4	8.12991554062664E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	5	2	9	2	24	37	52	46	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSAPGVADQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACTTGACAGGGGTCTATGGCTACACCTTCGGTTCG	CSADLTGVYGYTF	In	VDJ	2	645	6.981411045999381E-4	8.219115240915648E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	4	6	1	26	34	48	40	49		TCRBV20-01,TCRBV20-or09_02												CSADLTGVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACGTGGGGAATCGACACTGAAGCTTTCTTTGGACAA	CASSTWGIDTEAFF	In	VDJ	2	647	7.003058832188526E-4	8.24460086956965E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	0	8	3	5	4	26	38	47	43	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTWGIDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGACAGGGGGGCGGCTACACCTTCGGTTCG	CASSQRQGGGYTF	In	VDJ	3	649	7.024706618377672E-4	8.270086498223651E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	1	8	1	2	26	41	51	42	53		TCRBV03-01,TCRBV03-02												CASSQRQGGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGAAGGTTCCGTATTCGAGCAGTACTTCGGGCCG	CASSQDEGSVFEQYF	In	VDJ	3	651	7.046354404566817E-4	8.295572126877654E-4	45							TCRBJ02	TCRBJ02-07	01	0	5	4	6	3	9	18	35	41	38	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDEGSVFEQYF+X+TCRBJ02-07			TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAATCAGGGTATGGGAATTCACCCCTCCACTTTGGGAAC	CASSESGYGNSPLHF	In	VDJ	3	663	7.176241121701689E-4	8.448485898801666E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	3	7	4	6	22	34	43	38	49	TCRBV09,TCRBV12													CASSESGYGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCCACGGGACTCCTACCTACAATGAGCAGTTCTTCGGGCCA	CHGTPTYNEQFF	In	VDJ	3	665	7.197888907890834E-4	8.473971527455668E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	0	10	2	3	4	26	29	38	32	42		TCRBV20-01,TCRBV20-or09_02				01,02								CHGTPTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCACGGGGCAGCAATGGCAGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	667	7.21953669407998E-4		44	TCRBV24						TCRBJ02	TCRBJ02-01	01	9	7	0	7	3	12	24	33	41	36	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAGACCTGAGGGACAATGAGCAGTTCTTCGGGCCA	CSAKDLRDNEQFF	In	VDJ	3	679	7.349423411214853E-4	8.652370928033682E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	5	9	0	26	34	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAKDLRDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGGAYNEQFF	In	VDJ	3	685	7.414366769782288E-4	8.728827813995688E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	2	2	0	24	36	-1	38	46		TCRBV24-01,TCRBV24-or09_02												CASSPGGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGGACGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAEDVSSYNEQFF	In	VDJ	3	712	7.70661188333575E-4	9.072883800824715E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	1	7	0	3	5	26	34	41	37	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEDVSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAAGGGGGACAGGGGAGGGAAATATAATTCACCCCTCCACTTTGGGAAC	CSAPKGDRGGKYNSPLHF	In	VDJ	3	714	7.728259669524896E-4	9.098369429478717E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	4	7	7	26	35	52	42	59		TCRBV20-01,TCRBV20-or09_02												CSAPKGDRGGKYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGAGGGCGGAGGTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSEEGGGSSGNTIYF	In	VDJ	3	722	7.814850814281477E-4	9.200311944094725E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	10	1	0	5	3	23	39	49	44	52	TCRBV02,TCRBV09													CASSEEGGGSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGCGGGATTCGTCTGGAAACACCATATATTTTGGAGAG	CSARRDSSGNTIYF	In	VDJ	3	725	7.847322493565196E-4	9.238540387075728E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	7	3	1	3	4	26	34	43	37	47		TCRBV20-01,TCRBV20-or09_02												CSARRDSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTATTTAGGTCTCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	731	7.912265852132632E-4		44	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	4	1	5	4	26	39	47	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGCAGTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSAVYSNQPQHF	In	VDJ	3	737	7.977209210700067E-4	9.39145415899974E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	0	0	4	23	-1	39	36	43	TCRBV02,TCRBV09													CASSAVYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACCCCTGGGACACCACTTGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDPWDTTWAGELFF	In	VDJ	3	772	8.356045469010111E-4	9.837452660444775E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	6	6	5	9	23	40	51	45	60	TCRBV01,TCRBV04													CASSQDPWDTTWAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAAATTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQEKFSSYNEQFF	In	VDJ	3	776	8.399341041388402E-4	9.88842391775278E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	8	0	6	0	26	43	-1	49	52		TCRBV03-01,TCRBV03-02				01,02								CASSQEKFSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAACCGGGGGCTCTACACCTTCGGTTCG	CASSQDNRGLYTF	In	VDJ	3	797	8.626642796374428E-4	0.00101560230186198	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	6	0	10	5	1	26	43	54	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDNRGLYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGTCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CSAPGREYNEQFF	In	VDJ	3	797	8.626642796374428E-4	0.00101560230186198	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	4	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAPGREYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGATCTACTGGTATTCAGTACTTCGGCGCC	CASSSGSTGIQYF	In	VDJ	3	800	8.659114475658147E-4	0.0010194251461600804	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	8	3	10	0	9	26	-1	44	39	53		TCRBV12-03,TCRBV12-04												CASSSGSTGIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGACACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSDTGNTEAFF	In	VDJ	3	815	8.821472872076737E-4	0.0010385393676505819	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	1	1	0	23	37	-1	38	43	TCRBV02,TCRBV09													CASSDTGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGCTGAACACTGAAGCTTTCTTTGGACAA	CSARGQLNTEAFF	In	VDJ	3	819	8.864768444455028E-4	0.0010436364933813823	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	0	0	1	26	-1	44	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGQLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAACAGGGGGTAGTTATGGCTACACCTTCGGTTCG	CASSQETGGSYGYTF	In	VDJ	3	832	9.005479054684473E-4	0.0010602021520064835	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	1	5	1	4	23	40	49	41	53	TCRBV01,TCRBV04													CASSQETGGSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCCGGACTAGCGCCTCATACGAGCAGTACTTCGGGCCG	CASTRTSASYEQYF	In	VDJ	3	839	9.081246306346482E-4	0.0010691221220353842	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	1	6	4	3	5	23	33	45	36	50	TCRBV02,TCRBV09					01,02								CASTRTSASYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAGAAGGGGACAGGAGTCAGGAATGAGCAGTTCTTCGGGCCA	CASSEKGTGVRNEQFF	In	VDJ	3	842	9.1137179856302E-4	0.0010729449663334845	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	7	7	7	23	34	49	41	56	TCRBV09,TCRBV12													CASSEKGTGVRNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGGACTAGCGGGGGGTAGAGGGATACGCAGTATTTTGGCCCA	CATSDGTSGG*RDTQYF	Stop	VDJ	3	851	9.211133023481353E-4		51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	6	1	6	24	38	54	39	60		TCRBV24-01,TCRBV24-or09_02												CATSDGTSGG*RDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGCCGGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSQEAGGNEKLFF	In	VDJ	3	888	9.611617067980543E-4	0.0011315619122376891	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	1	5	3	0	23	40	-1	43	50	TCRBV01,TCRBV04													CASSQEAGGNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGGGAGGCTGGTGGCTACACCTTCGGTTCG	CSAPGEAGGYTF	In	VDJ	3	893	9.665736533453406E-4	0.0011379333194011896	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	7	5	4	26	34	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPGEAGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGACTGGATCAATGAGCAGTTCTTCGGGCCA	CSARDDWINEQFF	In	VDJ	3	897	9.709032105831697E-4	0.00114303044513199	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	10	6	1	4	26	40	45	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDDWINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGTCAGCAGCCAGACTTATCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	3	899	9.730679892020843E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	10	5	0	17	26	-1	44	40	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGAAACGGGACTAGGTGGGTATGAGCAGTTCTTCGGGCCA	CATETGLGGYEQFF	In	VDJ	3	899	9.730679892020843E-4	0.0011455790079973904	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	8	8	5	6	24	33	46	38	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATETGLGGYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGATCACCGCCATTTCAGGCTTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	928	0.001004457279176345		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	4	5	14	4	26	38	56	52	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGCCGGAACACGGAGATACGCAGTATTTTGGCCCA	CSARRPEHGDTQYF	In	VDJ	4	929	0.0010055396684858023	0.0011838074509783933	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	1	8	5	5	6	26	38	46	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRPEHGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACTTCGGACAGGGTAGTGACGGGGGTAAAAAACTGTTTTTTGGCAGT	CASSQDFGQGSDGGKKLFF	In	VDJ	4	945	0.0010228578974371186	0.0012041959539015948	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	3	9	4	14	23	40	52	44	66	TCRBV01,TCRBV04													CASSQDFGQGSDGGKKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGGAGACTAGCGGGGGGGCAGGTGAGCAGTTCTTCGGGCCA	CASRETSGGAGEQFF	In	VDJ	4	956	0.0010347641798411486	0.001218213049661296	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	0	9	3	4	23	34	51	37	55	TCRBV06,TCRBV10													CASRETSGGAGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGCGGACCTACCAGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	1005	0.0010878012560045548		46	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	1	7	4	5	8	26	39	48	44	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCGACAGGGGGGGTCACTGAAGCTTTCTTTGGACAA	CSARATGGVTEAFF	In	VDJ	4	1005	0.0010878012560045548	0.001280652839863601	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	3	3	26	37	49	40	52		TCRBV20-01,TCRBV20-or09_02												CSARATGGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCGAGGAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSPEEGTNTEAFF	In	VDJ	4	1009	0.0010921308132423838	0.0012857499655944014	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	1	5	3	23	35	46	40	49	TCRBV09,TCRBV21													CASSPEEGTNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSGTDTQYF	In	VJ	4	1013	0.0010964603704802128	0.0012908470913252017	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	0	0	1	0	1	26	-1	38	-1	39		TCRBV03-01,TCRBV03-02												CASSGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGCGGAGGGGGACACCAAAAATGATAATTCACCCCTCCACTTTGGGAAC	CASSEAEGDTKNDNSPLHF	In	VDJ	4	1013	0.0010964603704802128	0.0012908470913252017	57	unresolved						TCRBJ01	TCRBJ01-06	01	0	0	6	5	5	9	23	40	51	45	60	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAEGDTKNDNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGACAGGGGGTGAACATTCAGTACTTCGGCGCC	CSARPGQGVNIQYF	In	VDJ	4	1024	0.0011083666528842427	0.0013048641870849029	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	1	7	3	2	26	37	51	40	53		TCRBV20-01,TCRBV20-or09_02												CSARPGQGVNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTAGACAGGGGAGAGGATGCCGGAAACACCATATATTTTGGAGAG	CSALDRGEDAGNTIYF	In	VDJ	4	1035	0.0011202729352882727	0.001318881282844604	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	2	4	3	10	26	35	46	38	56		TCRBV20-01,TCRBV20-or09_02												CSALDRGEDAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTACGCGTTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	4	1064	0.0011516622252625336		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	14	0	26	38	-1	52	55		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGATAAACGGGGGCATTGGCATTCAGTACTTCGGCGCC	CASSPINGGIGIQYF	In	VDJ	4	1101	0.0011917106297124524	0.0014029838574028107	45	TCRBV12						TCRBJ02	TCRBJ02-04	01	5	6	0	9	9	5	26	38	53	47	58		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPINGGIGIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12		TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGACAGGGTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSASRTGYSGANVLTF	In	VDJ	4	1153	0.0012479948738042305	0.0014692464919032159	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	3	0	2	2	26	37	47	39	49		TCRBV20-01,TCRBV20-or09_02												CSASRTGYSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACACTCGGGTACAGATACGCAGTATTTTGGCCCA	CSARHSGTDTQYF	In	VDJ	5	1167	0.0012631483241366322	0.0014870864319610172	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	3	4	1	26	38	46	42	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARHSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGGGAAGAGCGGGATTAGCGGGGGCAGATACGCAGTATTTTGGCCCA	CSARDPGRAGLAGADTQYF	In	VDJ	5	1191	0.0012891256675636065	0.0015176691863458196	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	4	17	0	24	38	-1	55	64		TCRBV20-01,TCRBV20-or09_02												CSARDPGRAGLAGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGTGGGACAGAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSGWDRSSGNTIYF	In	VDJ	5	1193	0.0012912904461825211	0.00152021774921122	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	0	4	3	24	36	47	40	50	TCRBV09,TCRBV21													CASSGWDRSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAGGACACAATGAGCAGTTCTTCGGGCCA	CASSVEGHNEQFF	In	VDJ	5	1195	0.0012934552248014357	0.00152276631207662	39	unresolved						TCRBJ02	TCRBJ02-01	01	0	1	7	5	2	0	23	39	-1	41	45	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGHNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACAGAGTTCACCCCTCCACTTTGGGAAC	CASSEQSSPLHF	In	VDJ	5	1242	0.0013443275223459273	0.0015826575394135248	36	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	2	4	5	9	0	2	23	-1	41	38	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSEQSSPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGGGACAGAATCACAGATACGCAGTATTTTGGCCCA	CASSRDRITDTQYF	In	VDJ	5	1261	0.0013648929192256155	0.0016068688866348266	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	2	2	3	26	37	46	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRDRITDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCCAGTGCAGGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	1269	0.0013735520337012734		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	4	2	0	0	24	-1	-1	37	41		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGCCCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASRARGSTDTQYF	In	VDJ	5	1276	0.0013811287588674744	0.001625983108125328	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	2	0	4	0	26	37	-1	41	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRARGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTCGGACAGGGAAGACCTTCGCTGGAAGCAGTACGTCGGGCCG	CASSFSDREDLRWKQYV	In	VDJ	5	1277	0.0013822111481769316	0.0016272573895580282	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	17	5	24	24	36	49	41	73		TCRBV24-01,TCRBV24-or09_02												CASSFSDREDLRWKQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGACAACAGGGGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASRQQGAYNSPLHF	In	VDJ	5	1284	0.0013897878733431326	0.001636177359586929	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	2	3	0	23	34	-1	37	45	TCRBV02,TCRBV09													CASRQQGAYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGGACAGGAGATTAATGAGCAGTTCTTCGGGCCA	CSARDLGQEINEQFF	In	VDJ	5	1291	0.0013973645985093334	0.0016450973296158297	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	7	4	5	26	40	51	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDLGQEINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CSATGTSTDTQYF	In	VDJ	5	1340	0.0014504016746727396	0.0017075371198181347	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	0	2	0	26	36	-1	38	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSATGTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCTGCATACTATGGCTACACCTTCGGTTCG	CASSSAYYGYTF	In	VDJ	5	1350	0.0014612255677673124	0.0017202799341451355	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	4	6	3	5	1	26	37	44	42	45		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AGCAGCTTCTACATCTGCAGTGCTAGATCAGATACTAGCGGGGGGAAGGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARSDTSGGKAGSYNEQFF	In	VDJ	5	1372	0.0014850381325753723	0.0017483141256645377	60	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	1	1	6	9	15	27	45	33	54		TCRBV20-01,TCRBV20-or09_02												CSARSDTSGGKAGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCATGCTCGGGGGGGCGGGTGAGACCCAGTACTTCGGGCCA	CASSMLGGAGETQYF	In	VDJ	5	1402	0.0015175098118590902	0.0017865425686455407	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	0	5	6	5	24	35	49	41	54		TCRBV24-01,TCRBV24-or09_02												CASSMLGGAGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGGACAGTCGAGAGACCCAGTACTTCGGGCCA	CSASKDSRETQYF	In	VDJ	6	1533	0.0016593028113979923	0.001953473436329254	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	4	3	3	26	37	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSASKDSRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCGGATTTCCTCTAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	6	1533	0.0016593028113979923		46	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	1	8	0	1	9	24	36	40	37	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGATGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRMNTGELFF	In	VDJ	6	1680	0.0018184140398882108	0.002140792806936169	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	2	8	1	0	1	26	-1	39	37	40		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAGGGTGACTATGGCTACACCTTCGGTTCG	CATSDEGDYGYTF	In	VDJ	7	1811	0.001960207039427113	0.002307723674619882	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	0	3	0	2	24	-1	44	39	46		TCRBV24-01,TCRBV24-or09_02												CATSDEGDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGAGAGCGGGGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASRESGGAYNEQFF	In	VDJ	7	1842	0.001993761108020288	0.002347226399033585	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	4	4	2	22	33	47	37	49	TCRBV02,TCRBV12													CASRESGGAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAGGGAACGGAACACTGAAGCTTTCTTTGGACAA	CASSFRERNTEAFF	In	VDJ	7	1889	0.00204463340556478	0.0024071176263704896	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	1	0	4	26	-1	45	40	49		TCRBV12-03,TCRBV12-04												CASSFRERNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACCGAAGGAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSTEGAGGTDTQYF	In	VDJ	8	1955	0.0021160710999889596	0.002491220200928696	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	2	1	7	0	24	37	-1	44	52	TCRBV09,TCRBV21													CASSTEGAGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCAGAGTGCGGGTTATGGCTACACCTTCGGTTCG	CATSDQSAGYGYTF	In	VDJ	8	2064	0.0022340515347198018	0.002630116877093007	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	7	4	5	7	1	24	38	50	45	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDQSAGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGATTCTATGGCTACACCTTCGGTTCG		Out	VDJ	8	2126	0.0023011596719061523		35	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	2	8	4	2	2	26	39	43	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCGATGGCTCGGGAAAACTGTTTTTTGGCAGT	CASSPDGSGKLFF	In	VDJ	9	2311	0.002501401694155747	0.002944864390969932	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	4	10	10	0	24	36	-1	46	50	TCRBV09,TCRBV21					01,02								CASSPDGSGKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGATTTGCCAGGCCGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	9	2361	0.0025555211596286105		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	4	5	1	3	24	42	47	43	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGCGGACGGCGGGGGCAAGGGCTACACCTTCGGTTCG	CSATADGGGKGYTF	In	VDJ	9	2459	0.002661595311955423	0.003133458043009547	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	7	2	8	9	4	26	36	52	45	56		TCRBV20-01,TCRBV20-or09_02												CSATADGGGKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGTCTGAGTCCGATCCCTGAAGCTTTCTTTGGACAA	CASSSLSPIPEAFF	In	VDJ	10	2650	0.0028683316700617613	0.003376845796655266	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	2	6	5	8	26	38	46	43	54		TCRBV12-03,TCRBV12-04												CASSSLSPIPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTCAGGGAGGCACCACTGAAGCTTTCTTTGGACAA	CSALQGGTTEAFF	In	VDJ	11	2758	0.002985229715483146	0.003514468191386877	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	4	5	3	26	35	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSALQGGTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCTTAGCCGAGGGACTAGACCTCACAGATACGCAGTATTTTGGCCCA	CASTLAEGLDLTDTQYF	In	VDJ	12	3149	0.003408443935480938	0.004012712231572616	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	8	2	10	4	23	33	51	43	55	TCRBV09,TCRBV21					01,02								CASTLAEGLDLTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTTAACCGGGGGTGTGGAGACCCAGTACTTCGGGCCA	CASSLTGGVETQYF	In	VDJ	14	3615	0.003912837353688025	0.004606527379210863	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	2	5	2	4	18	33	41	35	45	TCRBV11,TCRBV12													CASSLTGGVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTTTTTCACACCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAPLFHTSNTGELFF	In	VDJ	15	3835	0.004150963001768624	0.004886869294404885	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	6	0	10	3	26	35	48	45	51		TCRBV20-01,TCRBV20-or09_02												CSAPLFHTSNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAGGGCGTGACGAACACTGAAGCTTTCTTTGGACAA	CASSLEGVTNTEAFF	In	VDJ	35	9143	0.009896285456367804	0.011650755139177018	45	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	5	3	1	0	6	26	-1	46	42	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGVTNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGGCAGACAGGAGCTCCTACGAGCAGTACGTCGGGCCG	CATSDGADRSSYEQYV	In	VDJ	41	10582	0.011453843672676814	0.013484446120832463	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	17	6	19	24	39	51	45	70		TCRBV24-01,TCRBV24-or09_02												CATSDGADRSSYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAACACAGCTCTATGGCTACACCTTCGGTTCG	CASSLTQLYGYTF	In	VDJ	1	70	7.576725166200879E-5	8.919970028900702E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	5	4	2	2	18	33	39	35	41														CASSLTQLYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCATCCAGGACGGAGAGTGTCTTTCTTTGGACAA	CASSHPGRRVSFF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	5	1	7	12	6	9	18	30	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPGRRVSFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCGCGATCAGAAGTATGGCTACACCTTCGGTTCG	CASSRDQKYGYTF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-02	01	5	4	5	5	6	3	18	30	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDQKYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACGGGGGGCCACTGAAGCTTTCTTTGGACAA	CASSLRGATEAFF	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	4	0	1	18	-1	40	33	41														CASSLRGATEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCAGCCAGTATTATGAGCAGTTCTTCGGGCCA	CASSFSQYYEQFF	In	VDJ	1	103	1.1148609887409864E-4	1.3125098756811034E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	3	4	5	8	0	8	18	-1	35	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSQYYEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGAAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSENSNQPQHF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-05	01	5	2	8	0	0	3	18	-1	32	30	35				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENSNQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCAGGGGTCCCGGAACGCTTCTTTGGACAA	CASSLAGVPERFF	In	VDJ	1	141	1.5261689263347484E-4	1.7967368201071417E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	14	0	11	18	-1	40	35	51														CASSLAGVPERFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGTGTAGATGGGGACACTGAAGCTTTCTTTGGACAA	CASSVDGDTEAFF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	6	6	2	3	7	0	18	29	-1	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDGDTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGGCCACGACTCCTACGAGCAGTACGTCGGGCCG	CASSGHDSYEQYV	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	17	6	15	18	30	40	36	55						01,02								CASSGHDSYEQYV+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCACCCCGGGGGGGGCCCGTGAAGCTTTCTTTGGACAA	CASTPGGAREAFF	In	VDJ	1	196	2.121483046536246E-4	2.497591608092197E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	7	3	5	18	28	39	31	44														CASTPGGAREAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCGGCCAGGGGATATGAAGCTTTCTTTGGACAA	CASSPARGYEAFF	In	VDJ	1	371	4.0156643380864657E-4	4.727584115317373E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	7	5	3	18	30	41	35	44														CASSPARGYEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGACTAGCGGGGGCCTCACAGATACGCAGTATTTTGGCCCA	CASSQGTSGGLTDTQYF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	2	3	3	18	30	47	33	50														CASSQGTSGGLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGAGGAGGGTCGGCCATTCAGTACTTCGGCGCC	CASSPGGGSAIQYF	In	VDJ	1	67	7.252008373363698E-5	8.537685599090673E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	10	0	9	6	5	18	30	42	36	47														CASSPGGGSAIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGTCCAGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSPRSSLNTEAFF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	5	0	8	2	18	30	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRSSLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAGGGGGCTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSARGLGANVLTF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	0	4	2	2	18	30	40	32	42														CASSARGLGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCCCAGGGAAGGATCAGCCCCAACATTTTGGTGAT		Out	VDJ	1	68	7.360247304309424E-5		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	16	4	15	18	31	40	35	55														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCACCTCGTGGCAACCTACGAGCAGTACTTCGGGCCG	CASSLHLVATYEQYF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	2	9	2	18	32	44	41	46														CASSLHLVATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTATTTGACACAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	69	7.468486235255151E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	6	1	6	1	18	32	42	38	43														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAGACAGGGGAGGGGTTCACCCCTCCACTTTGGGAAC	CASSSRQGRGSPLHF	In	VDJ	1	71	7.684964097146606E-5	9.047398172170713E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	2	9	3	5	18	31	42	34	47														CASSSRQGRGSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAACTCCGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSANSGDYNEQFF	In	VDJ	1	72	7.793203028092332E-5	9.174826315440723E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	3	8	1	18	30	43	38	44														CASSANSGDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCGGACAGACTCTTCGGGGGAGCAGTACTTCGGGCCG	CASSSRTDSSGEQYF	In	VDJ	1	72	7.793203028092332E-5	9.174826315440723E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	7	3	11	18	31	40	34	51														CASSSRTDSSGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGAGGGGTCGGAACAATGAGCAGTTCTTCGGGCCA	CASSLRGRNNEQFF	In	VDJ	1	73	7.901441959038059E-5	9.302254458710733E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	5	2	5	3	5	18	30	38	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGRNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACGACAGGGGTCTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSWDDRGLDTGELFF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	2	3	5	5	18	31	44	36	49														CASSWDDRGLDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCCGAGCTGAAACCAGATACGCAGTATTTTGGCCCA	CASSFPELKPDTQYF	In	VDJ	1	75	8.117919820929513E-5	9.557110745250753E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	7	4	5	6	18	32	40	37	46						01,02								CASSFPELKPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGAGTATTCTCGCAGATACGCAGTATTTTGGCCCA	CASSLGSILADTQYF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	2	4	0	8	18	-1	38	34	46														CASSLGSILADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACTCGCGGGGGGGTGCAGATACGCAGTATTTTGGCCCA	CASNSRGGADTQYF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	0	4	4	2	18	28	41	32	43														CASNSRGGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGATGGGAGCCTACGAGCAGTACGTCGGGCCG	CASSFGMGAYEQYV	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	3	17	0	21	18	-1	37	32	58														CASSFGMGAYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCTCAGGGACTCCTACGAGCAGTACGTCGGGCCG	CASSLLRDSYEQYV	In	VDJ	1	80	8.659114475658146E-5	1.0194251461600803E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	17	5	15	18	32	43	37	58						01,02								CASSLLRDSYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCCGGCAGGTGGCCTGAAGCTTTCTTTGGACAA	CASSSPGRWPEAFF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	6	7	4	18	31	42	38	46														CASSSPGRWPEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTAGCCCAATCGGTGAGCAGTTCTTCGGGCCA	CASSLVSPIGEQFF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	7	9	1	8	18	34	39	35	47						01,02								CASSLVSPIGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTAAACAGTCAGGGGATGAAAAACTGTTTTTTGGCAGT	CASSKQSGDEKLFF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	2	6	8	0	18	29	-1	37	43														CASSKQSGDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGCGATAGCGGGAGCGGGGACGGGAGAGACCCAGTACTTCGGGCCA	CASRAIAGAGTGETQYF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	5	2	4	5	10	18	29	43	34	53														CASRAIAGAGTGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACCGGGACAGGGGGCGCGAAGGCTTTCTTTGGACAA	CASSPTGTGGAKAFF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	11	6	6	18	30	48	36	54														CASSPTGTGGAKAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGAACGTGGGGCGGTGGCGACTATGGCTACACCTTCGGTTCG	CASSLGTWGGGDYGYTF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	7	0	3	10	7	18	30	45	40	52														CASSLGTWGGGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATCCCAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLIPGGYNEQFF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	3	5	0	18	32	-1	37	44														CASSLIPGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCCATCAGAGCGGAACTATGGCTACACCTTCGGTTCG	CASSLDPSERNYGYTF	In	VDJ	1	84	9.092070199441054E-5	1.0703964034680843E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	6	5	2	11	0	18	32	-1	43	48						01,02								CASSLDPSERNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCGACAGGGCCCATCAGAGACCCAGTACTTCGGGCCA	CASSTRQGPSETQYF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	4	4	6	18	30	41	34	47														CASSTRQGPSETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGAGAGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRRGAGANVLTF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	5	2	2	5	0	18	30	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRGAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACATTACCCTACCAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	89	9.633264854169688E-5		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	0	2	12	18	31	38	33	50														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGCTAGCGGGGGTTCCAGTGAGCAGTTCTTCGGGCCA	CASSLGASGGSSEQFF	In	VDJ	1	90	9.741503785115415E-5	1.1468532894300904E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	9	3	6	18	34	47	37	53														CASSLGASGGSSEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTTGGCAGGTGGAGGCACTGAAGCTTTCTTTGGACAA	CASTLAGGGTEAFF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	4	7	0	18	32	-1	39	44														CASTLAGGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAATTTACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSLKFTGGYEQYF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	1	3	6	0	18	33	-1	39	47														CASSLKFTGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGCTAATAGGTGGAAACACCATATATTTTGGAGAG	CASSLVGLIGGNTIYF	In	VDJ	1	92	9.95798164700687E-5	1.1723389180840923E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	7	0	3	1	7	18	34	40	35	47														CASSLVGLIGGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACAGGGGGTCGGGAGACAATGAGCAGTTCTTCGGGCCA	CASSHRGSGDNEQFF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	5	1	7	18	30	39	31	46														CASSHRGSGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCAAGAATTGGGGGCCCGTGGCTACACCTTCGGTTCG	CASNQELGARGYTF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	6	0	7	10	3	18	28	44	38	47														CASNQELGARGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATAGGCGGACACCCGGGGAGCTGTTTTTTGGAGAA	CASSLDRRTPGELFF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	6	6	5	1	18	35	45	40	46														CASSLDRRTPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTGGGGACAATCCTCCTACGAGCAGTACTTCGGGCCG	CASSFWGQSSYEQYF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	0	3	3	18	32	41	35	44														CASSFWGQSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGAAAGTGGCTCTGGGGCCAATGTCCTGACTTTCGGGGCC	CASSPESGSGANVLTF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	7	0	13	15	4	18	30	50	45	54														CASSPESGSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGGGAAGGACAGGGGGACGAAAAACTGTTTTTTGGCAGT	CASSSWEGQGDEKLFF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	1	8	8	2	18	31	49	39	51														CASSSWEGQGDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCATACAGGACAGGGGGCGACTATGGCTACACCTTCGGTTCG	CASSSYRTGGDYGYTF	In	VDJ	1	98	1.060741523268123E-4	1.2487958040460984E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	0	3	8	1	18	29	48	37	49														CASSSYRTGGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTATATCAGGGGGACGGCTACACCTTCGGTTCG	CASSFLYQGDGYTF	In	VDJ	1	99	1.0715654163626957E-4	1.2615386183730993E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	8	7	2	18	32	46	39	48														CASSFLYQGDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTGGGCTCAAACACTGAAGCTTTCTTTGGACAA	CASSSLGSNTEAFF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	2	4	3	18	31	39	35	42														CASSSLGSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGAGGGTTTGAGTAATTCACTCCTCCACTTTGGGAAC	CASSLGEGLSNSLLHF	In	VDJ	1	103	1.1148609887409864E-4	1.3125098756811034E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	0	15	2	15	18	34	41	36	56														CASSLGEGLSNSLLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTCTAGCGGGGGGGGTCGAGCAGTTCTTCGGGCCA	CASSLVLAGGVEQFF	In	VDJ	1	103	1.1148609887409864E-4	1.3125098756811034E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	0	10	2	3	18	34	48	36	51														CASSLVLAGGVEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCCTACAGGTCCTCGATGGACTGAAGCTTTCTTTGGACAA	CASRPTGPRWTEAFF	In	VDJ	1	104	1.1256848818355591E-4	1.3252526900081043E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	5	4	10	18	29	38	33	48														CASRPTGPRWTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGAGCAGCCGGTATCCCCTACGAGCAGTACTTCGGGCCG	CASSLDGAAGIPYEQYF	In	VDJ	1	105	1.1365087749301317E-4	1.3379955043351055E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	2	2	1	12	18	35	40	36	52														CASSLDGAAGIPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACAGGGGGCGAGGCGGGGAGCTGTTTTTTGGAGAA	CASSWDRGRGGELFF	In	VDJ	1	107	1.1581565611192772E-4	1.3634811329891076E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	0	7	0	4	18	-1	43	31	47														CASSWDRGRGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGGGACAGGGGCACTTGGAGGCTACACCTTCGGTTCG	CASSLSGTGALGGYTF	In	VDJ	1	108	1.1689804542138499E-4	1.3762239473161085E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	8	3	8	18	33	46	36	54														CASSLSGTGALGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCACAAGGTGGTTAGGGGATAGCTACACCTTCGGTTCG	CASSLTRWLGDSYTF	In	VDJ	1	111	1.2014521334975679E-4	1.4144523902971114E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	2	9	14	3	18	30	49	44	52														CASSLTRWLGDSYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGGACAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSRDRNTGELFF	In	VDJ	1	111	1.2014521334975679E-4	1.4144523902971114E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	2	3	1	18	31	41	34	42														CASSSRDRNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTAAAATTGGGACAGGCAGGGAGACCCAGTACTTCGGGCCA	CASSTKIGTGRETQYF	In	VDJ	1	114	1.233923812781286E-4	1.4526808332781144E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	5	9	4	18	30	47	39	51														CASSTKIGTGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCGGTGCGGGGGGCGGGGATGAATGACATTCAGTACTTCGGCGCC	CASSQAVRGAGMNDIQYF	In	VDJ	1	114	1.233923812781286E-4	1.4526808332781144E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	7	1	8	8	12	18	30	46	38	58														CASSQAVRGAGMNDIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGGGACAGGACTATGGCTACACCTTCGGTTCG	CASSPQGQDYGYTF	In	VDJ	1	115	1.2447477058758586E-4	1.4654236476051156E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	3	5	0	18	30	-1	35	43														CASSPQGQDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATTTGGCAGGGGGGAATTGAAAATCGACCCAGTACTTCGGGCCA		Out	VDJ	1	115	1.2447477058758586E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	7	7	12	18	32	46	39	58														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGAGGGGAGGGAGACCCAGTACTTCGGGCCA	CASSLGEGRETQYF	In	VDJ	1	116	1.2555715989704313E-4	1.4781664619321165E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	0	5	0	4	18	-1	41	34	45														CASSLGEGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGCAGACAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGRQGTGELFF	In	VDJ	1	119	1.2880432782541492E-4	1.5163949049131194E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	2	5	8	0	18	32	-1	40	48														CASSLAGRQGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGTCGCGGGGGATACCAAGAGACCCAGTACTTCGGGCCA	CASSGRGGYQETQYF	In	VDJ	1	121	1.3096910644432946E-4	1.5418805335671215E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	2	0	4	2	18	30	41	34	43														CASSGRGGYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATGGGACAGGGGGTAAATGAGCAGTTCTTCGGGCCA	CASSLMGQGVNEQFF	In	VDJ	1	122	1.3205149575378674E-4	1.5546233478941224E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	7	3	2	18	32	46	35	48														CASSLMGQGVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGCCCTGTTAAGGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	123	1.33133885063244E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	5	1	4	13	1	18	31	50	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGAGTAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSFGVGDTGELFF	In	VDJ	1	123	1.33133885063244E-4	1.5673661622211236E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	2	3	6	0	18	32	-1	38	43														CASSFGVGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCACTATGAACACTGAAGCTTTCTTTGGACAA	CASSLGTMNTEAFF	In	VDJ	1	126	1.3638105299161582E-4	1.6055946052021265E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	3	9	0	2	0	18	34	-1	36	40						01,02								CASSLGTMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGCGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSLVAGDQETQYF	In	VDJ	1	127	1.3746344230107307E-4	1.6183374195291274E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	2	0	2	0	18	32	-1	34	43														CASSLVAGDQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATAGGGAGTACAGATACGCAGTATTTTGGCCCA	CASSLIGSTDTQYF	In	VDJ	1	129	1.396282209199876E-4	1.6438230481831295E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	2	3	3	1	18	33	41	36	42														CASSLIGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGGCCTGAGCAGATTTGAGCAGTTCTTCGGGCCA	CASSRGLSRFEQFF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	9	0	12	18	-1	35	30	47														CASSRGLSRFEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGAGGACTAGCGGGGGGGAAAACATTCAGTACTTCGGCGCC	CASSLRTSGGENIQYF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	1	0	5	5	0	18	29	-1	34	49														CASSLRTSGGENIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGACGGCGCTAACTATGGCTACACCTTCGGTTCG	CASSFDGANYGYTF	In	VDJ	1	135	1.4612255677673124E-4	1.7202799341451354E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	2	7	0	1	4	18	32	36	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDGANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGTCAGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLDVRVNTGELFF	In	VDJ	1	135	1.4612255677673124E-4	1.7202799341451354E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	1	6	1	18	32	43	38	44														CASSLDVRVNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACCCGGCAACCATGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	136	1.4720494608618849E-4		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	18	30	48	44	53														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACAGGACCCTACGAGCAGTACGTCGGGCCG	CASSFGTGPYEQYV	In	VDJ	1	136	1.4720494608618849E-4	1.7330227484721366E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	17	1	17	18	32	41	33	58														CASSFGTGPYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGCGGGGGGGCCATATGAGCAGTTCTTCGGGCCA	CASSYAGGPYEQFF	In	VDJ	1	138	1.4936972470510303E-4	1.7585083771261387E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	0	8	2	4	18	31	42	33	46														CASSYAGGPYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGCGGGGTAATTTTCCCCCACGAGCAGTTCTTCGGGCCA	CASSPSGVIFPHEQFF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	10	1	14	18	30	40	31	54														CASSPSGVIFPHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGACAGCGAAACTGAAAAACTGTTTTTTGGCAGT	CASSRDSETEKLFF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	7	1	6	18	30	38	31	44														CASSRDSETEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGGACAGGGCTCTCGGGAAACACCATATATTTTGGAGAG	CASSLGTGLSGNTIYF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	4	3	6	18	30	42	33	48														CASSLGTGLSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCTGCCGGGACTTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPAGTFSTDTQYF	In	VDJ	1	142	1.5369928194293212E-4	1.8094796344341426E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	10	0	7	3	18	29	42	36	45						01,02								CASSPAGTFSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGCAGGGGGGGCGCGCACTGAAGCTTTCTTTGGACAA	CASSPAGGARTEAFF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	1	4	4	6	18	30	41	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAGGARTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACATCTCTCCTACGAGCAGTACTTCGGGCCG	CASSLEHLSYEQYF	In	VDJ	1	143	1.547816712523894E-4	1.8222224487611437E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	6	0	0	3	18	-1	38	35	41														CASSLEHLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGCGGGGGCAGCTCCTACGAGCAGTACGTCGGGCCG	CASSLSGGSSYEQYV	In	VDJ	1	146	1.5802883918076118E-4	1.8604508917421467E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	2	17	1	20	18	32	41	33	61														CASSLSGGSSYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGCGGGGGCCTTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGLAGAFQETQYF	In	VDJ	1	149	1.61276007109133E-4	1.8986793347231497E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	2	2	1	0	4	18	-1	46	34	50														CASSLGLAGAFQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACAAATAGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSSQIGGLNTEAFF	In	VDJ	1	150	1.6235839641859026E-4	1.9114221490501506E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	5	1	0	7	2	18	31	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQIGGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAAGGGACAGGGGGCAAATGAGCAGTTCTTCGGGCCA	CASSSKGQGANEQFF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	7	4	1	18	31	47	35	48														CASSSKGQGANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGGGGGAATCAACTGAAGCTTTCTTTGGACAA	CASSLWGESTEAFF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	5	2	5	18	32	40	34	45														CASSLWGESTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGAGGTCCAAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	154	1.6668795365641932E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	1	17	2	23	18	30	36	32	59														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGTGAAACAGGGGACCCAAACTATGGCTACACCTTCGGTTCG	CASSPSETGDPNYGYTF	In	VDJ	1	155	1.677703429658766E-4	1.9751362206851556E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	2	9	5	18	30	46	39	51														CASSPSETGDPNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAAAGGGATGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSKGMGANVLTF	In	VDJ	1	157	1.6993512158479114E-4	2.0006218493391577E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	0	8	4	5	2	18	31	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSKGMGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGACAATCCTATCGAGCAGTACTTCGGGCCG	CASSLGDNPIEQYF	In	VDJ	1	157	1.6993512158479114E-4	2.0006218493391577E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	6	2	7	18	32	40	34	47														CASSLGDNPIEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGTCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLESSSYNEQFF	In	VDJ	1	159	1.7209990020370568E-4	2.0261074779931597E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	0	0	5	18	-1	36	32	41														CASSLESSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGGGGGAGGACTATAACTATGGCTACACCTTCGGTTCG	CASSKGEDYNYGYTF	In	VDJ	1	160	1.7318228951316292E-4	2.0388502923201606E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	5	1	1	1	7	18	30	37	31	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGEDYNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGACAGGGGGACCTATTCTATGGCTACACCTTCGGTTCG	CASSLEGQGDLFYGYTF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	1	4	3	7	18	32	46	35	53														CASSLEGQGDLFYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGACCCGCAGGGACAGGGCGGAAATACGCAGTATTTTGGCCCA	CASDPQGQGGNTQYF	In	VDJ	1	162	1.7534706813207747E-4	2.0643359209741627E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	3	7	8	5	18	27	44	35	49														CASDPQGQGGNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGACTCAGGGGGTTCACGGCTACACCTTCGGTTCG	CASSRTQGVHGYTF	In	VDJ	1	163	1.7642945744153474E-4	2.0770787353011636E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	8	6	5	18	30	43	36	48														CASSRTQGVHGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATTTGGGCTCAAGAGACCCAGTACTTCGGGCCA	CASSLIWAQETQYF	In	VDJ	1	163	1.7642945744153474E-4	2.0770787353011636E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	8	0	2	5	1	18	32	41	37	42														CASSLIWAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGCAGGAGAAGTTACAGATACGCAGTATTTTGGCCCA	CASSSAGEVTDTQYF	In	VDJ	1	164	1.77511846750992E-4	2.0898215496281648E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	4	4	3	3	7	18	31	38	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAGEVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGATGGGGCTGCCTATGGCTACACCTTCGGTTCG	CASSLDGAAYGYTF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	7	0	4	6	3	18	30	41	36	44														CASSLDGAAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAGGGACGGCGGGTGGGAGACCCAGTACTTCGGGCCA	CASSSRDGGWETQYF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	4	0	7	5	3	9	18	31	39	34	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRDGGWETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGGGGGCCCCCAAGAGACCCAGTACTTCGGGCCA	CASSLGGGPQETQYF	In	VDJ	1	166	1.7967662536990655E-4	2.1153071782821666E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	1	2	3	18	32	41	34	44														CASSLGGGPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGACCCCGGTCGCGGGAAATTGCCCCTCCACTTTGGGAAC	CASSDPGRGKLPLHF	In	VDJ	1	168	1.8184140398882107E-4	2.1407928069361686E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	7	3	13	11	5	18	29	46	40	51														CASSDPGRGKLPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGTTAGCCGCTGCCAATGAGCAGTTCTTCGGGCCA	CASSLMLAAANEQFF	In	VDJ	1	169	1.8292379329827834E-4	2.1535356212631698E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	7	6	4	6	18	33	41	37	47						01,02								CASSLMLAAANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGGTAGCGAGGGAATGAGCAGTTCTTCGGGCCA	CASSLGG*RGNEQFF	Stop	VDJ	1	169	1.8292379329827834E-4		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	9	0	7	0	9	18	-1	39	32	48														CASSLGG*RGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCCGAGATCCGGGGAACTGAAGCTTTCTTTGGACAA	CASTPEIRGTEAFF	In	VDJ	1	170	1.8400618260773561E-4	2.1662784355901707E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	5	11	1	18	28	44	39	45														CASTPEIRGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCACCGAAGCGGCAGGGAGCCCCTATTAGCTAACTATGGCTACACCTTCGGTTCG	CASHRSGREPLLANYGYTF	In	VDJ	1	174	1.883357398455647E-4	2.2172496928981748E-4	57	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	8	4	3	0	11	12	18	27	43	38	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHRSGREPLLANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACTGCCCGATACAATGAGCAGTTCTTCGGGCCA	CASSFGTARYNEQFF	In	VDJ	1	177	1.915829077739365E-4	2.2554781358791778E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	4	1	6	18	32	39	33	45						01,02								CASSFGTARYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCAGGGCTTGAACACTGAAGCTTTCTTTGGACAA	CASSLDQGLNTEAFF	In	VDJ	1	178	1.9266529708339376E-4	2.2682209502061787E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	0	1	2	18	35	41	36	43														CASSLDQGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGCCTTGGGAGACTATGGCTACACCTTCGGTTCG	CASSFALGDYGYTF	In	VDJ	1	178	1.9266529708339376E-4	2.2682209502061787E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	2	3	6	0	18	32	-1	38	43														CASSFALGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAGCGGGCCAACCTACGAGCAGTACGTCGGGCCG	CASSPSGPTYEQYV	In	VDJ	1	187	2.0240680086850918E-4	2.382906279149188E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	4	17	3	19	18	30	39	33	58						01,02								CASSPSGPTYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACTCCCGTAGATACGCAGTATTTTGGCCCA	CASSPGTPVDTQYF	In	VDJ	1	189	2.0457157948742372E-4	2.4083919078031897E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	5	3	5	18	30	39	33	44						01,02								CASSPGTPVDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGCCGGGGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	194	2.0998352603471005E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	0	4	5	1	18	31	44	36	45														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCAAGGGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTSRGTGANVLTF	In	VDJ	1	198	2.1431308327253914E-4	2.5230772367461986E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	5	1	2	5	1	18	28	39	33	40														CASTSRGTGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACTTGGGGGTCCGAGCAGTACGTCGGGCCG	CASSFGTWGSEQYV	In	VDJ	1	200	2.1647786189145368E-4	2.548562865400201E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	10	17	1	19	18	32	39	33	58						01,02								CASSFGTWGSEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCACCGATACAGACGACAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	204	2.2080741912928274E-4		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	5	0	16	0	18	30	-1	46	51														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTACCGGGGGGCGGGGCCAGAGACCCAGTACTTCGGGCCA	CASSYRGAGPETQYF	In	VDJ	1	206	2.2297219774819729E-4	2.625019751362207E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	1	4	4	7	18	29	40	33	47														CASSYRGAGPETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGAGACAGCCGTTGAAGCTTTCTTTGGACAA	CASSLEETAVEAFF	In	VDJ	1	210	2.2730175498602634E-4	2.675991008670211E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	7	3	4	18	35	43	38	47														CASSLEETAVEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAATAGGTGGGGGTGGCTACACCTTCGGTTCG	CASSLEIGGGGYTF	In	VDJ	1	211	2.2838414429548362E-4	2.6887338229972116E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	6	1	7	10	0	18	32	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEIGGGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATCCCATCAGGGATTTTCCAAGAGACCCAGTACTTCGGGCCA	CASIPSGIFQETQYF	In	VDJ	1	213	2.3054892291439816E-4	2.714219451651214E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	3	1	6	5	18	28	39	34	44														CASIPSGIFQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGTCTACTAGCGGGGGAACAAGAGACCCAGTACTTCGGGCCA	CASSQGLLAGEQETQYF	In	VDJ	1	214	2.3163131222385543E-4	2.726962265978215E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	2	8	2	18	30	49	38	51														CASSQGLLAGEQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGTGGTGELFF	In	VDJ	1	215	2.327137015333127E-4	2.739705080305216E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	1	4	1	0	18	32	-1	33	44														CASSLGTGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACACGCGTTGGTGACCAGTACTTCGGGCCA	CASSSGTRVGDQYF	In	VDJ	1	217	2.3487848015222722E-4	2.765190708959218E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	6	10	2	11	18	31	39	33	50														CASSSGTRVGDQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACTAGCGGGGGGGCCCGGCTCGTCGATACGCAGTATTTTGGCCCA	CASSTSGGARLVDTQYF	In	VDJ	1	217	2.3487848015222722E-4	2.765190708959218E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	0	6	1	11	18	29	43	30	54														CASSTSGGARLVDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTAGCGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSLGSGGPDTQYF	In	VDJ	1	218	2.359608694616845E-4	2.7779335232862187E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	1	4	1	1	18	34	45	35	46														CASSLGSGGPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAACGTACCATCAGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	225	2.435375946278854E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	4	0	10	0	18	31	-1	41	45														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCGGACCGGTTAGGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	227	2.4570237324679994E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	1	7	3	3	9	18	30	37	33	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAACTGGGGGGAAAAATGAGCAGTTCTTCGGGCCA	CASSQTGGKNEQFF	In	VDJ	1	228	2.467847625562572E-4	2.905361666556229E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	1	7	6	3	18	30	42	36	45														CASSQTGGKNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCGGGACAGGGTGTCGGAGACCCAGTACTTCGGGCCA	CASSLRDRVSETQYF	In	VDJ	1	228	2.467847625562572E-4	2.905361666556229E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	4	5	18	30	43	34	48														CASSLRDRVSETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGACCCAGTGGCAGATACGCAGTATTTTGGCCCA	CASSLDPVADTQYF	In	VDJ	1	229	2.478671518657145E-4	2.91810448088323E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	2	7	4	3	7	18	30	36	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPVADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGGCGGTATAGTTGGCGGCGAGCAGTACTTCGGGCCG	CASSYGGIVGGEQYF	In	VDJ	1	231	2.5003193048462897E-4	2.943590109537232E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	5	6	3	12	18	31	38	34	50						01,02								CASSYGGIVGGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGCGGGTGATATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	231	2.5003193048462897E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	4	4	0	5	18	-1	41	35	46						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCAATGGCCGACAGTAATCAGCCCCAGCATTTTGGTGAT	CASSPSMADSNQPQHF	In	VDJ	1	236	2.5544387703191535E-4	3.007304181172237E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	4	12	1	18	30	47	42	48														CASSPSMADSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTGGGACGGTCGGAAACACCATATATTTTGGAGAG	CASSVGTVGNTIYF	In	VDJ	1	236	2.5544387703191535E-4	3.007304181172237E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	0	7	4	3	4	18	30	38	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGTVGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGCCCGGGACTAGCGGGGATACGAGCAGTACGTCGGGCCG	CASRARD*RGYEQYV	Stop	VDJ	1	238	2.5760865565082984E-4		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	17	5	14	18	29	47	34	61														CASRARD*RGYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTGGGTGGGGGACTCACAGATACGCAGTATTTTGGCCCA	CASSLLGGGLTDTQYF	In	VDJ	1	242	2.6193821288865893E-4	3.083761067134243E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	10	2	9	0	18	32	-1	41	47						01,02								CASSLLGGGLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCAGGGACGGTATTGAATTCACCCCTCCACTTTGGGAAC	CASSLSGTVLNSPLHF	In	VDJ	1	244	2.6410299150757347E-4	3.109246695788245E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	3	0	7	7	4	7	18	32	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGTVLNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCTATACAGGGGAATTTACCAAGAGACCCAGTACTTCGGGCCA	CASSLYRGIYQETQYF	In	VDJ	1	247	2.6735015943594526E-4	3.147475138769248E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	0	4	5	18	30	41	34	46														CASSLYRGIYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGAGCGGGGGGGCGAAAATGAGCAGTTCTTCGGGCCA	CASSPRERGGENEQFF	In	VDJ	1	251	2.7167971667377435E-4	3.198446396077252E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	7	7	4	18	30	47	37	51														CASSPRERGGENEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGGACACTTTTACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	253	2.738444952926889E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	1	6	0	3	8	18	32	40	35	48														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGAGGTACAGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSRGTGTGANVLTF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	3	2	8	1	18	31	45	39	46														CASSSRGTGTGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGTCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLRSDTGELFF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	7	5	3	0	4	18	-1	36	32	40						01,02								CASSLRSDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACTAGCGGGGGGCCAGAGTCCGGGGAGCTGTTTTTTGGAGAA	CASRTSGGPESGELFF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	2	1	6	0	7	18	-1	42	29	49														CASRTSGGPESGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACCATCGGGACGGTTTTCTACAATGAGCAGTTCTTCGGGCCA	CASSLTIGTVFYNEQFF	In	VDJ	1	259	2.803388311494325E-4	3.30038891069326E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	0	7	3	7	6	18	32	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTIGTVFYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGGACGGGGCCCAACTAATGAAAAACTGTTTTTTGGCAGT	CASTGRGPTNEKLFF	In	VDJ	1	260	2.8142122045888977E-4	3.313131725020261E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	7	7	0	0	6	1	18	28	39	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGRGPTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGAGACTAGCGGGGGGGCCTACAGATACGCAGTATTTTGGCCCA	CASSLRLAGGPTDTQYF	In	VDJ	1	260	2.8142122045888977E-4	3.313131725020261E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	3	4	3	18	30	48	34	51														CASSLRLAGGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGGAGGGAATACTTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGGNTFSYNEQFF	In	VDJ	1	261	2.8250360976834706E-4	3.325874539347262E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	0	4	8	18	32	42	36	50														CASSLGGGNTFSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGACTAGCGGGGGGGCCGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRLAGGPTNTGELFF	In	VDJ	1	263	2.8466838838726155E-4	3.3513601680012643E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	2	0	0	1	4	18	30	45	31	49														CASSRLAGGPTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCAAAGCCAGGGATATCAGCCCCAGCATTTTGGTGAT	CASSQSQGYQPQHF	In	VDJ	1	263	2.8466838838726155E-4	3.3513601680012643E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	5	7	2	18	29	41	36	43														CASSQSQGYQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCATGACGGAGAACGGGCTGGAAACACCATATATTTTGGAGAG	CASNHDGERAGNTIYF	In	VDJ	1	266	2.879155563156334E-4	3.3895886109822673E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	8	4	2	14	0	18	28	-1	42	46						01,02								CASNHDGERAGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACCGGGACAGGGATCTCTAAAACTGGAAACACCATATATTTTGGAGAG	CASSPTGTGISKTGNTIYF	In	VDJ	1	268	2.9008033493454794E-4	3.415074239636269E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	2	6	10	18	30	45	36	55														CASSPTGTGISKTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCATCCCCGGGACAGGGGGAAGTTTGGGCGGCTACACCTTCGGTTCG		Out	VDJ	1	269	2.911627242440052E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	8	9	10	18	29	49	38	59														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACAGGGGTGGCGGCACTGAAGCTTTCTTTGGACAA	CASSDRGGGTEAFF	In	VDJ	1	270	2.922451135534625E-4	3.440559868290271E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	4	0	6	18	-1	38	30	44														CASSDRGGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGCGGGGGAACCGGTGGGCGGAGACCCAGTACTTCGGGCCA	CASSLRRGNRWAETQYF	In	VDJ	1	272	2.9440989217237697E-4	3.466045496944273E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	5	3	12	18	32	42	35	54														CASSLRRGNRWAETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGACAGGGAGGCCAGCCCCAGCATTTTGGTGAT	CASSLEGQGGQPQHF	In	VDJ	1	274	2.965746707912915E-4	3.491531125598275E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	7	3	4	18	32	44	35	48														CASSLEGQGGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGGGGTTTCTATGGCTACACCTTCGGTTCG	CASSLGGGFYGYTF	In	VDJ	1	275	2.976570601007488E-4	3.504273939925276E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	1	4	1	3	18	34	41	35	44														CASSLGGGFYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGATGGAATTCACCCCTCCACTTTGGGAAC	CASSFQGWNSPLHF	In	VDJ	1	275	2.976570601007488E-4	3.504273939925276E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	7	1	4	18	32	38	33	42														CASSFQGWNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCGGGACAGCCGAAACACCATATATTTTGGAGAG	CASSPRDSRNTIYF	In	VDJ	1	276	2.9873944941020606E-4	3.5170167542522774E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	5	4	2	18	30	41	34	43														CASSPRDSRNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACCCGGGACAGGGGCCTTTTAATGAAAAACTGTTTTTTGGCAGT	CASSYPGQGPFNEKLFF	In	VDJ	1	280	3.0306900664803514E-4	3.567988011560281E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	4	4	5	18	31	45	35	50														CASSYPGQGPFNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTCAGCGGCTATGAGCAGTTCTTCGGGCCA	CASSSGLSGYEQFF	In	VDJ	1	280	3.0306900664803514E-4	3.567988011560281E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	8	1	8	18	31	38	32	46						01,02								CASSSGLSGYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCTTCGGGGGACTAGCGGGGCTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	282	3.052337852669497E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	8	2	18	30	51	38	53														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCGGGTCAATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSTRVNPYNEQFF	In	VDJ	1	288	3.1172812112369326E-4	3.669930526176289E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	2	3	6	18	30	37	33	43						01,02								CASSTRVNPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCGGCGAAGGGGGCGCCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	289	3.1281051043315056E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	2	10	3	18	32	49	42	52														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGCAACAGGCAGGGAAGACACCGGGGAGCTGTTTTTTGGAGAA	CASRATGREDTGELFF	In	VDJ	1	290	3.138928997426078E-4	3.695416154830291E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	4	3	4	8	18	29	38	33	46														CASRATGREDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAATACACAGGGCTACGAGCAGTACTTCGGGCCG	CASSPNTQGYEQYF	In	VDJ	1	290	3.138928997426078E-4	3.695416154830291E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	3	8	0	18	30	-1	38	44														CASSPNTQGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGCTCGCGGTCCCGGCCCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGSRSRPRSYNEQFF	In	VDJ	1	292	3.1605767836152235E-4	3.7209017834842934E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	0	8	11	18	30	42	38	53						01,02								CASSQGSRSRPRSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGACACGTTAGGACAGGAAACACCATATATTTTGGAGAG	CASSPGHVRTGNTIYF	In	VDJ	1	295	3.1930484628989414E-4	3.7591302264652963E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	6	4	3	10	18	30	38	33	48														CASSPGHVRTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACGGAAGAGGGGAAACGAGCAGTACTTCGGGCCG	CASSLGRKRGNEQYF	In	VDJ	1	297	3.214696249088087E-4	3.784615855119298E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	5	2	5	8	2	18	34	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRKRGNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGGTTTAGAAGGGAGAGGCCCGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	297	3.214696249088087E-4		61	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	6	1	0	0	20	18	-1	39	34	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGTGGYNEQFF	In	VDJ	1	298	3.22552014218266E-4	3.7973586694462993E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	1	3	0	0	18	-1	-1	34	44														CASSLGTGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACGGGACTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSSGRDFSTDTQYF	In	VDJ	1	299	3.236344035277232E-4	3.8101014837733005E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	0	6	2	18	31	43	37	45						01,02								CASSSGRDFSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACAGGGGGCGACGTCCAATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	300	3.247167928371805E-4		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	0	3	1	10	18	32	45	33	55														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACAGGAGAGGATTCACCCCTCCACTTTGGGAAC	CASSPTGEDSPLHF	In	VDJ	1	302	3.2688157145609507E-4	3.8483299267543034E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	4	8	3	5	18	30	38	33	43														CASSPTGEDSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACAGAGCGGATCACAGATACGCAGTATTTTGGCCCA	CASSTERITDTQYF	In	VDJ	1	302	3.2688157145609507E-4	3.8483299267543034E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	5	2	5	2	18	29	39	34	41						01,02								CASSTERITDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGGGGGGGCTGGATACGCAGTATTTTGGCCCA	CASSLKGGLDTQYF	In	VDJ	1	306	3.312111286939241E-4	3.899301184062307E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	6	2	3	18	33	42	35	45														CASSLKGGLDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGTTAACTCAAAGGGGGGAGACCCAGTACTTCGGGCCA	CASSLRLTQRGETQYF	In	VDJ	1	309	3.3445829662229594E-4	3.93752962704331E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	1	5	13	0	18	32	-1	45	51														CASSLRLTQRGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAAGGGGCGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASSRRGGGYNEQFF	In	VDJ	1	311	3.366230752412105E-4	3.9630152556973124E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	5	2	4	3	7	18	30	38	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRGGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAATGGCCTCTCCGAACACTGAAGCTTTCTTTGGACAA	CASSSMASPNTEAFF	In	VDJ	1	315	3.409526324790395E-4	4.0139865130053165E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	1	4	6	18	31	38	35	44														CASSSMASPNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTACAACCCGGGCGGAGAGACCCAGTACTTCGGGCCA	CASSFYNPGGETQYF	In	VDJ	1	315	3.409526324790395E-4	4.0139865130053165E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	8	0	4	9	2	18	32	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFYNPGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACACTAGCGGAGCCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSDTSGASQETQYF	In	VDJ	1	316	3.420350217884968E-4	4.026729327332317E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	5	1	3	6	18	30	41	33	47						01,02								CASSDTSGASQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCAAGGGCCTCTTCGGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	317	3.4311741109795406E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	7	17	15	10	18	30	50	45	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCCTCGACTCGGGACTAGCGGGAGGCTGATACGCAGTATTTTGGCCCA		Out	VDJ	1	317	3.4311741109795406E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	1	6	10	2	18	29	54	39	56														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGTTCGTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGQFVAGELFF	In	VDJ	1	319	3.452821897168686E-4	4.06495777031332E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	5	6	0	7	18	-1	39	34	46														CASSLGQFVAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAGGGACAGGCACAGATACGCAGTATTTTGGCCCA	CASSLGLGTGTDTQYF	In	VDJ	1	319	3.452821897168686E-4	4.06495777031332E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	8	1	0	6	18	-1	40	32	46						01,02								CASSLGLGTGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTGGGGCGACTCGACAGATACGCAGTATTTTGGCCCA	CASSPWGDSTDTQYF	In	VDJ	1	320	3.4636457902632585E-4	4.077700584640321E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	3	4	6	18	30	39	34	45														CASSPWGDSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCCGGACAGGGACAAAACAATGAGCAGTTCTTCGGGCCA	CASRSGQGQNNEQFF	In	VDJ	1	321	3.4744696833578315E-4	4.0904433989673224E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	5	4	5	18	29	41	33	46														CASRSGQGQNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGACAGCCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTGQPGANVLTF	In	VDJ	1	322	3.485293576452404E-4	4.1031862132943236E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	5	4	3	3	18	30	39	33	42														CASSTGQPGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACTAGCGGCCTCGGAGATACGCAGTATTTTGGCCCA	CASSSGTSGLGDTQYF	In	VDJ	1	323	3.496117469546977E-4	4.115929027621324E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	5	5	2	6	18	31	44	33	50						01,02								CASSSGTSGLGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATTGGACTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSYWTSGGETQYF	In	VDJ	1	326	3.528589148830695E-4	4.154157470602327E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	2	4	3	0	18	31	-1	34	47														CASSYWTSGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGCGGTACCCAAGAGACCCAGTACTTCGGGCCA	CASSFSGTQETQYF	In	VDJ	1	332	3.593532507398131E-4	4.230614356564333E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	5	5	1	0	3	18	-1	38	32	41						01,02								CASSFSGTQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGATGGGGAGACGGGATTGGAGCAGTTCTTCGGGCCA	CASSSDGETGLEQFF	In	VDJ	1	333	3.6043564004927035E-4	4.2433571708913343E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	10	12	3	18	31	48	43	51														CASSSDGETGLEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTACGGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVRGSGANVLTF	In	VDJ	1	334	3.6151802935872765E-4	4.2560999852183355E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	8	3	1	3	1	18	30	38	33	39														CASSVRGSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGCGGCACTTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	340	3.6801236521547123E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	2	5	3	0	0	8	18	-1	37	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGTGGGGATAGCTAACTATGGCTACACCTTCGGTTCG	CASSSGVGIANYGYTF	In	VDJ	1	343	3.7125953314384307E-4	4.3707853141613444E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	0	0	9	18	-1	37	31	46														CASSSGVGIANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGTGGTTCCCGGGGAGCTGTTTTTTGGAGAA	CASSLGVVPGELFF	In	VDJ	1	343	3.7125953314384307E-4	4.3707853141613444E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	11	2	6	0	6	18	-1	37	34	43														CASSLGVVPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGAGTCATACAATGAGCAGTTCTTCGGGCCA	CASSLGESYNEQFF	In	VDJ	1	355	3.842482048573303E-4	4.523699086085356E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	2	4	0	5	18	-1	37	34	42														CASSLGESYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTGCGTCATAGGGTTTATATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	357	3.864129834762448E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	6	5	3	6	9	5	18	29	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGACAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGTGELFF	In	VDJ	1	359	3.8857776209515936E-4	4.5746703433933604E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	5	3	0	18	30	-1	33	42														CASSPGQGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGGGGACGGAGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSPGGRRNNEKLFF	In	VDJ	1	359	3.8857776209515936E-4	4.5746703433933604E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	0	7	4	5	7	18	30	40	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGRRNNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAAAGGGGGGACAGCGGAGCAGTACTTCGGGCCG	CASSSKGGTAEQYF	In	VDJ	1	359	3.8857776209515936E-4	4.5746703433933604E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	7	8	2	18	31	46	39	48														CASSSKGGTAEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGGGCGGAACCCCTGGGAGCCTGAAGCTTTCTTTGGACAA	CASRGRNPWEPEAFF	In	VDJ	1	362	3.9182493002353115E-4	4.6128987863743633E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	6	7	0	6	0	15	18	-1	34	29	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGRNPWEPEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGACAGGGGTAGTGCTTCTGGAAACACCATATATTTTGGAGAG	CASSLRDRGSASGNTIYF	In	VDJ	1	363	3.929073193329884E-4	4.6256416007013645E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	2	1	1	7	18	33	44	34	51														CASSLRDRGSASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCTATCTTGAGGTTTACCGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	368	3.983192658802748E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	7	0	4	0	16	18	-1	37	32	53														X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGTCGACAGTCCAGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSPRSTVQANEKLFF	In	VDJ	1	369	3.99401655189732E-4	4.7020984866633705E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	3	8	6	18	30	43	38	49														CASSPRSTVQANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGVNTGELFF	In	VDJ	1	378	4.0914315897484744E-4	4.8167838156063794E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	0	9	1	0	1	18	-1	37	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGTCTCGACAGGGGTTGGCGATACGCAGTATTTTGGCCCA	CASSFVSTGVGDTQYF	In	VDJ	1	386	4.1780227345050556E-4	4.918726330222388E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	6	6	5	18	32	46	38	51														CASSFVSTGVGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGCAGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSSRRAQETQYF	In	VDJ	2	395	4.27543777235621E-4	5.033411659165397E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	1	4	1	18	31	40	35	41														CASSSRRAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGCCGGGAGCAGCGGGAAACACCATATATTTTGGAGAG	CASSWPGAAGNTIYF	In	VDJ	2	397	4.297085558545355E-4	5.058897287819399E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	8	2	4	3	5	18	31	40	34	45														CASSWPGAAGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTTCCACAGTACCAAGAGACCCAGTACTTCGGGCCA	CASSFFPQYQETQYF	In	VDJ	2	397	4.297085558545355E-4	5.058897287819399E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	5	0	6	1	18	32	42	38	43														CASSFFPQYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGCTACCCCGGGACTCTCACCCTACGAGCAGTACTTCGGGCCG	CASSAATPGLSPYEQYF	In	VDJ	2	399	4.3187333447345007E-4	5.0843829164734E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	2	11	5	18	30	47	41	52						01,02								CASSAATPGLSPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGAGGGACGGAGACGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	408	4.416148382585655E-4		56	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	0	7	5	4	15	18	30	39	34	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGTCTCCGCACGGCACAGATACGCAGTATTTTGGCCCA	CASSRSPHGTDTQYF	In	VDJ	2	412	4.4594439549639457E-4	5.250039502724414E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	1	0	10	18	-1	33	30	43						01,02								CASSRSPHGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGGGGCACGAGGGAGAAAAACTGTTTTTTGGCAGT	CASSPGGHEGEKLFF	In	VDJ	2	413	4.470267848058518E-4	5.262782317051414E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	1	8	1	10	18	30	38	31	48														CASSPGGHEGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGACCGCAGTCCGGGGAGCTGTTTTTTGGAGAA	CASSLGGPQSGELFF	In	VDJ	2	421	4.5568589928151E-4	5.364724831667423E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	1	0	7	6	1	6	18	34	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGPQSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATACTACGGGAAACCCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHTTGNPGSYNEQFF	In	VDJ	2	422	4.5676828859096723E-4	5.377467645994423E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	3	1	16	0	18	30	-1	46	51						01,02								CASSHTTGNPGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGTGGACAGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSSRGQGGNEQFF	In	VDJ	2	425	4.600154565193391E-4	5.415696088975427E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	6	5	1	18	31	46	36	47														CASSSRGQGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGAAGCGGCTAGCGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSWKRLAGNNEQFF	In	VDJ	2	425	4.600154565193391E-4	5.415696088975427E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	8	1	18	31	48	39	49														CASSWKRLAGNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGACAGGGGGGTGGCTACACCTTCGGTTCG	CASSLVGQGGGYTF	In	VDJ	2	443	4.7949846408956986E-4	5.645066746861445E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	7	1	1	18	34	46	35	47														CASSLVGQGGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGGACTAGCGGTCTACAAGAGACCCAGTACTTCGGGCCA	CASSPRTSGLQETQYF	In	VDJ	2	451	4.8815757856522803E-4	5.747009261477453E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	5	2	4	4	18	30	44	34	48						01,02								CASSPRTSGLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGTTGAGTCAGGCGGCTGAAGCTTTCTTTGGACAA	CASSLVLSQAAEAFF	In	VDJ	2	469	5.076405861354588E-4	5.976379919363471E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	4	6	10	3	18	32	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLSQAAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGACAGGGTGGGTAATGAGCAGTTCTTCGGGCCA	CASSFGDRVGNEQFF	In	VDJ	2	471	5.098053647543734E-4	6.001865548017472E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	2	5	18	32	43	34	48														CASSFGDRVGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCATTTGCACACCGGGGAGCTGTTTTTTGGAGAA	CASSPHLHTGELFF	In	VDJ	2	486	5.260412043962325E-4	6.193007762922488E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	4	6	3	3	5	18	30	35	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHLHTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGATCGGGACTGAGGACGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	486	5.260412043962325E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	4	6	7	18	30	42	36	49						01,02								X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGACACAGATACGCAGTATTTTGGCCCA	CASSPGQDTDTQYF	In	VDJ	2	491	5.314531509435187E-4	6.256721834557493E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	2	2	1	18	30	40	32	41														CASSPGQDTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACTAGCGGGGGTGGGGAGCTGTTTTTTGGAGAA	CASSSGTSGGGELFF	In	VDJ	2	506	5.476889905853778E-4	6.447864049462509E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	0	2	8	2	1	18	31	47	33	48														CASSSGTSGGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGAGGACTACCCCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFGGLPPSGANVLTF	In	VDJ	2	515	5.574304943704933E-4	6.562549378405517E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	1	9	0	4	5	18	32	42	36	47						01,02								CASSFGGLPPSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCGGGGGGCTGGAAGAAACACCATATATTTTGGAGAG	CASSHRGAGRNTIYF	In	VDJ	2	523	5.660896088461513E-4	6.664491893021526E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	8	1	5	3	6	18	30	40	33	46														CASSHRGAGRNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAAGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPKTVNTEAFF	In	VDJ	2	525	5.682543874650659E-4	6.689977521675527E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	0	5	0	18	30	-1	35	40														CASSPKTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTAAAGGTTATCGGGAGGTGAGCAGTTCTTCGGGCCA	CASSL*RLSGGEQFF	Stop	VDJ	2	529	5.72583944702895E-4		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	1	9	11	0	18	32	-1	43	50														CASSL*RLSGGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGAACTAGCAATCGAACCCCACGAGCAGTTCTTCGGGCCA	CASSRELAIEPHEQFF	In	VDJ	2	545	5.899021736542112E-4	6.944833808215547E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	7	10	5	13	18	30	41	35	54						01,02								CASSRELAIEPHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACCCAGGGAGTTCGGGGCTACACCTTCGGTTCG	CASSQTQGVRGYTF	In	VDJ	2	568	6.147971277717285E-4	7.23791853773657E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	4	3	8	6	7	18	30	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTQGVRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCGGTTGATGAACACTGAAGCTTTCTTTGGACAA	CASSLGRLMNTEAFF	In	VDJ	2	599	6.483511963649037E-4	7.632945781873602E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	0	0	6	18	-1	37	32	43														CASSLGRLMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLVTGNTEAFF	In	VDJ	2	644	6.970587152904808E-4	8.206372426588647E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	4	1	2	0	18	34	-1	36	41														CASSLVTGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAACAGGGAACGAGGGGAGCTGTTTTTTGGAGAA	CASSSNRERGELFF	In	VDJ	3	701	7.587549059295451E-4	8.932712843227704E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	8	3	5	18	31	40	34	45														CASSSNRERGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGTGGTCTTACACTGAAGCTTTCTTTGGACAA	CASSFGWSYTEAFF	In	VDJ	3	715	7.739083562619468E-4	9.111112243805718E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	0	9	3	1	7	18	32	36	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGWSYTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAACTAGCGGGGGGCCAATCAACAATGAGCAGTTCTTCGGGCCA	CASSPTSGGPINNEQFF	In	VDJ	3	727	7.868970279754341E-4	9.26402601572973E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	5	3	7	18	30	45	33	52														CASSPTSGGPINNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTGGACAGGGATGATGAACACTGAAGCTTTCTTTGGACAA	CASSPWTGMMNTEAFF	In	VDJ	3	758	8.204510965686094E-4	9.659053259866761E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	0	4	4	18	30	42	34	46														CASSPWTGMMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCCCTCTCCGGTAGCTCTTCAGTACTTCGGCGCC	CASSLDPSPVALQYF	In	VDJ	3	760	8.22615875187524E-4	9.684538888520763E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	5	7	11	11	2	18	35	50	46	52						01,02								CASSLDPSPVALQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCGAGGGCCGCAGAGCGGGGAGCTGTTTTTTGGAGAA	CASSLRGPQSGELFF	In	VDJ	3	794	8.59417111709071E-4	0.0010117794575638798	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	7	4	8	18	30	39	34	47														CASSLRGPQSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCAAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLKGGTDTQYF	In	VDJ	3	826	8.940535696117036E-4	0.0010525564634102829	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	1	4	0	18	30	-1	34	40														CASSLKGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQTNTGELFF	In	VDJ	3	840	9.092070199441054E-4	0.0010703964034680844	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	4	6	0	1	2	18	32	35	33	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACAGGGGGTTCTTAGTTCACCCCTCCACTTTGGGAAC	CASRQGVLSSPLHF	In	VDJ	3	866	9.373491419899944E-4	0.001103527720718287	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	1	9	0	7	18	-1	37	29	44														CASRQGVLSSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTGCAATCAGAGACAACTACGAGCAGTACTTCGGGCCG	CASTAIRDNYEQYF	In	VDJ	3	870	9.416786992278235E-4	0.0011086248464490874	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	6	3	11	1	18	28	43	39	44														CASTAIRDNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGACAGAGAGTTATGGAAGGGCTACACCTTCGGTTCG	CASSWDRELWKGYTF	In	VDJ	3	891	9.644088747264261E-4	0.0011353847565357894	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	8	0	13	18	-1	38	31	51														CASSWDRELWKGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGACAGGGTTTGAAGCTTTCTTTGGACAA	CASSLEGTGFEAFF	In	VDJ	3	898	9.71985599892627E-4	0.0011443047265646902	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	7	1	2	18	35	45	36	47														CASSLEGTGFEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGAGGGGCAGGGCGGAGGGGAGCTGTTTTTTGGAGAA	CASSPEGQGGGELFF	In	VDJ	4	924	0.0010001277219385159	0.0011774360438148927	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	0	8	2	10	18	30	38	32	48														CASSPEGQGGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACGGCAGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSPTAGPTDTQYF	In	VDJ	4	942	0.0010196107295087468	0.0012003731096034945	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	2	7	2	18	30	42	37	44														CASSPTAGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGTGGGGGGTACAGGATGAAGCTTTCTTTGGACAA	CASSPWGVQDEAFF	In	VDJ	4	986	0.0010672358591248667	0.001256441492642299	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	7	4	7	18	30	40	34	47														CASSPWGVQDEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGATTTAACGGACAGGGGGCAACTGAAGCTTTCTTTGGACAA	CASSRFNGQGATEAFF	In	VDJ	4	1011	0.0010942955918612984	0.0012882985284598015	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	0	5	9	1	18	30	50	39	51														CASSRFNGQGATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAGGGGCCAGGGACACAATGAGCAGTTCTTCGGGCCA	CASSSRGQGHNEQFF	In	VDJ	4	1067	0.0011549093931909054	0.0013596582886910072	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	0	7	5	10	0	18	31	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGQGHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTTCCCCGCTAGCGGGGGTGAGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	1087	0.0011765571793800507		59	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	0	10	5	18	32	52	42	57														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGCAGGGCCCTTCTAATACGCAGTATTTTGGCCCA	CASSLLQGPSNTQYF	In	VDJ	4	1140	0.001233923812781286	0.0014526808332781145	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	7	3	8	18	33	41	36	49														CASSLLQGPSNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGCGGGGGAGTCCTACGAGCAGTACTTCGGGCCG	CASSFRAGESYEQYF	In	VDJ	5	1352	0.0014633903463862267	0.0017228284970105358	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	1	4	2	18	32	43	36	45														CASSFRAGESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTGACGGAGGGGATTTCGCGCAGTATTTTGGCCCA	CASSVDGGDFAQYF	In	VDJ	5	1371	0.0014839557432659149	0.0017470398442318376	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	10	6	7	18	30	42	36	49														CASSVDGGDFAQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGCAGCGGGGGCTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAAAGATNTGELFF	In	VDJ	5	1375	0.001488285300503744	0.001752136969962638	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	6	2	0	6	3	18	32	46	38	49														CASSLAAAGATNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGAGGTGGCTGTGCTCAATCAGCCCCAGCATTTTGGTGAT	CASSSGEVAVLNQPQHF	In	VDJ	6	1487	0.001609512903162958	0.0018948564904250494	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	4	2	3	0	13	18	-1	37	31	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGEVAVLNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	1551	0.0016787858189682232		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	3	2	0	18	32	-1	34	43														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAACGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGTGSSYNSPLHF	In	VDJ	6	1648	0.0017837775819855783	0.0021000158010897655	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	3	8	3	0	5	2	18	32	42	37	44						01,02								CASSLGTGSSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGGGACAGGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSSRGQGSNEQFF	In	VDJ	7	1706	0.0018465561619340999	0.0021739241241863715	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	6	4	2	18	31	45	35	47														CASSSRGQGSNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCTCCGGGACGGAAGAGACCCAGTACTTCGGGCCA	CASSLSSGTEETQYF	In	VDJ	11	2782	0.0030112070589101204	0.0035450509457716794	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	0	7	3	6	2	18	33	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSGTEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGACAGGGGGCTTATGGCTACACCTTCGGTTCG	CASSFGQGAYGYTF	In	VDJ	16	4263	0.004614225626216335	0.005432261747600528	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	0	5	1	1	18	32	44	33	45														CASSFGQGAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCAAATCTCGAGGGGTTGTCAGTTCTTCGGGCCA	CASQISRGCQFF	In	VDJ	1	96	1.0390937370789777E-4	1.2233101753920963E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	12	5	2	13	13	4	26	31	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQISRGCQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTTCCTTTCTCGGCGATTGAACACTGAAGCTTTCTTTGGACAA	CASGLFLSRRLNTEAFF	In	VDJ	1	98	1.060741523268123E-4	1.2487958040460984E-4	51	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	2	9	0	0	10	3	26	41	54	51	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLFLSRRLNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTTAAGGGACAGGGATCTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	98	1.060741523268123E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	0	3	3	3	4	26	35	47	38	51														X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCTGGGGGTTTCGGTGAGCAGTTCTTCGGGCCA	CASGPGGFGEQFF	In	VDJ	1	120	1.298867171348722E-4	1.5291377192401206E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	5	6	1	9	3	6	26	38	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGGFGEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGGACAGCCACACAGATACGCAGTATTTTGGCCCA	CASGLGDSHTDTQYF	In	VDJ	1	123	1.33133885063244E-4	1.5673661622211236E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	5	2	0	3	26	-1	49	42	52														CASGLGDSHTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCTCGGACTAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CASGLSRTSGGNEQFF	In	VDJ	1	141	1.5261689263347484E-4	1.7967368201071417E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	6	4	0	26	41	-1	45	58														CASGLSRTSGGNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCTCCAGGGAATTCGACAATGAGCAGTTCTTCGGGCCA	CASGSSREFDNEQFF	In	VDJ	1	147	1.5911122849021845E-4	1.8731937060691476E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	4	6	26	39	48	43	54														CASGSSREFDNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCTGACAGGTCACTATGGCTACACCTTCGGTTCG	CASTLTGHYGYTF	In	VDJ	1	159	1.7209990020370568E-4	2.0261074779931597E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	2	4	3	9	2	26	31	46	40	48														CASTLTGHYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCGAGGGACCGGTTCTCGCACCATATATTTTGGAGAG	CASGRGTGSRTIYF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	6	0	7	9	4	9	26	37	46	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRGTGSRTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCCTTGACCAGCGGGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASGLSLTSGGVNEQFF	In	VDJ	1	180	1.948300757023083E-4	2.2937065788601808E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	6	9	1	26	41	60	50	61														CASGLSLTSGGVNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGCGGGGGGTGCTTCACCCCTCCACTTTGGGAAC	CASAGGASPLHF	In	VDJ	1	201	2.1756025120091093E-4	2.561305679727202E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	12	7	1	9	4	3	26	31	43	35	46														CASAGGASPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAACATCCTGGATGCTAACTATGGCTACACCTTCGGTTCG	CANILDANYGYTF	In	VDJ	1	249	2.695149380548598E-4	3.17296076742325E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	10	1	8	0	7	2	26	33	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANILDANYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATCGGGGTACCATCTTCAATGAGCAGTTCTTCGGGCCA	CASNRGTIFNEQFF	In	VDJ	1	319	3.452821897168686E-4	4.06495777031332E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	8	3	6	7	9	26	31	43	38	52														CASNRGTIFNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCCCGACAATGAAGCTTTCTTTGGACAA		Out	VDJ	1	387	4.1888466275996286E-4		34	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	7	5	1	26	37	46	42	47														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGTAGGGACATCGAGCAGGGAGATCAGCCCCAGCATTTTGGTGAT	CASGLGRDIEQGDQPQHF	In	VDJ	2	402	4.3512050240182185E-4	5.122611359454404E-4	54	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	6	5	3	12	26	42	51	45	63														CASGLGRDIEQGDQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCGCCTCAGGGTTTAAACACAATGAGCAGTTCTTCGGGCCA	CASGSASGFKHNEQFF	In	VDJ	2	431	4.6650979237608265E-4	5.492152974937433E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	6	7	26	39	50	45	57														CASGSASGFKHNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCCGGACTAGCGGGGGGGCGAATGAGCAGTTCTTCGGGCCA	CASGLARTSGGANEQFF	In	VDJ	2	439	4.751689068517408E-4	5.59409548955344E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	1	0	7	3	2	26	42	60	45	62														CASGLARTSGGANEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCCAGGGGGATCTGGGGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	2	515	5.574304943704933E-4		46	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	6	3	10	26	37	47	40	57														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CTCAGCTGTGTATTTTTGTGCTAGTGGTCAAATTCCCGGACAGACTACGCCGGACTCCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	544	5.888197843447539E-4		61	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	4	9	15	16	28	43	37	58														X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGAGGAGGGGCGTACACTGAAGCTTTCTTTGGACAA	CASGLGGGAYTEAFF	In	VDJ	2	557	6.028908453676985E-4	7.097747580139559E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	0	3	2	4	26	42	50	44	54														CASGLGGGAYTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAGGGACAGAACACTGAAGCTTTCTTTGGACAA	CASGLGQGQNTEAFF	In	VDJ	2	597	6.461864177459893E-4	7.607460153219599E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	1	0	3	26	-1	49	42	52														CASGLGQGQNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAGGGAACAGATACGCAGTATTTTGGCCCA	CASGLGQGTDTQYF	In	VDJ	3	792	8.572523330901566E-4	0.0010092308946984794	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	3	3	0	1	26	-1	49	42	50														CASGLGQGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACGTTTTGCAGGGAAACTTTGTTAGAAACACCATATATTTTGGAGAG		Out	VDJ	3	797	8.626642796374428E-4		58	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	3	5	8	11	23	40	53	48	64														X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTATTGACACTAAATCAGCCCCAGCATTTTGGTGAT	CASVLTLNQPQHF	In	VDJ	3	846	9.157013558008491E-4	0.001078042092064285	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	7	2	6	4	4	3	26	36	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVLTLNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
ACCCAGGGACTCAGCTGTGTATTTTTGTGCCATCGAATTGGGACGTACACCTAGTCACAAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	961	0.001040176126388435		56	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	12	0	7	1	9	18	25	30	44	39	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTATGGAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASYGGAGELFF	In	VDJ	5	1259	0.0013627281406067009	0.0016043203237694264	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	12	10	0	6	7	1	26	31	44	38	45														CASYGGAGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGCAAGGGGTCTGGGGGCGAGCAGTACTTCGGGCCG	CASSQGKGSGGEQYF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	2	5	2	6	4	8	20	35	44	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGKGSGGEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTTCGGGGGAAACTATGGCTACACCTTCGGTTCG	CASSFGGNYGYTF	In	VDJ	1	88	9.525025923223961E-5	1.1213676607760883E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	2	2	1	20	32	40	34	41														CASSFGGNYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTAATCTGGGACTAGCGGGCCAGGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	98	1.060741523268123E-4		56	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	4	2	1	6	20	37	50	38	56						01,02								X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACGTACAGGGGGCTATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	100	1.0823893094572684E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	0	10	3	2	20	34	46	37	48														X+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCTCAGGTTACAGATACGCAGTATTTTGGCCCA	CASSSQVTDTQYF	In	VDJ	1	102	1.1040370956464137E-4	1.2997670613541025E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	3	4	2	20	31	39	35	41														CASSSQVTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGACCACAGGGGGCAGAGACCCAGTACTTCGGGCCA	CASRPQGAETQYF	In	VDJ	1	112	1.2122760265921406E-4	1.4271952046241123E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	4	3	0	20	31	-1	34	43														CASRPQGAETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGAAGGAGAGGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CARRRGVTGELFF	In	VDJ	1	123	1.33133885063244E-4	1.5673661622211236E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	9	5	2	4	6	1	20	28	39	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARRRGVTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGGGTCCCCCTAGCGGGGGTCACTATGACAGATACGCAGTATTTTGGCCCA	CASSQWVPLAGVTMTDTQYF	In	VDJ	1	152	1.6452317503750478E-4	1.9369077777041526E-4	60	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	2	3	8	8	20	36	54	44	62														CASSQWVPLAGVTMTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGTGGTAGCGAATGAGCAGTTCTTCGGGCCA	CASSQVVANEQFF	In	VDJ	1	292	3.1605767836152235E-4	3.7209017834842934E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	6	7	8	0	20	31	-1	39	44						01,02								CASSQVVANEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCCCCGGCCAGGGACCAAATCAGCCCCAGCATTTTGGTGAT	CASSPPGQGPNQPQHF	In	VDJ	1	314	3.3987024316958227E-4	4.0012436986783153E-4	48	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	4	0	7	4	10	2	20	33	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGQGPNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGAAACAGGAGGGGAAGCTTTCTTTGGACAA	CASSQETGGEAFF	In	VDJ	1	354	3.83165815547873E-4	4.5109562717583556E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	8	10	0	20	31	-1	41	47														CASSQETGGEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATCTAGAAACGGCCGGGACACCGAGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	391	4.2321421999779195E-4		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	6	4	13	6	20	34	53	47	59														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAAATTCCCGGGACAGGGGAGACCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	394	4.2646138792616373E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	2	7	7	4	20	27	44	34	48														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAAGGGACAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	414	4.481091741153091E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	6	4	3	1	20	37	46	40	47														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAGAAAGAAGGCAGGGGGGCTTCGGGAGCTTTCTTTGGACAA		Out	VDJ	2	502	5.433594333475487E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	10	11	8	20	37	55	48	63														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACAGGGACAGGGGGCTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	550	5.953141202014976E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	17	2	13	20	34	48	36	61														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTTTTGACAGCTAGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	901	9.752327678209988E-4		47	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	6	2	5	3	7	5	20	31	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGGACTAGCTAGTTTAGCACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	67	7.252008373363698E-5		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	7	2	1	10	23	32	42	33	52						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTTCGGCAACCGAAGCTTTCTTTGGACAA	CASSPSATEAFF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	9	0	8	5	4	23	35	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSATEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCCCCGGGACGGAAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAISSPGRKSSYNEQFF	In	VDJ	1	70	7.576725166200879E-5	8.919970028900702E-5	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	4	0	7	0	4	7	23	36	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISSPGRKSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	71	7.684964097146606E-5		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	1	3	0	23	40	-1	43	48														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGTCGATCGGCGGGACAGGCTGCGGCTACACCTTCGGTTCG		Out	VDJ	1	72	7.793203028092332E-5		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	8	13	4	23	35	56	48	60														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCTGATGGGTCTTCCACAGATACGCAGTATTTTGGCCCA	CASSSDGSSTDTQYF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	0	9	2	7	5	23	34	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDGSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRGSYNEQFF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	1	0	1	23	-1	40	35	41														CASSRGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGCTACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSDATGGTDTQYF	In	VDJ	1	74	8.009680889983786E-5	9.429682601980742E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	1	6	0	23	35	-1	41	48														CASSDATGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACAGGTGGGAGACCCAGTACTTCGGGCCA	CASSRDRWETQYF	In	VDJ	1	76	8.226158751875239E-5	9.684538888520763E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	4	5	2	3	23	34	44	36	47														CASSRDRWETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATACAGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASRDTGGSTDTQYF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	0	4	1	23	34	46	38	47														CASRDTGGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTGGGGCGGAGTATGGCTACACCTTCGGTTCG	CASSPGAEYGYTF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	7	0	5	3	4	23	35	43	38	47														CASSPGAEYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGCTAGGGGGTTGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSYSGLGGWTNEKLFF	In	VDJ	1	77	8.334397682820966E-5	9.811967031790773E-5	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	1	2	6	4	23	40	52	46	56														CASSYSGLGGWTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTATATTCGGGACAGGGACTCTTGGGCGGCTACACCTTCGGTTCG	CASRLYSGQGLLGGYTF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	8	9	10	23	34	52	43	62														CASRLYSGQGLLGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSRDSTDTQYF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	0	7	0	2	0	23	34	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGGACGGAATTAACTATGGCTACACCTTCGGTTCG	CASSTDGINYGYTF	In	VDJ	1	79	8.55087554471242E-5	1.0066823318330793E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	1	7	1	2	5	23	35	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTDGINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAATGTCGGGGGTTACACTGAAGCTTTCTTTGGACAA	CASRNVGGYTEAFF	In	VDJ	1	81	8.767353406603873E-5	1.0321679604870813E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	3	6	2	23	34	46	40	48														CASRNVGGYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTCTACAGGGGGATTCAGGAAACACCATATATTTTGGAGAG	CASSRLQGDSGNTIYF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	1	4	5	5	23	35	48	40	53														CASSRLQGDSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTTCGGAGGGGACAGGGAGCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	83	8.983831268495328E-5		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	0	3	0	7	3	23	28	44	35	47														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGTTACGTTTGGGGAGGCCAATTAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	90	9.741503785115415E-5		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	1	8	5	6	23	38	49	43	55														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTAACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSYLTGGTEAFF	In	VDJ	1	91	9.849742716061142E-5	1.1595961037570914E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	1	4	2	0	23	39	-1	41	49														CASSYLTGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGGACAGGGCTAATGGAAACACCATATATTTTGGAGAG	CAISGDRANGNTIYF	In	VDJ	1	92	9.95798164700687E-5	1.1723389180840923E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	3	1	4	23	35	45	36	49														CAISGDRANGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGACAGGGGGACCCTCAAGAGACCCAGTACTTCGGGCCA	CASRGQGDPQETQYF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	1	2	1	5	23	34	45	35	50														CASRGQGDPQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTGGGGACAGGGGGGACCTACACCTTCGGTTCG		Out	VDJ	1	93	1.0066220577952595E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	1	10	3	3	23	40	54	43	57														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGGGGCCGTTCACCCCTCCACTTTGGGAAC	CASSYDRGRSPLHF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	2	2	9	0	3	23	-1	46	38	49														CASSYDRGRSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACAGGGGGCGTCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLQGASTNEKLFF	In	VDJ	1	94	1.0174459508898322E-4	1.1978245467380944E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	0	2	1	4	23	36	46	37	50														CASSLQGASTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGAGGGTCCTAACATTCAGTACTTCGGCGCC	CASSYSEGPNIQYF	In	VDJ	1	95	1.028269843984405E-4	1.2105673610650954E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	10	0	7	0	4	23	-1	46	40	50														CASSYSEGPNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGACACCAATACGAGCAGTACGTCGGGCCG	CASSEGHQYEQYV	In	VDJ	1	97	1.0499176301735503E-4	1.2360529897190975E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	17	2	17	23	35	43	37	60														CASSEGHQYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCGGGACAGTGGAACATTCAGTACTTCGGCGCC	CASRAGQWNIQYF	In	VDJ	1	99	1.0715654163626957E-4	1.2615386183730993E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	5	7	3	3	23	34	44	37	47														CASRAGQWNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGATAGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSG*GSGELFF	Stop	VDJ	1	99	1.0715654163626957E-4		39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	0	8	6	5	1	23	35	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSG*GSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTAGCGGGGCGATCCATGAGCAGTTCTTCGGGCCA	CASSDSSGAIHEQFF	In	VDJ	1	100	1.0823893094572684E-4	1.2742814327001005E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	8	0	6	23	-1	48	40	54														CASSDSSGAIHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTGAGGCGGGGTATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSGEAGYATNEKLFF	In	VDJ	1	101	1.093213202551841E-4	1.2870242470271014E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	3	0	6	4	23	35	47	41	51														CASSGEAGYATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACCTCCGGCGGCTACACCTTCGGTTCG	CASSYGTSGGYTF	In	VDJ	1	104	1.1256848818355591E-4	1.3252526900081043E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	7	8	0	7	23	-1	43	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGTSGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAGGGGGTCTAATTCACCCCTCCACTTTGGGAAC	CATRGSNSPLHF	In	VDJ	1	106	1.1473326680247044E-4	1.3507383186621064E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	6	2	6	0	2	23	-1	38	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRGSNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATCTCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSISGGTEAFF	In	VDJ	1	106	1.1473326680247044E-4	1.3507383186621064E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	4	0	23	35	-1	39	46														CASSISGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGATCGACAGGGGAAGAGCAGTACGTCGGGCCG	CASRRSTGEEQYV	In	VDJ	1	107	1.1581565611192772E-4	1.3634811329891076E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	17	6	12	23	34	48	40	60														CASRRSTGEEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAAGGACAGGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASRKDRGGNQPQHF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	2	3	2	23	34	46	37	48														CASRKDRGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCAAAAGGAGGACAGACTGAAGCTTTCTTTGGACAA	CASAKGGQTEAFF	In	VDJ	1	110	1.1906282404029952E-4	1.4017095759701105E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	5	5	9	0	23	32	-1	41	47														CASAKGGQTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCGAACGCCGGGACTCTGTAGACCCAGTACTTCGGGCCA		Out	VDJ	1	113	1.2230999196867132E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	10	6	9	4	23	39	54	48	58						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGTCCCCCCGGGACAGCAAAACGGGGCTACACCTTCGGTTCG	CASRPPGTAKRGYTF	In	VDJ	1	114	1.233923812781286E-4	1.4526808332781144E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	5	8	9	8	23	32	48	41	56														CASRPPGTAKRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTAGCGGGGGCCACCGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYSVAGATDSSYNEQFF	In	VDJ	1	115	1.2447477058758586E-4	1.4654236476051156E-4	60	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	0	2	10	21	38	49	40	59														CASSYSVAGATDSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGACAGAAACTATGGCTACACCTTCGGTTCG	CASSPDRNYGYTF	In	VDJ	1	119	1.2880432782541492E-4	1.5163949049131194E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	2	4	1	23	34	43	38	44														CASSPDRNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAGGACGGACAGGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASQDGQGDSNQPQHF	In	VDJ	1	121	1.3096910644432946E-4	1.5418805335671215E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	1	0	6	1	23	32	48	38	49														CASQDGQGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGATCTGGAACGTAGTGAGCAGTTCTTCGGGCCA	CASSEDLERSEQFF	In	VDJ	1	126	1.3638105299161582E-4	1.6055946052021265E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	1	9	0	13	23	-1	39	35	52														CASSEDLERSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGCCCATTTCACCCCTCCACTTTGGGAAC	CASSLPISPLHF	In	VDJ	1	127	1.3746344230107307E-4	1.6183374195291274E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	4	6	9	6	1	23	34	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPISPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAATTTAGTCGGGGCTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	128	1.3854583161053034E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	7	0	2	8	2	23	30	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACAGTACTCTGGAAACACCATATATTTTGGAGAG	CASGQYSGNTIYF	In	VDJ	1	128	1.3854583161053034E-4	1.6310802338561286E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	1	5	0	0	2	23	-1	38	32	40														CASGQYSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGTTACGGGGGAGCAGCTAACTATGGCTACACCTTCGGTTCG	CANSYGGAANYGYTF	In	VDJ	1	129	1.396282209199876E-4	1.6438230481831295E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	6	1	0	0	5	23	-1	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANSYGGAANYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTTTGGGGGCCAGGGAGGAGAGACCCAGTATTTCGGGCCA	CASSVFGGQGGETQYF	In	VDJ	1	129	1.396282209199876E-4	1.6438230481831295E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02			5	6	0	19	6	21	23	35	47	41	68				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSVFGGQGGETQYF+TCRBV06-08+TCRBJ02-X	TCRBV06-08*01		TCRBJ02	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSYVGSGELFF	In	VDJ	1	129	1.396282209199876E-4	1.6438230481831295E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	6	2	6	2	1	23	38	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVGSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGATTGAGGGAAAATAATTCACCCCTCCACTTTGGGAAC	CASSGLRENNSPLHF	In	VDJ	1	130	1.4071061022944488E-4	1.6565658625101304E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	0	5	5	3	23	35	45	40	48														CASSGLRENNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCGGGGGGGGGCCAAAGGGAGACCCAGTACTTCGGGCCA	CASSPPGGGQRETQYF	In	VDJ	1	134	1.4504016746727397E-4	1.7075371198181345E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	4	9	23	35	47	39	56														CASSPPGGGQRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACAGGGGGTACCTACAATGAGCAGTTCTTCGGGCCA	CASSETGGTYNEQFF	In	VDJ	1	136	1.4720494608618849E-4	1.7330227484721366E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	2	2	2	23	35	46	37	48														CASSETGGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGAGGTGAATGAGCAGTTCTTCGGGCCA	CASSDREVNEQFF	In	VDJ	1	139	1.504521140145603E-4	1.7712511914531396E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	7	0	5	23	-1	42	35	47														CASSDREVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGACAGTTTCTCTGGAAACACCATATATTTTGGAGAG	CASKDSFSGNTIYF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	5	0	2	3	23	33	40	35	43														CASKDSFSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAAGCGGAGGGACTAGCCCAACAATGAGCAGTTCTTCGGGCCA	CASTKRRD*PNNEQFF	Stop	VDJ	1	141	1.5261689263347484E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	7	5	9	3	23	33	51	42	54						01,02								CASTKRRD*PNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGTTCAATCGGGGCTGAACACTGAAGCTTTCTTTGGACAA	CAVQSGLNTEAFF	In	VDJ	1	142	1.5369928194293212E-4	1.8094796344341426E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	11	7	0	0	8	0	23	29	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAVQSGLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATCCTCAGGGAGATACGCAGTATTTTGGCCCA	CASNPQGDTQYF	In	VDJ	1	146	1.5802883918076118E-4	1.8604508917421467E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	5	5	0	23	33	-1	38	43														CASNPQGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSQGTGELFF	In	VDJ	1	146	1.5802883918076118E-4	1.8604508917421467E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	5	0	1	23	-1	40	35	41														CASSQGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGTGGAGCGCAGACCCAGTACTTCGGGCCA	CASSSGGAQTQYF	In	VDJ	1	147	1.5911122849021845E-4	1.8731937060691476E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	4	4	4	6	0	8	23	-1	40	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGGAQTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACGAACGCGGGGGGAGCCACAGATACGCAGTATTTTGGCCCA	CATNAGGATDTQYF	In	VDJ	1	150	1.6235839641859026E-4	1.9114221490501506E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	7	1	2	5	3	23	30	43	35	46														CATNAGGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACTAGYGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSYGLXGAQETQYF	In	VDJ	1	158	1.710175108942484E-4	2.0133646636661586E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	8	1	0	7	23	-1	45	38	52						unresolved								CASSYGLXGAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGAGACAGGGGTTGGATGAGCAGTTCTTCGGGCCA	CASSERQGLDEQFF	In	VDJ	1	168	1.8184140398882107E-4	2.1407928069361686E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	8	4	4	23	35	47	39	51														CASSERQGLDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACACTAGCACAGATACGCAGTATTTTGGCCCA	CASSRDTSTDTQYF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	0	2	2	23	34	42	36	44														CASSRDTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGTCCAGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSVVQGGYNEQFF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	3	8	0	23	35	-1	43	49														CASSVVQGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGACTCCTACAAGAGACCCAGTACTTCGGGCCA	CASSYSGLLQETQYF	In	VDJ	1	171	1.8508857191719289E-4	2.1790212499171716E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	1	10	2	1	4	23	40	46	41	50						01,02								CASSYSGLLQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSPGTQETQYF	In	VDJ	1	175	1.8941812915502197E-4	2.2299925072251757E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	1	3	0	23	35	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGGAGTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSGGESYNSPLHF	In	VDJ	1	177	1.915829077739365E-4	2.2554781358791778E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	9	0	1	0	2	23	-1	42	35	44														CASSGGESYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACATCCTTTCTGGGGCGGACAGTTATGGGGGCTACACCTTCGGTTCG	CANILSGADSYGGYTF	In	VDJ	1	179	1.9374768639285103E-4	2.28096376453318E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	5	8	16	7	23	30	52	46	59														CANILSGADSYGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSYQGSNTEAFF	In	VDJ	1	179	1.9374768639285103E-4	2.28096376453318E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	1	0	2	23	-1	44	38	46														CASSYQGSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCACTCCCAGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSDHSQGTYNEQFF	In	VDJ	1	181	1.9591246501176557E-4	2.3064493931871817E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	2	9	1	23	35	50	44	51														CASSDHSQGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCTAGGGACAGGGGGCATAGATACGCAGTATTTTGGCCCA	CASSLGTGGIDTQYF	In	VDJ	1	189	2.0457157948742372E-4	2.4083919078031897E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	0	5	6	2	23	32	50	38	52														CASSLGTGGIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTTTGACAGGGACGAGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	190	2.05653968796881E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	3	17	4	17	23	30	41	34	58														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTTTAGAGAATCAGCCCCAGCATTTTGGTGAT	CASSDSLENQPQHF	In	VDJ	1	191	2.0673635810633826E-4	2.4338775364571917E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	8	4	2	2	23	40	45	42	47						01,02								CASSDSLENQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGGGGTTCGGGGGACGAGGATGAAAAACTGTTTTTTGGCAGT	CAGGSGDEDEKLFF	In	VDJ	1	192	2.0781874741579554E-4	2.4466203507841926E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	11	8	2	6	7	6	23	29	42	36	48														CAGGSGDEDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTACAGGGGTGAGGGAGCTGTTTTTTGGAGAA	CASSLTGVRELFF	In	VDJ	1	193	2.0890113672525278E-4	2.459363165111194E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	9	3	3	23	35	45	38	48														CASSLTGVRELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGGGATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	195	2.1106591534416732E-4		37	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	8	3	0	0	0	23	-1	-1	33	38														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGACAGGACTCCCTTCTCTTCGGTTCG	CASSLGQDSLLF	In	VDJ	1	198	2.1431308327253914E-4	2.5230772367461986E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	16	2	10	23	36	45	38	55														CASSLGQDSLLF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGGGAGCGGGGGACCTCAGATACGCAGTATTTTGGCCCA	CASSAGERGTSDTQYF	In	VDJ	1	200	2.1647786189145368E-4	2.548562865400201E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	4	7	4	23	35	50	42	54														CASSAGERGTSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCCGGGACAGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSYTPGQGSSYEQYF	In	VDJ	1	200	2.1647786189145368E-4	2.548562865400201E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	0	5	2	23	38	53	43	55														CASSYTPGQGSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGAGGGGGCAATAACAGATACGCAGTATTTTGGCCCA	CASTEGAITDTQYF	In	VDJ	1	202	2.186426405103682E-4	2.5740484940542027E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	0	3	3	4	23	33	43	36	47														CASTEGAITDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCAGGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSDSRGTTDTQYF	In	VDJ	1	202	2.186426405103682E-4	2.5740484940542027E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	2	0	2	23	-1	47	40	49														CASSDSRGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGAGATGCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGEMLSGANVLTF	In	VDJ	1	205	2.2188980843874E-4	2.6122769370352057E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	8	9	2	0	1	5	23	32	38	33	43														CASGEMLSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGCGACTATGGCTACACCTTCGGTTCG	CASSYSDYGYTF	In	VDJ	1	208	2.2513697636711183E-4	2.6505053800162087E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	6	6	3	0	0	23	-1	-1	38	42						01,02								CASSYSDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGGACTAGCGGGGGGCCTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	209	2.2621936567656907E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	1	5	3	5	23	35	53	38	58														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGCTGGGGGACTTACAGAGTACACCTTCGGTTCG	CASSPAGGLTEYTF	In	VDJ	1	210	2.2730175498602634E-4	2.675991008670211E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	11	8	7	23	35	49	43	56						01,02								CASSPAGGLTEYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTAGGACAGGGCGAGAGACCCAGTACTTCGGGCCA	CASSLRTGRETQYF	In	VDJ	1	211	2.2838414429548362E-4	2.6887338229972116E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	4	4	2	23	35	47	39	49														CASSLRTGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGTTTTGATCAGCCCCAGCATTTTGGTGAT	CASSYQGFDQPQHF	In	VDJ	1	213	2.3054892291439816E-4	2.714219451651214E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	5	0	5	23	-1	43	38	48														CASSYQGFDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCACGGGGGAGACCCAGTACTTCGGGCCA	CASSPTGETQYF	In	VDJ	1	215	2.327137015333127E-4	2.739705080305216E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	3	5	5	0	23	34	-1	39	44														CASSPTGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGTTTACAGGGAAATTTTGGCTACACCTTCGGTTCG	CAISRLQGNFGYTF	In	VDJ	1	217	2.3487848015222722E-4	2.765190708959218E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	7	6	6	23	34	46	40	52														CAISRLQGNFGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGGGGACAGGATGTCCGGGGAGCTGTTTTTTGGAGAA	CASSYSGDRMSGELFF	In	VDJ	1	222	2.4029042669951358E-4	2.828904780594223E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	4	6	2	4	23	40	50	42	54														CASSYSGDRMSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGGACAAGTGAACTATGGCTACACCTTCGGTTCG	CASSRGQVNYGYTF	In	VDJ	1	228	2.467847625562572E-4	2.905361666556229E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	2	2	4	23	35	43	37	47														CASSRGQVNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCCCCGTGAGATTGCACTATGGCTACACCTTCGGTTCG	CASRPPVRLHYGYTF	In	VDJ	1	229	2.478671518657145E-4	2.91810448088323E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	2	3	9	5	23	34	46	43	51														CASRPPVRLHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCACAGGGTTAACTATGGCTACACCTTCGGTTCG	CASHRVNYGYTF	In	VDJ	1	229	2.478671518657145E-4	2.91810448088323E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	3	1	1	1	23	32	39	33	40														CASHRVNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTAGCGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSASGGYTGELFF	In	VDJ	1	231	2.5003193048462897E-4	2.943590109537232E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	3	1	1	23	35	47	36	48														CASSASGGYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGAACCTGACTCGCGGGGCTACACCTTCGGTTCG	CASSVEPDSRGYTF	In	VDJ	1	231	2.5003193048462897E-4	2.943590109537232E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	2	10	8	9	5	23	35	48	44	53						01,02								CASSVEPDSRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTCAGGGGGCAAGAAAACACCATATATTTTGGAGAG	CASSDLRGQENTIYF	In	VDJ	1	232	2.5111431979408627E-4	2.956332923864233E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	0	6	5	4	23	35	48	40	52														CASSDLRGQENTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGACAGAGGGGGAAACACCATATATTTTGGAGAG	CASSPDRGGNTIYF	In	VDJ	1	235	2.5436148772245806E-4	2.994561366845236E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	6	2	5	4	4	4	23	34	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDRGGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGCAGGTTCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSYWAGSANTEAFF	In	VDJ	1	240	2.597734342697444E-4	3.058275438480241E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	1	3	6	23	39	46	42	52														CASSYWAGSANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGGGGGGCATTGAGTACTTCGGCGCC	CASSYGGGIEYF	In	VDJ	1	243	2.6302060219811623E-4	3.096503881461244E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	3	9	0	14	1	6	23	37	45	38	51														CASSYGGGIEYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAGAGACTAGCGGGGAGGGCAATGAGCAGTTCTTCGGGCCA	CASGETSGEGNEQFF	In	VDJ	1	243	2.6302060219811623E-4	3.096503881461244E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	2	3	6	5	4	23	32	48	37	52														CASGETSGEGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCGGACAGGGGCGATGGCTACACCTTCGGTTCG		Out	VDJ	1	245	2.6518538081703077E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	6	4	2	23	34	47	38	49														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGAAGGGGTCGGGCACTGAAGCTTTCTTTGGACAA	CASGKGSGTEAFF	In	VDJ	1	245	2.6518538081703077E-4	3.121989510115246E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	2	4	4	5	23	32	41	36	46														CASGKGSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCGACAGAAACTACTACGAGCAGTACTTCGGGCCG	CASSLDRNYYEQYF	In	VDJ	1	246	2.66267770126488E-4	3.134732324442247E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	3	3	6	23	35	43	38	49														CASSLDRNYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCAAGGGGGGTTTAGACTATGGCTACACCTTCGGTTCG	CAISKGGLDYGYTF	In	VDJ	1	252	2.7276210598323165E-4	3.211189210404253E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	5	1	3	2	6	23	34	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISKGGLDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACGCGGACAGGGGGGTCCAGATACGCAGTATTTTGGCCCA	CASSYSRGQGGPDTQYF	In	VDJ	1	255	2.7600927391160343E-4	3.249417653385256E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	1	4	4	3	23	40	54	44	57														CASSYSRGQGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCTCGGACAGGGGTGAAGCTTTCTTTGGACAA	CASSDSSDRGEAFF	In	VDJ	1	256	2.770916632210607E-4	3.262160467712257E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	2	7	3	0	23	40	-1	43	52														CASSDSSDRGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTACAGGGGGCAATTCGTTGGCTACACCTTCGGTTCG	CATYRGQFVGYTF	In	VDJ	1	259	2.803388311494325E-4	3.30038891069326E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	3	0	7	3	7	23	30	42	33	49														CATYRGQFVGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTTGGGCAGCCCATGGGACGCAGTATTTTGGCCCA	CAISGWAAHGTQYF	In	VDJ	1	259	2.803388311494325E-4	3.30038891069326E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	9	4	10	23	35	43	39	53														CAISGWAAHGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGACCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGTGSYNEQFF	In	VDJ	1	260	2.8142122045888977E-4	3.313131725020261E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	0	7	0	4	3	23	34	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACTACCGCTATGGCTACACCTTCGGTTCG	CASSRDYRYGYTF	In	VDJ	1	261	2.8250360976834706E-4	3.325874539347262E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	9	4	1	3	23	35	43	36	46						01,02								CASSRDYRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCTTGGATAATAATTCACCCCTCCACTTTGGGAAC	CAITLDNNSPLHF	In	VDJ	1	265	2.868331670061761E-4	3.376845796655266E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	10	1	8	5	7	2	23	30	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAITLDNNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTTACAGGGGTGGGAAGAGACCCAGTACTTCGGGCCA	CAISLQGWEETQYF	In	VDJ	1	269	2.911627242440052E-4	3.42781705396327E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	3	1	4	23	36	44	37	48														CAISLQGWEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGAACAGGGGTAATGAGCAGTTCTTCGGGCCA	CASENRGNEQFF	In	VDJ	1	270	2.922451135534625E-4	3.440559868290271E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	3	2	7	4	1	23	32	43	36	44														CASENRGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGCAACTATGGCTACACCTTCGGTTCG	CASSYDSNYGYTF	In	VDJ	1	275	2.976570601007488E-4	3.504273939925276E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	2	0	1	23	-1	43	38	44														CASSYDSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGCCGGGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSDSAGGGTDTQYF	In	VDJ	1	279	3.0198661733857785E-4	3.5552451972332803E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	0	1	4	1	23	40	50	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSAGGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGGACAGGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASRGDRGGNQPQHF	In	VDJ	1	285	3.084809531953215E-4	3.631702083195286E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	2	2	2	2	23	34	46	36	48														CASRGDRGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAAGCGGGGGTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	285	3.084809531953215E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	2	2	2	1	23	36	46	38	47														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTCGGGGACGGTAGCACAGATACGCAGTATTTTGGCCCA	CALGDGSTDTQYF	In	VDJ	1	294	3.182224569804369E-4	3.746387412138295E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	11	0	7	0	4	3	23	29	38	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CALGDGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCGGGGGGATCGCTGGAAACACCATATATTTTGGAGAG	CASSYAGGIAGNTIYF	In	VDJ	1	297	3.214696249088087E-4	3.784615855119298E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	8	1	2	2	4	23	38	47	40	51														CASSYAGGIAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGCGTTCAGCCCCAGCATTTTGGTGAT	CASSPGVQPQHF	In	VDJ	1	304	3.2904635007500956E-4	3.873815555408305E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	8	0	6	3	2	23	34	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGVQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGAGATCCAGGGGGTAATAATATGTTTTTTGGCAGT	CASSGDPGGNNMFF	In	VDJ	1	304	3.2904635007500956E-4	3.873815555408305E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	1	15	7	8	23	35	49	42	57														CASSGDPGGNNMFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTAGCAGGACGGGACTCTGAAGCTTTCTTTGGACAA	CASSYVAGRDSEAFF	In	VDJ	1	305	3.3012873938446685E-4	3.8865583697353064E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	0	10	6	10	0	23	38	-1	48	54						01,02								CASSYVAGRDSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATCGTCGACAGGGAACATCTATGGCTACACCTTCGGTTCG	CASSLSSTGNIYGYTF	In	VDJ	1	307	3.322935180033814E-4	3.912043998389308E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	4	7	5	23	36	50	43	55														CASSLSSTGNIYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGGACTAGCGGGGTAACAGATACGCAGTATTTTGGCCCA	CASSDGTSGVTDTQYF	In	VDJ	1	309	3.3445829662229594E-4	3.93752962704331E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	3	3	2	23	35	51	38	53														CASSDGTSGVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCCTAGCGGGGGGGCCGGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	310	3.355406859317532E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	4	0	5	4	4	23	35	51	39	55														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCCAGGGGTCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPQGSNTGELFF	In	VDJ	1	315	3.409526324790395E-4	4.0139865130053165E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	2	4	3	23	34	44	38	47														CASRPQGSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTTGGGGGGGGAGAGCAATGAGCAGTTCTTCGGGCCA	CASSDLGGESNEQFF	In	VDJ	1	319	3.452821897168686E-4	4.06495777031332E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	6	5	5	23	35	47	40	52														CASSDLGGESNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCACTCCCGCAACGACTCACGGCTACACCTTCGGTTCG	CASSYSTPATTHGYTF	In	VDJ	1	322	3.485293576452404E-4	4.1031862132943236E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	2	10	8	12	3	23	40	56	52	59						01,02								CASSYSTPATTHGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGGGGGCGGGTGTGGTTAAGCAGTACGTCGGGCCG	CASSEGAGVVKQYV	In	VDJ	1	323	3.496117469546977E-4	4.115929027621324E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	0	17	2	20	23	34	43	36	63														CASSEGAGVVKQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSRTGGTEAFF	In	VDJ	1	326	3.528589148830695E-4	4.154157470602327E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	4	1	0	23	35	-1	36	46														CASSRTGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGTATATGAGCTTCGCACAGATACGCAGTATTTTGGCCCA	CASSEVYELRTDTQYF	In	VDJ	1	327	3.539413041925268E-4	4.1669002849293284E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	1	0	12	23	-1	39	35	51														CASSEVYELRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGGGACTCCACTGAAGCTTTCTTTGGACAA	CASSLGDSTEAFF	In	VDJ	1	329	3.5610608281144127E-4	4.19238591358333E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	4	3	1	23	36	45	39	46						01,02								CASSLGDSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGGACATCAGAGGGGGAGCTGTTTTTTGGAGAA	CASRGTSEGELFF	In	VDJ	1	333	3.6043564004927035E-4	4.2433571708913343E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	6	8	1	6	23	34	41	35	47														CASRGTSEGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCATCGGTGGGGGACACATTACTATCCTCGCTACGAGCAGTACTTCGGGCCG	CASHRWGTHYYPRYEQYF	In	VDJ	1	333	3.6043564004927035E-4	4.2433571708913343E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	3	9	14	23	32	47	41	61														CASHRWGTHYYPRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAATCGGGCAGGGGCCGATGAAGCTTTCTTTGGACAA	CASRNRAGADEAFF	In	VDJ	1	335	3.626004186681849E-4	4.2688427995453366E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	7	8	4	23	34	48	42	52														CASRNRAGADEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTTAGGGCAGACAGTTACAATGAGCAGTTCTTCGGGCCA	CASSYLRADSYNEQFF	In	VDJ	1	348	3.766714796911294E-4	4.4344993857963497E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	5	4	9	1	23	38	52	47	53														CASSYLRADSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACGACGGGGGAGACACTGAAGCTTTCTTTGGACAA	CASSYDGGDTEAFF	In	VDJ	1	351	3.799186476195012E-4	4.4727278287773526E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	3	2	2	23	38	46	40	48														CASSYDGGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTCTAGCGGGGGAGGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSSGGGYTGELFF	In	VDJ	1	356	3.853305941667875E-4	4.5364419004123574E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	3	4	5	23	35	49	39	54														CASSPSSGGGYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTGGGGGTACGGGAGATACGCAGTATTTTGGCCCA	CASSDSGGTGDTQYF	In	VDJ	1	359	3.8857776209515936E-4	4.5746703433933604E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	1	5	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGGTGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTTGAGGGGGCTTCGAGCACTGAAGCTTTCTTTGGACAA	CASSLEGASSTEAFF	In	VDJ	1	368	3.983192658802748E-4	4.6893556723363693E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	4	5	6	23	34	46	39	52														CASSLEGASSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGACTGCTCACAATGAGCAGTTCTTCGGGCCA	CAISGTAHNEQFF	In	VDJ	1	368	3.983192658802748E-4	4.6893556723363693E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	5	1	4	23	34	41	35	45						01,02								CAISGTAHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCGGCCAGGGGATTTCGGTGGAAACACCATATATTTTGGAGAG	CASSFRPGDFGGNTIYF	In	VDJ	1	369	3.99401655189732E-4	4.7020984866633705E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	2	3	6	7	23	36	48	42	55														CASSFRPGDFGGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTTTATCGAGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSDFIETTNEKLFF	In	VDJ	1	370	4.0048404449918927E-4	4.7148413009903716E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	2	0	9	1	23	35	47	44	48														CASSDFIETTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAGTTTTGGGGGGCGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	372	4.026488231181038E-4		55	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	0	1	9	3	23	40	55	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCACCCGCGAACACTGAAGCTTTCTTTGGACAA	CASRPPANTEAFF	In	VDJ	1	374	4.0481360173701836E-4	4.765812558298376E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	3	7	1	0	7	23	-1	36	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPPANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCTAGCGGGGGGGCCGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASTPSGGAGYTGELFF	In	VDJ	2	396	4.286261665450783E-4	5.046154473492397E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	4	0	3	3	6	23	33	48	36	54														CASTPSGGAGYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGGGGGGCCTAGCCGATACGCAGTATTTTGGCCCA	CASSGTSGGGLADTQYF	In	VDJ	2	396	4.286261665450783E-4	5.046154473492397E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	0	6	0	8	23	-1	51	35	59														CASSGTSGGGLADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTACATAGGGAACACTGAAGCTTTCTTTGGACAA	CASSYSYIGNTEAFF	In	VDJ	2	402	4.3512050240182185E-4	5.122611359454404E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	3	6	1	2	4	23	40	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSYIGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGGTTCCGGGCTCAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASAVPGSSSGANVLTF	In	VDJ	2	404	4.372852810207364E-4	5.148096988108405E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	8	0	0	8	5	23	32	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAVPGSSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGACAGGACTCTGGAAACACCATATATTTTGGAGAG	CASRGQDSGNTIYF	In	VDJ	2	414	4.481091741153091E-4	5.275525131378416E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	4	0	1	1	23	34	42	35	43														CASRGQDSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACAGCTACAATGAGCAGTTCTTCGGGCCA	CASSYSDSYNEQFF	In	VDJ	2	419	4.5352112066259544E-4	5.33923920301342E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	5	3	0	0	23	-1	-1	40	46														CASSYSDSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAGAGACAACTCTGGAAACACCATATATTTTGGAGAG	CASTRDNSGNTIYF	In	VDJ	2	425	4.600154565193391E-4	5.415696088975427E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	6	0	5	1	23	33	42	38	43														CASTRDNSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCGGGACAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRTGTDSNQPQHF	In	VDJ	2	425	4.600154565193391E-4	5.415696088975427E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	0	4	1	23	34	45	38	46														CASRTGTDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGGTACCACGCTAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSLVPR*QSRANVLTF	Stop	VDJ	2	428	4.6326262444771086E-4		54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	14	5	23	35	52	49	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVPR*QSRANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCCGGACAACCATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTPDNHSNQPQHF	In	VDJ	2	436	4.71921738923369E-4	5.555867046572437E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	6	0	4	4	23	33	42	37	46														CASTPDNHSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGACAGGGAGGTCCTACGAGCAGTACGTCGGGCCG	CASSGGTGRSYEQYV	In	VDJ	2	437	4.730041282328263E-4	5.568609860899439E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	17	3	19	23	35	47	38	66														CASSGGTGRSYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATGGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSYDGGDTEAFF	In	VDJ	2	439	4.751689068517408E-4	5.59409548955344E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	3	3	0	23	38	-1	41	48														CASSYDGGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGGGGGTCCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	455	4.924871358030571E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	6	1	2	23	40	47	41	49														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGAGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGGYSNQPQHF	In	VDJ	2	460	4.978990823503434E-4	5.861694590420462E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	1	0	1	3	23	34	40	35	43														CASRGGYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGTGGATCCGAGACAAGGGCTCTACAAGAGCAGTACGTCGGGCCG		Out	VDJ	2	462	5.000638609692579E-4		52	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	3	2	6	17	10	22	23	37	51	47	73				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTTACACCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTLHLSGANVLTF	In	VDJ	2	474	5.130525326827452E-4	6.040093990998476E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	3	6	0	4	3	23	33	40	37	43														CASTLHLSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGCTATCAGGGGAAGCAGATACGCAGTATTTTGGCCCA	CASKLSGEADTQYF	In	VDJ	2	475	5.141349219922025E-4	6.052836805325477E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	4	6	3	23	33	45	39	48														CASKLSGEADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAAACTCCGGGACAGGATGGAAATGAGCAGTTCTTCGGGCCA	CASSKTPGQDGNEQFF	In	VDJ	2	476	5.152173113016597E-4	6.065579619652478E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	7	8	5	23	35	51	43	56														CASSKTPGQDGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAAGGGGGCCTTGTTAACGAGCAGTACTTCGGGCCG	CASEGGLVNEQYF	In	VDJ	2	491	5.314531509435187E-4	6.256721834557493E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	5	0	5	2	7	23	32	41	34	48														CASEGGLVNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCAATCAGCGCCGTATAACACTGAAGCTTTCTTTGGACAA	CASSYSQSAPYNTEAFF	In	VDJ	2	493	5.336179295624333E-4	6.282207463211495E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	6	6	2	6	6	23	40	50	46	56						01,02								CASSYSQSAPYNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACGGGGCGGTTGAGCAGTTCTTCGGGCCA	CASSYNGAVEQFF	In	VDJ	2	504	5.455242119664633E-4	6.422378420808506E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	7	0	9	3	3	23	38	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNGAVEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTGAAGACAGACACCGGGGAGCTGTTTTTTGGAGAA	CASVKTDTGELFF	In	VDJ	2	509	5.509361585137496E-4	6.486092492443511E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	5	3	5	0	23	32	-1	37	42														CASVKTDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACATTCATCTGGGGGTCTAACTATGGCTACACCTTCGGTTCG	CASTFIWGSNYGYTF	In	VDJ	2	518	5.60677662298865E-4	6.60077782138652E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	6	1	0	9	1	23	33	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTFIWGSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTTGCTAACTCTGGAAACACCATATATTTTGGAGAG	CASSYVANSGNTIYF	In	VDJ	2	518	5.60677662298865E-4	6.60077782138652E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	4	9	0	4	1	23	38	45	42	46						01,02								CASSYVANSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCACCGACAGGGGAAAAGAAAGGCTACACCTTCGGTTCG		Out	VDJ	2	521	5.639248302272368E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	2	8	4	8	23	38	50	42	58														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCTTTTGGGGGGCACAATTCACCCCTCCACTTTGGGAAC	CASRAFGGHNSPLHF	In	VDJ	2	537	5.812430591785531E-4	6.842891293599539E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	6	0	7	8	2	23	34	48	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAFGGHNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCTGAACAGGGACCGACGAACTATGGCTACACCTTCGGTTCG	CASRPEQGPTNYGYTF	In	VDJ	2	541	5.855726164163822E-4	6.893862550907543E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	2	6	7	23	34	46	40	53														CASRPEQGPTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTGGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYWVSGANVLTF	In	VDJ	2	547	5.920669522731258E-4	6.970319436869549E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	3	0	9	0	2	1	23	37	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWVSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGATTCCGCCACCGGTGGGGAGCTGTTTTTTGGAGAA	CASSYSDSATGGELFF	In	VDJ	2	553	5.985612881298694E-4	7.046776322831555E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	1	8	8	0	13	23	-1	43	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDSATGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAACGACAGGACGGTCCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	560	6.061380132960703E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	4	4	6	7	23	34	46	40	53														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGCCCGGGTGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSPGGNTGELFF	In	VDJ	2	564	6.104675705338994E-4	7.186947280428567E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	7	2	0	9	23	-1	41	37	50						01,02								CASSYSPGGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCCTACCCCGGGGCGGGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	566	6.126323491528139E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	7	3	4	11	1	23	32	49	43	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACGAGGGGGTTTGGAAACACCATATATTTTGGAGAG	CAITRGFGNTIYF	In	VDJ	2	566	6.126323491528139E-4	7.212432909082568E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	5	1	3	5	2	23	30	41	35	43														CAITRGFGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTGGTCCGGAGGGAGAGACCCAGTACTTCGGGCCA	CAISGGPEGETQYF	In	VDJ	2	567	6.137147384622712E-4	7.22517572340957E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	4	8	0	23	35	-1	43	49														CAISGGPEGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAATGGCTTGGGGGAATGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	571	6.180442957001002E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	10	6	1	3	7	2	23	30	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGGTGTACAAGATACGCAGTATTTTGGCCCA	CASSQGVQDTQYF	In	VDJ	2	585	6.33197746032502E-4	7.454546381295587E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	5	0	6	23	-1	40	35	46														CASSQGVQDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGTTACGTACAGCCCACCGGGGAGCTGTTTTTTGGAGAA	CANSYVQPTGELFF	In	VDJ	2	618	6.689165932445919E-4	7.87505925408662E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	5	4	2	2	23	38	44	40	46														CANSYVQPTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACTGGGCTGGGGTCCTTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	618	6.689165932445919E-4		47	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	10	6	2	1	8	4	23	30	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCGGGGGGAAAGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	620	6.710813718635064E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	4	8	1	0	3	5	23	36	46	39	51														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGGGGCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYEGAATNEKLFF	In	VDJ	2	622	6.73246150482421E-4	7.926030511394625E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	5	0	0	1	2	23	38	46	39	48														CASSYEGAATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGGCGGGCTAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSRGGLVYNEQFF	In	VDJ	2	631	6.829876542675363E-4	8.040715840337634E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	7	0	3	2	8	23	34	41	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGGLVYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCTGGGCTGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASRLGWGQETQYF	In	VDJ	2	639	6.916467687431945E-4	8.142658354953642E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	6	1	2	8	0	23	34	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGWGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACGACAGGGAGAGACCCAGTACTTCGGGCCA	CASSRRQGETQYF	In	VDJ	2	647	7.003058832188526E-4	8.24460086956965E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	4	5	0	23	34	-1	39	46														CASSRRQGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCTCCGGCACAGGGTGGGGTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSFSGTGWGLAKNIQYF	In	VDJ	3	649	7.024706618377672E-4	8.270086498223651E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	3	3	0	4	8	23	40	50	44	58														CASSFSGTGWGLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTGGAGGGGGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CAISVEGGATNEKLFF	In	VDJ	3	661	7.154593335512544E-4	8.423000270147663E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	5	1	0	4	3	23	35	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISVEGGATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACAGAGCTTCCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYTELPTNEKLFF	In	VDJ	3	670	7.252008373363698E-4	8.537685599090673E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	5	0	1	6	23	37	42	38	48														CASSYTELPTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACGAGGCAGGACACTGAAGCTTTCTTTGGACAA	CASSYTRQDTEAFF	In	VDJ	3	691	7.479310128349724E-4	8.805284699957694E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	4	4	3	6	0	23	38	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTRQDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTGGAGGCCTTCCGGTCGGGAGTGACAAGAGACCCAGTACTTCGGGCCA	CAWRPSGRE*QETQYF	Stop	VDJ	3	734	7.94473753141635E-4		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	8	2	2	15	3	23	29	50	44	53														CAWRPSGRE*QETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCCTAGCGGGGGATACCGGGGAGCTGTTTTTTGGAGAA	CASSDSLAGDTGELFF	In	VDJ	3	748	8.096272034740367E-4	9.531625116596752E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	5	1	2	23	40	51	41	53														CASSDSLAGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGGGGTTGCGGAAAAACTGTTTTTTGGCAGT	CASNGVAEKLFF	In	VDJ	3	769	8.323573789726393E-4	9.799224217463772E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	7	6	2	8	2	5	23	33	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGVAEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAGGGACGGCCCAATCAGCCCCAGCATTTTGGTGAT	CASREGRPNQPQHF	In	VDJ	3	781	8.453460506861266E-4	9.952137989387784E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	0	3	0	6	23	-1	40	34	46														CASREGRPNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACCTGGGGGATTCAAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	797	8.626642796374428E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	10	6	1	1	4	8	23	30	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAACCGCCGCCCCAGGGCAGAACACTGAAGCTTTCTTTGGACAA	CASSITAAPGQNTEAFF	In	VDJ	3	808	8.745705620414728E-4	0.001029619397621681	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	1	14	2	23	34	53	48	55														CASSITAAPGQNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACAGAAGCCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSVTEAATNEKLFF	In	VDJ	3	832	9.005479054684473E-4	0.0010602021520064835	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	0	2	6	23	35	42	37	48														CASSVTEAATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAAGGGATGACACTGAAGCTTTCTTTGGACAA	CASSLRDDTEAFF	In	VDJ	3	832	9.005479054684473E-4	0.0010602021520064835	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	0	8	3	3	2	23	36	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRDDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTATGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASTLWTSGSTDTQYF	In	VDJ	3	863	9.341019740616226E-4	0.0010997048764201866	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	4	0	6	0	23	33	-1	39	50						01,02								CASTLWTSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACATCTTACAGGGCGAACTGAAGYTTTCTTTGGACAA	CASRHLTGRTEXFF	In	VDJ	3	880	9.525025923223961E-4	0.0011213676607760884	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	7	3	23	34	47	41	50														CASRHLTGRTEXFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGGAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTGDSGANVLTF	In	VDJ	4	969	0.0010488352408640931	0.0012347787082863974	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	4	0	0	3	23	-1	40	35	43														CASSTGDSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGAGTCGGGGGCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSPESGASGELFF	In	VDJ	4	992	0.0010737301949816102	0.0012640871812384996	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	6	0	6	8	2	23	35	49	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPESGASGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGTGACAGGGCGCATGAAAAACTGTTTTTTGGCAGT	CAIRDRAHEKLFF	In	VDJ	4	1047	0.00113326160700176	0.001334172660037005	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	2	3	6	5	3	23	30	42	35	45														CAIRDRAHEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAACCTGGGCCTGAAGCTTTCTTTGGACAA	CASSQPGPEAFF	In	VDJ	5	1266	0.0013703048657729016	0.0016132402937983272	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	6	6	0	23	35	-1	41	45														CASSQPGPEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCAGTTACATCAGAATATACCGGGGAGCTGTTTTTTGGAGAA	CASSVTSEYTGELFF	In	VDJ	5	1277	0.0013822111481769316	0.0016272573895580282	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	3	6	5	6	9	23	32	41	38	50														CASSVTSEYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACTCCCCCCCTGGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	1456	0.0015759588345697828		46	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	0	6	1	3	7	0	23	40	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGAGGCGGGAACGAAAAACTGTTTTTTGGCAGT	CAISGGGNEKLFF	In	VDJ	7	1797	0.0019450535890947111	0.0022898837345620804	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	7	3	8	4	2	23	35	45	39	47														CAISGGGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGACCTCGGGACAGGGGGCGAAAAACTGTTTTTTGGCAGT	CASSSDLGTGGEKLFF	In	VDJ	7	1801	0.0019493831463325403	0.002294980860292881	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	0	8	8	0	23	36	-1	44	56														CASSSDLGTGGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGGGCAGGGGATGAAAAACTGTTTTTTGGCAGT	CASSPGAGDEKLFF	In	VDJ	7	1802	0.0019504655356419975	0.002296255141725581	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	4	2	6	7	0	23	35	-1	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGAGDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTTCCCAGGAGACCTATGGCTACACCTTCGGTTCG	CASSYSSQETYGYTF	In	VDJ	8	2062	0.0022318867561008874	0.002627568314227607	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	4	4	6	4	23	38	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSSQETYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTAGAACTTTTAATGAGCAGTTCTTCGGGCCA	CASSSRTFNEQFF	In	VDJ	8	2112	0.002286006221573751	0.002691282385862612	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	8	7	0	7	23	-1	40	36	47						01,02								CASSSRTFNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTATGGCGCCCATTATGGCTACACCTTCGGTTCG	CASSYYGAHYGYTF	In	VDJ	10	2638	0.0028553429983482737	0.0033615544194628647	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	1	9	0	5	2	6	23	39	44	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYGAHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACCGGGACAGGAGATCAGCCCCAGCATTTTGGTGAT	CASSYTGTGDQPQHF	In	VDJ	12	3098	0.0033532420806986173	0.003947723878504911	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	5	4	2	23	37	49	41	51														CASSYTGTGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGGGGACGGTCCGCTGTGGCCCCAGCATTTTGGTGAT	CATGDGPLWPQHF	In	VDJ	43	11188	0.012109771594207919	0.014256660669048724	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	10	0	7	9	3	11	23	30	38	33	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGDGPLWPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTTTGGGGAGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	79	20472	0.0221586739432092		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	1	3	5	1	23	38	49	43	50														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCTCGGACAGGAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSRTGDSNQPQHF	In	VDJ	1	68	7.360247304309424E-5	8.665113742360683E-5	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	0	4	3	24	36	47	40	50													Vb 18	CASSSRTGDSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCCTCCGAAGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPSSEGGNQPQHF	In	VDJ	1	70	7.576725166200879E-5	8.919970028900702E-5	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	2	2	10	0	24	38	-1	48	52													Vb 18	CASSPSSEGGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGGACGGGACGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	81	8.767353406603873E-5		41	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	0	0	7	18	5	9	24	41	51	46	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGGCCGGACAGGGAGGCTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGRTGRLGANVLTF	In	VDJ	1	82	8.8755923375496E-5	1.0449107748140824E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	3	4	6	6	24	37	51	43	57													Vb 18	CASSQGRTGRLGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGTTTGGGGCACGGTCCTACGAGCAGTACTTCGGGCCG	CASSPGFGARSYEQYF	In	VDJ	1	83	8.983831268495328E-5	1.0576535891410833E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	1	7	4	24	38	50	45	54													Vb 18	CASSPGFGARSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAACACATAGGGGGACTCCGTTAGAATCAGCCCCAGCATTTTGGTGAT	CASSQHIGGLR*NQPQHF	Stop	VDJ	1	88	9.525025923223961E-5		54	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	6	5	1	4	9	10	24	35	50	44	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQHIGGLR*NQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGTTGGCAGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSPGVGRANTEAFF	In	VDJ	1	93	1.0066220577952595E-4	1.1850817324110934E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	4	3	1	9	1	24	38	52	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGVGRANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAAGGGACAGGAACCGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	100	1.0823893094572684E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	5	2	6	24	39	49	41	55													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGCGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSPPSGGNEQFF	In	VDJ	1	106	1.1473326680247044E-4	1.3507383186621064E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	7	1	1	24	41	50	42	51													Vb 18	CASSPPSGGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTATTTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA	CASSPQGIYTEAFF	In	VDJ	1	127	1.3746344230107307E-4	1.6183374195291274E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	3	1	5	39	53	59	54	64													Vb 18	CASSPQGIYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCAGAGGGGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPSEGTTNEKLFF	In	VDJ	1	129	1.396282209199876E-4	1.6438230481831295E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	3	5	2	0	5	1	24	38	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSEGTTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGTACCGGGCCTCCGAATTCACCCCTCCACTTTGGGAAC	CASSRTGPPNSPLHF	In	VDJ	1	131	1.4179299953890215E-4	1.6693086768371316E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-06	01	4	8	0	7	5	5	24	37	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRTGPPNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01		TCRBJ01-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATTATAACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSPIITGNTEAFF	In	VDJ	1	137	1.4828733539564576E-4	1.7457655627991375E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	1	7	0	24	38	-1	45	50													Vb 18	CASSPIITGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGCAGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSPQAGTNTEAFF	In	VDJ	1	138	1.4936972470510303E-4	1.7585083771261387E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	0	7	1	5	0	24	40	-1	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQAGTNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGGGGCAGACTTCCAAGAGACCCAGTACTTCGGGCCA	CASSLGADFQETQYF	In	VDJ	1	139	1.504521140145603E-4	1.7712511914531396E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	1	1	6	24	37	44	38	50													Vb 18	CASSLGADFQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCTGGGGCTCGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSAGARSNQPQHF	In	VDJ	1	139	1.504521140145603E-4	1.7712511914531396E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	7	0	1	4	4	24	35	44	39	48													Vb 18	CASSAGARSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTACAGAATTATGGCTACACCTTCGGTTCG	CASSPLQNYGYTF	In	VDJ	1	140	1.5153450332401757E-4	1.7839940057801405E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	5	5	1	3	24	40	45	41	48													Vb 18	CASSPLQNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGACAGGCTTGAACACTGAAGCTTTCTTTGGACAA	CASSTGLNTEAFF	In	VDJ	1	141	1.5261689263347484E-4	1.7967368201071417E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	0	0	2	24	-1	41	35	43													Vb 18	CASSTGLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAGCCACGTTTGGTGGCGAGGAGATTCGGCAGCTTATTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	151	1.6344078572804753E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	19	4	3	3	16	5	40	38	59	54	64													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAATACAGGTCCCAACGAGCAGTACGTCGGGCCG		Out	VDJ	1	167	1.8075901467936383E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	4	17	4	17	24	39	48	43	65													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACCCTCTTGCGGGGGGGCGGGCAGATACGCAGTATTTTGGCCCA	CASSPDPLAGGRADTQYF	In	VDJ	1	179	1.9374768639285103E-4	2.28096376453318E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	4	9	4	24	39	57	48	61													Vb 18	CASSPDPLAGGRADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACGGCCAGGGGGCGAATGAAAAACTGTTTTTTGGCAGT	CASSPDGQGANEKLFF	In	VDJ	1	196	2.121483046536246E-4	2.497591608092197E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	0	5	6	1	24	39	53	45	54													Vb 18	CASSPDGQGANEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCGGGGATGGCTGAAGCTTTCTTTGGACAA	CASSPAGMAEAFF	In	VDJ	1	197	2.1323069396308187E-4	2.510334422419198E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	6	1	4	24	38	45	39	49													Vb 18	CASSPAGMAEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGCTAGCGAGATAAGCACAGATACGCAGTATTTTGGCCCA	CASSPTASEISTDTQYF	In	VDJ	1	211	2.2838414429548362E-4	2.6887338229972116E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	6	0	4	5	24	39	49	43	54						01,02							Vb 18	CASSPTASEISTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGATGGGGGGTACGAGCAGTACGTCGGGCCG	CASSDGGYEQYV	In	VDJ	1	212	2.294665336049409E-4	2.701476637324213E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	1	17	4	13	24	35	45	39	58													Vb 18	CASSDGGYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCCAACAGGGGCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	255	2.7600927391160343E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	3	6	2	24	38	51	44	53													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAGAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRDSGANVLTF	In	VDJ	1	255	2.7600927391160343E-4	3.249417653385256E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	4	4	5	0	1	3	24	37	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLRDSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTACCGGAACAGGGGGATGAGCAGTTCTTCGGGCCA	CASSPLPEQGDEQFF	In	VDJ	1	334	3.6151802935872765E-4	4.2560999852183355E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	1	8	8	0	24	39	-1	47	55													Vb 18	CASSPLPEQGDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTATATACAGGGGTAAAAGAGACCCAGTACTTCGGGCCA	CASSLYTGVKETQYF	In	VDJ	1	340	3.6801236521547123E-4	4.3325568711803414E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	3	6	3	24	36	49	42	52													Vb 18	CASSLYTGVKETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGAGTGGGGCAAACAGCCCCAGCATTTTGGTGAT	CASSPPEWGKQPQHF	In	VDJ	1	343	3.7125953314384307E-4	4.3707853141613444E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	7	0	7	8	3	24	38	51	46	54													Vb 18	CASSPPEWGKQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGACAGGGCGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	349	3.7775386900058665E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	7	1	3	24	37	46	38	49													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCTTCGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPASGATNEKLFF	In	VDJ	1	386	4.1780227345050556E-4	4.918726330222388E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	2	0	4	0	24	39	-1	43	49													Vb 18	CASSPASGATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-04*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCTTCCTAGCGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPFLAGYQETQYF	In	VDJ	2	389	4.210494413788774E-4	4.956954773203391E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	0	7	1	24	35	51	42	52													Vb 18	CASSPFLAGYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCCGGGACAAGTTATGGCTACACCTTCGGTTCG	CASSPSGTSYGYTF	In	VDJ	2	429	4.643450137571681E-4	5.466667346283431E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	5	3	3	24	39	48	42	51													Vb 18	CASSPSGTSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAAGAAGGAAATTATGAAGCTTTCTTTGGACAA	CASSPQEGNYEAFF	In	VDJ	2	437	4.730041282328263E-4	5.568609860899439E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	1	8	7	7	5	24	38	48	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQEGNYEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACGACGACATAGACCATACGAGCAGTACGTCGGGCCG		Out	VDJ	2	439	4.751689068517408E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	6	17	5	20	24	33	42	38	62													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAGGGAGGGGACAGATACGCAGTATTTTGGCCCA	CASSLREGTDTQYF	In	VDJ	2	445	4.816632427084844E-4	5.670552375515446E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	0	3	3	1	24	37	47	40	48													Vb 18	CASSLREGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGATGGGGCCCGTTACGAGCAGTACTTCGGGCCG	CASSPPDGARYEQYF	In	VDJ	2	448	4.8491041063685624E-4	5.708780818496449E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	4	4	4	24	41	50	45	54													Vb 18	CASSPPDGARYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGGACAGCGGGGGGCCCTCCCTACGAGCAGTACTTCGGGCCG	CASSPRTAGGPPYEQYF	In	VDJ	2	461	4.989814716598007E-4	5.874437404747463E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	1	2	6	5	24	38	53	44	58													Vb 18	CASSPRTAGGPPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAGGGGACTAGTGGTAGGCGAGCAGTACTTCGGGCCG	CASSPRGLVVGEQYF	In	VDJ	2	466	5.04393418207087E-4	5.938151476382468E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	8	6	3	7	24	38	49	41	56						01,02							Vb 18	CASSPRGLVVGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCTTGGGACTACCAAGAGACCCAGTACTTCGGGCCA	CASSAWDYQETQYF	In	VDJ	2	469	5.076405861354588E-4	5.976379919363471E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	0	4	0	24	36	-1	40	46						01,02							Vb 18	CASSAWDYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAGCCGGACAGGGCGGGCGCCTACGAGCAGTACTTCGGGCCG	CASSQPDRAGAYEQYF	In	VDJ	2	482	5.217116471584034E-4	6.142036505614484E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	2	6	6	24	35	49	41	55													Vb 18	CASSQPDRAGAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGACTCTGGAAACACCATATATTTTGGAGAG	CASSPPDSGNTIYF	In	VDJ	2	510	5.520185478232069E-4	6.498835306770512E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	0	1	8	0	0	0	24	-1	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGCCTCCGGAGGGACCGAGCAGTACTTCGGGCCG	CASSPASGGTEQYF	In	VDJ	2	523	5.660896088461513E-4	6.664491893021526E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	6	7	2	24	38	51	45	53													Vb 18	CASSPASGGTEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGATGGACAGGTACCGAGCAGTACGTCGGGCCG		Out	VDJ	2	524	5.671719981556086E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	17	3	14	24	38	48	41	62													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPRQMNTEAFF	In	VDJ	2	579	6.267034101757584E-4	7.378089495333581E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	0	2	1	24	38	45	40	46													Vb 18	CASSPRQMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCTGGGAAGGACGGTGAAGCTTTCTTTGGACAA	CASSPPGKDGEAFF	In	VDJ	3	669	7.241184480269125E-4	8.524942784763672E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	0	8	7	4	7	24	38	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGKDGEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGACAGGGGAATTTGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	751	8.128743714024085E-4		52	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	1	1	7	24	39	50	40	57													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGACAGGGGGCTTCAGCTATGGCTACACCTTCGGTTCG	CASSPGTGGFSYGYTF	In	VDJ	3	808	8.745705620414728E-4	0.001029619397621681	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	4	1	5	24	38	51	39	56													Vb 18	CASSPGTGGFSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGATCAGAGCCGACAGCCCCAGCATTTTGGTGAT	CASSDQSRQPQHF	In	VDJ	4	930	0.0010066220577952597	0.0011850817324110933	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	5	4	5	7	3	6	24	36	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSDQSRQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGACAGRGGGCTTTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSDRGLSTGELFF	In	VDJ	5	1251	0.0013540690261310427	0.0015941260723078257	45	TCRBV18	TCRBV18-01	01	unresolved			TCRBJ02	TCRBJ02-02	01	6	2	0	4	1	4	24	35	46	36	50				TCRBD01,TCRBD02									Vb 18	CASSDRGLSTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	unresolved	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGGCAGGGACGAGCACTGAAGCTTTCTTTGGACAA	CASSPAAGTSTEAFF	In	VDJ	6	1527	0.0016528084755412487	0.0019458277477330532	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	7	4	6	3	24	39	50	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPAAGTSTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGGACGGGACGGGGAGCTGTTTTTTGGAGAA	CASSPPGRDGELFF	In	VDJ	20	5288	0.005723674668410035	0.006738400216118131	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	3	7	4	0	24	41	-1	45	50													Vb 18	CASSPPGRDGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGGTATATACACTGAAGCTTTCTTTGGACAA	CASSPQGIYTEAFF	In	VDJ	107	27725	0.030009243604702765	0.03532945272161028	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	3	1	5	24	38	44	39	49													Vb 18	CASSPQGIYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
AAAGCCCTTTCAGATGTCCCTGTGTGCCACCAGCAGAGATCACAGCTATGGCTACACCTTCGGTTCG	CATSRDHSYGYTF	In	VDJ	12	3152	0.00341169110340931	0.004016535075870717	39	TCRBVA	TCRBVA-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	16	3	5	4	16	0	22	25	-1	41	45														CATSRDHSYGYTF+TCRBVA-or09_02+TCRBJ01-02	TCRBVA-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3935A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3979	3379	573	25	0	1746	1486	239	21	0	923882	784756	133117	6009	0	0.193348676	8.49986172	0.184188887	8.78615379				75428	0.0479453057	0.131070033	0.111332402	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/16/2016 12:07:26	Age (Range):65+ Years (Old Age),Age:68 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1136,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 319,type of chemo:carbo/taxol	0.8492083206585954	MSKCC- Snyder- P01-02		3616.0	
